,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC000155-18,"October 01, 2007 -  September 30, 2008",Effect of Phytochemicals on Biochemical Mechanisms Relevant to Carcinogenesis,Grace  Yeh; PhD,NULL,"Laboratory of Metabolism, NCI",Yuk Sing Robert Cheng,NULL,Terry  Moody; PhD (Experimental Biochemistry Sect)|Laurie  Zipper (National Cancer Institute)|David Anderson Wink (National Cancer Institute)|Miriam Christine Poirier; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50465
1,BC000189-15,"October 01, 2007 -  September 30, 2008",Dietary Regulation of Molecular Changes in Carcinogen-Resistant Cells,Grace  Yeh; PhD,NULL,"Laboratory of Metabolism, NCI",Yuk Sing Robert Cheng,NULL,Lucy M Anderson; PhD (National Cancer Institute)|David Anderson Wink (National Cancer Institute),NULL,"1. Ciolino HP, Bass SE, MacDonald CJ, Cheng RY, Yeh GC (2008). Sulindac and its metabolites induce carcinogen metabolizing enzymes in human colon cancer cells. Int J Cancer  122, 990-8.   https://doi.org/10.1002/ijc.23218",https://intramural.nih.gov/search/searchview.taf?ipid=50466
2,BC003229-38,"October 01, 2007 -  September 30, 2008",T-Cell Antigen Recognition and Tumor Antigens,Ettore  Appella; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Lisa Marie Jenkins|Ryo  Hayashi|Hidetsugu  Fujigaki|Kan  Tanoue|Michal  Vascak,"Edward  Collins (Dept. of Biochemistry and Biophysics, Univ. of North Carolina, Chapel Hill)|Albert  DeLeo (Cancer Institute, Univ. of Pittsburgh)",Lawrence Elliot Samelson; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50467
3,BC004496-31,"October 01, 2007 -  September 30, 2008",Chromosomal Proteins and Chromosomal Functions,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI","Takashi  Furusawa|Yuri  Postnikov; MD, PhD|Tetsuya  Ueda|Srujana  Cherukuri|Gabi  Gerlitz|Mark  Rochman|Show all 8","Melinda K Duncan; PhD (Biological Sciences, The University of Delaware)|Sergey  Grigoryev (Biochemistry and Molecular Biology, Penn State University)|Leon  Mullenders (Radiation Genetics, University of Leiden)|Yosef  Shiloh (Tel Aviv University)|Hitoshi  Shirakawa (Tohoku U)|Anastassia  Stoykova (Max Plank)",Andre A Nussenzweig; PhD (National Cancer Institute)|Kenneth H Kraemer; MD (National Cancer Institute)|Charles  Vinson; PhD (National Cancer Institute)|Joost J Oppenheim; MD (National Cancer Institute),Keji  Zhao; PhD (NHLBI),"1. Lucey MM, Wang Y, Bustin M, Duncan MK (2008). Differential expression of the HMGN family of chromatin proteins during ocular development. Gene Expr Patterns  8, 433-7.   https://doi.org/10.1016/j.gep.2008.04.002|2. Yang D, Bustin M, Oppenheim J (submitted in 2008) Hmgn Polypeptides As Immune Enhancers And Hmgn Antagonists As Immune Suppressants. Patents issued: 8,227,417 (US in 2012); 9,567,566 (US in 2017). Patent pending: 15/191,000 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=50468
4,BC004504-36,"October 01, 2007 -  September 30, 2008",Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Joanna  Anders|Luowei  Li|Anjali  Shukla|Ronald  Wolf|Mariam Q Malik|Mary Ann A Stepp|Show all 11,NULL,Larry K Keefer; PhD (National Cancer Institute)|Joseph  Riss; PhD (National Cancer Institute)|Lino  Tessarollo (National Cancer Institute)|Dolph Lee Hatfield; PhD (National Cancer Institute)|Lalage  Wakefield; PhD (National Cancer Institute),Jinhui  Ding (NIA),"1. Lichti U, Anders J, Yuspa SH (2008). Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat Protoc  3, 799-810.   https://doi.org/10.1038/nprot.2008.50",https://intramural.nih.gov/search/searchview.taf?ipid=50469
5,BC004517-32,"October 01, 2007 -  September 30, 2008",DNA Repair in Human Cancer-Prone Genetic Diseases,Kenneth H Kraemer; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Sikandar  Khan|John  Digiovanna|Kyu-Seon  Oh|Priya  Mahindra,NULL,"Yun  Wang (Nucleic Acid NMR Section)|Yves  Pommier; PhD (National Cancer Institute)|Carl C Baker; MD, PhD (Laboratory of Cellular Oncology)|Margaret Anne Tucker (National Cancer Institute)|Alisa  Goldstein; PhD (National Cancer Institute)|Thomas J Hornyak (National Cancer Institute)","Raphael  Schiffmann; MD (NINDS) |Ira W Levin; PhD (NIDDK) |Nicholas  Patronas; MD (CC) |Vilhelm A Bohr; MD, PhD (NIA) |Brian Patrick Brooks; MD, PhD (NEI) |Philip John Brooks; PhD (NIAAA)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50470
6,BC005093-30,"October 01, 2007 -  September 30, 2008",GrowthDifferentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",Sergey  Plisov|Yili D Yang|Nirmala D Sharma|Jirouta  Kitagaki,NULL,Terence P Yamaguchi; PhD (National Cancer Institute)|Mark B Lewandoski (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50472
7,BC005148-29,"October 01, 2007 -  September 30, 2008",Mammary Tumorigenesis in Inbred and Feral Mice,Robert  Callahan; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI",Sharon A Bargo|David M Mccurdy|Ahmed M Raafat|Malgorzata B Klauzinska|Joseph Moon-Hee Lee|Idean  Amirjazil,"Spyros  Artavanis-Tsakonas (Developmental Biology and Cancer, Harvard Medical School)|Antonio  Marchetti (Clinical Research Center, University of Chieti)|Robert  Rhoads (LSU Shreveport)",NULL,NULL,"1. Callahan R, Smith GH (2008). Common integration sites for MMTV in viral induced mouse mammary tumors. J Mammary Gland Biol Neoplasia  13, 309-21.   https://doi.org/10.1007/s10911-008-9092-6|2. Callahan R, Smith GH (2008). The mouse as a model for mammary tumorigenesis: history and current aspects. J Mammary Gland Biol Neoplasia  13, 269.   https://doi.org/10.1007/s10911-008-9094-4|3. Raafat A (2008) Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis. Oncogene In Press.|4. Strizzi L, Mancino M, Bianco C, Raafat A, Gonzales M, Booth BW, Watanabe K, Nagaoka T, Mack DL, Howard B, Callahan R, Smith GH, Salomon DS (2008). Netrin-1 can affect morphogenesis and differentiation of the mouse mammary gland. J Cell Physiol  216, 824-34.   https://doi.org/10.1002/jcp.21462",https://intramural.nih.gov/search/searchview.taf?ipid=50473
8,BC005177-28,"October 01, 2007 -  September 30, 2008",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Tracey L Einem|Rao L Divi,NULL,Sanford Martin Dawsey; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50474
9,BC005254-27,"October 01, 2007 -  September 30, 2008",Regulation of HTLV-I Transcription,John N Brady; PhD,NULL,"Laboratory of Cellular Oncology, NCI",Cynthia  Masison|Michael  Radonovich|Meisheng  Zhou|Won-Kyung  Cho|Kyung Jin  Jung|Keven H Huang|Show all 7,"Renaud  Mahieux (Department of Viral Oncology, Pasteur Institute)|Sergei  Nekhai (Biochemistry Department, Howard University)",Dinah  Singer; PhD (National Cancer Institute),NULL,"1. Chevalier SA, Ko NL, Calattini S, Mallet A, Prévost MC, Kehn K, Brady JN, Kashanchi F, Gessain A, Mahieux R (2008). Construction and characterization of a human T-cell lymphotropic virus type 3 infectious molecular clone. J Virol  82, 6747-52.   https://doi.org/10.1128/JVI.00247-08|2. Dasgupta A, Jung KJ, Jeong SJ, Brady JN (2008). Inhibition of methyltransferases results in induction of g2/m checkpoint and programmed cell death in human T-lymphotropic virus type 1-transformed cells. J Virol  82, 49-59.   https://doi.org/10.1128/JVI.01497-07",https://intramural.nih.gov/search/searchview.taf?ipid=50476
10,BC005258-29,"October 01, 2007 -  September 30, 2008",Molecular Studies of Eukaryotic Gene Regulation,Bruce  Paterson; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Concetta  Lipardi|Qin  Wei|Steven L Htet,NULL,Yikang  Rong (National Cancer Institute),NULL,"1. Manceau M, Gros J, Savage K, Thomé V, McPherron A, Paterson B, Marcelle C (2008). Myostatin promotes the terminal differentiation of embryonic muscle progenitors. Genes Dev  22, 668-81.   https://doi.org/10.1101/gad.454408",https://intramural.nih.gov/search/searchview.taf?ipid=50477
11,BC005263-27,"October 01, 2007 -  September 30, 2008",Eukaryotic Chromatin Structure and Gene Regulation,Carl  Wu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Joseph W Landry|Manabu  Mizuguchi|Debbie  Wei|Wei-Hua  Wu|Hua  Xiao; PhD|Edward E Luk|Show all 10,NULL,Yawen  Bai; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50478
12,BC005268-21,"October 01, 2007 -  September 30, 2008",Mechanism of Meiotic Recombination,Michael Joseph Lichten; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Robert A Shroff|Anuradha  Sourirajan|Yaron  Dayani|Tamara  Goldfarb|Elizabeth Anne Kolar,NULL,Yikang  Rong (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50479
13,BC005270-27,"October 01, 2007 -  September 30, 2008",Molecular Mechanism of Action of Phorbol Ester,Peter  Blumberg; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Noemi  Kedei|Nancy E Lewin|Larry V Pearce|Dazhi  Yang|Jozsef  Lazar|Gabriella  Czifra|Show all 11,"Tamas  Biro (Physiology, Debrecen Medical School)|Chaya  Brodie (Depart;ment of Neurosurgery, Henry Ford Hospital)|Alan  Fields (Pharmacology, Mayo Clinic)|Marcelo G Kazanietz; PhD (Pharmacology, University of Pennsylvania)|Gary  Keck (Dept. of Chemistry, University of Utah)|Alan  Kozikowski (Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago)|Show all 13",Victor  Marquez; PhD (National Cancer Institute)|Susan H Garfield (National Cancer Institute)|Stuart H Yuspa; MD (National Cancer Institute)|Paul  Goldsmith; PhD (National Cancer Institute)|Yun  Wang  (Nucleic Acid NMR Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50480
14,BC005271-17,"October 01, 2007 -  September 30, 2008",Gene Regulation and Function: The B-ZIP Proteins,Charles  Vinson; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Paramita  Bhattacharya|Julian  Rozenburg|Vikas  Rishi|Jianfei  Zhao|Kimberly R Glass,NULL,"Frank Jess Gonzalez; PhD (National Cancer Institute)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Michael  Bustin; PhD (National Cancer Institute)|Gordon Lee Hager; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50481
15,BC005317-25,"October 01, 2007 -  September 30, 2008",Role of Selenium in Cancer and Health,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Bradley A Carlson|Min-Hyuk  Yoo|Aniruddha  Sengupta|Xueming  Xu,"Marla  Berry (Molecular Biology, U of Hawaii)|Alan  Diamond (Nutrition, U of IL at Chicago)|Vadim  Gladyshev (Department of Biochemistry, University of Nebraska)|Ulrich  Schweizer (Neuroscience Research Center and, Charit-Universittsmedizin Berlin)",Cindy D Davis (National Cancer Institute)|Jeffrey E Green; MD (National Cancer Institute)|Stuart H Yuspa; MD (National Cancer Institute),NULL,"1. Carlson BA, Lee BJ, Hatfield DL (2008). Ribosomal frameshifting in response to hypomodified tRNAs in Xenopus oocytes. Biochem Biophys Res Commun  375, 86-90.   https://doi.org/10.1016/j.bbrc.2008.07.118|2. Zhang Y, Turanov AA, Hatfield DL, Gladyshev VN (2008). In silico identification of genes involved in selenium metabolism: evidence for a third selenium utilization trait. BMC Genomics  9, 251.   https://doi.org/10.1186/1471-2164-9-251",https://intramural.nih.gov/search/searchview.taf?ipid=50482
16,BC005352-26,"October 01, 2007 -  September 30, 2008",Mechanisms in Perinatal Carcinogenesis,Lucy M Anderson; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Yih-horng  Shiao|Janet R Fields|Laura  Fornwald,Gregory  Alvord (Data Management Services)|Bhal  DIwan (SAIC),Miriam R Anver (Office Of The Director),"Gregory  Travlos; DVM, PhD (NIEHS)","1. Anderson L, Sipowicz M, Logsdon D, Gorelick P, Anver M, Kasprzak K (2008) Marked liver tumorigenesis by Helicobacter hepaticus requires perinatal exposure. Environmental Health Perspectives, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50483
17,BC005367-25,"October 01, 2007 -  September 30, 2008",The Genetic Structure of Natural Populations Past and Present,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",Warren  Johnson|Melody  Roekle-Parker|Mary A Thompson|Michael E Weedon|Bailey D Kessing|Meredith Ann Brown|Show all 10,NULL,Beena  Neelam (National Cancer Institute)|Robert H Stephens (National Cancer Institute)|Gary A Stone; BA (National Cancer Institute),James Copeland Mullikin; PhD (NHGRI),"1. Brown MA, Cunningham MW, Roca AL, Troyer JL, Johnson WE, O'Brien SJ (2008). Genetic characterization of feline leukemia virus from Florida panthers. Emerg Infect Dis  14, 252-9.   https://doi.org/10.3201/eid1402.070981|2. da Fonseca RR, Johnson WE, O'Brien SJ, Ramos MJ, Antunes A (2008). The adaptive evolution of the mammalian mitochondrial genome. BMC Genomics  9, 119.   https://doi.org/10.1186/1471-2164-9-119|3. Fontoura-Rodrigues M, Lima-Rosa C, Rodrigues F, de Paula R, Gough M, Johnson W, Bonatto S, Eizirik E   (2008) Cross-amplification and characterization of 13 tetranucleotide microsatellites in  mulitple species of Neotropical canids.  Molecular Ecology Notes  898-900 pp.|4. Luo SJ, Johnson WE, Martenson J, Antunes A, Martelli P, Uphyrkina O, Traylor-Holzer K, Smith JL, O'Brien SJ (2008). Subspecies genetic assignments of worldwide captive tigers increase conservation value of captive populations. Curr Biol  18, 592-6.   https://doi.org/10.1016/j.cub.2008.03.053|5. Menotti-Raymond M, David VA, Pflueger SM, Lindblad-Toh K, Wade CM, O'Brien SJ, Johnson WE (2008). Patterns of molecular genetic variation among cat breeds. Genomics  91, 1-11.   https://doi.org/10.1016/j.ygeno.2007.08.008|6. Napolitano C, Bennett M, Johnson WE, O'Brien SJ, Marquet PA, Barría I, Poulin E, Iriarte A (2008). Ecological and biogeographical inferences on two sympatric and enigmatic Andean cat species using genetic identification of faecal samples. Mol Ecol  17, 678-90.   https://doi.org/10.1111/j.1365-294X.2007.03606.x|7. O'Brien S, Johnson W, Smith J, O'Brien S (2008) What is a Tiger? Genetics and Phylogeny. Tigers of the World, in press.|8. O'Brien S, Troyer J, Roelke M, Pecon-Slattery J, Packer C, Winterbach C, Winterbach H, Hemson G, Frank L, Stander P, Siefert L, Driciru M, Funston P, Alexander K, Prager K, Mills G, Wildt D, Bush M, Johnson W   (2008) The Evolutionary History of Lion: Integrating Host/Pathogen Molecular Genetics.  PLOS Genetics, in press.|9. O'Brien S, Troyer J, Roelke M, Pecon-Slattery J, Packer C, Winterbach C, Winterbach H, Hemson G, Frank L, Stander P, Siefert L, Driciru M, Funston P, Alexander K, Prager K, Mills G, Wildt D, Bush M, O'Brien S, Johnson W (2008) The Evolutionary History of Lion: Integrating HostPathogen Molecular Genetics. PLOS Genetics, in press.|10. Roelke M, Johnson W, Millan J   (2008) Exposure to disease agents in the endangered lberian lynx (Lynxpardinus).  European Journal of Wildlife Research  171-178 pp.|11. Zapata B, Gonzalez J, Marin J, Cabello W, Johnson W, Skewes. O   (2008) A case of polydactyly in a wild guanaco (Lama guanicoe). Small Ruminent Research.  Small Ruminent Research  220-222 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=50484
18,BC005385-25,"October 01, 2007 -  September 30, 2008","The Development of the Domestic Cat, Felis catus, as      an Animal Model for Ge",Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",Warren  Johnson|Melody  Roekle-Parker|Carlos Antonio Driscoll; PhD|Bailey D Kessing|Marilyn  Raymond; PhD|James  Kehler|Show all 7,NULL,Robert H Stephens (National Cancer Institute),NULL,"1. Kehler JS, David VA, Schäffer AA, Bajema K, Eizirik E, Ryugo DK, Hannah SS, O'Brien SJ, Menotti-Raymond M (2007). Four independent mutations in the feline fibroblast growth factor 5 gene determine the long-haired phenotype in domestic cats. J Hered  98, 555-66.   https://doi.org/10.1093/jhered/esm072",https://intramural.nih.gov/search/searchview.taf?ipid=50485
19,BC005389-25,"October 01, 2007 -  September 30, 2008",Reproductive Strategies in Animal Species Emphasizing Developmental Biology,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",Melody  Roekle-Parker|James  Kehler,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50486
20,BC005399-25,"October 01, 2007 -  September 30, 2008",Mechanistic Targeting of Lung Cancer,Lucy M Anderson; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Yih-horng  Shiao|Janet R Fields|Laura  Fornwald|Gunamani  Sithanandam|Marvin  Gee|Christopher  Hwang,NULL,NULL,NULL,"1. Sithanandam G, Anderson LM (2008). The ERBB3 receptor in cancer and cancer gene therapy. Cancer Gene Ther  15, 413-48.   https://doi.org/10.1038/cgt.2008.15",https://intramural.nih.gov/search/searchview.taf?ipid=50487
21,BC005445-24,"October 01, 2007 -  September 30, 2008",Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Joanna  Anders|Luowei  Li|Anjali  Shukla|Ronald  Wolf|Mariam Q Malik|Mary Ann A Stepp|Show all 9,NULL,Peter  Blumberg; PhD (National Cancer Institute)|Triantafyllos  Chavakis (National Cancer Institute)|Glenn  Merlino; PhD (National Cancer Institute)|Victor  Marquez; PhD (National Cancer Institute)|Maria L Turner; MD (National Cancer Institute)|Suneet  Shukla (National Cancer Institute),Jiliang  Gao (NIAID) |Craig Joseph Thomas (NHGRI) |David J Maloney (NHGRI),"1. Scortegagna M, Cataisson C, Martin RJ, Hicklin DJ, Schreiber RD, Yuspa SH, Arbeit JM (2008). HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Blood  111, 3343-54.   https://doi.org/10.1182/blood-2007-10-115758|2. Wolf R, Howard OM, Dong HF, Voscopoulos C, Boeshans K, Winston J, Divi R, Gunsior M, Goldsmith P, Ahvazi B, Chavakis T, Oppenheim JJ, Yuspa SH (2008). Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J Immunol  181, 1499-506.   https://doi.org/10.4049/jimmunol.181.2.1499",https://intramural.nih.gov/search/searchview.taf?ipid=50488
22,BC005450-25,"October 01, 2007 -  September 30, 2008",Chromatin Structure and Gene Expression,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Sam  John|Tom  Johnson|Ty Cole Voss|Malgorzata  Wiench|Anuja  George|Kip  Nalley|Show all 8,"Philippe  Georgel (NCI)|Bhavin  Parekh (Lilly Corporate Center, Eli Lilly)|Ken  Pearce (Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)|John  Stamatoyanopolus (Genome Sciences, University of Washington)|Keith A Yamamoto","Paul S Meltzer; MD, PhD (National Cancer Institute)|Sean Richard Davis; MD, PhD (National Cancer Institute)",S Stoney  Simons; PhD (NIDDK),"1. Johnson TA, Elbi C, Parekh BS, Hager GL, John S (2008). Chromatin remodeling complexes interact dynamically with a glucocorticoid receptor-regulated promoter. Mol Biol Cell  19, 3308-22.   https://doi.org/10.1091/mbc.e08-02-0123|2. Voss TC, Hager GL (2008). Visualizing chromatin dynamics in intact cells. Biochim Biophys Acta  1783, 2044-51.   https://doi.org/10.1016/j.bbamcr.2008.06.022",https://intramural.nih.gov/search/searchview.taf?ipid=50489
23,BC005453-24,"October 01, 2007 -  September 30, 2008",Cellular and Molecular Biology of the Hepatic Stem Cell Compartment,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",Marian E Durkin|Anita  Ton|Agnes  Holczbauer|Dongho  Choi,NULL,Valentina  Factor (Cellular and Molecular Biology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50490
24,BC005480-23,"October 01, 2007 -  September 30, 2008",Molecular Epidemiology of Human Lung Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Elise Dawn Bowman|Mohammed A. Khan; PhD|Judith A Welsh|Sharon R Pine|Susan  Olivo-Marston|Rosemary Irene Braun|Show all 9,NULL,"Neil Edward Caporaso; MS, MD (National Cancer Institute)",NULL,"1. Ben Khedher S, Neri M, Papadopoulos A, Christiani DC, Diao N, Harris CC, Olivo-Marston S, Schwartz AG, Cote M, Koushik A, Siemiatycki J, Landi MT, Hung RJ, McLaughlin J, Duell EJ, Andrew AS, Orlow I, Park BJ, Brenner H, Saum KU, Pesatori AC, Stücker I (2017). Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the international lung cancer consortium. Int J Cancer  141, 309-323.   https://doi.org/10.1002/ijc.30750|2. Gardner LD, Loffredo PhD CA, Langenberg P, George DMS, Deepak J, Harris CC, Amr S (2018). Associations between history of chronic lung disease and non-small cell lung carcinoma in Maryland: variations by sex and race. Ann Epidemiol  28, 543-548.   https://doi.org/10.1016/j.annepidem.2018.04.012|3. Haznadar M, Cai Q, Krausz KW, Bowman ED, Margono E, Noro R, Thompson MD, Mathé EA, Munro HM, Steinwandel MD, Gonzalez FJ, Blot WJ, Harris CC (2016). Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev  25, 978-86.   https://doi.org/10.1158/1055-9965.EPI-15-1191|4. Hung RJ, Spitz MR, Houlston RS, Schwartz AG, Field JK, Ying J, Li Y, Han Y, Ji X, Chen W, Wu X, Gorlov IP, Na J, de Andrade M, Liu G, Brhane Y, Diao N, Wenzlaff A, Davies MPA, Liloglou T, Timofeeva M, Muley T, Rennert H, Saliba W, Ryan BM, et al. [41 more authors] (2019). Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. J Thorac Oncol  14, 1360-1369.   https://doi.org/10.1016/j.jtho.2019.04.008|5. Lissa D, Ishigame T, Noro R, Tucker MJ, Bliskovsky V, Shema S, Beck JA, Bowman ED, Harris CC, Robles AI (2018). HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients. Lung Cancer  122, 151-159.   https://doi.org/10.1016/j.lungcan.2018.05.021|6. Loeb LA, Harris CC (2008). Advances in chemical carcinogenesis: a historical review and prospective. Cancer Res  68, 6863-72.   https://doi.org/10.1158/0008-5472.CAN-08-2852|7. Martin RC, Barker DF, Doll MA, Pine SR, Mechanic L, Bowman ED, Harris CC, Hein DW (2008). Manganese superoxide dismutase gene coding region polymorphisms lack clinical incidence in general population. DNA Cell Biol  27, 321-3.   https://doi.org/10.1089/dna.2007.0725|8. Mechanic LE, Luke BT, Goodman JE, Chanock SJ, Harris CC (2008). Polymorphism Interaction Analysis (PIA): a method for investigating complex gene-gene interactions. BMC Bioinformatics  9, 146.   https://doi.org/10.1186/1471-2105-9-146|9. Nakaoku T, Tsuta K, Ichikawa H, Shiraishi K, Sakamoto H, Enari M, Furuta K, Shimada Y, Ogiwara H, Watanabe S, Nokihara H, Yasuda K, Hiramoto M, Nammo T, Ishigame T, Schetter AJ, Okayama H, Harris CC, Kim YH, Mishima M, Yokota J, Yoshida T, Kohno T (2014). Druggable oncogene fusions in invasive mucinous lung adenocarcinoma. Clin Cancer Res  20, 3087-93.   https://doi.org/10.1158/1078-0432.CCR-14-0107|10. Noro R, Ishigame T, Walsh N, Shiraishi K, Robles AI, Ryan BM, Schetter AJ, Bowman ED, Welsh JA, Seike M, Gemma A, Skaug V, Mollerup S, Haugen A, Yokota J, Kohno T, Harris CC (2017). A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts. J Thorac Oncol  12, 65-76.   https://doi.org/10.1016/j.jtho.2016.08.141",https://intramural.nih.gov/search/searchview.taf?ipid=50491
25,BC005488-23,"October 01, 2007 -  September 30, 2008",Mechanisms of Inorganic Carcinogenesis,Michael  Waalkes; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Jie  Liu; MD, PhD|Wei  Qu; PhD|Robert A Goyer|Jean-Francois L Coppin|Erik James Tokar; PhD|Chikara  Kojima|Show all 9",NULL,Larry K Keefer; PhD (National Cancer Institute)|Alan O Perantoni; PhD (National Cancer Institute),"Raymond W. Tennant; PhD (NIEHS) |Colin F Chignell; PhD (NIEHS) |Jau Shyong  Hong; PhD (NIEHS) |Jonathan H Freedman; MS, PhD (NIEHS) |Dori Rabin Germolec; PhD (NIEHS)","1. Pelch KE, Tokar EJ, Merrick BA, Waalkes MP (2015). Differential DNA methylation profile of key genes in malignant prostate epithelial cells transformed by inorganic arsenic or cadmium. Toxicol Appl Pharmacol  286, 159-67.   https://doi.org/10.1016/j.taap.2015.04.011",https://intramural.nih.gov/search/searchview.taf?ipid=50492
26,BC005522-21,"October 01, 2007 -  September 30, 2008",Thyroid StemProgenitor Cells,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Yoshihito  Sasaki|Masaaki  Miyakoshi,NULL,"Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)",NULL,"1. Kimura S, Kessaris N, Du T, Anderson S, Marin O   (2008) Postmitotic Nkx2-1 controls the migration of telencephalic interneurons by direct  repression of guidance receptors.  Neuron, in press.|2. Kimura S, Sousa V, Fuccillo M, Hjerling-Leffler J, Miyoshi G, Fishell G   (2008) The requirement of Nkx2-1 in the temporal specification of cortical interneuron  subtypes.  Neuron, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50493
27,BC005548-21,"October 01, 2007 -  September 30, 2008",Biological Functions of the Oncogenes Encoding Rho-Specific Exchange Factors,Toru  Miki; PhD,NULL,"Laboratory of Cell Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50495
28,BC005561-21,"October 01, 2007 -  September 30, 2008",Liver-Enriched Transcription Factors,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Linda G Byrd|Kristopher W Krausz|Sung-Hoon  Ahn|Tsutomu  Matsubara,"Tatsuhiko  Kodama (Laboratory of Systems Biology and Medicine, Research Center for Advanced               Science and Technology, Tokyo University)|Yuichi  Sugiyama (Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical               Sciences, University of Tokyo)",NULL,NULL,"1. Elizondo G, Medina-Díaz IM, Cruz R, Gonzalez FJ, Vega L (2009). Retinoic acid modulates retinaldehyde dehydrogenase 1 gene expression through the induction of GADD153-C/EBPbeta interaction. Biochem Pharmacol  77, 248-57.   https://doi.org/10.1016/j.bcp.2008.10.011|2. Gonzalez FJ, Jiang C, Patterson AD (2016). An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease. Gastroenterology  151, 845-859.   https://doi.org/10.1053/j.gastro.2016.08.057|3. Nomoto M, Miyata M, Yin S, Kurata Y, Shimada M, Yoshinari K, Gonzalez FJ, Suzuki K, Shibasaki S, Kurosawa T, Yamazoe Y (2009). Bile acid-induced elevated oxidative stress in the absence of farnesoid X receptor. Biol Pharm Bull  32, 172-8.   https://doi.org/10.1248/bpb.32.172|4. Ohguchi H, Tanaka T, Uchida A, Magoori K, Kudo H, Kim I, Daigo K, Sakakibara I, Okamura M, Harigae H, Sasaki T, Osborne TF, Gonzalez FJ, Hamakubo T, Kodama T, Sakai J (2008). Hepatocyte nuclear factor 4alpha contributes to thyroid hormone homeostasis by cooperatively regulating the type 1 iodothyronine deiodinase gene with GATA4 and Kruppel-like transcription factor 9. Mol Cell Biol  28, 3917-31.   https://doi.org/10.1128/MCB.02154-07|5. Qu A, Jiang C, Cai Y, Kim JH, Tanaka N, Ward JM, Shah YM, Gonzalez FJ (2014). Role of Myc in hepatocellular proliferation and hepatocarcinogenesis. J Hepatol  60, 331-8.   https://doi.org/10.1016/j.jhep.2013.09.024|6. Rageul J, Mottier S, Jarry A, Shah Y, Théoleyre S, Masson D, Gonzalez FJ, Laboisse CL, Denis MG (2009). KLF4-dependent, PPARgamma-induced expression of GPA33 in colon cancer cell lines. Int J Cancer  125, 2802-9.   https://doi.org/10.1002/ijc.24683|7. Saji T, Kikuchi R, Kusuhara H, Kim I, Gonzalez FJ, Sugiyama Y (2008). Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 alpha/beta. J Pharmacol Exp Ther  324, 784-90.   https://doi.org/10.1124/jpet.107.128249|8. Shi C, Min L, Yang J, Dai M, Song D, Hua H, Xu G, Gonzalez FJ, Liu A (2017). Peroxisome Proliferator-Activated Receptor α Activation Suppresses Cytochrome P450 Induction Potential in Mice Treated with Gemfibrozil. Basic Clin Pharmacol Toxicol  121, 169-174.   https://doi.org/10.1111/bcpt.12794|9. Tanaka N, Takahashi S, Zhang Y, Krausz KW, Smith PB, Patterson AD, Gonzalez FJ (2015). Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet. Biochim Biophys Acta  1852, 1242-52.   https://doi.org/10.1016/j.bbadis.2015.02.012|10. Wang H, Fang ZZ, Meng R, Cao YF, Tanaka N, Krausz KW, Gonzalez FJ (2017). Glycyrrhizin and glycyrrhetinic acid inhibits alpha-naphthyl isothiocyanate-induced liver injury and bile acid cycle disruption. Toxicology  386, 133-142.   https://doi.org/10.1016/j.tox.2017.05.012|11. Zheng B, Chen L, Gonzalez FJ (2016). ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic Nephropathy. Kidney Int Rep  1, 177-188.   https://doi.org/10.1016/j.ekir.2016.07.007",https://intramural.nih.gov/search/searchview.taf?ipid=50496
29,BC005562-21,"October 01, 2007 -  September 30, 2008",Xenobiotic-Metabolizing Enzymes,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Linda G Byrd|Kristopher W Krausz|Ting  Wang|Joo Youn  Cho; PhD|Jie  Cheng|Maria  Konstandi,NULL,NULL,NULL,"1. Chen C, Krausz KW, Idle JR, Gonzalez FJ (2008). Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice. J Biol Chem  283, 4543-59.   https://doi.org/10.1074/jbc.M706299200|2. Chen C, Shah YM, Morimura K, Krausz KW, Miyazaki M, Richardson TA, Morgan ET, Ntambi JM, Idle JR, Gonzalez FJ (2008). Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab  7, 135-47.   https://doi.org/10.1016/j.cmet.2007.12.003|3. Dostalek M, Hardy KD, Milne GL, Morrow JD, Chen C, Gonzalez FJ, Gu J, Ding X, Johnson DA, Johnson JA, Martin MV, Guengerich FP (2008). Development of oxidative stress by cytochrome P450 induction in rodents is selective for barbiturates and related to loss of pyridine nucleotide-dependent protective systems. J Biol Chem  283, 17147-57.   https://doi.org/10.1074/jbc.M802447200|4. Dragin N, Shi Z, Madan R, Karp CL, Sartor MA, Chen C, Gonzalez FJ, Nebert DW (2008). Phenotype of the Cyp1a1/1a2/1b1-/- triple-knockout mouse. Mol Pharmacol  73, 1844-56.   https://doi.org/10.1124/mol.108.045658|5. Felmlee MA, Lon HK, Gonzalez FJ, Yu AM (2008). Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice. Drug Metab Dispos  36, 435-41.   https://doi.org/10.1124/dmd.107.018838|6. Holdener M, Hintermann E, Bayer M, Rhode A, Rodrigo E, Hintereder G, Johnson EF, Gonzalez FJ, Pfeilschifter J, Manns MP, Herrath Mv, Christen U (2008). Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med  205, 1409-22.   https://doi.org/10.1084/jem.20071859|7. Kang JS, Wanibuchi H, Morimura K, Wongpoomchai R, Chusiri Y, Gonzalez FJ, Fukushima S (2008). Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity. Toxicol Appl Pharmacol  228, 295-300.   https://doi.org/10.1016/j.taap.2007.11.010|8. Ma X, Chen C, Krausz KW, Idle JR, Gonzalez FJ (2008). A metabolomic perspective of melatonin metabolism in the mouse. Endocrinology  149, 1869-79.   https://doi.org/10.1210/en.2007-1412|9. Patterson AD, Li H, Eichler GS, Krausz KW, Weinstein JN, Fornace AJ, Gonzalez FJ, Idle JR (2008). UPLC-ESI-TOFMS-based metabolomics and gene expression dynamics inspector self-organizing metabolomic maps as tools for understanding the cellular response to ionizing radiation. Anal Chem  80, 665-74.   https://doi.org/10.1021/ac701807v|10. Smith NF, Baker SD, Gonzalez FJ, Harris JW, Figg WD, Sparreboom A (2008). Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100. Br J Cancer  98, 1630-2.   https://doi.org/10.1038/sj.bjc.6604353|11. Tyburski JB, Patterson AD, Krausz KW, Slavík J, Fornace AJ, Gonzalez FJ, Idle JR (2008). Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice. Radiat Res  170, 1-14.   https://doi.org/10.1667/RR1265.1|12. Vasiliou V, Gonzalez FJ (2008). Role of CYP1B1 in glaucoma. Annu Rev Pharmacol Toxicol  48, 333-58.   https://doi.org/10.1146/annurev.pharmtox.48.061807.154729|13. Wang T, Ma X, Krausz KW, Idle JR, Gonzalez FJ (2008). Role of pregnane X receptor in control of all-trans retinoic acid (ATRA) metabolism and its potential contribution to ATRA resistance. J Pharmacol Exp Ther  324, 674-84.   https://doi.org/10.1124/jpet.107.131045",https://intramural.nih.gov/search/searchview.taf?ipid=50497
30,BC005596-39,"October 01, 2007 -  September 30, 2008",Pathogenesis of plasma cell tumors in mice,Michael  Potter; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Elizabeth B Mushinski|Patrick J Nelson,NULL,"Alexander L Kovalchuk; MD, PhD (Laboratory of Genetics)|David  Levens; PhD (National Cancer Institute)|James B Mitchell; PhD (National Cancer Institute)",Herbert Carpenter Morse; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50498
31,BC005597-19,"October 01, 2007 -  September 30, 2008",Biochemistry of Energy-Dependent (Intracellular) Protein Degradation,Michael  Maurizi; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Mark A Lies|Yang  Zhang|Ebenezer  Joseph|Zonglin  Hu; PhD,NULL,Susan  Gottesman; PhD (National Cancer Institute)|Alexander  Wlodawer; PhD (National Cancer Institute),Alasdair C Steven; PhD (NIAMS) |Grzegorz  Piszczek; PhD (NHLBI),"1. Lies M, Maurizi MR (2008). Turnover of endogenous SsrA-tagged proteins mediated by ATP-dependent proteases in Escherichia coli. J Biol Chem  283, 22918-29.   https://doi.org/10.1074/jbc.M801692200",https://intramural.nih.gov/search/searchview.taf?ipid=50499
32,BC005598-19,"October 01, 2007 -  September 30, 2008",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Adorjan  Aszalos|Carol O Cardarelli|Wilfred D Vieira|Matthew David Hall|Benjamin R Macadangdang|Kyle Ryan Brimacombe|Show all 8,NULL,NULL,NULL,"1. Gottesman M, Kimchi-Sarfaty C, Shinar S, Licht T, Lee C, Hafkemeyer P, Hrycyna C, Pastan I (2008) Selectable Markers for Gene Therapy, in Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Third Edition. Templeton N, ed, Taylor and Francis (Boca Raton, Florida), in press.|2. Hall MD, Fales HD, Gottesman MD, Hellwell JD, Ludwig JD, Salaam ND, Szakacs GD (submitted in 2008) Compounds With Mdr1-inverse Activity. Patents issued: 602009012428 (DE in 2013); 2240175 (EP in 2013); 2240175 (FR in 2013); 2240175 (GB in 2013). Patents pending: PCT/US2009/000861 (PC application); 12/867,206 (US application); 2009213153 (AU application); 2713288 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=50500
33,BC005599-18,"October 01, 2007 -  September 30, 2008","Tumor Suppressor Protein, p53",Ettore  Appella; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Sharlyn  Mazur; PhD|Matteo  Rossi|Lisa Marie Jenkins|Ryo  Hayashi|Mark M Slabodnick|Kan  Tanoue|Show all 8,"Or  Gozani (Stanford Cancer Center, Stanford University)|James G. Omichinski; PhD (Department of Biochemistry, University of Montreal)|Yang  Xu (California Breast Cancer Research Program, University of California)",Curtis  Harris; MD (National Cancer Institute),NULL,"1. Bang J, Yamaguchi H, Durell SR, Appella E, Appella DH (2008). A small molecular scaffold for selective inhibition of Wip1 phosphatase. ChemMedChem  3, 230-2.   https://doi.org/10.1002/cmdc.200700281",https://intramural.nih.gov/search/searchview.taf?ipid=50501
34,BC005643-18,"October 01, 2007 -  September 30, 2008",Mechanism and Regulation of mRNA Export,Ravi  Dhar; PhD,NULL,"Basic Research Laboratory, NCI",Saravana P Selvanathan|Saikat  Saha|Xiaoyuan  He,NULL,Andrew  Patterson (Gene Response Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50503
35,BC005645-19,"October 01, 2007 -  September 30, 2008",T-cell Transformation by Oncoviruses,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Robyn  Parks|Wen-Po  Tsai|Vibeke  Andresen|Risaku  Fukumoto|Valerio William Valeri|Izabela  Bialuk|Show all 9,"Vincenzo  Ciminale (Department of Oncology and Surgical Sciences, University of Padova)|Joe  Giam (University of the Health Sciences, University of Connecticut)|Christophe  Nicot (-, University of Kansas Medical Center)",Kathryn  Jones; PhD (National Cancer Institute)|John N Brady; PhD (National Cancer Institute)|Francis W Ruscetti; PhD (National Cancer Institute),NULL,"1. Fukumoto R, Andresen V, Bialuk I, Cecchinato V, Walser JC, Valeri VW, Nauroth JM, Gessain A, Nicot C, Franchini G (2009). In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein. Blood  113, 3726-34.   https://doi.org/10.1182/blood-2008-04-146928",https://intramural.nih.gov/search/searchview.taf?ipid=50504
36,BC005652-18,"October 01, 2007 -  September 30, 2008",Identification of Single Nucleotide Polymorphisms in Cancer-Related Genes,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Albert M Gold|Zhang-Qun  Chen|Julie  Sawitzke|Wei  Tan|Hong  Lou|Mark  Scally|Show all 10,"Rando  Allikmets (NCI)|Greg  Hageman (Ophthalmology, University of Iowa)|Ken  Offitt (Medicine, Sloan Kettering Cancer Center)|Joe  Sodroski (Immunology & Infectious Diseases, Harvard School of Public Health)","Stephen J O'Brien; PhD (National Cancer Institute)|Thomas R O'Brien; BA, MPH, MD (National Cancer Institute)",NULL,"1. Allikmets R, Dean M (2008). Bringing age-related macular degeneration into focus. Nat Genet  40, 820-1.   https://doi.org/10.1038/ng0708-820|2. Boland JF, Chung CC, Roberson D, Mitchell J, Zhang X, Im KM, He J, Chanock SJ, Yeager M, Dean M (2013) The new sequencer on the block: comparison of Life Technologys Proton sequencer to an Illumina HiSeq for whole-exome sequencing. Hum Genet 132:1153-63|3. Garrido C, Santizo VG, Müllers P, Soriano DR, Avila GB, Dean M, Jimenez-Morales S (2013). Frequency of thiopurine S-methyltransferase mutant alleles in indigenous and admixed Guatemalan patients with acute lymphoblastic leukemia. Med Oncol  30, 474.   https://doi.org/10.1007/s12032-013-0474-2|4. Lou H, Villagran G, Boland JF, Im KM, Polo S, Zhou W, Odey U, Juárez-Torres E, Medina-Martínez I, Roman-Basaure E, Mitchell J, Roberson D, Sawitzke J, Garland L, Rodríguez-Herrera M, Wells D, Troyer J, Pinto FC, Bass S, Zhang X, Castillo M, Gold B, Morales H, Yeager M, Berumen J, et al. [3 more authors] (2015). Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway. Clin Cancer Res  21, 5360-70.   https://doi.org/10.1158/1078-0432.CCR-14-1837|5. Meyer-Lindenberg A, Kolachana B, Gold B, Olsh A, Nicodemus KK, Mattay V, Dean M, Weinberger DR (2009). Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Mol Psychiatry  14, 968-75.   https://doi.org/10.1038/mp.2008.54|6. Petrovics G, Price DK, Lou H, Chen Y, Garland L, Bass S, Jones K, Kohaar I, Ali A, Ravindranath L, Young D, Cullen J, Dorsey TH, Sesterhenn IA, Brassell SA, Rosner IL, Ross D, Dahut W, Ambs S, Figg WD, Srivastava S, Dean M (2019). Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population. Prostate Cancer Prostatic Dis  22, 406-410.   https://doi.org/10.1038/s41391-018-0114-1|7. Zhou W, Goldin L, Wang M, McMaster ML, Jones K, Burdett L, Chanock SJ, Yeager M, Dean M, Caporaso NE (2018). Combined somatic mutation and copy number analysis in the survival of familial CLL. Br J Haematol  181, 604-613.   https://doi.org/10.1111/bjh.15239",https://intramural.nih.gov/search/searchview.taf?ipid=50459
37,BC005657-19,"October 01, 2007 -  September 30, 2008",Molecular Basis for the Pathogenesis of Murine Retroviruses,Sandra  Ruscetti; PhD,NULL,"Laboratory of Cancer Prevention, NCI",Charlotte A Hanson|Joan L Cmarik|Monika  Kaczmarek|Karen  Wylie|Xiujie  Li,"Paul  Hoffman (Depts. of Neuroscience and Neurology, University of Florida School of Medicine)|Marcel  Leist (Dept. of Neuroscience and Neurology, H. Lundbeck A/S)","Michael I Lerman; MD, PhD (National Cancer Institute)|Donald P Bottaro; PhD (National Cancer Institute)|Michael  Birrer (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50505
38,BC005673-18,"October 01, 2007 -  September 30, 2008",Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies,Larry K Keefer; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Michael Louis Citro|Keith M Davies|Paul J Donovan|Joseph  Saavedra|Carlos A Velazquez Martinez|Daniela  Andrei|Show all 9,NULL,Mariam Q Malik (National Cancer Institute)|Xinhua  Ji; PhD (National Cancer Institute)|Michael  Waalkes; PhD (National Cancer Institute)|Jie  Liu (National Cancer Institute)|David Anderson Wink (National Cancer Institute)|Stuart H Yuspa; MD (National Cancer Institute),NULL,"1. Chakrapani H, Goodblatt MM, Udupi V, Malaviya S, Shami PJ, Keefer LK, Saavedra JE (2008). Synthesis and in vitro anti-leukemic activity of structural analogues of JS-K, an anti-cancer lead compound. Bioorg Med Chem Lett  18, 950-3.   https://doi.org/10.1016/j.bmcl.2007.12.044|2. Chakrapani H, Wilde TC, Citro ML, Goodblatt MM, Keefer LK, Saavedra JE (2008). Synthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compound. Bioorg Med Chem  16, 2657-64.   https://doi.org/10.1016/j.bmc.2007.11.035|3. Ji X, Kalathur R, Hu X, Gu Y, Saavedra J, Buzard G, Srinivasan A, Keefer L, Singh S (2008) Structure-based design of anticancer prodrug PABA/NO. Drug Design, Development and Therapy 123-130.|4. Keefer L, Kalathur R, Maciag A, Citro M, Ji X, Saavedra J   (2008) Synthesis, mechanistic studies, and anti-proliferative activity of  glutathione/glutathione -transferase-activated nitric oxide prodrugs.  Bioorg. Med. Chem, in press.|5. Keefer L, Yang Y, Saavedra J, Colburn N, Perantoni A   (2008) Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining  wild type p53.  Oncogene, in press.|6. Simeone AM, McMurtry V, Nieves-Alicea R, Saavedra JE, Keefer LK, Johnson MM, Tari AM (2008). TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells. Breast Cancer Res  10, R44.   https://doi.org/10.1186/bcr2095",https://intramural.nih.gov/search/searchview.taf?ipid=50506
39,BC005688-18,"October 01, 2007 -  September 30, 2008",Understanding the Role of the Host Response in HIVSIV Infection,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Robyn  Parks|Wen-Po  Tsai|Monica  Vaccari|Shari  Gordon; PhD|Anna  Hryniewicz|Melvin Nelson Doster,"Claire  Chougnet (University of Cincinnati)|Ditemar  Fuchs (Innsbruck Medical University)|Israel  Lowy (Medarex)|Savita  Pahwa (Miller School of Medicine, University of Miami)|Eckhard  Podack (Department of Microbiology, University of Miami)|Rafick  Sekaly; PhD (Vaccine & Gene Therapy Institute)",Gene  Shearer; PhD (National Cancer Institute),Vanessa  Hirsch (NIAID),"1. Vaccari M, Mattapallil J, Song K, Tsai WP, Hryniewicz A, Venzon D, Zanetti M, Reimann KA, Roederer M, Franchini G (2008). Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency. J Virol  82, 9629-38.   https://doi.org/10.1128/JVI.00893-08",https://intramural.nih.gov/search/searchview.taf?ipid=50507
40,BC005691-17,"October 01, 2007 -  September 30, 2008",Inhibition of p53 Tumor Suppressor Function by HTLV-I,John N Brady; PhD,NULL,"Laboratory of Cellular Oncology, NCI",Cynthia  Masison|Michael  Radonovich|Kyung Jin  Jung|Amane  Sasada,"Katerina  Gurova (Department of Molecular Genetics and Taussig Cancer Center, Cleveland Clinic Foundation)|Aneth  Shalev (Medical Center, University of Wisconsin)","Michael  Birrer (National Cancer Institute)|Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)|John  Janik; MD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50508
41,BC005708-17,"October 01, 2007 -  September 30, 2008",Xenobiotic Receptors,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Linda G Byrd|Kristopher W Krausz|Yatrik  Shah|Tomotaka  Tanabe|Tsutomu  Matsubara|Jessica  Bonzo|Show all 8,"Toshifumi  Aoyama (Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)|Jeffrey  Peters (NCI)",NULL,NULL,"1. Hollingshead HE, Borland MG, Billin AN, Willson TM, Gonzalez FJ, Peters JM (2008). Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms. Carcinogenesis  29, 169-76.   https://doi.org/10.1093/carcin/bgm209",https://intramural.nih.gov/search/searchview.taf?ipid=50509
42,BC005725-16,"October 01, 2007 -  September 30, 2008",ABC Transporters in Human Disease and Multidrug Resistance,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Albert M Gold|Zhang-Qun  Chen|Julie  Sawitzke|Hong  Lou|Mark  Scally,"Rando  Allikmets (NCI)|Stephen  Farber (Pediatrics, Carnegie Institute)|Larry  Nogee (Pediatrics, Johns Hopkins University)|Ina  Urbatsch (Cell Biology and Biochemistry, Texas Tech University Health Sciences)","Antonio  Fojo; MD, PhD (National Cancer Institute)|Susan  Bates; MD (National Cancer Institute)",NULL,"1. Dean M, Cunningham P (2008) The ABC transporter gene family of Daphnia pulex. BMC Genomics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50460
43,BC005740-16,"October 01, 2007 -  September 30, 2008",Transgenic Models for Prostate and Breast Cancer,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Dalit  Barkan|Zi-yao  Liu|Ting-Hu  Qiu|Christina  Bennett|Min  Zhu|Isabel  Chu|Show all 7,Chu-Xia  Deng (NIDDK)|Hynda K Kleinman; PhD (NIDCR),"Dolph Lee Hatfield; PhD (National Cancer Institute)|John A Beutler (National Cancer Institute)|Melinda  Hollingshead (National Cancer Institute)|Chand  Khanna; MD (National Cancer Institute)|Stanley  Lipkowitz; MD, PhD (National Cancer Institute)",NULL,"1. Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenorhoff MJ, Liu ZY, Costes SV, Cho EH, Lockett S, Khanna C, Chambers AF, Green JE (2008). Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res  68, 6241-50.   https://doi.org/10.1158/0008-5472.CAN-07-6849|2. Catena R, Muniz-Medina V, Moralejo B, Javierre B, Best CJ, Emmert-Buck MR, Green JE, Baker CC, Calvo A (2007). Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis. Int J Cancer  120, 2096-109.   https://doi.org/10.1002/ijc.22461|3. Datta S, Hoenerhoff MJ, Bommi P, Sainger R, Guo WJ, Dimri M, Band H, Band V, Green JE, Dimri GP (2007). Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. Cancer Res  67, 10286-95.   https://doi.org/10.1158/0008-5472.CAN-07-1636|4. Deeb KK, Michalowska AM, Yoon CY, Krummey SM, Hoenerhoff MJ, Kavanaugh C, Li MC, Demayo FJ, Linnoila I, Deng CX, Lee EY, Medina D, Shih JH, Green JE (2007). Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. Cancer Res  67, 8065-80.   https://doi.org/10.1158/0008-5472.CAN-07-1515|5. Green J (2008) Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of pre-clinical models. Breast Cancer Research, in press.|6. Green J, Leland P, Calvo A, Montuenga L, Puri R (2008) Human Adrenomedullin Upregulates IL-13Rα2 Chain in Human Prostate Cancer in vitro and in vivo: a Novel Approach for Sensitizing Prostate Cancer to Receptor Directed Anti-Cancer Therapy. Cancer Research, in press.|7. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, et al. [1 more author] (2007). Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol  8, R76.   https://doi.org/10.1186/gb-2007-8-5-r76|8. Hudson TS, Hartle DK, Hursting SD, Nunez NP, Wang TT, Young HA, Arany P, Green JE (2007). Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer Res  67, 8396-405.   https://doi.org/10.1158/0008-5472.CAN-06-4069|9. Huh JI, Qiu TH, Chandramouli GV, Charles R, Wiench M, Hager GL, Catena R, Calvo A, LaVallee TM, Desprez PY, Green JE (2007). 2-methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: molecular distinctions from the mammary gland of pregnant mice. Endocrinology  148, 1266-77.   https://doi.org/10.1210/en.2006-0964|10. Ohta S, Lai EW, Morris JC, Pang AL, Watanabe M, Yazawa H, Zhang R, Green JE, Chan WY, Sirajuddin P, Taniguchi S, Powers JF, Tischler AS, Pacak K (2008). Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells. Mol Carcinog  47, 245-51.   https://doi.org/10.1002/mc.20388|11. Shoushtari AN, Michalowska AM, Green JE (2007). Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profiling. Breast Dis  28, 39-51.   https://doi.org/10.3233/bd-2007-28105|12. Varticovski L, Hollingshead MG, Robles AI, Wu X, Cherry J, Munroe DJ, Lukes L, Anver MR, Carter JP, Borgel SD, Stotler H, Bonomi CA, Nunez NP, Hursting SD, Qiao W, Deng CX, Green JE, Hunter KW, Merlino G, Steeg PS, Wakefield LM, Barrett JC (2007). Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models. Clin Cancer Res  13, 2168-77.   https://doi.org/10.1158/1078-0432.CCR-06-0918",https://intramural.nih.gov/search/searchview.taf?ipid=50510
44,BC005753-16,"October 01, 2007 -  September 30, 2008",HIV Tat Transcriptional Activation,John N Brady; PhD,NULL,"Laboratory of Cellular Oncology, NCI",Cynthia  Masison|Michael  Radonovich|Meisheng  Zhou|Won-Kyung  Cho|Keven H Huang,"Fatah  Kashanchi (Department of Biochemistry and Molecular Biology, George Washington University Medical Center)|Sergei  Nekhai (Biochemistry Department, Howard University)",Dinah  Singer; PhD (National Cancer Institute),NULL,"1. Gegonne A, Weissman JD, Lu H, Zhou M, Dasgupta A, Ribble R, Brady JN, Singer DS (2008). TFIID component TAF7 functionally interacts with both TFIIH and P-TEFb. Proc Natl Acad Sci U S A  105, 5367-72.   https://doi.org/10.1073/pnas.0801637105",https://intramural.nih.gov/search/searchview.taf?ipid=50511
45,BC005785-14,"October 01, 2007 -  September 30, 2008",TGF-betas in breast cancer progression,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Binwu  Tang|Ethan  Kohn|Misako  Sato|Yu-an  Yang,NULL,Maxwell P Lee; PhD (National Cancer Institute)|Miriam R Anver (National Cancer Institute)|Kent W Hunter; PhD (National Cancer Institute)|Christina  Stuelten (National Cancer Institute)|Chand  Khanna; MD (National Cancer Institute)|Barbara V Vonderhaar; PhD (National Cancer Institute),NULL,"1. Nam JS, Terabe M, Kang MJ, Chae H, Voong N, Yang YA, Laurence A, Michalowska A, Mamura M, Lonning S, Berzofsky JA, Wakefield LM (2008). Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res  68, 3915-23.   https://doi.org/10.1158/0008-5472.CAN-08-0206|2. Nam JS, Terabe M, Mamura M, Kang MJ, Chae H, Stuelten C, Kohn E, Tang B, Sabzevari H, Anver MR, Lawrence S, Danielpour D, Lonning S, Berzofsky JA, Wakefield LM (2008). An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments. Cancer Res  68, 3835-43.   https://doi.org/10.1158/0008-5472.CAN-08-0215",https://intramural.nih.gov/search/searchview.taf?ipid=50512
46,BC005793-14,"October 01, 2007 -  September 30, 2008",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Zhipeng  Yu|Chuan-Ging  Wu|Junfang  Ji,NULL,Nicolae C Popescu; PhD (National Cancer Institute)|Curtis  Harris; MD (National Cancer Institute)|Robert  Wiltrout; PhD (National Cancer Institute)|Howard A Young; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50513
47,BC005795-14,"October 01, 2007 -  September 30, 2008",p53 Tumor Suppressor Pathway,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Izumi  Horikawa|Elisa A Spillare|Kaori  Fujita,NULL,Ettore  Appella; MD (National Cancer Institute),NULL,"1. Yang Q, Zhang R, Horikawa I, Fujita K, Afshar Y, Kokko A, Laiho P, Aaltonen LA, Harris CC (2007). Functional diversity of human protection of telomeres 1 isoforms in telomere protection and cellular senescence. Cancer Res  67, 11677-86.   https://doi.org/10.1158/0008-5472.CAN-07-1390",https://intramural.nih.gov/search/searchview.taf?ipid=50514
48,BC005800-14,"October 01, 2007 -  September 30, 2008",Discovering Disease Susceptibility Genes in African Americans,Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI",Taras K Oleksyk|Yvette  Berthier-schaad|Viktoriya  Grinberg|Efe  Sezgin|Melanie  Springer|Cheryl Ann Winkler,"Francisco  De La Vega (Applied Biosystems)|Myron  Essex (Dept. of Immunology & Infectious Diseases, Harvard School of Public Health)|Dennis  Gilbert (Chief Scientific Officer and Vice President for Research, Applied Biosystems)|Linda  Kao (Dept. of Epidemiology, Johns Hopkins University)|Michael  Klag (Dept. of Epidemiology, Johns Hopkins University)|Jason H. Moore; PhD (Division of Biomedical Informatics, The Perelman School of Medicine)|Show all 13",Stephen J O'Brien; PhD (National Cancer Institute),NULL,"1. Oleksyk TK, Zhao K, De La Vega FM, Gilbert DA, O'Brien SJ, Smith MW (2008). Identifying selected regions from heterozygosity and divergence using a light-coverage genomic dataset from two human populations. PLoS One  3, e1712.   https://doi.org/10.1371/journal.pone.0001712|2. Schelling JR, Abboud HE, Nicholas SB, Pahl MV, Sedor JR, Adler SG, Arar NH, Bowden DW, Elston RC, Freedman BI, Goddard KA, Guo X, Hanson RL, Ipp E, Iyengar SK, Jun G, Kao WH, Kasinath BS, Kimmel PL, Klag MJ, Knowler WC, Nelson RG, Parekh RS, Quade SR, Rich SS, Family Investigation of Nephropathy and Diabetes Research Group, et al. [7 more authors] (2008). Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes  57, 235-43.   https://doi.org/10.2337/db07-0313|3. Truelove AL, Oleksyk TK, Shrestha S, Thio CL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ, Smith MW (2008). Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Int J Immunogenet  35, 255-64.   https://doi.org/10.1111/j.1744-313X.2008.00770.x",https://intramural.nih.gov/search/searchview.taf?ipid=50515
49,BC006140-32,"October 01, 2007 -  September 30, 2008",Studies of Histone Functions in Chromatin; H2AX and DNA DSBs,William M Bonner; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Olga A Sedelnikova; PhD|Asako  Nakamura|Jennifer Susan Dickey|Christophe  Redon,"David  Brenner (Columbia University)|Eric  Hall (Columbia University, New York, NY)|Igor  Koturbash (Department of Biological Sciences, University of Lethbridge)|Olga  Kovalchuk (Department of Biological Sciences, University of Lethbridge)|Stephen  Marino (Radiological Research Accelerator Facility, Center for Radiological Research, College of Physicians and Surgeons, Columbia University)|Stephen  Mitchell (Radiological Research Accelerator Facility, Center for Radiological Research, College of Physicians and Surgeons, Columbia University)","Yves  Pommier; PhD (National Cancer Institute)|Mirit I Aladjem; PhD (National Cancer Institute)|Melanie S Vacchio; PhD (National Cancer Institute)|Richard J Hodes; MD (National Cancer Institute)|Thomas A Misteli; PhD (National Cancer Institute)|Vladimir L Larionov; PhD, DSc (National Cancer Institute)",Ronald D Neumann; MD (CC) |Igor  Panyutin; PhD (CC) |Irina  Panyutin; MD (CC) |Karen P Usdin; PhD (NIDDK) |Daman  Kumari; PhD (NIDDK),"1. Bonner W, Chiang J, Hathcock K, Horikawa I, Sedelnikova O, Hodes R (2008) Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence. Epigenetics and Chromatin, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50516
50,BC006150-27,"October 01, 2007 -  September 30, 2008","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Christophe R Marchand|Ann  Orr|Hongliang  Zhang|Keli  Agama|Olivier  Sordet|Andrew  Jobson|Show all 13,NULL,"Frank M Balis; MD, PhD (National Cancer Institute)|Robert  Shoemaker (National Cancer Institute)|Robert J Fisher (National Cancer Institute)|Alexander  Wlodawer; PhD (National Cancer Institute)|Mirit I Aladjem; PhD (National Cancer Institute)|Frank Jess Gonzalez; PhD (National Cancer Institute)",NULL,"1. Kummar S, Kinders R, Rubinstein L, Parchment RE, Murgo AJ, Collins J, Pickeral O, Low J, Steinberg SM, Gutierrez M, Yang S, Helman L, Wiltrout R, Tomaszewski JE, Doroshow JH (2007). Compressing drug development timelines in oncology using phase '0' trials. Nat Rev Cancer  7, 131-9.   https://doi.org/10.1038/nrc2066|2. Pommier Y, Ghosh A, Zhang Y (submitted in 2008) Lasonolide Compounds As Reagents For Inducing Premature Chromosome Condensation And Methods Of Treating Disorders. Patent issued: 8,278,100 (US in 2013).",https://intramural.nih.gov/search/searchview.taf?ipid=50517
51,BC006161-25,"October 01, 2007 -  September 30, 2008",DNA Topoisomerases as Target of Action of Anticancer Drugs,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Ann  Orr|Hongliang  Zhang|Keli  Agama|Olivier  Sordet|Thomas  Dexheimer|Benu Brata  Das|Show all 8,NULL,Melinda  Hollingshead (National Cancer Institute)|William M Bonner; PhD (National Cancer Institute)|Robert  Shoemaker (National Cancer Institute)|Joseph E Tomaszewski (National Cancer Institute)|James Halpern Doroshow (National Cancer Institute)|Susan  Bates; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50518
52,BC006173-23,"October 01, 2007 -  September 30, 2008",Dideoxynucleosides as Potential Anti-AIDS Drugs,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Pamela L Russ|Hisao  Saneyoshi,NULL,Stephen H Hughes; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50519
53,BC006174-23,"October 01, 2007 -  September 30, 2008",Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Olaf R Ludek|Hisao  Saneyoshi,NULL,Stephen H Hughes; PhD (National Cancer Institute)|Joseph John Barchi (National Cancer Institute)|James A Kelley; PhD (National Cancer Institute),"Kenneth A Jacobson; BA, MS, PhD (NIDDK) |Adriaan  Bax; PhD (NIDDK)","1. Marquez V   (2008) The Properties of Locked Methanocarba Nucleosides in Biochemistry,  Biotechnology, and Medicinal Chemistry., in Modified Nucleosides: in Biochemistry, Biotechnology and Medicine. Herewijn P, ed., Wiley-VCH Verlag GmbH and Co. KGaA (Weinheim), pp. 307-341.|2. Comin MJ, Vu BC, Boyer PL, Liao C, Hughes SH, Marquez VE (2008). D-(+)-iso-methanocarbathymidine: a high-affinity substrate for herpes simplex virus 1 thymidine kinase. ChemMedChem  3, 1129-34.   https://doi.org/10.1002/cmdc.200800027|3. Ludek OR, Marquez VE (2012). Synthesis of conformationally North-locked pyrimidine nucleosides built on an oxabicyclo[3.1.0]hexane scaffold. J Org Chem  77, 815-24.   https://doi.org/10.1021/jo201716c|4. Marquez VE, Sun G, Siddiqui MA, Lee YC, Barchi JJ, Filippov IV, Landsman NA, Kelley JA (2008). What are the consequences of freezing the anomeric effect in nucleosides? Nucleic Acids Symp Ser (Oxf)   543-4  https://doi.org/10.1093/nass/nrn275|5. Saneyoshi H, Vu BC, Hughes SH, Boyer PL, Sarafianos SG, Marquez VE (2008). Synthesis of conformationally locked carbocyclic nucleoside phosphonates to probe the active site of HIV-1 RT. Nucleic Acids Symp Ser (Oxf)   623-4  https://doi.org/10.1093/nass/nrn315|6. Wierda RJ, Kuipers HF, van Eggermond MC, Benard A, van Leeuwen JC, Carluccio S, Geutskens SB, Jukema JW, Marquez VE, Quax PH, van den Elsen PJ (2012). Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors. J Cell Mol Med  16, 1866-77.   https://doi.org/10.1111/j.1582-4934.2011.01482.x",https://intramural.nih.gov/search/searchview.taf?ipid=50520
54,BC006177-23,"October 01, 2007 -  September 30, 2008",The Analytical Chemistry of Anti-AIDS Agents,James A Kelley; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Christopher Cong Lai,NULL,Victor  Marquez; PhD (National Cancer Institute)|Terrence R Burke; PhD (National Cancer Institute)|Yves  Pommier; PhD (National Cancer Institute)|Lawrence R Phillips (National Cancer Institute)|Joseph John Barchi (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50522
55,BC006178-23,"October 01, 2007 -  September 30, 2008",Applications of New Mass Spectral Techniques,James A Kelley; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Christopher Cong Lai,NULL,Victor  Marquez; PhD (National Cancer Institute)|Kirk R Gustafson; PhD (National Cancer Institute)|Lawrence R Phillips (National Cancer Institute),Serge  Beaucage (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50523
56,BC006192-20,"October 01, 2007 -  September 30, 2008",Investigating regulatory networks that control cell proliferation and apoptosis,Kurt  Kohn; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Sohyoung  Kim,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50524
57,BC006198-19,"October 01, 2007 -  September 30, 2008",Inhibitors of Tyrosine Kinase-Dependent Signalling as Anti-Cancer Agents,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Laboratory of Medicinal Chemistry, NCI",Fa  Liu|Sung-Eun  Kim|Joshua D Thomas|Medhanit  Bahta|Ulrike  Muus,NULL,David S Waugh; PhD (Protein Engineering Section)|Donald P Bottaro; PhD (National Cancer Institute),NULL,"1. Burke T, Shiga T, Yokuchi M, Yuzawa S, Inagaki F (2008) Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor. J. Biol. NMR, in press.|2. Liu F, Park JE, Lee KS, Burke TR (2009). Preparation of orthogonally protected (2S, 3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) as a phosphatase-stable phosphothreonine mimetic and its use in the synthesis of Polo-box domain-binding peptides. Tetrahedron  65, 9673-9679.   https://doi.org/10.1016/j.tet.2009.09.093",https://intramural.nih.gov/search/searchview.taf?ipid=50525
58,BC007333-17,"October 01, 2007 -  September 30, 2008",Pharmacology of HIV Viral DNA & Retroviral Integrases,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Christophe R Marchand|Ann  Orr|Keli  Agama|Kasthuraiah  Maddali|Jessica  Marinello,NULL,Robert  Yarchoan; MD (National Cancer Institute)|Terrence R Burke; PhD (National Cancer Institute)|Victor  Marquez; PhD (National Cancer Institute)|Stuart F J Le Grice; PhD (National Cancer Institute),NULL,"1. Pommier Y, Cardellina J, Collasanti A, Cook C, Currens M, Jobson A, Kondapaka S, Lountos G, Scudiero D, Self C, Shoemaker R, Waugh D, Zhang G (submitted in 2008) Kinase Inhibitors, Compositions Thereof And Method Of Use Therewith. Patents issued: 2008267081 (AU in 2013); 602008030357 (DE in 2014); 2155675 (EP in 2014); 2155675 (FR in 2014); 2155675 (GB in 2014); 8,765,802 (US in 2014); 2690410 (CA in 2015). Patent pending: PCT/US2008/007181 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=50526
59,BC007349-16,"October 01, 2007 -  September 30, 2008",New Cancer Drugs: Integrative Pharmacogenomics and Pharmacoproteomics,"John N Weinstein; MD, PhD",NULL,"Developmental Therapeutics Branch, NCI",Satoshi  Nishizuka|William Curtis Reinhold|Margot  Sunshine|Hong  Cao|David  Kane|Barry R Zeeberg; PhD|Show all 7,NULL,Natasha  Caplen (National Cancer Institute)|Paul  Goldsmith; PhD (National Cancer Institute)|Robert H Stephens (National Cancer Institute)|Stefan  Ambs (National Cancer Institute)|Mirit I Aladjem; PhD (National Cancer Institute)|Frank Jess Gonzalez; PhD (National Cancer Institute),"Peter Jonathan Munson; BA, MA, PhD (CIT) |Henry M. Fales; PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50527
60,BC007363-14,"October 01, 2007 -  September 30, 2008",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Laboratory of Medicinal Chemistry, NCI",Fa  Liu,NULL,Yves  Pommier; PhD (National Cancer Institute)|Eric O Freed; PhD (National Cancer Institute)|Vinay K Pathak; PhD (National Cancer Institute),NULL,"1. Burke T (2008) Application of protein modification to studying the structure and function of HIV-1 integrase and its inhibitors, in HIV-1 integrase: Mechanism and inhibitor design. Neamati N, ed, Wiley and Sons (Hoboken, NJ), in press.|2. Burke T, Burke T (2008) Application of protein modification to studying the structure and function of HIV-1 integrase and its inhibitors, in HIV-1 integrase: Mechanism and inhibitor design. Wiley and Sons (Hoboken, NJ), in press.|3. Burke T, Thomas J (2008) Synthesis of a homologous series of side chain extended orthogonally protected aminooxy-containing amino acids. Synthesis 2432-2438.",https://intramural.nih.gov/search/searchview.taf?ipid=50529
61,BC007365-14,"October 01, 2007 -  September 30, 2008",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Xiaoying  Jian; PhD|Hye-Young  Yoon|Fanny  Campa|Vi Luan  Ha|Hiroki  Inoue|Ruibai  Luo|Show all 7,NULL,Lino  Tessarollo (National Cancer Institute)|Carole A Parent; PhD (National Cancer Institute)|Ira  Daar; PhD (National Cancer Institute),"Kenneth Manao Yamada; MD, PhD (NIDCR) |Susette C Mueller; PhD (NIDCR) |James  Gruschus; PhD (NHLBI) |J Silvio  Gutkind; PhD (NIDCR)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50530
62,BC008226-32,"October 01, 2007 -  September 30, 2008",Prolactin Interactions in Mammary Gland Development and Tumorigenesis,Barbara V Vonderhaar; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI",Renqin  Duan|Erika P Ginsburg|Anita  Goldhar|Jennifer L Rudolph,NULL,Paul  Goldsmith; PhD (National Cancer Institute)|David  Salomon; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50532
63,BC008303-36,"October 01, 2007 -  September 30, 2008",Regulation of Membrane Fusion by Viral and Cellular Proteins and Lipids,Robert  Blumenthal; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Anu  Puri; PhD|Yossef  Raviv|Mathias  Viard|Benitra T Johnson|Himanshu  Garg|Julie M Belanger|Show all 7,"Javad  Aman (Medicine, USAMRID)|Assaf  Friedler (Hebrew University)|Alfredo  Garzino-Demo (Chemistry, University of Maryland Biotechnology Institute)|Robert  Hogan (Image Analysis Lab,Research Technology Program, University of Georgia)|Radha  Maheshwari (Dept of Pathology, Uniformed Services University of the Health Sciences)|Omar  Quraishi (Biochemistry and Medicine, Conjuchem Biotechnologies Inc.)|Show all 7","Ji Ming  Wang; MD, PhD (National Cancer Institute)|Vineet Narain KewalRamani; PhD (National Cancer Institute)|Jeffrey D Lifson; MD (National Cancer Institute)|Eric O Freed; PhD (National Cancer Institute)|Stephen J Lockett; PhD (National Cancer Institute)|Timothy D Veenstra (National Cancer Institute)",NULL,"1. Rawat SS, Zimmerman C, Johnson BT, Cho E, Lockett SJ, Blumenthal R, Puri A (2008). Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion. Mol Membr Biol  25, 83-94.   https://doi.org/10.1080/09687680701613713",https://intramural.nih.gov/search/searchview.taf?ipid=50534
64,BC008382-25,"October 01, 2007 -  September 30, 2008",Computational Approaches for RNA StructureFunction Determination,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Kazimierz Wojcieck Kasprzak|Eckart  Bindewald|Brett  Boyle|Mey  Khalili; PhD,"Juan  Arroyo (Developmental Biology, Mitre Corporation)|John  Casey (Microbiology and Immunology, Georgetown University)|Gregory  Chirikjian (Mechanical Engineering, Johns Hopkins University)|Hugo  Martinez (Consultant, SAIC)|R  Padmanabhan (Department of Microbiology and Immunology, Geogetown University School of Medicine)|Luiz  Penalva (Cellular and Structural Biology, Research Institute, University of Texas Health Science Center at San Antonio)|Show all 10",Yun  Wang (Nucleic Acid NMR Section)|Nancy H Colburn; PhD (National Cancer Institute)|Thomas Dana Schneider; PhD (National Cancer Institute)|Susan  Gottesman; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50535
65,BC008396-20,"October 01, 2007 -  September 30, 2008",Molecular Information Theory,Thomas Dana Schneider; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Ilya  Lyakhov|Danielle  Needle|Peyman  Khalichi; PhD|Adam C Diehl|Blake A Sweeney,"James  Adair (www.keystonenano.com, Keystone Nano)|Paul  Anagnostopoulos (-, Windfall Software)|Thorkell  Andresson|Raul Eduardo Cachau|King Cheung Chan|Zehua  Chen|Show all 17",David S Waugh; PhD (Protein Engineering Section)|Haleem  Issaq (National Cancer Institute)|Donald L Court; PhD (National Cancer Institute)|Ding Jun Jin (National Cancer Institute)|Mikhail V Kashlev (National Cancer Institute)|Jacek  Capala; PhD (National Cancer Institute),Martin  Gellert; PhD (NIDDK) |Gisela  Storz; PhD (NICHD),"1. Jeong JH, Kim HJ, Kim KH, Shin M, Hong Y, Rhee JH, Schneider TD, Choy HE (2012). An unusual feature associated with LEE1 P1 promoters in enteropathogenic Escherichia coli (EPEC). Mol Microbiol  83, 612-22.   https://doi.org/10.1111/j.1365-2958.2011.07956.x",https://intramural.nih.gov/search/searchview.taf?ipid=50536
66,BC008579-15,"October 01, 2007 -  September 30, 2008",Functional Analysis of Cancer Genes from Human Chromosome 3p,"Michael I Lerman; MD, PhD",NULL,"Basic Research Laboratory, NCI",Razi  Raziuddin,NULL,Lino  Tessarollo (National Cancer Institute),Richard  Childs; MD (NHLBI) |Arya  Biragyn; PhD (NIA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50537
67,BC008710-30,"October 01, 2007 -  September 30, 2008",Molecular Chaperones and DNA Replication,Sue H Wickner; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Joel R Hoskins|Matthew R Chenoweth; BA|Shannon M Doyle|Jodi  Camberg|Danielle M Johnston,NULL,Susan  Gottesman; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50461
68,BC008714-31,"October 01, 2007 -  September 30, 2008",Bacterial Functions Involved in Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Nadim  Majdalani|Colleen A Mccullen|Maude  Guillier|Pierre Marquis Mandin|Kyung  Moon|Nicholas  de Lay|Show all 7,NULL,Sue H Wickner; PhD (DNA Molecular Biology Section)|Yan Ning H Zhou (National Cancer Institute)|Xinhua  Ji; PhD (National Cancer Institute)|Michael  Maurizi; PhD (National Cancer Institute)|Peter C Fitzgerald (National Cancer Institute),Gisela  Storz; PhD (NICHD) |Stephen H Leppla; PhD (NIAID),"1. Bougdour A, Cunning C, Baptiste PJ, Elliott T, Gottesman S (2008). Multiple pathways for regulation of sigmaS (RpoS) stability in Escherichia coli via the action of multiple anti-adaptors. Mol Microbiol  68, 298-313.   https://doi.org/10.1111/j.1365-2958.2008.06146.x",https://intramural.nih.gov/search/searchview.taf?ipid=50538
69,BC008727-30,"October 01, 2007 -  September 30, 2008",Gene Expression and Signal Transduction in Transformation and Differentiation,J. Frederic Mushinski; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",James D Owens|Jason  Legrand,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50539
70,BC008751-28,"October 01, 2007 -  September 30, 2008",Regulation of Gene Transcription,Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Dale  Lewis; PhD|Rotem  Edgar|Andrei  Trostel|Sang Jun  Lee|Phuoc  Le|Zsolt  Csiszovszki|Show all 7,"Laura  Finzi (University of Milan)|Kim  Sneppen (Center for Models of Life, Niels Bohr Institute)",Victor  Zhurkin; PhD (National Cancer Institute),NULL,"1. Adhya SL, Court DL, Friedman DI, Gottesman ME (2008). Amos Oppenheim (31 October 1934 to 24 September 2006). Mol Microbiol  67, 685-6.   https://doi.org/10.1111/j.1365-2958.2007.06097.x|2. Edgar R, Rokney A, Feeney M, Semsey S, Kessel M, Goldberg MB, Adhya S, Oppenheim AB (2008). Bacteriophage infection is targeted to cellular poles. Mol Microbiol  68, 1107-16.   https://doi.org/10.1111/j.1365-2958.2008.06205.x|3. Lewis DE, Komissarova N, Le P, Kashlev M, Adhya S (2008). DNA sequences in gal operon override transcription elongation blocks. J Mol Biol  382, 843-58.   https://doi.org/10.1016/j.jmb.2008.07.060|4. Lia G, Semsey S, Lewis DE, Adhya S, Bensimon D, Dunlap D, Finzi L (2008). The antiparallel loops in gal DNA. Nucleic Acids Res  36, 4204-10.   https://doi.org/10.1093/nar/gkn389|5. Rokney A, Kobiler O, Amir A, Court DL, Stavans J, Adhya S, Oppenheim AB (2008). Host responses influence on the induction of lambda prophage. Mol Microbiol  68, 29-36.   https://doi.org/10.1111/j.1365-2958.2008.06119.x",https://intramural.nih.gov/search/searchview.taf?ipid=50540
71,BC008752-28,"October 01, 2007 -  September 30, 2008",Thyroid Hormone Receptors in Health and Disease,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Li  Zhao|Osamu  Araki|Celine Julie Guigon|Changxue  Lu|Laura  Fozzatti|Xuguang  Zhu,"CAROLINE  KIM (Tufts University)|CHRIS  MCCABE (University of Birmingham)|G.R.  Williams (Imperial College London, Imperial College London)|Mark  Willingham (Wake Forest University School of Medicine)","Paul S Meltzer; MD, PhD (National Cancer Institute)|Chandramouli  Gadisetti (National Cancer Institute)",John Allan Hanover; PhD (NIDDK),"1. Guigon CJ, Zhao L, Lu C, Willingham MC, Cheng SY (2008). Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor. Mol Cell Biol  28, 4598-608.   https://doi.org/10.1128/MCB.02192-07|2. Lu C, Willingham MC, Furuya F, Cheng SY (2008). Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumors. Endocrinology  149, 3339-45.   https://doi.org/10.1210/en.2007-1696|3. Ying H, Willingham MC, Cheng SY (2008). The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer. Oncogene  27, 823-30.   https://doi.org/10.1038/sj.onc.1210680",https://intramural.nih.gov/search/searchview.taf?ipid=50541
72,BC008753-26,"October 01, 2007 -  September 30, 2008",Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Masanori  Onda|Richard A Beers|Qing cheng F Wang|Laiman  Xiang|Tapan K Bera|Xing  Du|Show all 9,NULL,"David J Fitzgerald; PhD (National Cancer Institute)|Raffit  Hassan (National Cancer Institute)|Robert J Kreitman; MD, PhD (National Cancer Institute)",NULL,"1. Das S, Hahn Y, Walker DA, Nagata S, Willingham MC, Peehl DM, Bera TK, Lee B, Pastan I (2008). Topology of NGEP, a prostate-specific cell:cell junction protein widely expressed in many cancers of different grade level. Cancer Res  68, 6306-12.   https://doi.org/10.1158/0008-5472.CAN-08-0870|2. Du X, Beers R, Fitzgerald DJ, Pastan I (2008). Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity. Cancer Res  68, 6300-5.   https://doi.org/10.1158/0008-5472.CAN-08-0461|3. Du X, Nagata S, Ise T, Stetler-Stevenson M, Pastan I (2008). FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins. Blood  111, 338-43.   https://doi.org/10.1182/blood-2007-07-102350|4. Epel M, Carmi I, Soueid-Baumgarten S, Oh S, Bera T, Pastan I, Berzofsky J, Reiter Y (2008). Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies. Eur J Immunol  38, 1706-20.   https://doi.org/10.1002/eji.200737524|5. Hafkemeyer P, Brinkmann U, Brinkmann E, Pastan I, Blum HE, Baumert TF (2008). Pseudomonas exotoxin antisense RNA selectively kills hepatitis B virus infected cells. World J Gastroenterol  14, 2810-7.   https://doi.org/10.3748/wjg.14.2810|6. Khaibullina A, Jang BS, Sun H, Le N, Yu S, Frenkel V, Carrasquillo JA, Pastan I, Li KC, Paik CH (2008). Pulsed high-intensity focused ultrasound enhances uptake of radiolabeled monoclonal antibody to human epidermoid tumor in nude mice. J Nucl Med  49, 295-302.   https://doi.org/10.2967/jnumed.107.046888|7. Onda M, Beers R, Xiang L, Nagata S, Wang QC, Pastan I (2008). An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes. Proc Natl Acad Sci U S A  105, 11311-6.   https://doi.org/10.1073/pnas.0804851105|8. Bigner DD, Kuan CD, Pastan ID, Pegram CD (submitted in 2008) Dual Specific Immunotoxin For Brain Tumor Therapy. Patent issued: 9,492,564 (US in 2017). Patents pending: 15/290,040 (US application); 12/418,975 (US application); 13/482,406 (US application).|9. Dimitrov DS, Feng YS, Pastan IS (submitted in 2008) Human Anti-mesothelin Monoclonal Antibodies. Patent issued: 8,357,783 (US in 2013). Patents pending: 09726082.2 (EP application); PCT/US2009/038228 (PC application); 2009228361 (AU application); 2,718,321 (CA application).|10. Dimitrov DS, Pastan IS, Xiao XS (submitted in 2008) Human Monoclonal Antibodies Specific For Cd22. Patents issued: 8,591,889 (US in 2014); 9,279,019 (US in 2016); 9,598,492 (US in 2017). Patents pending: 15/424,238 (US application); PCT/US2009/039080 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=50542
73,BC008756-21,"October 01, 2007 -  September 30, 2008",Genetically Engineered Mouse Models to Study RTK Function in Melanoma,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yanlin  Yu|Richard D Sharp|Chi-Ping  Day,NULL,"Javed  Khan; MD (National Cancer Institute)|Melinda  Hollingshead (National Cancer Institute)|Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)|Miriam R Anver (National Cancer Institute)|Chand  Khanna; MD (National Cancer Institute)",NULL,"1. Fisher DE, Medrano EE, McMahon M, Soengas MS, Schuchter L, Wolchok JD, Merlino G (2008). Meeting report: fourth international congress of the Society for Melanoma Research. Pigment Cell Melanoma Res  21, 15-26.   https://doi.org/10.1111/j.1755-148X.2007.00437.x",https://intramural.nih.gov/search/searchview.taf?ipid=50543
74,BC008757-21,"October 01, 2007 -  September 30, 2008",Bio-Therapies for the Treatment of Cancer and Infectious Disease,David J Fitzgerald; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Robert J Sarnovsky|Diana  Pastrana|Ashima K Sharma,NULL,Ira H Pastan; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50544
75,BC008905-27,"October 01, 2007 -  September 30, 2008",Tumor gene expression in vitro and in vivo,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI","Richard B Braverman|Alex  Papageorge|Xiaolan  Qian; MD, PhD|William C Vass|Laura  Asnaghi|Guorong  Li",NULL,Kent W Hunter; PhD (National Cancer Institute)|Nicolae C Popescu; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50546
76,BC009003-26,"October 01, 2007 -  September 30, 2008",The Role of Cripto in the Pathogenesis of Breast and Colon Cancer,David  Salomon; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI",Caterina  Bianco; MD|Mario  Mancino|Kazuhide  Watanabe|Tadahiro  Nagaoka|Monica I Gonzales|Subha  Perni,"Gabriella  Minchiotti (CNR, Institute of Genetics)|Masaharu  Seno (Biotechnology, Okayama University)",NULL,NULL,"1. Cuttitta F, Avis I, Salomon D (submitted in 2008) Apelin Peptides And Methods Of Use. Patent issued: 8,946,382 (US in 2015). Patent pending: 14/593,099 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=50548
77,BC009052-19,"October 01, 2007 -  September 30, 2008",Papillomavirus Virion Proteins and Vaccines,John  Schiller; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Cynthia D Thompson|Patricia  Day; PhD|Rhonda C Kines|Nicolas  Cuburu; PhD|Rebecca  Cerio,"Bryce C Chackerian|Denise  Nardelli-Haefliger (Centre Hospitalier Universitaire Vaudois)|Richard  Roden (Pathology, Johns Hopkins University)",Allan  Hildesheim; PhD (National Cancer Institute)|Ligia  Pinto (Infection & Immunoepidemiology Branch)|Peter L Choyke; MD (National Cancer Institute)|Christopher  Buck (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50550
78,BC009101-16,"October 01, 2007 -  September 30, 2008",Design of Antiviral Drugs Effective Against the HIV-1 Virus,Ettore  Appella; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Lisa Marie Jenkins|Ryo  Hayashi|Mark M Slabodnick,"Cecilia  Cheng-Mayer (The Aaron Diamond AIDS Research Center, Rockefeller University)|Robin  Shattock; PhD (St George's Hospital Medical School)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50551
79,BC009254-34,"October 01, 2007 -  September 30, 2008",Structure and Function of Toll-like Receptors,David M Segal; PhD,NULL,"Experimental Immunology Branch, NCI",Joshua  Leonard|Charles  Ho|Yan  Wang,NULL,NULL,"David Harvey Margulies; MD, PhD (NIAID) |David R Davies; PhD (NIDDK)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50552
80,BC009255-33,"October 01, 2007 -  September 30, 2008",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Anthony J Adams|Larry  Granger|Don  Plugge,NULL,NULL,NULL,"1. Catalfamo M, Tai X, Karpova T, McNally J, Henkart PA (2008). TcR-induced regulated secretion leads to surface expression of CTLA-4 in CD4+CD25+ T cells. Immunology  125, 70-9.   https://doi.org/10.1111/j.1365-2567.2008.02822.x|2. Chiang YJ, Hsiao SJ, Yver D, Cushman SW, Tessarollo L, Smith S, Hodes RJ (2008). Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development. PLoS One  3, e2639.   https://doi.org/10.1371/journal.pone.0002639|3. Dubois S, Patel HJ, Zhang M, Waldmann TA, Müller JR (2008). Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action. J Immunol  180, 2099-106.   https://doi.org/10.4049/jimmunol.180.4.2099|4. Leonard JN, Ghirlando R, Askins J, Bell JK, Margulies DH, Davies DR, Segal DM (2008). The TLR3 signaling complex forms by cooperative receptor dimerization. Proc Natl Acad Sci U S A  105, 258-63.   https://doi.org/10.1073/pnas.0710779105|5. Lutsiak ME, Tagaya Y, Adams AJ, Schlom J, Sabzevari H (2008). Tumor-induced impairment of TCR signaling results in compromised functionality of tumor-infiltrating regulatory T cells. J Immunol  180, 5871-81.   https://doi.org/10.4049/jimmunol.180.9.5871|6. Patino-Lopez G, Dong X, Ben-Aissa K, Bernot KM, Itoh T, Fukuda M, Kruhlak MJ, Samelson LE, Shaw S (2008). Rab35 and its GAP EPI64C in T cells regulate receptor recycling and immunological synapse formation. J Biol Chem  283, 18323-30.   https://doi.org/10.1074/jbc.M800056200|7. Puri N, Roche PA (2008). Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc Natl Acad Sci U S A  105, 2580-5.   https://doi.org/10.1073/pnas.0707854105|8. Terabe M, Tagaya Y, Zhu Q, Granger L, Roederer M, Waldmann TA, Berzofsky JA (2008). IL-15 expands unconventional CD8alphaalphaNK1.1+ T cells but not Valpha14Jalpha18+ NKT cells. J Immunol  180, 7276-86.   https://doi.org/10.4049/jimmunol.180.11.7276|9. Walseng E, Bakke O, Roche PA (2008). Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway. J Biol Chem  283, 14717-27.   https://doi.org/10.1074/jbc.M801070200|10. Williams JA, Lumsden JM, Yu X, Feigenbaum L, Zhang J, Steinberg SM, Hodes RJ (2008). Regulation of thymic NKT cell development by the B7-CD28 costimulatory pathway. J Immunol  181, 907-17.   https://doi.org/10.4049/jimmunol.181.2.907",https://intramural.nih.gov/search/searchview.taf?ipid=50462
81,BC009257-33,"October 01, 2007 -  September 30, 2008",Mechanisms of Cellular Immune Responses,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Khadija  Ben-aissa,NULL,Michael John Kruhlak; PhD (National Cancer Institute)|Philip J Lucas; PhD (National Cancer Institute)|Lawrence Elliot Samelson; MD (National Cancer Institute)|Kelsie M Bernot (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50553
82,BC009262-26,"October 01, 2007 -  September 30, 2008",Immunophysiological Mechanisms in the Biological Therapy of Cancer,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Jeffrey J Subleski|Jonathan  Weiss|Tim  Chan|Jimmy  Stauffer|Anthony J Scarzello|Show all 7,NULL,John R Ortaldo; PhD (National Cancer Institute)|Howard A Young; PhD (National Cancer Institute)|Curtis  Harris; MD (National Cancer Institute)|William Marston Linehan; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50554
83,BC009264-25,"October 01, 2007 -  September 30, 2008",Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Daniel C Bertolette|Maria  Birchenall-Roberts|Tao  Fu|Yi  Huang|Cari  Sadowski,"Steven  Bartelmez (stem cell biology, Betastem Therapeutics)|David  Danielpour (NCI)|Pat  Iversen (AVI-Biopharma)|John  Letterio (Pediatric Oncology, Case Western Medical Center)",Seong-Jin  Kim; PhD (National Cancer Institute)|Lalage  Wakefield; PhD (National Cancer Institute),NULL,"1. Ruscetti F   (2008) Role of TGF-beta in myeloid and lympoid homeostatis., in The TGF-beta Family. Derynck R, ed., Cold Spring Harbor Press (NY), pp. 789-818.|2. Ruscetti F, Birchenall-Roberts M, Cao Z, Roberts A   (2008) Smad Signaling in Leukemic Growth and Differentiation., in Transforming Growth Factor-beta in Cancer Therapy. Jakowlew S, ed., Humana Press (Totowa NJ), pp. 247-261.",https://intramural.nih.gov/search/searchview.taf?ipid=50555
84,BC009265-26,"October 01, 2007 -  September 30, 2008",Analysis of the T Cell Repertoire,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karen  Hathcock|Joy A Williams|Sarah Rhiannon Jenkinson|Jingjing  Zhang,NULL,Lionel  Feigenbaum (Office Of The Director),NULL,"1. Williams JA, Lumsden JM, Yu X, Feigenbaum L, Zhang J, Steinberg SM, Hodes RJ (2008). Regulation of thymic NKT cell development by the B7-CD28 costimulatory pathway. J Immunol  181, 907-17.   https://doi.org/10.4049/jimmunol.181.2.907",https://intramural.nih.gov/search/searchview.taf?ipid=50556
85,BC009267-26,"October 01, 2007 -  September 30, 2008",Immune ProtectionDysregulation in HIVAIDS,Gene  Shearer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Adriano  Boasso,"Jan  Andersson (Medicine, Karolinska Institutet)|Claire  Chougnet (Molecular Immunology, Children's Hospital)|Fuchs  Dietmar (Chemestry and Biochemestry, Innsbruck Medical University)|Matthew  Dolan (AIDS, Wilford Hall Med Inst)|Jean-Philippe  Herbeuval",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50557
86,BC009273-21,"October 01, 2007 -  September 30, 2008",T Cell Differentiation and Repertoire Selection,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Amala Shenai Alag|Terry I Guinter|Jung-Hyun  Park|Xuguang C Tai|Francois  Van Laethem|Stanley  Adoro|Show all 8,"Wilfried  Ellmeier (Immunology, University of Vienna)|Batu M Erman|Deitmar  Kappes (Immunology, Fox Chase Cancer Center)|David  McKean (Immunology, Mayo Clinic)|Sophia D Sarafova (NCI)|Arlene  Sharpe (Dept of Pathology, Harvard Medical School)|Show all 7","Remy J Bosselut; MD, PhD (National Cancer Institute)|Lionel  Feigenbaum (Office Of The Director)|Dinah  Singer; PhD (National Cancer Institute)","Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50558
87,BC009279-23,"October 01, 2007 -  September 30, 2008",Regulation of Expression of MHC Class I Genes,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Jocelyn D Weissman|Jie  Mu|Anat  Ohali,NULL,Brian  Lewis (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50559
88,BC009281-22,"October 01, 2007 -  September 30, 2008",Receptor Mediated T and B Cell Activation,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Yungping  Chiang|Sumeena  Bhatia,"Hua  Gu (Microbiology, Columbia University)|Gary  Koretsky (School of Medicine, University of Pennsylvania)|Arlene  Sharpe (Dept of Pathology, Harvard Medical School)",NULL,NULL,"1. Chiang JY, Jang IK, Hodes R, Gu H (2007). Ablation of Cbl-b provides protection against transplanted and spontaneous tumors. J Clin Invest  117, 1029-36.   https://doi.org/10.1172/JCI29472|2. Song H, Zhang J, Chiang YJ, Siraganian RP, Hodes RJ (2007). Redundancy in B cell developmental pathways: c-Cbl inactivation rescues early B cell development through a B cell linker protein-independent pathway. J Immunol  178, 926-35.   https://doi.org/10.4049/jimmunol.178.2.926",https://intramural.nih.gov/search/searchview.taf?ipid=50560
89,BC009283-24,"October 01, 2007 -  September 30, 2008",Control of Cytokine Gene Expression in LymphoidMyeloid Cells,Howard A Young; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Deborah L Hodge|Della A Reynolds|Michael E Sanford|Ram  Savan|Catriona T Miller|Paul M Schaughency,NULL,"George N Pavlakis; MD, PhD (National Cancer Institute)|Dennis M Klinman; MD, PhD (National Cancer Institute)|Thomas Joseph Sayers; PhD (National Cancer Institute)|Daniel  McVicar; PhD (National Cancer Institute)|Robert  Wiltrout; PhD (National Cancer Institute)|Victor  Marquez; PhD (ORGANIC CHEMSTRY SECT)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50561
90,BC009285-22,"October 01, 2007 -  September 30, 2008",Responses of MHC Class I Genes to Exogeneous Stimuli,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Aparna  Kotekar|Jie  Mu|Anat  Ohali,"Leonard  Kohn (Edison Biotechnology Institue, Ohio State Universit)|Martin  Villalba (Institut de Génétique Moléculaire de Montpellier (IGMM))",Xuguang C Tai (National Cancer Institute)|Alfred  Singer; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50562
91,BC009287-24,"October 01, 2007 -  September 30, 2008",Cytokines and T Cell Development,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Julie  Hixon|Ashraf Omar Abdel Aziz El Fiky|Wei  Shen,NULL,Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Jonathan  Keller; PhD (Cancer and Developmental Biology Laboratory),NULL,"1. Mazzucchelli R, Hixon JA, Spolski R, Chen X, Li WQ, Hall VL, Willette-Brown J, Hurwitz AA, Leonard WJ, Durum SK (2008). Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP. Blood  112, 3283-92.   https://doi.org/10.1182/blood-2008-02-137414|2. Wuest TY, Willette-Brown J, Durum SK, Hurwitz AA (2008). The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells. J Leukoc Biol  84, 973-80.   https://doi.org/10.1189/jlb.1107778",https://intramural.nih.gov/search/searchview.taf?ipid=50563
92,BC009297-17,"October 01, 2007 -  September 30, 2008",Ubiquitin And SUMO Post-Translational Modifications In Development And Disease,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",George T Lezin|Margaret M O'Toole-Lualdi,NULL,Allan M Weissman; MD (National Cancer Institute)|Kent W Hunter; PhD (National Cancer Institute),NULL,"1. Kuehn M, Sharma P, Lockett S, Lualdi M   (2008) Loss of SUMO-1 in mice affects RanGAP1 perinuclear localization and PML nuclear  body formation but is not lethal due to compensation by SUMO-2/3.  Journal of Cell Science, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50564
93,BC009304-14,"October 01, 2007 -  September 30, 2008",Structure-Function Studies and Design of Novel Glycosyltransferases,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Boopathy  Ramakrishna|Marta  Pasek|Maria Rita Manzoni|Holly M Roumeliotis|Christina J Randall,NULL,NULL,NULL,"1. Qasba PK, Boeggeman E, Ramakrishnan B (2008). Site-specific linking of biomolecules via glycan residues using glycosyltransferases. Biotechnol Prog  24, 520-6.   https://doi.org/10.1021/bp0704034|2. Ramakrishnan B, Boeggeman E, Qasba PK (2008). Applications of glycosyltransferases in the site-specific conjugation of biomolecules and the development of a targeted drug delivery system and contrast agents for MRI. Expert Opin Drug Deliv  5, 149-53.   https://doi.org/10.1517/17425247.5.2.149",https://intramural.nih.gov/search/searchview.taf?ipid=50565
94,BC009322-20,"October 01, 2007 -  September 30, 2008",Mechanisms of Leukocyte Migration Following Cytokine Administration to Mice,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Jeffrey J Subleski|Tim  Chan|Jimmy  Stauffer|Anthony J Scarzello|Veronica L Hall,NULL,"John R Ortaldo; PhD (National Cancer Institute)|Curtis  Harris; MD (National Cancer Institute)|Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)|William Marston Linehan; MD (National Cancer Institute)",NULL,"1. Hussain SP, He P, Subleski J, Hofseth LJ, Trivers GE, Mechanic L, Hofseth AB, Bernard M, Schwank J, Nguyen G, Mathe E, Djurickovic D, Haines D, Weiss J, Back T, Gruys E, Laubach VE, Wiltrout RH, Harris CC (2008). Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res  68, 7130-6.   https://doi.org/10.1158/0008-5472.CAN-08-0410",https://intramural.nih.gov/search/searchview.taf?ipid=50566
95,BC009369-18,"October 01, 2007 -  September 30, 2008",Studies of Chemokine-Receptor Interactions with Chemokines and alarmins,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Ola Mae Zack Howard|De  Yang|Poonam  Tewary|Gonzalo  De La Rosa,NULL,Michael  Bustin; PhD (National Cancer Institute)|Arthur A Hurwitz (National Cancer Institute)|Stuart H Yuspa; MD (National Cancer Institute),"Rachel R Caspi; PhD (NEI) |Helene Fischer Rosenberg; PhD, MD (NIAID)","1. Yang D, Bustin M, Oppenheim J (submitted in 2008) Hmgn Polypeptides As Immune Enhancers And Hmgn Antagonists As Immune Suppressants. Patents issued: 8,227,417 (US in 2012); 9,567,566 (US in 2017). Patent pending: 15/191,000 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=50567
96,BC009392-15,"October 01, 2007 -  September 30, 2008",Determining the Fate of Transmembrane Proteins,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Jennifer B Mariano|Yien-Che  Tsai|Mickael M Cohen|Guillaume  Leboucher|Mary  Braun; PhD|Rhyan P Maditz,NULL,"John A Beutler (National Cancer Institute)|Chand  Khanna; MD (Pediatric Oncology Br)|Robert Andrew Byrd (National Cancer Institute)|Lee Jay Helman; MD (National Cancer Institute)|Walter M Kuehl; MD, PhD (National Cancer Institute)",NULL,"1. Das R, Mariano J, Tsai YC, Kalathur RC, Kostova Z, Li J, Tarasov SG, McFeeters RL, Altieri AS, Ji X, Byrd RA, Weissman AM (2009). Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78. Mol Cell  34, 674-85.   https://doi.org/10.1016/j.molcel.2009.05.010",https://intramural.nih.gov/search/searchview.taf?ipid=50445
97,BC009404-14,"October 01, 2007 -  September 30, 2008",Regulation of MHC Class II Trafficking in Antigen Presenting Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Even  Walseng|Adam  Berger|Karis  Faust|Kazuyuki  Furuta,"Oddmund  Bakke (Biology, Univ. of Oslo)|Lisa  Denzin (Immunology Program, Sloan-Kettering Institute)|Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering)|Sidney  Whiteheart (Mol. and Cellular Biochemistry, Univ. of Kentucky)",Lionel  Feigenbaum (Office Of The Director),Katherine Walton Roche; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50568
98,BC009405-14,"October 01, 2007 -  September 30, 2008",Regulation of Lymphocyte Proliferation and Replicative Capacity,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Yungping  Chiang|Karen  Hathcock,NULL,Lino  Tessarollo (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50569
99,BC010001-13,"October 01, 2007 -  September 30, 2008",MolecularCellular Regulation of Hematopoiesis,Jonathan  Keller; PhD,NULL,"Laboratory of Cancer Prevention, NCI",NULL,NULL,Howard A Young; PhD (National Cancer Institute)|Steven X Hou (National Cancer Institute)|Serguei V Kozlov (National Cancer Institute)|Laura  Schmidt (National Cancer Institute)|Terence P Yamaguchi; PhD (National Cancer Institute),NULL,"1. Ludlow LE, Purton LE, Klarmann K, Gough DJ, Hii LL, Trapani JA, Keller JR, Clarke CJ, Johnstone RW (2008). The role of p202 in regulating hematopoietic cell proliferation and differentiation. J Interferon Cytokine Res  28, 5-11.   https://doi.org/10.1089/jir.2007.0070",https://intramural.nih.gov/search/searchview.taf?ipid=50570
100,BC010003-13,"October 01, 2007 -  September 30, 2008",Molecular Mechanisms of HTLV-1 Infection and Replication,David  Derse; PhD,NULL,"Retroviral Replication Laboratory, NCI",Gisela H Fanning-Heidecker|Patricia A Lloyd|Gerald L Princler|Anna N Ilinskaya|Vladimir  Pak,"Madeleine  Duc Dodon (-, Ecole Normale Superieure de Lyon)|Henrik  Garoff (Karolinska Institute)|Reuben  Harris (Biochemistry, University of Minnesota)|Walther  Mothes (Yale University)|Karin  Musier-Forsyth (Ohio State University)|William  Switzer (-, Centers for Disease Control and Prevention)",Xiaolin  Wu; PhD (Office Of The Director)|Alan  Rein; PhD (National Cancer Institute)|Stephen H Hughes; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50571
101,BC010006-13,"October 01, 2007 -  September 30, 2008",Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways,Ira  Daar; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Kathleen T Soria|Hyun-Shik  Lee|Yon Ju  Ji|Arvinder J Singh,NULL,Lino  Tessarollo (National Cancer Institute),NULL,"1. Bong YS, Lee HS, Carim-Todd L, Mood K, Nishanian TG, Tessarollo L, Daar IO (2007). ephrinB1 signals from the cell surface to the nucleus by recruitment of STAT3. Proc Natl Acad Sci U S A  104, 17305-10.   https://doi.org/10.1073/pnas.0702337104",https://intramural.nih.gov/search/searchview.taf?ipid=50572
102,BC010008-13,"October 01, 2007 -  September 30, 2008",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Shuling  Zhang; MD, PhD|Richard C Robinson|Jyoti  Patel|Laura A Roth",NULL,Carole A Parent; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50573
103,BC010012-13,"October 01, 2007 -  September 30, 2008",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Alan  Brooks|Anil  Shanker,"Hyam  Levitsky (Department of Oncology, Johns Hopkins University)|Linda A Sherman|Hideo  Yagita (Immunology, Juntendo University)",Robert  Wiltrout; PhD (National Cancer Institute),William T Murphy (OD),"1. Hallett WH, Ames E, Motarjemi M, Barao I, Shanker A, Tamang DL, Sayers TJ, Hudig D, Murphy WJ (2008). Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition. J Immunol  180, 163-70.   https://doi.org/10.4049/jimmunol.180.1.163|2. Shanker A, Brooks AD, Tristan CA, Wine JW, Elliott PJ, Yagita H, Takeda K, Smyth MJ, Murphy WJ, Sayers TJ (2008). Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody. J Natl Cancer Inst  100, 649-62.   https://doi.org/10.1093/jnci/djn113|3. Sun K, Li M, Sayers TJ, Welniak LA, Murphy WJ (2008). Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation. Blood  112, 1522-9.   https://doi.org/10.1182/blood-2008-03-143461",https://intramural.nih.gov/search/searchview.taf?ipid=50574
104,BC010013-13,"October 01, 2007 -  September 30, 2008",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Paul  Wright|Neeraj  Sharma|Veronique  Pascal,"Colin  Brooks (School of Biosciences, University of Newcastle)|Kerry  Campbell (Immunobiology, Fox Chase Cancer Institute)|Dan  Kaufman (Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center)|Andrew  Makrigiannis (Lab of Molecular Immunology, ICRM)|Jeffrey  Miller (Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center)",Daniel  McVicar; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50575
105,BC010014-13,"October 01, 2007 -  September 30, 2008",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,NULL,"Laboratory of Cancer Prevention, NCI",Theresa M Geiman|Sichuan  Xi|Victorino Cristito Robles Briones,NULL,Jonathan  Keller; PhD (National Cancer Institute)|Sandra  Ruscetti; PhD (National Cancer Institute),NULL,"1. Fan T, Schmidtmann A, Xi S, Briones V, Zhu H, Suh HC, Gooya J, Keller JR, Xu H, Roayaei J, Anver M, Ruscetti S, Muegge K (2008). DNA hypomethylation caused by Lsh deletion promotes erythroleukemia development. Epigenetics  3, 134-42.   https://doi.org/10.4161/epi.3.3.6252",https://intramural.nih.gov/search/searchview.taf?ipid=50576
106,BC010015-13,"October 01, 2007 -  September 30, 2008",The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",Nancy M Dunlop|Wang-Hua  Gong|Jian  Huang,NULL,NULL,NULL,"1. Huang J, Chen K, Gong W, Zhou Y, Le Y, Bian X, Wang JM (2008). Receptor ""hijacking"" by malignant glioma cells: a tactic for tumor progression. Cancer Lett  267, 254-61.   https://doi.org/10.1016/j.canlet.2008.03.014",https://intramural.nih.gov/search/searchview.taf?ipid=50577
107,BC010017-13,"October 01, 2007 -  September 30, 2008","Using Bacteriophages to Prevent, Diagnose, and Treat Diseases",Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Rotem  Edgar|Catherine  Bair,NULL,NULL,NULL,"1. Bair CL, Oppenheim A, Trostel A, Prag G, Adhya S (2008). A phage display system designed to detect and study protein-protein interactions. Mol Microbiol  67, 719-28.   https://doi.org/10.1111/j.1365-2958.2007.06077.x",https://intramural.nih.gov/search/searchview.taf?ipid=50578
108,BC010020-13,"October 01, 2007 -  September 30, 2008",Clinical Trials with Immunotoxins,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Linda  Ellison-Dejewski|Barbara  Debrah|Elizabeth J Maestri|Barbara S Schuler,NULL,"David J Fitzgerald; PhD (National Cancer Institute)|Wyndham H Wilson; MD, PhD (National Cancer Institute)|Alan S Wayne; MD (National Cancer Institute)|Raffit  Hassan (National Cancer Institute)|Robert J Kreitman; MD, PhD (National Cancer Institute)",NULL,"1. Sampson JH, Akabani G, Archer GE, Berger MS, Coleman RE, Friedman AH, Friedman HS, Greer K, Herndon JE, Kunwar S, McLendon RE, Paolino A, Petry NA, Provenzale JM, Reardon DA, Wong TZ, Zalutsky MR, Pastan I, Bigner DD (2008). Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors. Neuro Oncol  10, 320-9.   https://doi.org/10.1215/15228517-2008-012",https://intramural.nih.gov/search/searchview.taf?ipid=50579
109,BC010021-13,"October 01, 2007 -  September 30, 2008",Biology of Mammary Gland Development and Tumorigenesis,Gilbert  Smith; PhD|IRP Faculty Profile,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI",Corinne A Boulanger-Espeut|David L Mack|Brian  Booth,NULL,David  Salomon; PhD (National Cancer Institute)|Barbara V Vonderhaar; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50580
110,BC010022-13,"October 01, 2007 -  September 30, 2008",Genetics of Renal Disease in African Americans,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI",Elizabeth  Binns-Roemer|Yu-Chun  Zhou|Jamba  Maidar,NULL,George  Nelson (National Cancer Institute),Jeffrey Burnett Kopp; MD (NIDDK) |Paul Lawrence Kimmel (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50581
111,BC010025-13,"October 01, 2007 -  September 30, 2008",The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention,Nancy H Colburn; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Glenn  Hegamyer|Matthew R Young; PhD|Alyson R Baker|Moon-Il  Kang|Gerd  Bobe|Roycelynn  Mentor-Marcel|Show all 8,"George  Beck (Emory University)|Powel  Brown (Baylor Breast Center, Baylor College of Medicine)|Robert  Chapkin (Texas A&M)|Terry  Hartman (Penn State Univ)",Peter L Choyke; MD (National Cancer Institute)|Curtis  Henrich (National Cancer Institute),NULL,"1. Bobe G, Barrett KG, Mentor-Marcel RA, Saffiotti U, Young MR, Colburn NH, Albert PS, Bennink MR, Lanza E (2008). Dietary cooked navy beans and their fractions attenuate colon carcinogenesis in azoxymethane-induced ob/ob mice. Nutr Cancer  60, 373-81.   https://doi.org/10.1080/01635580701775142|2. Colburn N (2008) Targeting transcription factors for cancer prevention - the case of Nrf2. Cancer Prevention Research 153-155.|3. Colburn N, Uray I, Li Y, Zhang Y, Hill J, Xu X, Young M, Gunther E, Hilsenbeck S, Chodosh L, Brown P (2008) Targeting the activator protein 1 transcription factor for the prevention of estrogen receptor-negative mammary tumors. Cancer Prevention Research 45-55.|4. Henrich C, Bokesch H, Colburn N, Gustafson K, Kang M, McMahon J, Young M (submitted in 2008) Nuclear Factor Kappa B Pathway Inhibitor Composition And Use Of Same. Patent issued: 8,729,053 (US in 2014). Patents pending: 09792812.1 (EP application); PCT/US09/57761 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=50582
112,BC010026-13,"October 01, 2007 -  September 30, 2008","The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression",Nancy H Colburn; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Glenn  Hegamyer|Matthew R Young; PhD|Alyson R Baker|Arti  Santhanam|Brett D Hollingshead,"Heike  Allgayer (University of Munich)|Myung  Cho (Laboratory of Toxicology, Seoul National University)|Gabriel  Lopez-Berestein (MD Anderson Cancer Ctr)|Michele  Pagano (New York Univ)|Nahum  Sonenberg (McGill University)|Ana  Tari (Department of Experimental Therapeutics, M.D. Anderson Cancer Center)",Bruce Allen Shapiro; PhD (National Cancer Institute)|Alexander  Wlodawer; PhD (National Cancer Institute)|Stuart F J Le Grice; PhD (National Cancer Institute)|Curtis  Henrich (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50583
113,BC010027-14,"October 01, 2007 -  September 30, 2008",Function of Steroid Receptors in Subcellular Compartments,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Ty Cole Voss|Anuja  George,NULL,Angie  Dull (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50584
114,BC010030-13,"October 01, 2007 -  September 30, 2008",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,Suresh V Ambudkar; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI","Zuben  Sauna; PhD|Suneet  Shukla|Luciann L Cuenca|Shinobu  Ohnuma; MD, PhD","Maria  Baer (Medicine, Roswell Park Cancer Institute)|Catherine  Booth-Genthe (Pharamcokinetics and drug metabolism, Amgen, Inc.)|Zhe-Sheng  Chen (Pharmaceutical Sciences, St. John's University)|Peter  Chiba (Inst Med Chem, Med Univ Vienna)|John E Golin|Rajendra  Prasad (School of Biological Sciences, Jawaharlal Nehru University)|Show all 7",Lyuba  Varticovski (National Cancer Institute)|Michael Marc Gottesman; MD (National Cancer Institute)|Susan  Bates; MD (National Cancer Institute)|Michael  Dean; PhD (National Cancer Institute)|Peter C Fitzgerald (National Cancer Institute),NULL,"1. Ambudkar S, Calcagno A (2008) Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: Evaluation of current strategies. Current Molecular Pharmacology 93-105.|2. Calcagno AM, Fostel JM, To KK, Salcido CD, Martin SE, Chewning KJ, Wu CP, Varticovski L, Bates SE, Caplen NJ, Ambudkar SV (2008). Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes. Br J Cancer  98, 1515-24.   https://doi.org/10.1038/sj.bjc.6604334|3. Chen SY, Pan CJ, Nandigama K, Mansfield BC, Ambudkar SV, Chou JY (2008). The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic. FASEB J  22, 2206-13.   https://doi.org/10.1096/fj.07-104851|4. Gardner ER, Ahlers CM, Shukla S, Sissung TM, Ockers SB, Price DK, Hamada A, Robey RW, Steinberg SM, Ambudkar SV, Dahut WL, Figg WD (2008). Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival. BJU Int  102, 1694-9.   https://doi.org/10.1111/j.1464-410X.2008.07913.x|5. Kim IW, Booth-Genthe C, Ambudkar SV (2008). Relationship between drugs and functional activity of various mammalian P-glycoproteins (ABCB1). Mini Rev Med Chem  8, 193-200.   https://doi.org/10.2174/138955708783744100|6. Robey RW, Shukla S, Finley EM, Oldham RK, Barnett D, Ambudkar SV, Fojo T, Bates SE (2008). Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)). Biochem Pharmacol  75, 1302-12.   https://doi.org/10.1016/j.bcp.2007.12.001|7. Shukla S, Wu CP, Ambudkar SV (2008). Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges. Expert Opin Drug Metab Toxicol  4, 205-23.   https://doi.org/10.1517/17425255.4.2.205|8. Tsai CJ, Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM, Nussinov R (2008). Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima. J Mol Biol  383, 281-91.   https://doi.org/10.1016/j.jmb.2008.08.012|9. Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L (2008). Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res  10, R10.   https://doi.org/10.1186/bcr1855|10. Wu CP, Calcagno AM, Ambudkar SV (2008). Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr Mol Pharmacol  1, 93-105.   https://doi.org/10.2174/1874467210801020093",https://intramural.nih.gov/search/searchview.taf?ipid=50585
115,BC010033-13,"October 01, 2007 -  September 30, 2008",Inflammation and Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Elise Dawn Bowman|Syed Perwez  Hussain|Mohammed A. Khan; PhD|Elisa A Spillare|Jane J Sohn|Masahiro  Seike|Show all 7,NULL,Robert  Wiltrout; PhD (National Cancer Institute)|David Anderson Wink (National Cancer Institute),NULL,"1. Hussain SP, He P, Subleski J, Hofseth LJ, Trivers GE, Mechanic L, Hofseth AB, Bernard M, Schwank J, Nguyen G, Mathe E, Djurickovic D, Haines D, Weiss J, Back T, Gruys E, Laubach VE, Wiltrout RH, Harris CC (2008). Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res  68, 7130-6.   https://doi.org/10.1158/0008-5472.CAN-08-0410|2. Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, Donzelli S, Hussain P, Vecoli C, Paolocci N, Ambs S, Colton CA, Harris CC, Roberts DD, Wink DA (2008). The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med  45, 18-31.   https://doi.org/10.1016/j.freeradbiomed.2008.03.020|3. Wink DA, Ridnour LA, Hussain SP, Harris CC (2008). The reemergence of nitric oxide and cancer. Nitric Oxide  19, 65-7.   https://doi.org/10.1016/j.niox.2008.05.003",https://intramural.nih.gov/search/searchview.taf?ipid=50586
116,BC010036-13,"October 01, 2007 -  September 30, 2008",Comparative Functional Genomics: Identifying Best-fit Models for Human Cancers,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",Timothy V Benjamin|Elizabeth A Conner|Marian E Durkin|Anita  Ton|Tanya N Hoang|Cedric  Coulouarn|Show all 9,NULL,Valentina  Factor (Cellular and Molecular Biology Section)|Douglas  Lowy; MD (National Cancer Institute)|Nicolae C Popescu; PhD (National Cancer Institute)|Frank Jess Gonzalez; PhD (National Cancer Institute),NULL,"1. Coulouarn C, Factor VM, Thorgeirsson SS (2008). Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer. Hepatology  47, 2059-67.   https://doi.org/10.1002/hep.22283|2. Matter MS, Marquardt JU, Andersen JB, Quintavalle C, Korokhov N, Stauffer JK, Kaji K, Decaens T, Quagliata L, Elloumi F, Hoang T, Molinolo A, Conner EA, Weber A, Heikenwalder M, Factor VM, Thorgeirsson SS (2016). Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype. Hepatology  63, 1888-99.   https://doi.org/10.1002/hep.28487|3. Thorgeirsson S, Calvisi D, Conner E, Farina M, Factor V   (2008) E2F1 inhibits c-Myc driven apoptosis via PI3CA/AKT/mTOR and COX-2 in a mouse  model of human liver cancer.  Gastroenterology, in press.|4. Thorgeirsson SS, Judge AS, Lee YS, Maclachlan IS (submitted in 2008) Therapeutic Targeting Of Csn5, A Negative Regulator Of P53 And P27, In Human Hepatocellular Carcinoma. Patents issued: 8,227443 (US in 2012); 602009025083 (DE in 2014); 2281041 (EP in 2014); 2281041 (GB in 2014); 2009236219 (AU in 2015). Patents pending: 14169140.2 (EP application); 2011-505173 (JP application); PCT/US2009/040685 (PC application); 13/551,580 (US application); 2721380 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=50587
117,BC010038-13,"October 01, 2007 -  September 30, 2008",Molecular Cytogenetics of Solid Tumors,Nicolae C Popescu; PhD,NULL,"Laboratory of Experimental Carcinogenesis, NCI",Marian E Durkin|Xiaoling  Zhou|Drazen  Zimonjic; PhD|Veenu  Tripathi; PhD,NULL,William M Bonner; PhD (National Cancer Institute),NULL,"1. Guan M, Tripathi V, Zhou X, Popescu NC (2008). Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy. Cancer Gene Ther  15, 371-81.   https://doi.org/10.1038/cgt.2008.13|2. Sedelnikova OA, Horikawa I, Redon C, Nakamura A, Zimonjic DB, Popescu NC, Bonner WM (2008). Delayed kinetics of DNA double-strand break processing in normal and pathological aging. Aging Cell  7, 89-100.   https://doi.org/10.1111/j.1474-9726.2007.00354.x",https://intramural.nih.gov/search/searchview.taf?ipid=50588
118,BC010041-13,"October 01, 2007 -  September 30, 2008","Oligosaccharide Substrate and Inhibitor Interactions with beta-1,4-Gal-T1",Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Elizabeth  Boeggeman|Boopathy  Ramakrishna|Maria Rita Manzoni,NULL,NULL,NULL,"1. Qasba PK, Boeggeman E, Ramakrishnan B (2008). Site-specific linking of biomolecules via glycan residues using glycosyltransferases. Biotechnol Prog  24, 520-6.   https://doi.org/10.1021/bp0704034|2. Qasba PK, Ramakrishnan B, Boeggeman E (2008). Structure and function of beta -1,4-galactosyltransferase. Curr Drug Targets  9, 292-309.   https://doi.org/10.2174/138945008783954943|3. Schuyler AD, Jernigan RL, Qasba PK, Ramakrishnan B, Chirikjian GS (2009). Iterative cluster-NMA: A tool for generating conformational transitions in proteins. Proteins  74, 760-76.   https://doi.org/10.1002/prot.22200",https://intramural.nih.gov/search/searchview.taf?ipid=50589
119,BC010251-13,"October 01, 2007 -  September 30, 2008",Secreted Frizzled-Related Proteins and Wnt Signaling,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Bolormaa  Baljinnyam|Shengjian  Li|Aarti  Vadalia,"Abbot  Clark (Alcon Labs, Alcon Research, Ltd.)|Bruce  Macher (Department of Chemistry and Biochemistry, San Francisco State University)|Paul  Marker (University of Minnesota Cancer Center)|Jeffrey  Toretsky (NCI)|Aykut  Uren (Lombardi Cancer Center, Georgetown University Medical Center)",Donald P Bottaro; PhD (National Cancer Institute),NULL,"1. Endo Y, Beauchamp E, Woods D, Taylor WG, Toretsky JA, Uren A, Rubin JS (2008). Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3- and c-Jun N-terminal kinase-dependent mechanism. Mol Cell Biol  28, 2368-79.   https://doi.org/10.1128/MCB.01780-07",https://intramural.nih.gov/search/searchview.taf?ipid=50590
120,BC010252-13,"October 01, 2007 -  September 30, 2008",Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Daniel C Bertolette|Yi  Huang|Kathryn  Jones; PhD|Cari  Sadowski,NULL,Robert  Blumenthal; PhD (National Cancer Institute)|Gene  Shearer; PhD (National Cancer Institute),Samuel W Cushman; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50591
121,BC010253-13,"October 01, 2007 -  September 30, 2008",Molecular Mechanisms of Growth Factor Modulated Proliferation,William  Farrar,NULL,"Laboratory of Cancer Prevention, NCI",Xiaohu  Zhang|Suneethe  Thomas|Elaine M Hurt|Haiyan  Qin,NULL,Ettore  Appella; MD (National Cancer Institute),NULL,"1. Sharifi N, Farrar WL (2008). Re: ""Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the women's health initiative (United States)"". Am J Epidemiol  167, 1016; author reply 1016.   https://doi.org/10.1093/aje/kwn040|2. Sharifi N, Hurt EM, Farrar WL (2008). Androgen receptor expression in prostate cancer stem cells: is there a conundrum? Cancer Chemother Pharmacol  62, 921-3.   https://doi.org/10.1007/s00280-007-0659-5",https://intramural.nih.gov/search/searchview.taf?ipid=50592
122,BC010256-13,"October 01, 2007 -  September 30, 2008",The Nodal Signaling Pathway In Embryonic Development,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",George T Lezin|Margaret M O'Toole-Lualdi|Oyvind  Dahle,NULL,Mark B Lewandoski (National Cancer Institute)|Terence P Yamaguchi; PhD (National Cancer Institute),Amit  Kumar; PhD (NIDDK),"1. Landry J, Sharov A, Piao Y, Sharova L, Xiao H, Southon E, Matta J, Tessarollo L, Zhang Y, Ko M, Kuehn M, Yamaguchi T, Wu C (2008) Essential Role of Chromatin Remodeling Protein Bptf in Early Mouse Embryos and Embryonic Stem Cells. PLOS Genetics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50593
123,BC010270-12,"October 01, 2007 -  September 30, 2008",High-Throughput Genotyping for Genetic Epidemiology,Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI",Taras K Oleksyk|Yvette  Berthier-schaad|Viktoriya  Grinberg|Efe  Sezgin|Melanie  Springer,"Anthony  Alberg (Dept. of Epidemiology, Johns Hopkins University)|Josef  Coresh; MD, PhD (Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health)|Linda  Kao (Dept. of Epidemiology, Johns Hopkins University)|Elizabeth  Platz; PhD (School of Public Health, Johns Hopkins University)|Sadeep  Shrestha|Paul  Strickland (Dept. of Environmental Health Sciences, Johns Hopkins University)",Stephen J O'Brien; PhD (National Cancer Institute),NULL,"1. Hutcheson HB, Lautenberger JA, Nelson GW, Pontius JU, Kessing BD, Winkler CA, Smith MW, Johnson R, Stephens R, Phair J, Goedert JJ, Donfield S, O'Brien SJ (2008). Detecting AIDS restriction genes: from candidate genes to genome-wide association discovery. Vaccine  26, 2951-65.   https://doi.org/10.1016/j.vaccine.2007.12.054|2. Oleksyk TK, Zhao K, De La Vega FM, Gilbert DA, O'Brien SJ, Smith MW (2008). Identifying selected regions from heterozygosity and divergence using a light-coverage genomic dataset from two human populations. PLoS One  3, e1712.   https://doi.org/10.1371/journal.pone.0001712|3. Schelling JR, Abboud HE, Nicholas SB, Pahl MV, Sedor JR, Adler SG, Arar NH, Bowden DW, Elston RC, Freedman BI, Goddard KA, Guo X, Hanson RL, Ipp E, Iyengar SK, Jun G, Kao WH, Kasinath BS, Kimmel PL, Klag MJ, Knowler WC, Nelson RG, Parekh RS, Quade SR, Rich SS, Family Investigation of Nephropathy and Diabetes Research Group, et al. [7 more authors] (2008). Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes  57, 235-43.   https://doi.org/10.2337/db07-0313|4. Truelove AL, Oleksyk TK, Shrestha S, Thio CL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ, Smith MW (2008). Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Int J Immunogenet  35, 255-64.   https://doi.org/10.1111/j.1744-313X.2008.00770.x",https://intramural.nih.gov/search/searchview.taf?ipid=50595
124,BC010271-12,"October 01, 2007 -  September 30, 2008","Identification of Genes Involved in HIV-1AIDS, HBV and HCV",Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI",Taras K Oleksyk|Viktoriya  Grinberg|Melanie  Springer|Cheryl Ann Winkler,"Gregory D Kirk|Sadeep  Shrestha|David  Vlahov (Center for Urban Epidemiologic Studies, New York Academy of Medicine)",James Jerome Goedert; MD (National Cancer Institute)|Stephen J O'Brien; PhD (National Cancer Institute),NULL,"1. Hutcheson HB, Lautenberger JA, Nelson GW, Pontius JU, Kessing BD, Winkler CA, Smith MW, Johnson R, Stephens R, Phair J, Goedert JJ, Donfield S, O'Brien SJ (2008). Detecting AIDS restriction genes: from candidate genes to genome-wide association discovery. Vaccine  26, 2951-65.   https://doi.org/10.1016/j.vaccine.2007.12.054|2. Truelove AL, Oleksyk TK, Shrestha S, Thio CL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ, Smith MW (2008). Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Int J Immunogenet  35, 255-64.   https://doi.org/10.1111/j.1744-313X.2008.00770.x",https://intramural.nih.gov/search/searchview.taf?ipid=50596
125,BC010272-12,"October 01, 2007 -  September 30, 2008",Facilitating Access to Information on Human Proteins and Their Phosphorylation,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Mark A Parsons (National Cancer Institute)|Zachary Todd Kight (Center For Biomedical Informatics & Information Technology)|Matthew S Scilipoti (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50597
126,BC010276-11,"October 01, 2007 -  September 30, 2008",Protein Folding Mechanism,Yawen  Bai; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Hanqiao  Feng|Bing-Rui  Zhou,NULL,NULL,NULL,"1. Bai Y (2008) Hydrogen exchange experiments: Detection and characterization of protein folding intermediates, in Protein Folding, Misfolding, and Aggregation: Classical Themes and Novel Approaches. RSC Biomolecular Sciences (London), pp. 302 pp.|2. Tu C, Tan YH, Shaw G, Zhou Z, Bai Y, Luo R, Ji X (2008). Impact of low-frequency hotspot mutation R282Q on the structure of p53 DNA-binding domain as revealed by crystallography at 1.54 angstroms resolution. Acta Crystallogr D Biol Crystallogr  64, 471-7.   https://doi.org/10.1107/S0907444908003338",https://intramural.nih.gov/search/searchview.taf?ipid=50599
127,BC010277-11,"October 01, 2007 -  September 30, 2008",Mechanisms of Chromosome Maintenance in Bacteria,Dhruba K Chattoraj; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Tatiana B Venkova-Canova|Ryosuke  Kadoya|Ranajit Kumar Ghosh|Gaelle  Demarre,"Chanchal  Dasgupta (Biophysics, Mol Biol & Genetics, U of Calcutta)|Petra  Levin; PhD (Biology, Washington U)|Johan  Paulsson (Appl Math and Theoretical Physics, U of Cambridge)",James G McNally; PhD (National Cancer Institute),NULL,"1. Chattoraj DK (2007). Tryptophanase in sRNA control of the Escherichia coli cell cycle. Mol Microbiol  63, 1-3.   https://doi.org/10.1111/j.1365-2958.2006.05517.x|2. Srivastava P, Chattoraj DK (2007). Selective chromosome amplification in Vibrio cholerae. Mol Microbiol  66, 1016-28.   https://doi.org/10.1111/j.1365-2958.2007.05973.x|3. Srivastava P, Demarre G, Karpova TS, McNally J, Chattoraj DK (2007). Changes in nucleoid morphology and origin localization upon inhibition or alteration of the actin homolog, MreB, of Vibrio cholerae. J Bacteriol  189, 7450-63.   https://doi.org/10.1128/JB.00362-07",https://intramural.nih.gov/search/searchview.taf?ipid=50600
128,BC010278-11,"October 01, 2007 -  September 30, 2008",Imaging cellular assemblies with three-dimensional electron microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Jeffrey S Lengyel|Gavin Erick Murphy|Jing  Fu,Esther H Chang|Mark  Hildebrand (Scripps Institute of Oceanography)|John Henry  Scott (NIST),NULL,NULL,"1. Narasimha R, Aganj I, Bennett AE, Borgnia MJ, Zabransky D, Sapiro G, McLaughlin SW, Milne JL, Subramaniam S (2008). Evaluation of denoising algorithms for biological electron tomography. J Struct Biol  164, 7-17.   https://doi.org/10.1016/j.jsb.2008.04.006",https://intramural.nih.gov/search/searchview.taf?ipid=50601
129,BC010283-11,"October 01, 2007 -  September 30, 2008",DNA Repair,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Hua Tang (Henry)  Chen|Samuel  Bunting|Federica  Polato,NULL,NULL,NULL,"1. Schotta G, Sengupta R, Kubicek S, Malin S, Kauer M, Callén E, Celeste A, Pagani M, Opravil S, De La Rosa-Velazquez IA, Espejo A, Bedford MT, Nussenzweig A, Busslinger M, Jenuwein T (2008). A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev  22, 2048-61.   https://doi.org/10.1101/gad.476008|2. Takizawa M, Tolarová H, Li Z, Dubois W, Lim S, Callen E, Franco S, Mosaico M, Feigenbaum L, Alt FW, Nussenzweig A, Potter M, Casellas R (2008). AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J Exp Med  205, 1949-57.   https://doi.org/10.1084/jem.20081007",https://intramural.nih.gov/search/searchview.taf?ipid=50603
130,BC010292-10,"October 01, 2007 -  September 30, 2008",Enzymes and Substrates of the Ubiquitin Conjugating System,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Jennifer B Mariano|Yien-Che  Tsai|Zlatka  Kostova Lenard|Mary  Braun; PhD|Rhyan P Maditz,NULL,Barry R O'Keefe (National Cancer Institute)|Yves  Pommier; PhD (National Cancer Institute)|Michael Robert Kuehn; PhD (National Cancer Institute)|Stefan  Ambs (National Cancer Institute),Juan S Bonifacino; PhD (NICHD),"1. Weissman A, Kitagaki J, Saiela C, Beutler J, O' Keefe B   (2008) Inhibiting Hdm2 and ubiquitin-activating enzyme: targeting the ubiquitin  conjugating system in cancer., in Ernst Schering Res Found Workshop, in press.|2. Ding W, Li C, Hu T, Graves-Deal R, Fotia AB, Weissman AM, Coffey RJ (2008). EGF receptor-independent action of TGF-alpha protects Naked2 from AO7-mediated ubiquitylation and proteasomal degradation. Proc Natl Acad Sci U S A  105, 13433-8.   https://doi.org/10.1073/pnas.0806298105",https://intramural.nih.gov/search/searchview.taf?ipid=50446
131,BC010297-11,"October 01, 2007 -  September 30, 2008",Identification of Gene Polymorphisms Associated with Infectious Diseases,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI",Ping  An; PhD|Elizabeth  Binns-Roemer|Yu-Chun  Zhou|Jamba  Maidar|Liana M Nice,NULL,James Jerome Goedert; MD (National Cancer Institute)|Stephen J O'Brien; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50605
132,BC010298-11,"October 01, 2007 -  September 30, 2008",Growth Regulation Section,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Richard A Beers|Tapan K Bera|Xiu-Fen  Liu|Masanori  Yamada|Thelma  Escobar|Charissa  Kahue,NULL,NULL,NULL,"1. Bera TK, Liu XF, Yamada M, Gavrilova O, Mezey E, Tessarollo L, Anver M, Hahn Y, Lee B, Pastan I (2008). A model for obesity and gigantism due to disruption of the Ankrd26 gene. Proc Natl Acad Sci U S A  105, 270-5.   https://doi.org/10.1073/pnas.0710978105|2. Ise T, Das S, Nagata S, Maeda H, Lee Y, Onda M, Anver MR, Bera TK, Pastan I (2008). Expression of POTE protein in human testis detected by novel monoclonal antibodies. Biochem Biophys Res Commun  365, 603-8.   https://doi.org/10.1016/j.bbrc.2007.10.195|3. Levitin F, Weiss M, Hahn Y, Stern O, Papke RL, Matusik R, Nandana SR, Ziv R, Pichinuk E, Salame S, Bera T, Vincent J, Lee B, Pastan I, Wreschner DH (2008). PATE gene clusters code for multiple, secreted TFP/Ly-6/uPAR proteins that are expressed in reproductive and neuron-rich tissues and possess neuromodulatory activity. J Biol Chem  283, 16928-39.   https://doi.org/10.1074/jbc.M801454200",https://intramural.nih.gov/search/searchview.taf?ipid=50606
133,BC010300-11,"October 01, 2007 -  September 30, 2008",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Anthony V Washington|Selinda Jane Orr|Geraldine Martina O'Connor|Jill Wallace Ford,NULL,Oleg Y Chertov (Office Of The Director),"Ivo  Francischetti; MD, PhD (NIAID) |Pamela Lee Schwartzberg; MD, PhD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50607
134,BC010301-11,"October 01, 2007 -  September 30, 2008",Development of Recombinant Toxins to Treat Hematologic Malignancies,"Robert J Kreitman; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI",Evgeny  Arons|Linda  Ellison-Dejewski|Inger M Margulies|Barbara  Debrah|David  Waters|Roberta  Traini|Show all 9,NULL,"Wyndham H Wilson; MD, PhD (National Cancer Institute)|John  Janik; MD (National Cancer Institute)|Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)|Alan S Wayne; MD (National Cancer Institute)|Daniel J Powell (National Cancer Institute)|Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)",NULL,"1. Ahmad E, Steinberg SM, Goldin L, Hess CJ, Caporaso N, Kreitman RJ, Wiestner A, Wilson W, White T, Marti G, Stetler-Stevenson M (2008). Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia. Cytometry B Clin Cytom  74, 221-6.   https://doi.org/10.1002/cyto.b.20423",https://intramural.nih.gov/search/searchview.taf?ipid=50608
135,BC010304-10,"October 01, 2007 -  September 30, 2008",Biochemical Basis of T Cell Activation,Lawrence Elliot Samelson; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Valarie  Barr; PhD|Connie  Sommers; PhD|Kelsie M Bernot|Michihiko  Miyaji|Robert L Kortum|Alexandre Katchaz Oscar Antoine Rouquette-Jazdanian|Show all 9,NULL,Ettore  Appella; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50610
136,BC010306-10,"October 01, 2007 -  September 30, 2008",Identification of Needle Sharing: A Risk Factor for Viral Infection,Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI",NULL,"Karl  Broman (University of Michigan)|Homayoon  Farzadegan (Dept. of Epidemiology, Johns Hopkins University)|Sadeep  Shrestha|Steffanie  Strathdee (Dept. of Epidemiology, Johns Hopkins University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50613
137,BC010307-09,"October 01, 2007 -  September 30, 2008",Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells,Gisela Esta Sterneck; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Shikha  Sharan|Snehalata Anil Pawar|Jun  Wang,"Lane  Christenson (Center for Research on Reproduction and Women's Health, University of Pennsylvania)|Vadivel  Ganapathy (Department of Biochemistry and Molecular Biology, Medical College of Georgia)|Zdenek  Kleibel (Dept. of Biochemistry and Experimental Oncology, Charles University in Prague)",Thomas Dana Schneider; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50463
138,BC010308-10,"October 01, 2007 -  September 30, 2008",In vivo Imaging Analysis of SteroidNuclear Receptor Function,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Sam  John|Tom  Johnson|Diana  Stavreva|Ty Cole Voss|Malgorzata  Wiench|Ofir  Hakim,"Miroslav  Dundr|Fahri  Saatcioglu (Department of Biology, University of Oslo)",James G McNally; PhD (National Cancer Institute),NULL,"1. Hager G, Stavreva D, Voss T (2008) Nuclear mechanisms of glucocorticoid action, in Hormones, Brain and Behavior. Elsevier (San Diego, CA), in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50614
139,BC010309-10,"October 01, 2007 -  September 30, 2008",Nuclear Architecture and Disease,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Stephen A Mabon|Paola  Scaffidi|Sara K Snyder|Evi  Soutoglou|Takumi  Takizawa|Karen J Meaburn|Show all 12,NULL,Karl Thomas Ried; MD (National Cancer Institute)|Stephen J Lockett; PhD (National Cancer Institute)|William M Bonner; PhD (National Cancer Institute),NULL,"1. Gudla PR, Nandy K, Collins J, Meaburn KJ, Misteli T, Lockett SJ (2008). A high-throughput system for segmenting nuclei using multiscale techniques. Cytometry A  73, 451-66.   https://doi.org/10.1002/cyto.a.20550|2. Hager GL, McNally JG, Misteli T (2009). Transcription dynamics. Mol Cell  35, 741-53.   https://doi.org/10.1016/j.molcel.2009.09.005|3. Pegoraro G, Misteli T (2009). The central role of chromatin maintenance in aging. Aging (Albany NY)  1, 1017-22.   https://doi.org/10.18632/aging.100106|4. Misteli TA, Meaburn KA (submitted in 2008) Method For Detection Of Cancer Based On Spatial Genome Organization. Patents issued: 2321428 (DE in 2013); 2321428 (EP in 2013); 2321428 (FR in 2013); 2321428 (GB in 2013); 9,617,599 (US in 2017); 2015271909 (AU in 2017). Patents pending: 2735232 (CA application); 2009288030 (AU application).",https://intramural.nih.gov/search/searchview.taf?ipid=50615
140,BC010313-10,"October 01, 2007 -  September 30, 2008",Molecular signatures for liver cancer diagnosis and treatment stratification,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Zhipeng  Yu|Taro  Yamashita|Stephanie  Roessler|Junfang  Ji|Show all 9,NULL,"Udai S Kammula (National Cancer Institute)|Curtis  Harris; MD (National Cancer Institute)|Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)|Robert  Wiltrout; PhD (National Cancer Institute)|Howard A Young; PhD (National Cancer Institute)|Richard  Simon (National Cancer Institute)",NULL,"1. Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC, Wang XW (2009). MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med  361, 1437-47.   https://doi.org/10.1056/NEJMoa0901282|2. Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, Tang ZY, Wang XW (2008). EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res  68, 1451-61.   https://doi.org/10.1158/0008-5472.CAN-07-6013|3. Wang XW, Croce CW, Ji JW, Sun HW, Tang ZW (submitted in 2008) Use Of Mir-26 Family As Predictive Markers Of Hepatocellular Carcinoma And Responsiveness To Therapy. Patents issued: 2009-8012652 (CN in 2014); 2307028 (DE in 2014); 2307028 (EP in 2014); 2307028 (ES in 2014); 2009257410 (AU in 2014); 5745401 (JP in 2015). Patents pending: PCT/US2009/046999 (PC application); 12/997,419 (US application); 14/817,774 (US application); 2727633 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=50617
141,BC010317-10,"October 01, 2007 -  September 30, 2008",Rapid Analysis of Single Nucleotide Polymorphism Genotypes in AIDS Cohorts,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",Shawn R Palmer|Michael J Malasky|Guan  Li|Mary  Mcnally|James  Lautenberger; PhD|Bailey D Kessing|Show all 13,NULL,NULL,NULL,"1. O'Brien S, Hutcheson H, Ruiz-Pesini E, Poole J, Lautenberger J, Sezgin E, Kingsley L, Goedert J, Vlahov D, Donfield S, Wallace D, O'Brien S (2008) Mitochondrial DNA Haplogroups influence AIDS Progression. AIDS, in press.|2. Stefanov S, Lautenberger J, Gold B   (2008) An Analysis Pipeline for Genome-wide Association Studies.  Cancer Informatics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50618
142,BC010319-10,"October 01, 2007 -  September 30, 2008",Structural Analysis of Biological Membrane Proteins,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI",Lothar  Esser|Jichun  Ma|Robert M Rutledge|Daniel  Gilmer,NULL,Susan  Bates; MD (National Cancer Institute)|Michael Marc Gottesman; MD (National Cancer Institute),NULL,"1. Xia D, Elberry M, Zhou F, yu L, Yu C   (2008) The road to the crystal structure of the cytochrome bc1 complex from the  anoxigenic photosynthetic bacterium Rhodobacter sphaeroides.  Journal of Bioenergetics and Biomembrane  In press pp.|2. Xia D, Yu L, Yu C   (2008) Insights into the Mechanisms of Quinol Oxidation in Cytochrome bc1 in Light of  the Structure of Bacterial Complex.  Biohysical Review and Letters  229-257 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=50620
143,BC010326-09,"October 01, 2007 -  September 30, 2008","Biomolecular Structure and Mechanism, Structure-Based Drug Design",Xinhua  Ji; PhD|IRP Faculty Profile,NULL,"Macromolecular Crystallography Laboratory, NCI",Gary X Shaw|Chao  Tu|Ravi Charan Reddy Kalathur|Priadarsini  Subburaman|Genbin  Shi,NULL,Donald L Court; PhD (National Cancer Institute)|Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)|Ding Jun Jin (National Cancer Institute)|Larry K Keefer; PhD (National Cancer Institute)|David S Waugh; PhD (Protein Engineering Section),NULL,"1. Gan J, Shaw G, Tropea JE, Waugh DS, Court DL, Ji X (2008). A stepwise model for double-stranded RNA processing by ribonuclease III. Mol Microbiol  67, 143-54.   https://doi.org/10.1111/j.1365-2958.2007.06032.x|2. Ji X (2008). The mechanism of RNase III action: how dicer dices. Curr Top Microbiol Immunol  320, 99-116.   https://doi.org/10.1007/978-3-540-75157-1_5|3. Ji X, Kalathur R, Hu X, Gu Y, Saavedra J, Buzard G, Srinivasan A, Keefer L, Singh S (2008) Structure-based design of anticancer prodrug PABA/NO. Drug Design, Development and Therapy 123-130.|4. Ji X, Vu B, Gan J, Feng Y, Dimitrov D   (2008) Structure of an isolated unglycosylated antibody CH2 domain.  Acta Crystallogr. D Biol. Crystallogr.  1062-1067 pp.|5. Shaw G, Gan J, Zhou YN, Zhi H, Subburaman P, Zhang R, Joachimiak A, Jin DJ, Ji X (2008). Structure of RapA, a Swi2/Snf2 protein that recycles RNA polymerase during transcription. Structure  16, 1417-27.   https://doi.org/10.1016/j.str.2008.06.012|6. Tu C, Tan YH, Shaw G, Zhou Z, Bai Y, Luo R, Ji X (2008). Impact of low-frequency hotspot mutation R282Q on the structure of p53 DNA-binding domain as revealed by crystallography at 1.54 angstroms resolution. Acta Crystallogr D Biol Crystallogr  64, 471-7.   https://doi.org/10.1107/S0907444908003338",https://intramural.nih.gov/search/searchview.taf?ipid=50621
144,BC010328-09,"October 01, 2007 -  September 30, 2008",Role of CEBP transcription factors in regulating cell growth and tumorigenesis,Peter F Johnson; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Nancy C Martin|Sook  Lee|Krisada  Sakchaisri|Sandip  Basu,NULL,Jonathan  Keller; PhD (National Cancer Institute)|Maria  Miller (National Cancer Institute)|Alexander  Wlodawer; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50622
145,BC010329-09,"October 01, 2007 -  September 30, 2008",Regulation of Ras-Dependent Signal Transduction Pathways,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Melissa M Mckay,NULL,Timothy D Veenstra (National Cancer Institute)|Martin  Gutierrez (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50623
146,BC010331-09,"October 01, 2007 -  September 30, 2008",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI",Teresa  Kosakowska Cholo|Chang-Qing  Yuan|Pralhada Rao  Raghavendra,"Usha  Acharya (Programe in Gene Function and Expression, University of Mass. Medical School)|Pedro  Labarca (Arturo Prat 514, Centro de Estudios Cientificos)",Deborah K Morrison (National Cancer Institute)|Lino  Tessarollo (National Cancer Institute)|Shyam K Sharan (National Cancer Institute),NULL,"1. Rao RP, Acharya JK (2008). Sphingolipids and membrane biology as determined from genetic models. Prostaglandins Other Lipid Mediat  85, 1-16.   https://doi.org/10.1016/j.prostaglandins.2007.10.002",https://intramural.nih.gov/search/searchview.taf?ipid=50624
147,BC010333-09,"October 01, 2007 -  September 30, 2008",The Segregation of Bacterial Chromosomes to Daughter Cells,Stuart J Austin|IRP Faculty Profile,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Therese G Brendler; BS, PhD|Brenda L Youngren|Manjistha  Sengupta|Sujatha B Gowda","Alba  Guarne; PhD|Flemming  Hansen (BioCentrum, Technical University of Denmank)",Donald L Court; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50625
148,BC010334-09,"October 01, 2007 -  September 30, 2008",Posttranscriptional control of gene expression,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Jenifer L Bear|Andrei S Zolotukhin|Rashmi  Jalah|Gen-Mu  Zhang|Viraj M Kulkarni,Walter  Gunzberg (Institute of Virology)|Matthias  Renner (Institute of Virology)|Brian  Salmons (Austrianova Biomanufacturing)|Ralf  Schneider (GSF-National Research Center for Environment and Health),"George N Pavlakis; MD, PhD (National Cancer Institute)|Zhi Ming  Zheng; MD, PhD (National Cancer Institute)|Giorgio  Trinchieri (National Cancer Institute)",NULL,"1. Pavlakis GN, Felber BN (submitted in 2008) Expression Of Il-12 Family Heterodimers. Patents issued: 8,715,964 (US in 2014); 9,546,202 (US in 2017).|2. Pavlakis GN, Felber BN, Finkielsztein SN, Vournakis JN (submitted in 2008) Complexes Of Il-15 And Il-15r Aipha And Uses Thereof. Patents issued: 2173378 (DE in 2014); 2173378 (DK in 2014); 2173378 (EP in 2014); 2173378 (ES in 2014); 2173378 (FR in 2014); 2173378 (GB in 2014); 2173378 (IE in 2014); 2173378 (IT in 2014); 2173378 (NL in 2014); 2008269032 (AU in 2014); 599338 (NZ in 2014); 2173378 (SE in 2014); 1143084 (HK in 2015); 616254 (NZ in 2015); 2013203204 (AU in 2016); 2016206235 (AU in 2017); 2691785 (CA in 2017); 202997 (IL in 2017); 703668 (NZ in 2017). Patents pending: 13195499.2 (EP application); 14110832.5 (HK application); 14110833.4 (HK application); 2010514839 (JP application); 2014-001373 (JP application); 2015-115431 (JP application); 2016-226503 (JP application); 582330 (NZ application); 12/666,052 (US application); 15/424,621 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=50626
149,BC010336-09,"October 01, 2007 -  September 30, 2008",Lambda Genetic Networks and Lambda Red-Mediated Recombination,Donald L Court; PhD|IRP Faculty Profile,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Nina C Costantino|Mikhail G Bubunenko|Lynn C Thomason|James A Sawitzke|Teresa L Baker|Xiaomei  Zhou|Show all 7,"Gloria  Culver (Biochemistry, biophysics, and Molecular Biology, Iowa State University)|David  Friedman (Microbiology and Immunology, University of Michigan School of Medicine)|Max  Gottesman (Institute of Cancer Research, Columbia University)|William  Margolin (Microbiology and Molecular Genetics, University of Texas Medical School)|Kenon  Murphy (Molecular Genetics and Microbiology, University of Massachusetts Med. School)|Amos  Oppenheim|Show all 8",Mikhail V Kashlev (National Cancer Institute)|Sankar  Adhya; PhD (National Cancer Institute)|Ding Jun Jin (National Cancer Institute)|Xinhua  Ji; PhD (National Cancer Institute)|David S Waugh; PhD (Protein Engineering Section),NULL,"1. Gan J, Shaw G, Tropea JE, Waugh DS, Court DL, Ji X (2008). A stepwise model for double-stranded RNA processing by ribonuclease III. Mol Microbiol  67, 143-54.   https://doi.org/10.1111/j.1365-2958.2007.06032.x",https://intramural.nih.gov/search/searchview.taf?ipid=50627
150,BC010337-09,"October 01, 2007 -  September 30, 2008",Identifying Protein Factors and Pathways Leading to the Active Chromatin State,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Maria L Kireeva|Lucyna E Lubkowska|Celine Marguerite Paulette Walmacq,NULL,NULL,NULL,"1. Lewis DE, Komissarova N, Le P, Kashlev M, Adhya S (2008). DNA sequences in gal operon override transcription elongation blocks. J Mol Biol  382, 843-58.   https://doi.org/10.1016/j.jmb.2008.07.060",https://intramural.nih.gov/search/searchview.taf?ipid=50628
151,BC010338-09,"October 01, 2007 -  September 30, 2008",The Role of Fgf Signaling in Vertebrate Development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Cindy  Elder|Naiche L Adler|Matthew J Anderson,NULL,Terence P Yamaguchi; PhD (National Cancer Institute)|Alan O Perantoni; PhD (National Cancer Institute)|Carl  Wu; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50629
152,BC010339-09,"October 01, 2007 -  September 30, 2008",The Role of Rx in the Adult Retina,Mark B Lewandoski|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Cindy  Elder,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50630
153,BC010340-09,"October 01, 2007 -  September 30, 2008",Ty Element Retrotransposition in Saccharomyces cerevisiae,David J. Garfinkel; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Sharon P Moore|Karen Marie Stefanisko|Arun  Dakshinamurthy|Emiko  Matsuda|Mary Ann  Checkley,"Joan  Curcio (Center for Medical Sciences, Wadsworth Center)|Philip  Farabaugh (Biological Sciences, University of Maryland-Baltimore County)",Dwight V Nissley (National Cancer Institute)|Robert H Stephens (National Cancer Institute)|Shu Yun  Le (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50631
154,BC010341-09,"October 01, 2007 -  September 30, 2008",Protein Expression and Purification in the Fast Lane,David S Waugh; PhD|IRP Faculty Profile,NULL,"Macromolecular Crystallography Laboratory, NCI",Brian P Austin|Ping  Sun|Di  Zhang,NULL,NULL,NULL,"1. Das R, Loss S, Li J, Waugh DS, Tarasov S, Wingfield PT, Byrd RA, Altieri AS (2008). Structural biophysics of the NusB:NusE antitermination complex. J Mol Biol  376, 705-20.   https://doi.org/10.1016/j.jmb.2007.11.022|2. Gan J, Shaw G, Tropea JE, Waugh DS, Court DL, Ji X (2008). A stepwise model for double-stranded RNA processing by ribonuclease III. Mol Microbiol  67, 143-54.   https://doi.org/10.1111/j.1365-2958.2007.06032.x|3. Waugh D, Cherry S   (2008) Expression and purification of soluble His6-tagged TEV protease.  Methods Mol. Biol.  0 pp.|4. Waugh D, Nallamsetty S   (2008) Hexahistidine-tagged maltose-binding protein as a fusion partner for teh  production of soluble recombinant proteins in Escherichia coli.  Methods Mol. Biol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50632
155,BC010342-09,"October 01, 2007 -  September 30, 2008",Structural Proteomics of the Yersinia Yop Virulon,David S Waugh; PhD|IRP Faculty Profile,NULL,"Macromolecular Crystallography Laboratory, NCI",Brian P Austin|George T Lountos|Ping  Sun|Di  Zhang,NULL,Terrence R Burke; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50633
156,BC010345-09,"October 01, 2007 -  September 30, 2008",The Role of Wnt Genes in Vertebrate Development and Cancer,Terence P Yamaguchi; PhD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Kristin K Biris|William C Dunty|Rieko  Ajima|Ravindra Babu  Chalamalasetty,NULL,Mark B Lewandoski (National Cancer Institute),Benjamin  Feldman; PhD (NHGRI),"1. Yamaguchi T   (2008) Genetics of Wnt signaling during early mammalian development, in Wnt Signaling, Methods in Molecular Biology. Vincan E, ed.,  Humana Press, in press.|2. Joesting MS, Cheever TR, Volzing KG, Yamaguchi TP, Wolf V, Naf D, Rubin JS, Marker PC (2008). Secreted frizzled related protein 1 is a paracrine modulator of epithelial branching morphogenesis, proliferation, and secretory gene expression in the prostate. Dev Biol  317, 161-73.   https://doi.org/10.1016/j.ydbio.2008.02.021|3. McCullough DP, Gudla PR, Harris BS, Collins JA, Meaburn KJ, Nakaya MA, Yamaguchi TP, Misteli T, Lockett SJ (2008). Segmentation of whole cells and cell nuclei from 3-D optical microscope images using dynamic programming. IEEE Trans Med Imaging  27, 723-34.   https://doi.org/10.1109/TMI.2007.913135|4. Yamaguchi T, Sharov A, Piao Y, Sharova L, Xiao H, Southon E, Matta J, Tessarollo L, Zhang Y, Ko M, Kuehn M, Wu C   (2008) Essential role of chromatin remodeling protein Bptf in early mouse embryos and  embryonic stem cells.  PLoS Genetics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50634
157,BC010346-09,"October 01, 2007 -  September 30, 2008",Structural Biology of Proteins Involved in Signal Transduction and Regulation of,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Jess R Li|Hana  Krizova|Ravi Sankar Ampapathi|Catherine L Deatherage,NULL,Howard A Young; PhD (National Cancer Institute)|Yun  Wang (Nucleic Acid NMR Section),NULL,"1. Das R, Loss S, Li J, Waugh DS, Tarasov S, Wingfield PT, Byrd RA, Altieri AS (2008). Structural biophysics of the NusB:NusE antitermination complex. J Mol Biol  376, 705-20.   https://doi.org/10.1016/j.jmb.2007.11.022",https://intramural.nih.gov/search/searchview.taf?ipid=50635
158,BC010348-09,"October 01, 2007 -  September 30, 2008",Protein Structure,Alexander  Wlodawer; PhD|IRP Faculty Profile,NULL,"Macromolecular Crystallography Laboratory, NCI",Alla E Gustchina|Maria E Miller|Alexander S Zdanov|Tinoush  Moulaei|Prasenjit  Bhaumik|Jamaine S Davis|Show all 7,NULL,Nancy H Colburn; PhD (National Cancer Institute)|Barry R O'Keefe (National Cancer Institute)|Zbigniew  Dauter (National Cancer Institute),NULL,"1. Miller M   (2008) The importance of being flexible: The case of basic region leucine Zipper per  transcriptional regulators.  Current Protein and Peptide Science, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50637
159,BC010350-09,"October 01, 2007 -  September 30, 2008",Prevention of AIDS,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Jenifer L Bear|Candido  Alicea; PhD|Rashmi  Jalah|Gen-Mu  Zhang|Viraj M Kulkarni,"J. Thomas  August (Molecular Biology and Genetics Department, Johns Hopkins University School of Medicine)|Ronald  Desrosiers (New England Primate Research Center)|Ruxandra  Draghia-Akli (VGX Pharmaceuticals)|Michael  Egan (Cancer Immunology and AIDS, Wyeth Lederle Vaccines)|John  Eldridge (Wyeth Lederle Vaccines)|Michael  Fons (Inovio Biomedical Corporatiton)|Show all 26","George N Pavlakis; MD, PhD (National Cancer Institute)|Marjorie  Robert-Guroff; PhD (National Cancer Institute)|Lauren V Wood; MD (National Cancer Institute)|Claes  Ohlen (National Cancer Institute)|Jeffrey D Lifson; MD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50639
160,BC010378-09,"October 01, 2007 -  September 30, 2008",Macromolecular Crystallography Research with Synchrotron Radiation,Zbigniew  Dauter|IRP Faculty Profile,NULL,"Macromolecular Crystallography Laboratory, NCI",John  Cobuzzi|Sergei V Pletnev|Elzbieta  Nowak|Anna  Brzuszkiewicz,"Mariusz  Jaskolski (Crystallography, University of Poznan)|Andrzej  Joachimiak (Biosciences, Argonne Natl. Lab.)|Jozef  Kur (Microbiology, University of Technology)|Wladek  Minor|Zbyszek  Otwinowski (Biomedical Sciences, Southwestern Medical School)|Gerold  Rosenbaum (SER-CAT, Univeresity of Georgia)|Show all 7",Alexander  Wlodawer; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50642
161,BC010379-09,"October 01, 2007 -  September 30, 2008",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun  Wang,NULL,"Nucleic Acid NMR Section, NCI",Ping  Yu|Jinbu  Wang|Xiaobing  Zuo,NULL,Bruce Allen Shapiro; PhD (National Cancer Institute)|Stuart F J Le Grice; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50643
162,BC010380-09,"October 01, 2007 -  September 30, 2008",Recombination and Regulation,Jeffrey N Strathern,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Alison J Rattray|Brenda K Shafer|Deanna R Gotte|Hui  Yang,NULL,Stephen H Hughes; PhD (National Cancer Institute)|Mikhail V Kashlev (National Cancer Institute)|Ding Jun Jin (National Cancer Institute),NULL,"1. Santoyo G, Strathern JN (2008). Non-homologous end joining is important for repair of Cr(VI)-induced DNA damage in Saccharomyces cerevisiae. Microbiol Res  163, 113-9.   https://doi.org/10.1016/j.micres.2007.09.001",https://intramural.nih.gov/search/searchview.taf?ipid=50644
163,BC010381-09,"October 01, 2007 -  September 30, 2008",Studies on Silencing,Amar J S Klar; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Gurjeet  Singh|Deepak  Sidhu,NULL,NULL,NULL,"1. Singh G, Klar AJ (2008). Mutations in deoxyribonucleotide biosynthesis pathway cause spreading of silencing across heterochromatic barriers at the mating-type region of the fission yeast. Yeast  25, 117-28.   https://doi.org/10.1002/yea.1569",https://intramural.nih.gov/search/searchview.taf?ipid=50645
164,BC010385-09,"October 01, 2007 -  September 30, 2008",Studies on mat1 Imprinting,Amar J S Klar; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Michael J Bonaduce|Deepak  Sidhu,NULL,NULL,NULL,"1. Singh G, Klar AJ (2008). Mutations in deoxyribonucleotide biosynthesis pathway cause spreading of silencing across heterochromatic barriers at the mating-type region of the fission yeast. Yeast  25, 117-28.   https://doi.org/10.1002/yea.1569",https://intramural.nih.gov/search/searchview.taf?ipid=50647
165,BC010386-09,"October 01, 2007 -  September 30, 2008",Human Handedness Psychosis Etiology Studies,Amar J S Klar; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Stephan  Sauer,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50648
166,BC010387-09,"October 01, 2007 -  September 30, 2008",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,Shyam K Sharan|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Susan L North|Sergey  Kuznetsov|Subha  Philip|Kajal  Biswas|Stacey S Stauffer|Suhwan  Chang,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|Anthony  Pegg (Department of Physiology, Penn State College of Medicine)",Andre A Nussenzweig; PhD (National Cancer Institute),NULL,"1. Kuznetsov SG, Liu P, Sharan SK (2008). Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2. Nat Med  14, 875-81.   https://doi.org/10.1038/nm.1719|2. Li L, Biswas K, Habib LA, Kuznetsov SG, Hamel N, Kirchhoff T, Wong N, Armel S, Chong G, Narod SA, Claes K, Offit K, Robson ME, Stauffer S, Sharan SK, Foulkes WD (2009). Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant. Hum Mutat  30, 1543-50.   https://doi.org/10.1002/humu.21101",https://intramural.nih.gov/search/searchview.taf?ipid=50649
167,BC010390-09,"October 01, 2007 -  September 30, 2008",Role of Neurotrophins in the Development of the Mammalian Nervous System,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Mary Ellen  Palko|Sudhirkumar U Yanpallewar|Henry C Schaefer,NULL,"Paul A Randazzo; MD, PhD (National Cancer Institute)",NULL,"1. Bera TK, Liu XF, Yamada M, Gavrilova O, Mezey E, Tessarollo L, Anver M, Hahn Y, Lee B, Pastan I (2008). A model for obesity and gigantism due to disruption of the Ankrd26 gene. Proc Natl Acad Sci U S A  105, 270-5.   https://doi.org/10.1073/pnas.0710978105|2. Rivera J, Tessarollo L (2008). Genetic background and the dilemma of translating mouse studies to humans. Immunity  28, 1-4.   https://doi.org/10.1016/j.immuni.2007.12.008|3. Taylor GA, Rodriguiz RM, Greene RI, Daniell X, Henry SC, Crooks KR, Kotloski R, Tessarollo L, Phillips LE, Wetsel WC (2008). Behavioral characterization of P311 knockout mice. Genes Brain Behav  7, 786-95.   https://doi.org/10.1111/j.1601-183X.2008.00420.x",https://intramural.nih.gov/search/searchview.taf?ipid=50650
168,BC010391-09,"October 01, 2007 -  September 30, 2008",Role of Trk Receptors in the Development and Function of Non-neuronal Structures,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Mary Ellen  Palko|Henry C Schaefer|Dawn Chin Ing Koh,NULL,"Paul A Randazzo; MD, PhD (National Cancer Institute)|Ola Mae Zack Howard (National Cancer Institute)",NULL,"1. Ahmed F, Tessarollo L, Thiele C, Mocchetti I (2008). Brain-derived neurotrophic factor modulates expression of chemokine receptors in the brain. Brain Res  1227, 1-11.   https://doi.org/10.1016/j.brainres.2008.05.086|2. Baba M, Furihata M, Hong SB, Tessarollo L, Haines DC, Southon E, Patel V, Igarashi P, Alvord WG, Leighty R, Yao M, Bernardo M, Ileva L, Choyke P, Warren MB, Zbar B, Linehan WM, Schmidt LS (2008). Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst  100, 140-54.   https://doi.org/10.1093/jnci/djm288|3. Rivera J, Tessarollo L (2008). Genetic background and the dilemma of translating mouse studies to humans. Immunity  28, 1-4.   https://doi.org/10.1016/j.immuni.2007.12.008|4. Zeng H, Horie K, Madisen L, Pavlova MN, Gragerova G, Rohde AD, Schimpf BA, Liang Y, Ojala E, Kramer F, Roth P, Slobodskaya O, Dolka I, Southon EA, Tessarollo L, Bornfeldt KE, Gragerov A, Pavlakis GN, Gaitanaris GA (2008). An inducible and reversible mouse genetic rescue system. PLoS Genet  4, e1000069.   https://doi.org/10.1371/journal.pgen.1000069",https://intramural.nih.gov/search/searchview.taf?ipid=50651
169,BC010411-09,"October 01, 2007 -  September 30, 2008",Initiation of DNA Replication in Mammalian Cells,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Chiimei (Cindy) L Tseng|Melvenia  Martin|Liang  Huang|Haiqing  Fu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50652
170,BC010412-09,"October 01, 2007 -  September 30, 2008",Structural Analysis of Macromolecular Complexes by Electron Microscopy,Jacqueline L Milne,NULL,"Laboratory of Cell Biology, NCI",Mario J Borgnia; PhD|Dan  Shi|Tommi Anna White,NULL,NULL,Bernard R Brooks; PhD (NHLBI),"1. Narasimha R, Aganj I, Bennett AE, Borgnia MJ, Zabransky D, Sapiro G, McLaughlin SW, Milne JL, Subramaniam S (2008). Evaluation of denoising algorithms for biological electron tomography. J Struct Biol  164, 7-17.   https://doi.org/10.1016/j.jsb.2008.04.006",https://intramural.nih.gov/search/searchview.taf?ipid=50653
171,BC010413-08,"October 01, 2007 -  September 30, 2008",Study of hereditary prostate cancer and human artificial chromosomes,"Vladimir L Larionov; PhD, DSc|IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",Natalay  Kouprina|Jun-Ichirou  Ohzeki|Megumi  Nakano|Jung-Hyun  Kim|Thomas A Ebersole,NULL,William M Bonner; PhD (National Cancer Institute),Arya  Biragyn; PhD (NIA),"1. Kouprina N, Larionov V (2008). Selective isolation of genomic loci from complex genomes by transformation-associated recombination cloning in the yeast Saccharomyces cerevisiae. Nat Protoc  3, 371-7.   https://doi.org/10.1038/nprot.2008.5|2. Leem SH, Yoon YH, Kim SI, Larionov V (2008). Purification of circular YACs from yeast cells for DNA sequencing. Genome  51, 155-8.   https://doi.org/10.1139/g07-109|3. Nakano M, Cardinale S, Noskov VN, Gassmann R, Vagnarelli P, Kandels-Lewis S, Larionov V, Earnshaw WC, Masumoto H (2008). Inactivation of a human kinetochore by specific targeting of chromatin modifiers. Dev Cell  14, 507-22.   https://doi.org/10.1016/j.devcel.2008.02.001",https://intramural.nih.gov/search/searchview.taf?ipid=50464
172,BC010418-09,"October 01, 2007 -  September 30, 2008",Signaling events regulating chemotaxis,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Paul W Kriebel|Mirkka Maarit Janka-junttila|Gene  Garcia|Lunhua  Liu|Colin P Mccann|Vidya  Vedham,NULL,NULL,NULL,"1. Bagorda A, Parent CA (2008). Eukaryotic chemotaxis at a glance. J Cell Sci  121, 2621-4.   https://doi.org/10.1242/jcs.018077|2. Garcia GL, Parent CA (2008). Signal relay during chemotaxis. J Microsc  231, 529-34.   https://doi.org/10.1111/j.1365-2818.2008.02066.x|3. Rericha EC, Parent CA (2008). Steering in quadruplet: the complex signaling pathways directing chemotaxis. Sci Signal  1, pe26.   https://doi.org/10.1126/scisignal.122pe26",https://intramural.nih.gov/search/searchview.taf?ipid=50654
173,BC010419-09,"October 01, 2007 -  September 30, 2008",Molecular Mechanisms of TGF-beta Signaling Pathway,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Mary E Heller|Xiangchun  Wang|Michael  Blank|Yi  Tang,NULL,Zhenggang  Liu; PhD (National Cancer Institute)|Carl  Wu; PhD (National Cancer Institute),"Sushil Gopal Rane; MS, PhD (NIDDK)","1. Zhang Y, Fatyol K, Jin C, Wang X, Liu Z   (2008) TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta.  Molecular Cell  918-24 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=50655
174,BC010425-09,"October 01, 2007 -  September 30, 2008",Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Marjorie P Duberstein|Diane J Poole|Judith M Dipietro|Kenneth W Hance|Mary T Litzinger|Romaine Ingrid Fernando|Show all 8,"Kenneth  Foon (Hematology-Oncology, University of Pittsburgh Cancer Institute)|Alex  Franzusoff (Research and Development, GlobeImmune)","William Laurence Dahut; MD (National Cancer Institute)|Kwong Yok Tsang (National Cancer Institute)|Philip M Arlen; MD (National Cancer Institute)|James L Gulley; MD, PhD (National Cancer Institute)|Claudia Mercedes Palena (National Cancer Institute)|James W Hodge; PhD (National Cancer Institute)",NULL,"1. Schlom J, Arlen P, Hodge J   (2008) Vaccines and Immunostimulants., in Cancer Medicine 8. Kufe D, ed.,  BC Decker, in press.|2. Lutsiak ME, Tagaya Y, Adams AJ, Schlom J, Sabzevari H (2008). Tumor-induced impairment of TCR signaling results in compromised functionality of tumor-infiltrating regulatory T cells. J Immunol  180, 5871-81.   https://doi.org/10.4049/jimmunol.180.9.5871|3. Mostböck S, Lutsiak ME, Milenic DE, Baidoo K, Schlom J, Sabzevari H (2008). IL-2/anti-IL-2 antibody complex enhances vaccine-mediated antigen-specific CD8+ T cell responses and increases the ratio of effector/memory CD8+ T cells to regulatory T cells. J Immunol  180, 5118-29.   https://doi.org/10.4049/jimmunol.180.7.5118|4. Yang S, Schlom J (2009). Antigen-presenting cells containing multiple costimulatory molecules promote activation and expansion of human antigen-specific memory CD8+ T cells. Cancer Immunol Immunother  58, 503-15.   https://doi.org/10.1007/s00262-008-0572-8",https://intramural.nih.gov/search/searchview.taf?ipid=50656
175,BC010440-07,"October 01, 2007 -  September 30, 2008","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Chung  Tsai|Buyong  Ma|Hyunbum  Jang|Jin  Liu|Yifat  Miller,NULL,NULL,NULL,"1. Casanovas J, Jiménez AI, Cativiela C, Nussinov R, Alemán C (2008). 1-amino-2-phenylcyclopentane-1-carboxylic acid: a conformationally restricted phenylalanine analogue. J Org Chem  73, 644-51.   https://doi.org/10.1021/jo702107s|2. Liu J, Nussinov R (2008). Allosteric effects in the marginally stable von Hippel-Lindau tumor suppressor protein and allostery-based rescue mutant design. Proc Natl Acad Sci U S A  105, 901-6.   https://doi.org/10.1073/pnas.0707401105",https://intramural.nih.gov/search/searchview.taf?ipid=50611
176,BC010441-07,"October 01, 2007 -  September 30, 2008",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Chung  Tsai|Buyong  Ma|Yongping  Pan|Jin  Liu,NULL,NULL,NULL,"1. Andrusier N, Mashiach E, Nussinov R, Wolfson HJ (2008). Principles of flexible protein-protein docking. Proteins  73, 271-89.   https://doi.org/10.1002/prot.22170|2. Dror O, Schneidman-Duhovny D, Shulman-Peleg A, Nussinov R, Wolfson HJ, Sharan R (2008). Structural similarity of genetically interacting proteins. BMC Syst Biol  2, 69.   https://doi.org/10.1186/1752-0509-2-69|3. Emekli U, Schneidman-Duhovny D, Wolfson HJ, Nussinov R, Haliloglu T (2008). HingeProt: automated prediction of hinges in protein structures. Proteins  70, 1219-27.   https://doi.org/10.1002/prot.21613|4. Flores-Ortega A, Jiménez AI, Cativiela C, Nussinov R, Alemán C, Casanovas J (2008). Conformational preferences of alpha-substituted proline analogues. J Org Chem  73, 3418-27.   https://doi.org/10.1021/jo702710x|5. Liu J, Nussinov R (2008). Allosteric effects in the marginally stable von Hippel-Lindau tumor suppressor protein and allostery-based rescue mutant design. Proc Natl Acad Sci U S A  105, 901-6.   https://doi.org/10.1073/pnas.0707401105|6. Mashiach E, Schneidman-Duhovny D, Andrusier N, Nussinov R, Wolfson HJ (2008). FireDock: a web server for fast interaction refinement in molecular docking. Nucleic Acids Res  36, W229-32.   https://doi.org/10.1093/nar/gkn186|7. Rodríguez-Ropero F, Zanuy D, Casanovas J, Nussinov R, Alemán C (2008). Application of 1-aminocyclohexane carboxylic acid to protein nanostructure computer design. J Chem Inf Model  48, 333-43.   https://doi.org/10.1021/ci700291x|8. Schneidman-Duhovny D, Dror O, Inbar Y, Nussinov R, Wolfson HJ (2008). Deterministic pharmacophore detection via multiple flexible alignment of drug-like molecules. J Comput Biol  15, 737-54.   https://doi.org/10.1089/cmb.2007.0130|9. Schneidman-Duhovny D, Dror O, Inbar Y, Nussinov R, Wolfson HJ (2008). PharmaGist: a webserver for ligand-based pharmacophore detection. Nucleic Acids Res  36, W223-8.   https://doi.org/10.1093/nar/gkn187|10. Shulman-Peleg A, Shatsky M, Nussinov R, Wolfson HJ (2008). MultiBind and MAPPIS: webservers for multiple alignment of protein 3D-binding sites and their interactions. Nucleic Acids Res  36, W260-4.   https://doi.org/10.1093/nar/gkn185|11. Yogurtcu ON, Erdemli SB, Nussinov R, Turkay M, Keskin O (2008). Restricted mobility of conserved residues in protein-protein interfaces in molecular simulations. Biophys J  94, 3475-85.   https://doi.org/10.1529/biophysj.107.114835|12. Zanuy D, Flores-Ortega A, Casanovas J, Curcó D, Nussinov R, Alemán C (2008). The energy landscape of a selective tumor-homing pentapeptide. J Phys Chem B  112, 8692-700.   https://doi.org/10.1021/jp711477k",https://intramural.nih.gov/search/searchview.taf?ipid=50612
177,BC010442-07,"October 01, 2007 -  September 30, 2008",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Chung  Tsai|Buyong  Ma,NULL,NULL,NULL,"1. Shatsky M, Nussinov R, Wolfson HJ (2008). Algorithms for multiple protein structure alignment and structure-derived multiple sequence alignment. Methods Mol Biol  413, 125-46.   https://doi.org/10.1007/978-1-59745-574-9_5",https://intramural.nih.gov/search/searchview.taf?ipid=50616
178,BC010446-07,"October 01, 2007 -  September 30, 2008",DNA Double Strand Break Repair in Drosophila Melanogaster,Yikang  Rong,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Natalia  Wesolowska|Patrizia  Morciano|Michelle  Beaucher|Jie  Chen,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50619
179,BC010448-07,"October 01, 2007 -  September 30, 2008",Genetic Alterations in Lung Cancer,Jonathan S Wiest; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Zhihong  Shan,NULL,Jin  Jen (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50658
180,BC010449-07,"October 01, 2007 -  September 30, 2008",Role of a novel cytokine-like molecule Secretoglobin (SCGB) 3A2 in lung,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Taketomo  Kido,NULL,NULL,NULL,"1. Kimura S, Ishida T, Watanabe K, Sugawara A, Kanazawa K, Kanno R, Suzuki T, Niimi T, Munakata M   (2008) Expression of secretoglobin 3A2 (SCGB3A2) in primary pulmonary carcinomas.  Fukushima J. Med. Sci, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50659
181,BC010450-07,"October 01, 2007 -  September 30, 2008",Development of Akt Inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI",Chunyu  Zhang|Wei  Han|Shigeru  Kawabata,NULL,Ilona  Linnoila; MD (National Cancer Institute)|Susan L Holbeck (National Cancer Institute)|Melinda  Hollingshead (National Cancer Institute)|William D Figg; PharmD (National Cancer Institute)|Maria  Tsokos; MD (National Cancer Institute)|Timothy D Veenstra (National Cancer Institute),NULL,"1. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, Bamber BA, Bassham DC, Bergamini E, Bi X, Biard-Piechaczyk M, Blum JS, Bredesen DE, Brodsky JL, Brumell JH, Brunk UT, Bursch W, Camougrand N, Cebollero E, Cecconi F, Chen Y, et al. [211 more authors] (2008). Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy  4, 151-75.   https://doi.org/10.4161/auto.5338",https://intramural.nih.gov/search/searchview.taf?ipid=50660
182,BC010451-07,"October 01, 2007 -  September 30, 2008",Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines,Joseph John Barchi|IRP Faculty Profile,Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI",Piotr  Kaczmarek|Kristie M Adams|Raymond P Brinas,"Vladislav  Glinskii (Biochemistry, University of Missouri)|Kate  Rittenhouse-Olson (Biotechnical and Clinical Laboratory Science, University of Buffalo)",Robert  Blumenthal; PhD (National Cancer Institute)|Anil K Patri (National Cancer Institute)|Ola Mae Zack Howard (National Cancer Institute),NULL,"1. Sundgren A, Barchi JJ (2008). Varied presentation of the Thomsen-Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticles. Carbohydr Res  343, 1594-604.   https://doi.org/10.1016/j.carres.2008.05.003",https://intramural.nih.gov/search/searchview.taf?ipid=50802
183,BC010453-07,"October 01, 2007 -  September 30, 2008",Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Douglas K Price|Erika K Smith|Caitlin  Baum|Bevin Cathleen English,Romano  Danesi|Alex  Sparreboom,"James L Gulley; MD, PhD (National Cancer Institute)|William Laurence Dahut; MD (National Cancer Institute)",NULL,"1. Rajan A, Giaccone G (2008). Treatment of advanced thymoma and thymic carcinoma. Curr Treat Options Oncol  9, 277-87.   https://doi.org/10.1007/s11864-009-0083-7|2. Sharifi N, Dahut WL, Figg WD (2008). The genetics of castration-resistant prostate cancer: what can the germline tell us? Clin Cancer Res  14, 4691-3.   https://doi.org/10.1158/1078-0432.CCR-08-0453",https://intramural.nih.gov/search/searchview.taf?ipid=50661
184,BC010469-06,"October 01, 2007 -  September 30, 2008",Molecular Targets Development Program,James  McMahon; PhD,NULL,"Molecular Targets Development Program, NCI",Kirk R Gustafson; PhD|John A Beutler|Heidi  Bokesch|Laura  Cartner|Richard W Fuller|Roberta  Gardella|Show all 23,NULL,"William D Figg; PharmD (National Cancer Institute)|Howard A Fine; MD, PhD (National Cancer Institute)|Nealapheur L Khan (National Cancer Institute)|Giuseppe  Giaccone; MD (National Cancer Institute)|Yves  Pommier; PhD (National Cancer Institute)|David  Salomon; PhD (National Cancer Institute)",Michael P Bray (NIAID),"1. Beutler JA, Covell DA, Johnson TA, Ratnayake RA (submitted in 2008) Epoxy-guaiane Derivatives And Treatment Of Cancer. Patents issued: 2235021 (BE in 2012); 2235021 (CH in 2012); 2235021 (DK in 2012); 2235021 (EP in 2012); 2235021 (ES in 2012); 2235021 (FR in 2012); 2235021 (GB in 2012); 2235021 (IE in 2012); 2235021 (IT in 2012); 2235021 (LU in 2012); 2235021 (NL in 2012); 2235021 (NO in 2012); 2235021 (SE in 2012); 2235021 (AT in 2012); 2235021 (DE in 2013); 8,410,292 (US in 2013); 2008347299 (AU in 2013); 5547653 (JP in 2014); 2711434 (CA in 2017). Patent pending: PCT/US2008/088529 (PC application).|2. Henrich C, Bokesch H, Colburn N, Gustafson K, Kang M, McMahon J, Young M (submitted in 2008) Nuclear Factor Kappa B Pathway Inhibitor Composition And Use Of Same. Patent issued: 8,729,053 (US in 2014). Patents pending: 09792812.1 (EP application); PCT/US09/57761 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=50697
185,BC010470-06,"October 01, 2007 -  September 30, 2008",Bioinformatic Tools in Cancer Research,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Jinghui E Zhang; PhD|Michael N Edmonson|Robert  Clifford|Hongen  Zhang|Cu  Nguyen|William L Rowe|Show all 8,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50665
186,BC010474-06,"October 01, 2007 -  September 30, 2008",Signal Transduction Mechanisms of Type I IFNs,Ana M Gamero,Giorgio  Trinchieri,"Laboratory of Experimental Immunology, NCI",NULL,NULL,Howard A Young; PhD (National Cancer Institute),NULL,"1. Maher SG, Sheikh F, Scarzello AJ, Romero-Weaver AL, Baker DP, Donnelly RP, Gamero AM (2008). IFN-alpha and IFN-lambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol Ther  7, nihpa47781.|2. Smith CK, Trinchieri G (2018). The interplay between neutrophils and microbiota in cancer. J Leukoc Biol  104, 701-715.   https://doi.org/10.1002/JLB.4RI0418-151R",https://intramural.nih.gov/search/searchview.taf?ipid=50668
187,BC010476-06,"October 01, 2007 -  September 30, 2008",Time Domian Electron Paramagnetic Resonance Imaging,Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Nallathamby  Devasahayam|Sankaran  Subramanian; MD|Shingo  Matsumoto|Janusz W Koscielniak|Krishna K Nagineni,NULL,James B Mitchell; PhD (National Cancer Institute),Anthony R Fletcher; PhD (CIT) |Jeeva P Munasinghe (NINDS) |Alan Paul Koretsky; PhD (NINDS) |Calvin A Johnson; PhD (CIT) |Thomas J Pohida; MS (CIT),"1. Devasahayam N, Subramanian S, Krishna MC (2008) A novel programmable pulse generator with nanosecond resolution for pulsed electron paramagnetic resonance applications. Rev Sci Instrum 79:026106|2. Hyodo F, Murugesan R, Matsumoto K, Hyodo E, Subramanian S, Mitchell JB, Krishna MC (2008). Monitoring redox-sensitive paramagnetic contrast agent by EPRI, OMRI and MRI. J Magn Reson  190, 105-12.   https://doi.org/10.1016/j.jmr.2007.10.013|3. Hyodo F, Subramanian S, Devasahayam N, Murugesan R, Matsumoto K, Mitchell JB, Krishna MC (2008) Evaluation of sub-microsecond recovery resonators for in vivo electron paramagnetic resonance imaging. J Magn Reson 190:248-54.|4. Matsumoto S, Hyodo F, Subramanian S, Devasahayam N, Munasinghe J, Hyodo E, Gadisetti C, Cook JA, Mitchell JB, Krishna MC (2008) Low-field paramagnetic resonance imaging of tumor oxygenation and glycolytic activity in mice. J Clin Invest 118:1965-73.",https://intramural.nih.gov/search/searchview.taf?ipid=50681
188,BC010477-06,"October 01, 2007 -  September 30, 2008",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Nallathamby  Devasahayam|Sankaran  Subramanian; MD|Shingo  Matsumoto|Janusz W Koscielniak,NULL,James B Mitchell; PhD (National Cancer Institute),Jeeva P Munasinghe (NINDS) |Sardha Lalith Talagala; PhD (NINDS) |Alan Paul Koretsky; PhD (NINDS),"1. Hyodo F, Murugesan R, Matsumoto K, Hyodo E, Subramanian S, Mitchell JB, Krishna MC (2008). Monitoring redox-sensitive paramagnetic contrast agent by EPRI, OMRI and MRI. J Magn Reson  190, 105-12.   https://doi.org/10.1016/j.jmr.2007.10.013",https://intramural.nih.gov/search/searchview.taf?ipid=50679
189,BC010478-06,"October 01, 2007 -  September 30, 2008",Continuous Wave Electron Paramagnetic Resonance Imaging,Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Nallathamby  Devasahayam|Sankaran  Subramanian; MD|Shingo  Matsumoto|Janusz W Koscielniak,NULL,James B Mitchell; PhD (National Cancer Institute),Thomas J Pohida; MS (CIT),"1. Hyodo F, Murugesan R, Matsumoto K, Hyodo E, Subramanian S, Mitchell JB, Krishna MC (2008). Monitoring redox-sensitive paramagnetic contrast agent by EPRI, OMRI and MRI. J Magn Reson  190, 105-12.   https://doi.org/10.1016/j.jmr.2007.10.013|2. Hyodo F, Soule BP, Matsumoto K, Matusmoto S, Cook JA, Hyodo E, Sowers AL, Krishna MC, Mitchell JB (2008). Assessment of tissue redox status using metabolic responsive contrast agents and magnetic resonance imaging. J Pharm Pharmacol  60, 1049-60.   https://doi.org/10.1211/jpp.60.8.0011",https://intramural.nih.gov/search/searchview.taf?ipid=50680
190,BC010479-06,"October 01, 2007 -  September 30, 2008",Regulation of Melanocyte Development and Differentiation,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",Shunlin  Jiang|Christina  Ni,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50671
191,BC010481-06,"October 01, 2007 -  September 30, 2008",Structure and Function of HIV-1 Reverse Transcriptase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Paul L Boyer|Andrea L Ferris|Patrick K Clark|Baohan Christie Vu|Caroline A Davis|Barry  Johnson|Show all 7,NULL,Victor  Marquez; PhD (National Cancer Institute),NULL,"1. Hughes S, Clark A, Lewi P, Arnold E   (2008) Detection of non-nucleoside inhibitor binding to HIV-1 reverse transcriptase by  dynamic light scattering.  Biophys J, in press.|2. Vu BC, Hughes SC, Marquez VC, Siddiqui MC (submitted in 2008) C4-substitutes-2-deoxyadenosine Analogs And Methods Of Treating Hiv. Patent issued: 8,513,214 (US in 2013). Patents pending: 08850780.1 (EP application); PCT/US2008/012663 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=50675
192,BC010482-06,"October 01, 2007 -  September 30, 2008",Retroviral Replication and Vector Design,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Linda L Dunn|Andrea L Ferris|Mary J McWilliams|Baohan Christie Vu|Michael E Abram|Caroline A Davis|Show all 8,NULL,Vineet Narain KewalRamani; PhD (National Cancer Institute)|Jeffrey D Lifson; MD (Office Of The Director)|Dwight V Nissley (Genome Recombination and Regulation Section)|Terrence R Burke; PhD (National Cancer Institute)|David  Derse; PhD (National Cancer Institute)|Yves  Pommier; PhD (National Cancer Institute),"Gary Leonard Griffiths; BSc, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50674
193,BC010483-06,"October 01, 2007 -  September 30, 2008",TEM5 Ligand Hunt,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Lihong  Xu; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50692
194,BC010484-06,"October 01, 2007 -  September 30, 2008",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Amit Madhulal Chaudhary|Mohammed Khair Elzarrad; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50693
195,BC010485-06,"October 01, 2007 -  September 30, 2008",Mechanism of DC-SIGN-Mediated Transmission of HIV,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Pui Yee  Chung,NULL,Alan  Rein; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50676
196,BC010486-06,"October 01, 2007 -  September 30, 2008",Search for New Tumor Endothelial Markers,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50694
197,BC010487-06,"October 01, 2007 -  September 30, 2008",The Postentry Pathway of HIV-1,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Kyeongeun  Lee|Taichiro  Takemura|Alok  Mulky|Julie  Tang|Wendy  Yuen,NULL,Stephen H Hughes; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50677
198,BC010488-06,"October 01, 2007 -  September 30, 2008","New Animal Models to Study HIV-1 Pathogenesis, Therapy, and Reservoirs",Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Kyeongeun  Lee|Pui Yee  Chung|Wendy  Yuen,NULL,Stephen H Hughes; PhD (National Cancer Institute)|Jeffrey D Lifson; MD (National Cancer Institute)|Sarah E Palmer (National Cancer Institute),NULL,1. KewalRamani V (2008) Of mice and monkeys: New advances in animal models to study HIV-1 therapy and prophylaxis. Future HIV Ther 363-373.,https://intramural.nih.gov/search/searchview.taf?ipid=50678
199,BC010493-06,"October 01, 2007 -  September 30, 2008",High-Resolution Protein and Nucleic Acid Footprinting,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Chandravanu  Dash|Jennifer T Miller|Robert G Brinson; PhD|Michal  Legiewicz|Yi  Wang,NULL,"Nancy H Colburn; PhD (National Cancer Institute)|Barbara K Felber (National Cancer Institute)|George N Pavlakis; MD, PhD (National Cancer Institute)",NULL,"1. Le Grice S, Lee H, Bermingham A, Miller J, Chertov O, Bona M, Baichoo N, Ehteshami M, Beutler J, O''Keefe B, Goette M, Kvaratskhelia M   (2008) Vinylogous ureas as a novel class of inhibitors of reverse  transcriptase-associated ribonuclease H activity.  ACS Chem Biol, in press.|2. Le Grice S, Scarth B, Badorrek C, Gotte M   (2008) Examining the ribonuclease H primer grip of HIV-1 reverse transcriptase by charge  neutralization of RNA/DNA hybrids.  Nucleic Acids Res, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50684
200,BC010494-06,"October 01, 2007 -  September 30, 2008",Viral and Host Proteins as Therapeutic Targets,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Marion Karla Bona; PhD|Jennifer T Miller|Jason William Rausch|Michal  Legiewicz|Michaela  Wendeler|Suhman  Chung,NULL,John A Beutler (National Cancer Institute),Robert Joseph Crouch; PhD (NICHD) |Wei  Yang; PhD (NIDDK),"1. Le Grice S, Lee H, Bermingham A, Miller J, Chertov O, Bona M, Baichoo N, Ehteshami M, Beutler J, O''Keefe B, Goette M, Kvaratskhelia M   (2008) Vinylogous ureas as a novel class of inhibitors of reverse  transcriptase-associated ribonuclease H activity.  ACS Chem Biol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50682
201,BC010495-06,"October 01, 2007 -  September 30, 2008",Nucleoside and Amino Acid Analogs as Probes of HIV Replication Complexes,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Chandravanu  Dash|Jason William Rausch|Robert G Brinson; PhD|Michaela  Wendeler|Suhman  Chung,NULL,NULL,NULL,"1. Le Grice S, Lee H, Bermingham A, Miller J, Chertov O, Bona M, Baichoo N, Ehteshami M, Beutler J, O''Keefe B, Goette M, Kvaratskhelia M   (2008) Vinylogous ureas as a novel class of inhibitors of reverse  transcriptase-associated ribonuclease H activity.  ACS Chem Biol, in press.|2. Le Grice S, Scarth B, Badorrek C, Gotte M   (2008) Examining the ribonuclease H primer grip of HIV-1 reverse transcriptase by charge  neutralization of RNA/DNA hybrids.  Nucleic Acids Res, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50683
202,BC010499-06,"October 01, 2007 -  September 30, 2008",Maryland Prostate Cancer Case-Control Study,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Tiffany A Wallace|Robert Scott Hudson,"Carlo M Croce|William  Isaacs; PhD (Department of Urology, Johns Hopkins School of Medicine)|Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Jun  Luo (Urology, Johns Hopkins University)","Stephen J Chanock; MD, PhD (National Cancer Institute)|Neil Edward Caporaso; MS, MD (National Cancer Institute)|William Marston Linehan; MD (National Cancer Institute)|Howard A Young; PhD (National Cancer Institute)|Robert H Stephens (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50664
203,BC010504-06,"October 01, 2007 -  September 30, 2008","HIV Recombination, Double Infection, and Replication Fitness",Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Olga A Nikolaitchik|Jianbo  Chen|Po San Mario  Chin|Na  Ni|Andrea  Galli|Grant  Hansman,NULL,Matthew  Fivash (National Cancer Institute)|Frank  Maldarelli (National Cancer Institute)|Vinay K Pathak; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50673
204,BC010506-06,"October 01, 2007 -  September 30, 2008",Assembly and Complementation of Viral Proteins during Retroviral Replication,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jianbo  Chen|Vitaly P Boyko|Islam T Mohammad Hussein|Grant  Hansman,NULL,Eric O Freed; PhD (National Cancer Institute)|Vinay K Pathak; PhD (National Cancer Institute)|Kunio  Nagashima (Office Of The Director)|Alan  Rein; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50672
205,BC010511-06,"October 01, 2007 -  September 30, 2008",Retrovirus Assembly and Maturation,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Siddhartha  Datta; PhD|Demetria P Harvin|Jane  Mirro|Shilpa  Kulkarni|Rachael M Crist|Jayashree  Nandi,"Eran  Bacharach (Tel Aviv University)|Alexander A Kogon|Susan  Krueger (National Institute of Standards and Technology)|Massimo  Palmarini (Veterinary School, University of Glasgow)|Elena N Peletskaya|Itay  Rousso (Weizmann Institute)|Show all 7",Raul Eduardo Cachau (National Cancer Institute)|Robert J Fisher (National Cancer Institute),NULL,"1. Rein A   (2008) Preparation of recombinant HIV-1 Gag protein and assembly of virus-like  particles in vitro., in HIV Protocols, 2nd Edition (V Prasad and G Kalpana, eds).  Humana Press, Inc., in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50690
206,BC010512-06,"October 01, 2007 -  September 30, 2008",Interactions of Retroviral Proteins with Nucleic Acids,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Siddhartha  Datta; PhD|Demetria P Harvin|Jane  Mirro,Karin  Musier-Forsyth (Ohio State University)|Mark  Williams (Northeastern University),Robert J Fisher (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50691
207,BC010516-06,"October 01, 2007 -  September 30, 2008",Gated Optical DetectorsDose Guided Radiotherapy,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Guang  Li|Hu-Chen  Xie|Holly  Ning|Frank S Harrington|Barbara Chin Arora|Jason Yulin Cheng; PhD|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50698
208,BC010517-06,"October 01, 2007 -  September 30, 2008",Large Databases of Small Molecules - Drug Development Tool and Public Resource,Marc C Nicklaus|IRP Faculty Profile,Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI",Igor V Filippov|Markus  Sitzmann,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50701
209,BC010518-06,"October 01, 2007 -  September 30, 2008",Role of BMP and FGF signaling during limb development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Sangeeta  Underwood|Cindy  Elder|Matthew J Anderson,NULL,NULL,Yuji  Mishina; PhD (NIEHS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50705
210,BC010520-06,"October 01, 2007 -  September 30, 2008","Characterization of PBIP1, a novel polo-box-binding protein at the kinetochores",Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",NULL,NULL,Timothy D Veenstra (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50685
211,BC010523-05,"October 01, 2007 -  September 30, 2008",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Martin  Zofall|Hugh P Cam|Ee Sin  Chen|Tamas  Fischer|Bowen  Cui|Kenichi  Yamane|Show all 9,"Wolfgang  Fischle (Max Planck INst.)|Ryuji  Kobayashi (Molecular Pathology, MD Anderson)|Gerald  Smith (Fred Hutchinson Cancer Center)",Peter C Fitzgerald (National Cancer Institute),Henry L Levin; PhD (NICHD),"1. Cam HP, Noma K, Ebina H, Levin HL, Grewal SI (2008). Host genome surveillance for retrotransposons by transposon-derived proteins. Nature  451, 431-6.   https://doi.org/10.1038/nature06499",https://intramural.nih.gov/search/searchview.taf?ipid=50449
212,BC010524-06,"October 01, 2007 -  September 30, 2008",HIV Integrase Modeling and Computer-Aided Inhibitor Development,Marc C Nicklaus|IRP Faculty Profile,Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI",Chenzhong  Liao,NULL,Yves  Pommier; PhD (National Cancer Institute)|Stuart F J Le Grice; PhD (National Cancer Institute)|Vinay K Pathak; PhD (National Cancer Institute)|Terrence R Burke; PhD (National Cancer Institute)|Stephen H Hughes; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50700
213,BC010525-06,"October 01, 2007 -  September 30, 2008",Immune Reconstitution,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Francis  Flomerfelt; PhD|Catherine Virginia Bare|Jiun  Wang|Chandra  Gurunathan|Kirsten  Williams|Giovanna  Zappala; PhD|Show all 9,NULL,Alfred  Singer; MD (National Cancer Institute)|James Stephen Shaw; PhD (National Cancer Institute)|Richard J Hodes; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50669
214,BC010530-06,"October 01, 2007 -  September 30, 2008",Molecular Therapeutics for HIVAIDS,Dean H. Hamer; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Louise L Mchugh|Tao  Wang|Christopher J Richards|Margaret Edgington Mckinney,Laurel  Lagenaur; PhD|Dominik  Wodarz (U C Irvine),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50670
215,BC010532-06,"October 01, 2007 -  September 30, 2008",Role of Connection and RNase H Domains of HIV-1 RT in Antiviral Drug Resistance,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Galina  Nikolenko|Krista A Delviks-Frankenberry|Ryan C Burdick|Renan  Lengruber,NULL,Frank  Maldarelli (National Cancer Institute)|Sarah E Palmer (National Cancer Institute),NULL,"1. Delviks-Frankenberry KA, Lengruber RB, Santos AF, Silveira JM, Soares MA, Kearney MF, Maldarelli F, Pathak VK (2013). Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance. Virology  435, 433-41.   https://doi.org/10.1016/j.virol.2012.09.021",https://intramural.nih.gov/search/searchview.taf?ipid=50703
216,BC010533-06,"October 01, 2007 -  September 30, 2008",Mechanisms of HIV-1 Reverse Transcription,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Krista A Delviks-Frankenberry|Yeshitila  Friew|Ryan C Burdick,NULL,NULL,NULL,"1. Delviks-Frankenberry KA, Lengruber RB, Santos AF, Silveira JM, Soares MA, Kearney MF, Maldarelli F, Pathak VK (2013). Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance. Virology  435, 433-41.   https://doi.org/10.1016/j.virol.2012.09.021",https://intramural.nih.gov/search/searchview.taf?ipid=50704
217,BC010537-06,"October 01, 2007 -  September 30, 2008",Comparative Genomics: Mechanism(s) Against Emerging Infectious Diseases,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",Naoya  Yuhki; MD|Lisa  Maslan,NULL,Robert H Stephens (National Cancer Institute),James Copeland Mullikin; PhD (NHGRI),"1. Brown MA, Munkhtsog B, Troyer JL, Ross S, Sellers R, Fine AE, Swanson WF, Roelke ME, O'Brien SJ (2010). Feline immunodeficiency virus (FIV) in wild Pallas' cats. Vet Immunol Immunopathol  134, 90-5.   https://doi.org/10.1016/j.vetimm.2009.10.014",https://intramural.nih.gov/search/searchview.taf?ipid=50702
218,BC010538-06,"October 01, 2007 -  September 30, 2008",Molecular Analysis of Breast Cancer Metastasis to the Brain,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",NULL,"Kenneth Dean Aldape; MD (Laboratory Of Pathology)|Ann  Chambers (London Regional Cancer Center)|Raffael  Kurek (Department of Obstetrics and Gynecology, University of Tuebingen)|Victoria  Richon (Cancer Biology and Therapeutics, Merck)|Steven  Rubin (Oncology, GlaxoSmithKline)|George  Sledge, Jr. (Indiana University)|Show all 9","Paul S Meltzer; MD, PhD (National Cancer Institute)|Jeanne  Herring (National Cancer Institute)|Seth M Steinberg; PhD (National Cancer Institute)|Maria  Merino; PhD (National Cancer Institute)|Lionel  Feigenbaum (Office Of The Director)",Abdel G Elkahloun; PhD (NHGRI) |Alexander Oliver Vortmeyer; MD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50695
219,BC010539-06,"October 01, 2007 -  September 30, 2008",Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Jessica Catherine Walrath|Jessica Corinne Van Schaick,"Karl  Broman (University of Michigan)|Norman  Lee (Pharmacology & Physiology, George Washington Univ)",Colin L Stewart; PhD (National Cancer Institute),"Douglas Russell Stewart; BA, MD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50688
220,BC010540-06,"October 01, 2007 -  September 30, 2008",Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Jessica J Hawes|Yvette Simone Connell-Albert|Jessica Catherine Walrath|Jessica Corinne Van Schaick,"Ancha  Baranov (Molecular and Microbiology, George Mason University)|Yetrib  Hathout",Thomas J Turbyville (National Cancer Institute)|Colin L Stewart; PhD (National Cancer Institute)|John A Beutler (National Cancer Institute)|Curtis  Henrich (National Cancer Institute)|James  McMahon; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50689
221,BC010541-06,"October 01, 2007 -  September 30, 2008",Development of Mouse Astrocytoma Model for Preclinical Testing,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Jessica J Hawes|Terry Anne Van Dyke,"Yetrib  Hathout|Tobey  MacDonald (Neuro-Oncology, CNMC)|Roger  Packer (Neurology, CNMC)|Brian  Rood (Pediatric Hematology-Oncology, Children's National Medical Center)|David  Wiemer (organic synthesis/molecular target identification, University of Iowa)",Brigitte  Widemann; MD (National Cancer Institute)|Thomas J Turbyville (National Cancer Institute)|John A Beutler (National Cancer Institute)|Peter L Choyke; MD (National Cancer Institute)|Marcelino  Bernardo (National Cancer Institute)|Curtis  Henrich (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50687
222,BC010542-06,"October 01, 2007 -  September 30, 2008",Biology of Keratinocyte and Cancer Stem Cells,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI",Carole L Yee|Atsushi  Terunuma|Girish  Patel|Isha  Choudhary,NULL,Mark  Udey; MD (National Cancer Institute)|John N Brady; PhD (National Cancer Institute)|William G Telford (National Cancer Institute)|Christoph  Rader; PhD (National Cancer Institute),NULL,"1. Terunuma A, Cross JW, Dyke M, Kapoor V, Telford WG, Vogel JC (2008). Behavior of human foreskin keratinocytes expressing a hair follicle stem cell marker CD200. J Invest Dermatol  128, 1332-4.   https://doi.org/10.1038/sj.jid.5701154",https://intramural.nih.gov/search/searchview.taf?ipid=50686
223,BC010543-05,"October 01, 2007 -  September 30, 2008",HSP90 as a Molecular Target for Ionizing Radiation,"David R Gius; MD, PhD",NULL,"Radiation Oncology Branch, NCI",Kheem Singh Bisht|Lunching  Sun|Alexandra  Lin,NULL,Leonard  Neckers; PhD (National Cancer Institute),NULL,"1. Mishra MV, Bisht KS, Sun L, Muldoon-Jacobs K, Awwad R, Kaushal A, Nguyen P, Huang L, Pennington JD, Markovina S, Bradbury CM, Gius D (2008). DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells. Mol Cancer Res  6, 243-9.   https://doi.org/10.1158/1541-7786.MCR-07-0373|2. Nguyen P, Cui H, Bisht KS, Sun L, Patel K, Lee RS, Kugoh H, Oshimura M, Feinberg AP, Gius D (2008). CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region. Cancer Res  68, 5546-51.   https://doi.org/10.1158/0008-5472.CAN-08-1005|3. Sun L, Huang L, Nguyen P, Bisht KS, Bar-Sela G, Ho AS, Bradbury CM, Yu W, Cui H, Lee S, Trepel JB, Feinberg AP, Gius D (2008). DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation. Cancer Res  68, 2726-35.   https://doi.org/10.1158/0008-5472.CAN-07-6654",https://intramural.nih.gov/search/searchview.taf?ipid=50447
224,BC010544-05,"October 01, 2007 -  September 30, 2008",Epigenetic Regulation of Gene Expression and Resistance in Tumor Cells,"David R Gius; MD, PhD",NULL,"Radiation Oncology Branch, NCI",Kristi  Jacobs,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50448
225,BC010547-06,"October 01, 2007 -  September 30, 2008",Development of Drugs That Target Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Cindy Huong-Bich Chau|Erika K Smith|Lokesh  Jain|Rui  Gao|Caitlin  Baum|Haihao  Sun|Show all 8,NULL,"Howard  Parnes (National Cancer Institute)|Seth M Steinberg; PhD (National Cancer Institute)|Mustafa  Hussain (National Cancer Institute)|John J Wright (National Cancer Institute)|Philip M Arlen; MD (National Cancer Institute)|James L Gulley; MD, PhD (National Cancer Institute)",Clara Chi Chen; MD (NIDDK),"1. Al-Chalabi T, Figg WD (2007). Benefits of the combination of thalidomide plus cyclophosphamide in hormone refractory prostate cancer patients. Cancer Biol Ther  6, 318-9.   https://doi.org/10.4161/cbt.6.3.4235|2. Aragon-Ching JB, Gillespie J, Price DK, Chuaqui R, Rodriguez-Canales J, Steinberg SM, Dahut WL, Figg WD (2007). Lack of prognostic significance of prostate biopsies in metastatic androgen independent prostate cancer. BJU Int  100, 1245-8.   https://doi.org/10.1111/j.1464-410X.2007.07173.x|3. Arlen PM, Bianco F, Dahut WL, D'Amico A, Figg WD, Freedland SJ, Gulley JL, Kantoff PW, Kattan MW, Lee A, Regan MM, Sartor O, Prostate Specific Antigen Working Group (2008). Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time. J Urol  179, 2181-5; discussion 2185-6.   https://doi.org/10.1016/j.juro.2008.01.099|4. Dahut WL, Scripture C, Posadas E, Jain L, Gulley JL, Arlen PM, Wright JJ, Yu Y, Cao L, Steinberg SM, Aragon-Ching JB, Venitz J, Jones E, Chen CC, Figg WD (2008). A phase II clinical trial of sorafenib in androgen-independent prostate cancer. Clin Cancer Res  14, 209-14.   https://doi.org/10.1158/1078-0432.CCR-07-1355|5. Di Lorenzo G, Autorino R, Figg WD, De Placido S (2007). Hormone-refractory prostate cancer: where are we going? Drugs  67, 1109-24.   https://doi.org/10.2165/00003495-200767080-00002|6. Di Lorenzo G, Autorino R, Perdonà S, De Laurentiis M, D'Armiento M, Cancello G, Mirone V, Imbimbo C, Longo N, Altieri V, Tortora G, Figg WD, De Placido S (2007). Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study. Eur Urol  52, 1020-7.   https://doi.org/10.1016/j.eururo.2007.02.060|7. Di Lorenzo G, Figg WD, Fossa SD, Mirone V, Autorino R, Longo N, Imbimbo C, Perdonà S, Giordano A, Giuliano M, Labianca R, De Placido S (2008). Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study. Eur Urol  54, 1089-94.   https://doi.org/10.1016/j.eururo.2008.01.082|8. Figg WD, Li H, Sissung T, Retter A, Wu S, Gulley JL, Arlen P, Wright JJ, Parnes H, Fedenko K, Latham L, Steinberg SM, Jones E, Chen C, Dahut W (2007). Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer. BJU Int  99, 1047-55.   https://doi.org/10.1111/j.1464-410X.2007.06763.x|9. Gulley JL, Aragon-Ching JB, Steinberg SM, Hussain MH, Sartor O, Higano CS, Petrylak DP, Chatta GS, Arlen PM, Figg WD, Dahut WL (2008). Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer. J Urol  180, 1432-7; discussion 1437.   https://doi.org/10.1016/j.juro.2008.06.017|10. Li H, Price DK, Figg WD (2007). ADH1, an N-cadherin inhibitor, evaluated in preclinical models of angiogenesis and androgen-independent prostate cancer. Anticancer Drugs  18, 563-8.   https://doi.org/10.1097/CAD.0b013e328020043e|11. Miles RJ, Price DK, Figg WD (2008). Temporal-mediated FGFR1 independence: implications for targeting candidate molecules in prostate cancer. Cancer Biol Ther  7, 1180-1.   https://doi.org/10.4161/cbt.7.8.6658|12. Scher HI, Halabi S, Tannock I, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, Petrylak D, Kantoff P, Basch E, Kelly WK, Figg WD, Small EJ, Beer TM, Wilding G, Martin A, Hussain M, Prostate Cancer Clinical Trials Working Group (2008). Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol  26, 1148-59.   https://doi.org/10.1200/JCO.2007.12.4487|13. Sharifi N, Dahut WL, Figg WD (2008). Secondary hormonal therapy for prostate cancer: what lies on the horizon? BJU Int  101, 271-4.   https://doi.org/10.1111/j.1464-410X.2007.07236.x|14. Wu SL, Jones E, Gulley JL, Arlen PM, Chen CC, Figg WD, Dahut WL (2007). Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone. BJU Int  99, 525-8.   https://doi.org/10.1111/j.1464-410X.2006.06654.x",https://intramural.nih.gov/search/searchview.taf?ipid=50666
226,BC010548-03,"October 01, 2007 -  September 30, 2008",Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Kathryn  Compton|Lokesh  Jain|Matthew  Danish|Sukyung  Woo|Sarah Jean Prasse,"Judy  Karp (Department of Oncology, Johns Hopkins University)|Edward  Sausville (Greenebaum Cancer Center, University of Maryland)|Alex  Sparreboom",James A Zwiebel (National Cancer Institute)|William Laurence Dahut; MD (National Cancer Institute),NULL,"1. Chu Z, Chen JS, Liau CT, Wang HM, Lin YC, Yang MH, Chen PM, Gardner ER, Figg WD, Sparreboom A (2008). Oral bioavailability of a novel paclitaxel formulation (Genetaxyl) administered with cyclosporin A in cancer patients. Anticancer Drugs  19, 275-81.   https://doi.org/10.1097/cad.0b013e3282f3fd2e|2. Gardner ER, Dahut WL, Scripture CD, Jones J, Aragon-Ching JB, Desai N, Hawkins MJ, Sparreboom A, Figg WD (2008). Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel. Clin Cancer Res  14, 4200-5.   https://doi.org/10.1158/1078-0432.CCR-07-4592",https://intramural.nih.gov/search/searchview.taf?ipid=50920
227,BC010549-05,"October 01, 2007 -  September 30, 2008",Zebrafish Models of Cancer,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Lisa J Embree|Mizuki  Azuma|Robert R West|Heather R Shive,NULL,Paul Saiho Liu; PhD (Pharmaceutical Resources Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50450
228,BC010558-05,"October 01, 2007 -  September 30, 2008",The Maintenance of Plasmids in Pathogenic Organisms,Stuart J Austin|IRP Faculty Profile,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Therese G Brendler; BS, PhD|Brenda L Youngren|Manjistha  Sengupta|Sujatha B Gowda","Flemming  Hansen (BioCentrum, Technical University of Denmank)|Finbarr  Hayes (Genetics, University of Manchester)",Donald L Court; PhD (National Cancer Institute)|Xinhua  Ji; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50797
229,BC010561-05,"October 01, 2007 -  September 30, 2008",Transcription factor mobility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Tatiana  Karpova|Min Jeong Kim|Florian  Mueller|Timothy J Stasevich,NULL,Gordon Lee Hager; PhD (National Cancer Institute)|Charles  Vinson; PhD (National Cancer Institute),NULL,"1. Morisaki T, Müller WG, Golob N, Mazza D, McNally JG (2014). Single-molecule analysis of transcription factor binding at transcription sites in live cells. Nat Commun  5, 4456.|2. Nishiyama A, Mochizuki K, Mueller F, Karpova T, McNally JG, Ozato K (2008). Intracellular delivery of acetyl-histone peptides inhibits native bromodomain-chromatin interactions and impairs mitotic progression. FEBS Lett  582, 1501-7.   https://doi.org/10.1016/j.febslet.2008.03.044",https://intramural.nih.gov/search/searchview.taf?ipid=50744
230,BC010562-05,"October 01, 2007 -  September 30, 2008",Molecular Interaction Maps and Analysis of Bioregulatory Networks,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,Yves  Pommier; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50722
231,BC010564-05,"October 01, 2007 -  September 30, 2008",Large Scale Chromatin Structure,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Hillary  Mueller,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50745
232,BC010565-05,"October 01, 2007 -  September 30, 2008",Determinants of Melanocyte Transformation and Melanoma Progression,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",Shunlin  Jiang|Christina  Ni|Tao  Fan,NULL,Leonard  Neckers; PhD (National Cancer Institute)|Carol J Thiele (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50729
233,BC010566-05,"October 01, 2007 -  September 30, 2008",Tumor and Metastasis Biology,Chand  Khanna; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",Ling  Ren|Sung-Hyeok  Hong|Martin  Mendoza; BS|Joseph  Briggs|Lauren E Buquo|Anita C Epps,NULL,Allan M Weissman; MD (National Cancer Institute)|Patricia  Steeg; PhD (National Cancer Institute)|Lee Jay Helman; MD (National Cancer Institute)|Jeffrey E Green; MD (National Cancer Institute)|Nancy H Colburn; PhD (National Cancer Institute)|Joseph John Barchi (National Cancer Institute),Rocky S Tuan; PhD (NIAMS),"1. Guimond M, Freud AG, Mao HC, Yu J, Blaser BW, Leong JW, Vandeusen JB, Dorrance A, Zhang J, Mackall CL, Caligiuri MA (2010). In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. J Immunol  184, 2769-75.   https://doi.org/10.4049/jimmunol.0900685",https://intramural.nih.gov/search/searchview.taf?ipid=50740
234,BC010569-05,"October 01, 2007 -  September 30, 2008",Comparative Oncology Program,Chand  Khanna; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",Christina  Mazcko|Melissa C Paoloni|Anita C Epps,NULL,"Caryn  Steakley; BA, BSN, MSW (National Cancer Institute)|Lee Jay Helman; MD (National Cancer Institute)|Steven  Libutti; MD (National Cancer Institute)|Stephen M Hewitt; MD, PhD (National Cancer Institute)|Paul S Meltzer; MD, PhD (National Cancer Institute)|Joseph E Tomaszewski (National Cancer Institute)",NULL,"1. Guimond M, Freud AG, Mao HC, Yu J, Blaser BW, Leong JW, Vandeusen JB, Dorrance A, Zhang J, Mackall CL, Caligiuri MA (2010). In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. J Immunol  184, 2769-75.   https://doi.org/10.4049/jimmunol.0900685",https://intramural.nih.gov/search/searchview.taf?ipid=50741
235,BC010571-05,"October 01, 2007 -  September 30, 2008",Fluorescence Imaging Facility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Tatiana  Karpova,NULL,Gordon Lee Hager; PhD (National Cancer Institute)|Dhruba K Chattoraj; PhD (National Cancer Institute),"Mary C Dasso; BA, PhD (NICHD) |Kyoung-Hwa  Lee (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50743
236,BC010578-05,"October 01, 2007 -  September 30, 2008",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Amit Madhulal Chaudhary,NULL,NULL,Stephen H Leppla; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50456
237,BC010579-05,"October 01, 2007 -  September 30, 2008",Papillomavirus Virion Proteins and Vaccines,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Alex  Papageorge|William C Vass,NULL,John  Schiller; PhD (National Cancer Institute)|Lauren V Wood; MD (National Cancer Institute)|Allan  Hildesheim; PhD (National Cancer Institute)|Ligia  Pinto (Infection & Immunoepidemiology Branch)|Peter L Choyke; MD (National Cancer Institute)|Christopher  Buck (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50742
238,BC010580-05,"October 01, 2007 -  September 30, 2008",Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Laurie  Steffen|Robyn S Bent,NULL,Paul Stuart Albert (National Cancer Institute)|Pamela  Wolters (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50716
239,BC010585-05,"October 01, 2007 -  September 30, 2008",A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent o,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50800
240,BC010589-05,"October 01, 2007 -  September 30, 2008",Imaging as a Biomarker for Diffuse Intrinsic Brainstem Gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Laurie  Steffen|Robyn S Bent,NULL,Paul Stuart Albert (National Cancer Institute),"Nicholas  Patronas; MD (CC) |Joseph A Frank; MD, MS (CC) |Eva Halle Baker; MD, PhD (CC) |Alan Seth Barnett; PhD (NIMH)","1. Morales La Madrid A, Ranjan S, Warren KE (2018). Gliomatosis cerebri: a consensus summary report from the Second International Gliomatosis cerebri Group Meeting, June 22-23, 2017, Bethesda, USA. J Neurooncol  140, 1-4.   https://doi.org/10.1007/s11060-018-2938-x",https://intramural.nih.gov/search/searchview.taf?ipid=50712
241,BC010590-05,"October 01, 2007 -  September 30, 2008",Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,"Frank M Balis; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50713
242,BC010591-05,"October 01, 2007 -  September 30, 2008",Characterization of Xenograft Models of Childhood Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei,NULL,Chand  Khanna; MD (Pediatric Oncology Br)|Malcolm A Smith (National Cancer Institute)|Carol J Thiele (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50738
243,BC010592-05,"October 01, 2007 -  September 30, 2008",Comparative Genomic Hybridization of Neuroblastoma,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Qingrong  Chen,NULL,NULL,NULL,"1. Bilke S, Chen QR, Wei JS, Khan J (2008). Whole chromosome alterations predict survival in high-risk neuroblastoma without MYCN amplification. Clin Cancer Res  14, 5540-7.   https://doi.org/10.1158/1078-0432.CCR-07-4461|2. Kowalska A, Brunner B, Bozsaky E, Chen QR, Stock C, Lörch T, Khan J, Ambros PF (2008). Sequence based high resolution chromosomal CGH. Cytogenet Genome Res  121, 1-6.   https://doi.org/10.1159/000124373",https://intramural.nih.gov/search/searchview.taf?ipid=50739
244,BC010593-05,"October 01, 2007 -  September 30, 2008",Gene Expression Profiling of Normal Tissues,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Qingrong  Chen|Xinyu  Wen,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50736
245,BC010594-05,"October 01, 2007 -  September 30, 2008",Molecular Mechanisms of Drugs,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Patricia S Tsang; PhD|Qingrong  Chen,NULL,Chand  Khanna; MD (Pediatric Oncology Br)|Malcolm A Smith (National Cancer Institute)|Carol J Thiele (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50737
246,BC010595-05,"October 01, 2007 -  September 30, 2008",Structure and Function of APOBEC Proteins,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Patricia A Henry; PhD|Rebecca A Russell|Yeshitila  Friew|Wei  Bu|Jessica  Smith|Ryan C Burdick,NULL,Eric O Freed; PhD (National Cancer Institute)|David  Derse; PhD (National Cancer Institute)|Elena  Chertova (National Cancer Institute)|William  Gillette (National Cancer Institute)|Alan  Rein; PhD (National Cancer Institute)|Andrew G Stephen (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50748
247,BC010596-05,"October 01, 2007 -  September 30, 2008",Pediatric Graft-vs-Host Disease,Alan S Wayne; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",Kelly D Richards,NULL,"Crystal L. Mackall; MD (National Cancer Institute)|Michael R Bishop; MD (National Cancer Institute)|Steven  Pavletic; MD, MS (National Cancer Institute)|Terry J Fry (National Cancer Institute)|Ronald E Gress; MD (National Cancer Institute)|Frances  Hakim; PhD (National Cancer Institute)","Austin John Barrett; MD (NHLBI) |Charles  Bolan; BS, MS, MD (CC)","1. Guimond M, Freud AG, Mao HC, Yu J, Blaser BW, Leong JW, Vandeusen JB, Dorrance A, Zhang J, Mackall CL, Caligiuri MA (2010). In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. J Immunol  184, 2769-75.   https://doi.org/10.4049/jimmunol.0900685|2. Rau R, Fitzhugh CD, Baird K, Cortez KJ, Li L, Fischer SH, Cowen EW, Balow JE, Walsh TJ, Cohen JI, Wayne AS (2008). Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapy. Pediatr Infect Dis J  27, 265-8.   https://doi.org/10.1097/INF.0b013e31815cb239",https://intramural.nih.gov/search/searchview.taf?ipid=50719
248,BC010598-05,"October 01, 2007 -  September 30, 2008",Human T Cell Responses to Tumor Antigens for Cancer Vaccine Development,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Judith M Dipietro,NULL,Kwong Yok Tsang (National Cancer Institute)|Claudia Mercedes Palena (National Cancer Institute),NULL,"1. Schlom J, Arlen P, Hodge J   (2008) Vaccines and Immunostimulants., in Cancer Medicine 8. Kufe D, ed.,  BC Decker, in press.|2. Bernstein MB, Chakraborty M, Wansley EK, Guo Z, Franzusoff A, Mostböck S, Sabzevari H, Schlom J, Hodge JW (2008). Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells. Vaccine  26, 509-21.   https://doi.org/10.1016/j.vaccine.2007.11.033|3. Chakraborty M, Gelbard A, Carrasquillo JA, Yu S, Mamede M, Paik CH, Camphausen K, Schlom J, Hodge JW (2008). Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects. Cancer Immunol Immunother  57, 1173-83.   https://doi.org/10.1007/s00262-008-0449-x|4. Chakraborty M, Wansley EK, Carrasquillo JA, Yu S, Paik CH, Camphausen K, Becker MD, Goeckeler WF, Schlom J, Hodge JW (2008). The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing. Clin Cancer Res  14, 4241-9.   https://doi.org/10.1158/1078-0432.CCR-08-0335|5. Gulley JL, Arlen PM, Tsang KY, Yokokawa J, Palena C, Poole DJ, Remondo C, Cereda V, Jones JL, Pazdur MP, Higgins JP, Hodge JW, Steinberg SM, Kotz H, Dahut WL, Schlom J (2008). Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma. Clin Cancer Res  14, 3060-9.   https://doi.org/10.1158/1078-0432.CCR-08-0126|6. Lechleider RJ, Arlen PM, Tsang KY, Steinberg SM, Yokokawa J, Cereda V, Camphausen K, Schlom J, Dahut WL, Gulley JL (2008). Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant. Clin Cancer Res  14, 5284-91.   https://doi.org/10.1158/1078-0432.CCR-07-5162|7. Lutsiak ME, Tagaya Y, Adams AJ, Schlom J, Sabzevari H (2008). Tumor-induced impairment of TCR signaling results in compromised functionality of tumor-infiltrating regulatory T cells. J Immunol  180, 5871-81.   https://doi.org/10.4049/jimmunol.180.9.5871|8. Madan RA, Gulley JL, Schlom J, Steinberg SM, Liewehr DJ, Dahut WL, Arlen PM (2008). Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, nilutamide, and combination therapy. Clin Cancer Res  14, 4526-31.   https://doi.org/10.1158/1078-0432.CCR-07-5048|9. Mostböck S, Lutsiak ME, Milenic DE, Baidoo K, Schlom J, Sabzevari H (2008). IL-2/anti-IL-2 antibody complex enhances vaccine-mediated antigen-specific CD8+ T cell responses and increases the ratio of effector/memory CD8+ T cells to regulatory T cells. J Immunol  180, 5118-29.   https://doi.org/10.4049/jimmunol.180.7.5118|10. Rogers CJ, Berrigan D, Zaharoff DA, Hance KW, Patel AC, Perkins SN, Schlom J, Greiner JW, Hursting SD (2008). Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in mice. J Nutr  138, 115-22.   https://doi.org/10.1093/jn/138.1.115|11. Rogers CJ, Zaharoff DA, Hance KW, Perkins SN, Hursting SD, Schlom J, Greiner JW (2008). Exercise enhances vaccine-induced antigen-specific T cell responses. Vaccine  26, 5407-15.   https://doi.org/10.1016/j.vaccine.2008.07.081|12. Wansley EK, Chakraborty M, Hance KW, Bernstein MB, Boehm AL, Guo Z, Quick D, Franzusoff A, Greiner JW, Schlom J, Hodge JW (2008). Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin Cancer Res  14, 4316-25.   https://doi.org/10.1158/1078-0432.CCR-08-0393|13. Zeytin H, Reali E, Zaharoff DA, Rogers CJ, Schlom J, Greiner JW (2008). Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity. J Interferon Cytokine Res  28, 73-87.   https://doi.org/10.1089/jir.2007.0063",https://intramural.nih.gov/search/searchview.taf?ipid=50452
249,BC010600-05,"October 01, 2007 -  September 30, 2008",Study of AAA proteins by X-ray protein crystallography,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI",Wai-Kwan  Tang,NULL,Michael  Maurizi; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50721
250,BC010603-05,"October 01, 2007 -  September 30, 2008",Receptor-directed Therapy,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI",Arlethia J Spencer|Joseph A Fiorillo,NULL,John N Brady; PhD (National Cancer Institute)|Jane Beth Trepel (National Cancer Institute)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Francis W Ruscetti; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50731
251,BC010607-05,"October 01, 2007 -  September 30, 2008",Ras-mediated signals in human epithelial cell transformation and metastasis,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Ivy (Juan Juan)  Yin|Luhua  Zhang,NULL,Louis  Staudt; MD (Metabolism Br),Alan Paul Koretsky; PhD (NINDS),"1. Oberst MD, Beberman SJ, Zhao L, Yin JJ, Ward Y, Kelly K (2008). TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation. BMC Cancer  8, 189.   https://doi.org/10.1186/1471-2407-8-189",https://intramural.nih.gov/search/searchview.taf?ipid=50735
252,BC010612-04,"October 01, 2007 -  September 30, 2008",The Role of miRNA-mediated RNAI in the Biology of Cancer,Natasha  Caplen|IRP Faculty Profile,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD|Scott E Martin|Mark  Mackiewicz",NULL,J. Frederic Mushinski; MD (National Cancer Institute)|Robert H Stephens (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50762
253,BC010613-04,"October 01, 2007 -  September 30, 2008",The Induction of Gene-specific RNAi Against Cancer-associated Genes,Natasha  Caplen|IRP Faculty Profile,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD|Scott E Martin|Tamara L Jones|Mark  Mackiewicz",NULL,Paul  Goldsmith; PhD (National Cancer Institute),Marjan  Huizing; PhD (NHGRI),"1. Klootwijk RD, Savelkoul PJ, Ciccone C, Manoli I, Caplen NJ, Krasnewich DM, Gahl WA, Huizing M (2008). Allele-specific silencing of the dominant disease allele in sialuria by RNA interference. FASEB J  22, 3846-52.   https://doi.org/10.1096/fj.08-110890",https://intramural.nih.gov/search/searchview.taf?ipid=50763
254,BC010615-04,"October 01, 2007 -  September 30, 2008",RNAi Screening for the Systematic Discovery of Cancer Gene Function,Natasha  Caplen|IRP Faculty Profile,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD|Scott E Martin|Tamara L Jones","Eric  Lader (Gene Silencing, Qiagen Inc.)|John  Weinstein (Bioinformatics and Computational Biology, MD Anderson)",Karl Thomas Ried; MD (National Cancer Institute)|Yves  Pommier; PhD (National Cancer Institute)|Paul  Goldsmith; PhD (National Cancer Institute),NULL,"1. Martin SE, Caplen NJ (2007). Applications of RNA interference in mammalian systems. Annu Rev Genomics Hum Genet  8, 81-108.   https://doi.org/10.1146/annurev.genom.8.080706.092424|2. Martin SE, Jones TL, Thomas CL, Lorenzi PL, Nguyen DA, Runfola T, Gunsior M, Weinstein JN, Goldsmith PK, Lader E, Huppi K, Caplen NJ (2007). Multiplexing siRNAs to compress RNAi-based screen size in human cells. Nucleic Acids Res  35, e57.   https://doi.org/10.1093/nar/gkm141",https://intramural.nih.gov/search/searchview.taf?ipid=50765
255,BC010620-05,"October 01, 2007 -  September 30, 2008",Clinical Studies of Multidrug Resistance Reversal,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI",Robert W Robey|Zhirong  Zhan,"Merrill  Egorin (Division of Hematology/Oncology, University of Pittsburgh)|Thomas  Litman (BioInformatics, University of Copenhagen)|Wilfred  Stein (Biological Chemistry, Silberman Institute of Life Sciences, Hebrew University of Jerusalem)","William D Figg; PharmD (National Cancer Institute)|Antonio  Fojo; MD, PhD (National Cancer Institute)|Seth M Steinberg; PhD (National Cancer Institute)|Yves  Pommier; PhD (National Cancer Institute)",Clara Chi Chen; MD (NIDDK) |Robert  Innis; MD (NIMH),"1. Liao Z, Robey RW, Guirouilh-Barbat J, To KK, Polgar O, Bates SE, Pommier Y (2008). Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecan. Mol Pharmacol  73, 490-7.   https://doi.org/10.1124/mol.107.041178",https://intramural.nih.gov/search/searchview.taf?ipid=50725
256,BC010621-05,"October 01, 2007 -  September 30, 2008",Translational Studies of the Histone Deacetylase Inhibitor Romidepsin,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI",Robert W Robey|Zhirong  Zhan|Richard Lawrence Piekarz|Kin Wah  To|Victoria  Luchenko,NULL,"William D Figg; PharmD (National Cancer Institute)|Elaine S Jaffe; MD (National Cancer Institute)|Antonio  Fojo; MD, PhD (National Cancer Institute)|Patricia A Fetsch (National Cancer Institute)|Seth M Steinberg; PhD (National Cancer Institute)|Maria L Turner; MD (National Cancer Institute)",Douglas R Rosing; MD (NHLBI) |April R Robbins; PhD (NIDDK) |Danny L Sackett; PhD (NICHD) |Alexander  Ling (CC),"1. To KK, Polgar O, Huff LM, Morisaki K, Bates SE (2008). Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells. Mol Cancer Res  6, 151-64.   https://doi.org/10.1158/1541-7786.MCR-07-0175",https://intramural.nih.gov/search/searchview.taf?ipid=50723
257,BC010622-05,"October 01, 2007 -  September 30, 2008",Investigation of the ABC Half-Transporter ABCG2,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI",Robert W Robey|Zhirong  Zhan|Orsolya  Polgar|Kin Wah  To,"Gary  Kruh; MD, PhD (Medical Science Division, Fox Chase Cancer Center)|Thomas  Litman (BioInformatics, University of Copenhagen)|Balazs  Sarkadi (Dept Cell Metabolism, National Insitute of Hematology and Immunology)|Alex  Sparreboom|Hendrik  van Veen (Department of Pharmacology, University of Cambridge)",William D Figg; PharmD (National Cancer Institute)|Michael  Dean; PhD (National Cancer Institute)|Curtis  Henrich (National Cancer Institute)|Patricia A Fetsch (National Cancer Institute)|Yves  Pommier; PhD (National Cancer Institute)|Nadya I Tarasova; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50724
258,BC010623-05,"October 01, 2007 -  September 30, 2008",Molecular recognition of proteins by antibodies: A model for rational design,"Sandra  Smith-Gill; MS, PhD, BS",NULL,"Structural Biophysics Laboratory, NCI",Claudia A Lipschultz|Mauro  Acchione|Aranganathan  Shanmuganathan|Warren W Kretzschmar,"Roy  Mariuzza (W.M. Keck Laboratory for Structural Biology, University of Maryland Biotechnology Institute)|Neeti  Sinha|Richard  Willson (Chemical Engineering, University of Houston)",Joseph John Barchi (National Cancer Institute)|Alexander  Wlodawer; PhD (National Cancer Institute)|Matthew  Fivash (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50454
259,BC010624-04,"October 01, 2007 -  September 30, 2008",The Molecular Profile of Prostate Tumors in African-American Men,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Tiffany A Wallace,"Carlo M Croce|Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)","Neil Edward Caporaso; MS, MD (National Cancer Institute)|William Marston Linehan; MD (National Cancer Institute)|Howard A Young; PhD (National Cancer Institute)|Robert H Stephens (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50753
260,BC010625-05,"October 01, 2007 -  September 30, 2008",Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Lyn  Mickley Huff|Marianne  Poruchynsky|Shana Y Trostel|Edina M Komlodi-pasztor,NULL,Yvona  Ward; PhD (National Cancer Institute)|Susan  Bates; MD (National Cancer Institute)|William D Figg; PharmD (National Cancer Institute),Danny L Sackett; PhD (NICHD),"1. Edgerly M, Fojo T (2008) Is there room for improvement in adverse event reporting in the era of targeted therapies? J Natl Cancer Inst 100:240-2",https://intramural.nih.gov/search/searchview.taf?ipid=50727
261,BC010626-05,"October 01, 2007 -  September 30, 2008",Adrenocortical Cancer and Thyroid Carcinomas: Models with Unique Properties,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Edina M Komlodi-pasztor,NULL,Susan  Bates; MD (National Cancer Institute)|Richard Lawrence Piekarz (National Cancer Institute),Bradford J Wood; MD (CC),"1. Goldsmith ME, Aguila A, Steadman K, Martinez A, Steinberg SM, Alley MC, Waud WR, Bates SE, Fojo T (2007). The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems. Mol Cancer Ther  6, 496-505.   https://doi.org/10.1158/1535-7163.MCT-06-0431",https://intramural.nih.gov/search/searchview.taf?ipid=50922
262,BC010627-05,"October 01, 2007 -  September 30, 2008",Clinical Pharmacogenetics,William D Figg; PharmD|IRP Faculty Profile,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Tristan  Sissung|Douglas K Price|Caitlin  Baum,"Anthony  D'Amico (Radiation Oncology, Harvard Medical School)|Romano  Danesi|Howard  McLeod (Washington University)|Alex  Sparreboom",Seth M Steinberg; PhD (National Cancer Institute)|Susan  Bates; MD (National Cancer Institute)|William Laurence Dahut; MD (National Cancer Institute)|Frank Jess Gonzalez; PhD (National Cancer Institute),NULL,"1. Gao R, Price DK, Sissung T, Reed E, Figg WD (2008). Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1. Mol Cancer Ther  7, 1246-50.   https://doi.org/10.1158/1535-7163.MCT-07-2206|2. Gardner ER, Ahlers CM, Shukla S, Sissung TM, Ockers SB, Price DK, Hamada A, Robey RW, Steinberg SM, Ambudkar SV, Dahut WL, Figg WD (2008). Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival. BJU Int  102, 1694-9.   https://doi.org/10.1111/j.1464-410X.2008.07913.x|3. Gardner ER, Sparreboom A, Verweij J, Figg WD (2008). Lack of ABC transporter autoinduction in mice following long-term exposure to imatinib. Cancer Biol Ther  7, 412-5.   https://doi.org/10.4161/cbt.7.3.5412|4. Hoque A, Goodman P, Ambrosone CB, Figg WD, Price DK, Kopp W, Wu X, Conroy J, Lehman TA, Santella RM (2008). Extraction of DNA from serum for high-throughput genotyping: findings from pilot studies within the Prostate Cancer Prevention Trial. Urology  71, 967-70.   https://doi.org/10.1016/j.urology.2007.11.042|5. Sissung TM, Baum CE, Deeken J, Price DK, Aragon-Ching J, Steinberg SM, Dahut W, Sparreboom A, Figg WD (2008). ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel. Clin Cancer Res  14, 4543-9.   https://doi.org/10.1158/1078-0432.CCR-07-4230|6. Sissung TM, Danesi R, Price DK, Steinberg SM, de Wit R, Zahid M, Gaikwad N, Cavalieri E, Dahut WL, Sackett DL, Figg WD, Sparreboom A (2008). Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel. Mol Cancer Ther  7, 19-26.   https://doi.org/10.1158/1535-7163.MCT-07-0557|7. Sissung TM, Gardner ER, Gao R, Figg WD (2008). Pharmacogenetics of membrane transporters: a review of current approaches. Methods Mol Biol  448, 41-62.   https://doi.org/10.1007/978-1-59745-205-2_4|8. Smith NF, Baker SD, Gonzalez FJ, Harris JW, Figg WD, Sparreboom A (2008). Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100. Br J Cancer  98, 1630-2.   https://doi.org/10.1038/sj.bjc.6604353|9. Wang W, Figg WD (2008). Secondary BRCA1 and BRCA2 alterations and acquired chemoresistance. Cancer Biol Ther  7, 1004-5.   https://doi.org/10.4161/cbt.7.7.6409",https://intramural.nih.gov/search/searchview.taf?ipid=50726
263,BC010628-05,"October 01, 2007 -  September 30, 2008","Genomic, Transcriptional and Epigenetic Variation Due to Retrotransposition",David E Symer,NULL,"Basic Research Laboratory, NCI",NULL,"Jef  Boeke (Molecular Biology and Genetics, Johns Hopkins University)|Ira  Hall|Giovanni  Parmigiani (The Sydney Kimmel Comprehensive Cancer Center)|Susan  Ptak (Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology)",Robert H Stephens (National Cancer Institute)|Keiko  Akagi (National Cancer Institute)|Kathrin  Muegge; MD (National Cancer Institute),NULL,"1. Akagi K, Li J, Stephens RM, Volfovsky N, Symer DE (2008). Extensive variation between inbred mouse strains due to endogenous L1 retrotransposition. Genome Res  18, 869-80.   https://doi.org/10.1101/gr.075770.107",https://intramural.nih.gov/search/searchview.taf?ipid=50709
264,BC010629-05,"October 01, 2007 -  September 30, 2008",Characterization of Signaling Pathways involved in Cell Death and Survival,Srinivasa M Srinivasula,NULL,"Laboratory of Immune Cell Biology, NCI",Wentao  Liao|Qi  Xiao|Ken-Ichi  Fujita|Sadhanshu  Shukla; PhD,"Wafik  El-Deiry (Department of Medicine, University of Pennsylvania)|Stefan  Schutze (Universitatsklinikum Schleswig Holstein, Institut fur Immunologie)",Susan H Garfield (National Cancer Institute)|Triantafyllos  Chavakis (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50455
265,BC010630-05,"October 01, 2007 -  September 30, 2008",Cancer Vaccines and Modulation of Checkpoint Controls in Immunization,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI",Arlethia J Spencer|Joseph A Fiorillo,NULL,"Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)|Louis  Staudt; MD (Lymphoid Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50732
266,BC010631-05,"October 01, 2007 -  September 30, 2008",Characterization of candidate histone methyltransferases,David E Symer,NULL,"Basic Research Laboratory, NCI",NULL,NULL,Keiko  Akagi (National Cancer Institute)|Kathrin  Muegge; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50710
267,BC010632-05,"October 01, 2007 -  September 30, 2008",Transcription Regulation in E. coli and H. pylori,Ding Jun Jin,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Cedric Nicolas Lionel Cagliero|Carolyn B McGill|Shuo  Chen,NULL,Xinhua  Ji; PhD (National Cancer Institute)|Donald L Court; PhD (National Cancer Institute)|Mikhail V Kashlev (National Cancer Institute)|Jeffrey N Strathern (National Cancer Institute),NULL,"1. Durfee T, Hansen AM, Zhi H, Blattner FR, Jin DJ (2008). Transcription profiling of the stringent response in Escherichia coli. J Bacteriol  190, 1084-96.   https://doi.org/10.1128/JB.01092-07|2. Shaw G, Gan J, Zhou YN, Zhi H, Subburaman P, Zhang R, Joachimiak A, Jin DJ, Ji X (2008). Structure of RapA, a Swi2/Snf2 protein that recycles RNA polymerase during transcription. Structure  16, 1417-27.   https://doi.org/10.1016/j.str.2008.06.012",https://intramural.nih.gov/search/searchview.taf?ipid=50733
268,BC010638-05,"October 01, 2007 -  September 30, 2008",The role of c-met in liver biology,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Anita  Ton|Tanya N Hoang|Joe W Grisham|Daekwan  Seo; PhD, MS, BA|Tsuyoshi  Ishikawa",NULL,Valentina  Factor (Cellular and Molecular Biology Section)|Glenn  Merlino; PhD (National Cancer Institute)|Robert  Wiltrout; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50711
269,BC010639-05,"October 01, 2007 -  September 30, 2008",In Silico Screening for Cancer Targets,Marc C Nicklaus|IRP Faculty Profile,Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI",Igor V Filippov|Megan L Peach|Iwona Elzbieta Weidlich|Chenzhong  Liao,NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)|Donald P Bottaro; PhD (National Cancer Institute)|Kyung  Lee; PhD (National Cancer Institute)|Yves  Pommier; PhD (National Cancer Institute)|Stuart F J Le Grice; PhD (National Cancer Institute)|Peter  Blumberg; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50747
270,BC010646-05,"October 01, 2007 -  September 30, 2008",Chromatin Remodeling Proteins,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Sam  John|Ronit  Salomon,NULL,NULL,NULL,"1. Hager G, Stavreva D, Voss T (2008) Nuclear mechanisms of glucocorticoid action, in Hormones, Brain and Behavior. Elsevier (San Diego, CA), in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50728
271,BC010647-04,"October 01, 2007 -  September 30, 2008",Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies,Christoph  Rader; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Sivasubramanian  Baskar|Lauren R Skeffington|Jiahui  Yang,"Roman  Giger (CENTER FOR AGING AND DEVELOPMENTAL BIOLOGY, University of Rochester School of Medicine and Dentistry)|GERALD  QUINNAN, JR. (Preventive Medicine, Uniformed Services University of the Health Sciences)",Terrence R Burke; PhD (National Cancer Institute)|Crystal L. Mackall; MD (National Cancer Institute)|Dimiter Stanchev Dimitrov; PhD (National Cancer Institute),Rose G Mage; PhD (NIAID) |Paul T Wingfield; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50787
272,BC010648-04,"October 01, 2007 -  September 30, 2008","Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL",Christoph  Rader; PhD,NULL,"Experimental Transplantation and Immunology Branch, NCI",Sivasubramanian  Baskar|Ivan  Samija|Jiahui  Yang,NULL,"Wyndham H Wilson; MD, PhD (National Cancer Institute)|Michael R Bishop; MD (National Cancer Institute)|Steven  Pavletic; MD, MS (National Cancer Institute)|Ira H Pastan; MD (National Cancer Institute)|Daniel H Fowler (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI) |Gerald Ernest Marti (OD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50788
273,BC010649-04,"October 01, 2007 -  September 30, 2008",Immunotherapy Strategies for Gastrointestinal and Hepatocellular Cancer,Udai S Kammula,NULL,"Surgery Branch, NCI",Baiqin  Teng|Roozbeh  Razmpour|Anran  Wang,NULL,"Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)|Xin Wei Wang; PhD (National Cancer Institute)",Francesco M. Marincola; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50778
274,BC010652-04,"October 01, 2007 -  September 30, 2008",Lipid-based Nanocapsules and Nano Fusion Machines,Robert  Blumenthal; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Anu  Puri; PhD|Yossef  Raviv|Mathias  Viard|Benitra T Johnson|Himanshu  Garg|Julie M Belanger|Show all 10,"Wei  Chen (Physics, University of Texas at Arlington)|Mark  Kester (Pharmacology, Penn State College of Medicine)|Radha  Maheshwari (Dept of Pathology, Uniformed Services University of the Health Sciences)|Alok  Singh (Center for Bio/Molecular Science & Engineering, Naval Research Laboratory)",Victor  Marquez; PhD (National Cancer Institute)|Joseph John Barchi (National Cancer Institute)|Jacek  Capala; PhD (National Cancer Institute)|Stephen J Lockett; PhD (National Cancer Institute)|Scott E McNeil (National Cancer Institute)|Dimiter Stanchev Dimitrov; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50758
275,BC010654-04,"October 01, 2007 -  September 30, 2008",Lymphatic Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Hisataka  Kobayashi|Nobuyuki  Kosaka|Celeste A Regino|Mark  Williams,NULL,Martin W Brechbiel; PhD (Radiation Oncology Branch),David M Thomasson; PhD (CC),"1. Hama Y, Bernardo M, Regino CA, Koyama Y, Brechbiel MW, Krishna MC, Choyke PL, Kobayashi H (2007). MR lymphangiography using dendrimer-based contrast agents: a comparison at 1.5T and 3.0T. Magn Reson Med  57, 431-6.   https://doi.org/10.1002/mrm.21126|2. Hama Y, Koyama Y, Urano Y, Choyke PL, Kobayashi H (2007). Two-color lymphatic mapping using Ig-conjugated near infrared optical probes. J Invest Dermatol  127, 2351-6.   https://doi.org/10.1038/sj.jid.5700892|3. Kobayashi H, Hama Y, Koyama Y, Barrett T, Regino CA, Urano Y, Choyke PL (2007). Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. Nano Lett  7, 1711-6.   https://doi.org/10.1021/nl0707003|4. Koyama Y, Talanov VS, Bernardo M, Hama Y, Regino CA, Brechbiel MW, Choyke PL, Kobayashi H (2007). A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J Magn Reson Imaging  25, 866-71.   https://doi.org/10.1002/jmri.20852",https://intramural.nih.gov/search/searchview.taf?ipid=50769
276,BC010655-04,"October 01, 2007 -  September 30, 2008",Prostate Cancer Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Marcelino  Bernardo|Karen A Kurdziel; MD,NULL,William Marston Linehan; MD (National Cancer Institute)|Kevin A Camphausen; MD (National Cancer Institute)|William Laurence Dahut; MD (National Cancer Institute)|Peter A Pinto; MD (Urologic Oncology Branch)|Martin W Brechbiel; PhD (Radiation Oncology Branch),David M Thomasson; PhD (CC) |Bradford J Wood; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50770
277,BC010656-04,"October 01, 2007 -  September 30, 2008",Growth Factor Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Hisataka  Kobayashi|Mikako  Ogawa|Nobuyuki  Kosaka|Karen A Kurdziel; MD|Celeste A Regino|Noriko  Sato; PhD,NULL,William Marston Linehan; MD (National Cancer Institute)|Peter A Pinto; MD (Urologic Oncology Branch)|Martin W Brechbiel; PhD (Radiation Oncology Branch),NULL,"1. Barrett T, Koyama Y, Hama Y, Ravizzini G, Shin IS, Jang BS, Paik CH, Urano Y, Choyke PL, Kobayashi H (2007). In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies. Clin Cancer Res  13, 6639-48.   https://doi.org/10.1158/1078-0432.CCR-07-1119|2. Hama Y, Urano Y, Koyama Y, Choyke PL, Kobayashi H (2007). Activatable fluorescent molecular imaging of peritoneal metastases following pretargeting with a biotinylated monoclonal antibody. Cancer Res  67, 3809-17.   https://doi.org/10.1158/0008-5472.CAN-06-3794|3. Koyama Y, Barrett T, Hama Y, Ravizzini G, Choyke PL, Kobayashi H (2007). In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies. Neoplasia  9, 1021-9.   https://doi.org/10.1593/neo.07787|4. Xu H, Baidoo K, Gunn AJ, Boswell CA, Milenic DE, Choyke PL, Brechbiel MW (2007). Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging. J Med Chem  50, 4759-65.   https://doi.org/10.1021/jm070657w|5. Xu H, Regino CA, Koyama Y, Hama Y, Gunn AJ, Bernardo M, Kobayashi H, Choyke PL, Brechbiel MW (2007). Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjug Chem  18, 1474-82.   https://doi.org/10.1021/bc0701085",https://intramural.nih.gov/search/searchview.taf?ipid=50771
278,BC010657-04,"October 01, 2007 -  September 30, 2008",Intracellular In vivo Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Hisataka  Kobayashi,NULL,NULL,NULL,"1. Longmire MR, Ogawa M, Hama Y, Kosaka N, Regino CA, Choyke PL, Kobayashi H (2008). Determination of optimal rhodamine fluorophore for in vivo optical imaging. Bioconjug Chem  19, 1735-42.   https://doi.org/10.1021/bc800140c",https://intramural.nih.gov/search/searchview.taf?ipid=50772
279,BC010658-04,"October 01, 2007 -  September 30, 2008",Combination of Radiation with Multi-Target Molecular Therapy for Cancer,Jacek  Capala; PhD,NULL,"Radiation Oncology Branch, NCI",Alesia J Holly|Rafal Jerzy Zielinski,NULL,NULL,Teresa M Przytycka (NLM) |Martin  Meier-Schellersheim; PhD (NIAID),"1. Koll TT, Feis SS, Wright MH, Teniola MM, Richardson MM, Robles AI, Bradsher J, Capala J, Varticovski L (2008). HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair. Mol Cancer Ther  7, 1985-92.   https://doi.org/10.1158/1535-7163.MCT-07-2104",https://intramural.nih.gov/search/searchview.taf?ipid=50759
280,BC010660-04,"October 01, 2007 -  September 30, 2008",The Molecular Profile of Prostate Tumors in Smokers,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Tiffany A Wallace,"William  Isaacs; PhD (Department of Urology, Johns Hopkins School of Medicine)|Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Jun  Luo (Urology, Johns Hopkins University)","Neil Edward Caporaso; MS, MD (National Cancer Institute)|Arthur A Hurwitz (National Cancer Institute)|Robert H Stephens (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50754
281,BC010661-04,"October 01, 2007 -  September 30, 2008",Vaccine and Drug Combination Therapy for Human Cancers,James W Hodge; PhD|IRP Faculty Profile,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Marion G Taylor|Amanda L Boehm; PhD|Jack P Higgins|Anais  Kasten-sportes|Sofia Ribeiro Gameiro,NULL,Jeffrey  Schlom; PhD (National Cancer Institute)|Robert  Wiltrout; PhD (National Cancer Institute),NULL,"1. Hodge J, Arlen P, Schlom J   (2008) Vaccines and immunostimulants., in Cancer Medicine 8. Kufe D, ed., BC Decker (Philadelphia, PA), in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50793
282,BC010662-04,"October 01, 2007 -  September 30, 2008",Clinical Trials Involving Vaccine and Standard of Care Cancer Therapies,Philip M Arlen; MD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Myrna B Rauckhorst|Arun  Rajan,"William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Robert  DiPaola (Medicine, Cancer Institute of New Jersey)|John  Marshall","William Marston Linehan; MD (National Cancer Institute)|William Laurence Dahut; MD (National Cancer Institute)|Peter A Pinto; MD (National Cancer Institute)|William D Figg; PharmD (National Cancer Institute)|Kevin A Camphausen; MD (National Cancer Institute)|James L Gulley; MD, PhD (National Cancer Institute)",NULL,"1. Arlen P, Hodge J, Schlom J (2008) Vaccines and immunostimulants, in Cancer Medicine 8. Kufe D, ed, BC Decker (Philadelphia, PA), in press.|2. Arlen PM, Bianco F, Dahut WL, D'Amico A, Figg WD, Freedland SJ, Gulley JL, Kantoff PW, Kattan MW, Lee A, Regan MM, Sartor O, Prostate Specific Antigen Working Group (2008). Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time. J Urol  179, 2181-5; discussion 2185-6.   https://doi.org/10.1016/j.juro.2008.01.099|3. Dahut WL, Scripture C, Posadas E, Jain L, Gulley JL, Arlen PM, Wright JJ, Yu Y, Cao L, Steinberg SM, Aragon-Ching JB, Venitz J, Jones E, Chen CC, Figg WD (2008). A phase II clinical trial of sorafenib in androgen-independent prostate cancer. Clin Cancer Res  14, 209-14.   https://doi.org/10.1158/1078-0432.CCR-07-1355|4. Gulley JL, Arlen PM, Tsang KY, Yokokawa J, Palena C, Poole DJ, Remondo C, Cereda V, Jones JL, Pazdur MP, Higgins JP, Hodge JW, Steinberg SM, Kotz H, Dahut WL, Schlom J (2008). Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma. Clin Cancer Res  14, 3060-9.   https://doi.org/10.1158/1078-0432.CCR-08-0126|5. Lechleider RJ, Arlen PM, Tsang KY, Steinberg SM, Yokokawa J, Cereda V, Camphausen K, Schlom J, Dahut WL, Gulley JL (2008). Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant. Clin Cancer Res  14, 5284-91.   https://doi.org/10.1158/1078-0432.CCR-07-5162|6. Madan RA, Gulley JL, Schlom J, Steinberg SM, Liewehr DJ, Dahut WL, Arlen PM (2008). Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, nilutamide, and combination therapy. Clin Cancer Res  14, 4526-31.   https://doi.org/10.1158/1078-0432.CCR-07-5048|7. Schlom J, Gulley JL, Arlen PM (2008). Paradigm shifts in cancer vaccine therapy. Exp Biol Med (Maywood)  233, 522-34.   https://doi.org/10.3181/0708-MR-226|8. Yokokawa J, Cereda V, Remondo C, Gulley JL, Arlen PM, Schlom J, Tsang KY (2008). Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer. Clin Cancer Res  14, 1032-40.   https://doi.org/10.1158/1078-0432.CCR-07-2056",https://intramural.nih.gov/search/searchview.taf?ipid=50749
283,BC010663-04,"October 01, 2007 -  September 30, 2008",The Role of JAM-C in Adhesive Interactions of Immune Cells,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI",Valeria  Orlova|Eun-Young  Choi|Sunil  Kaul,"Sentot  Santoso (Clinical Immunology, University Giessen)|Dietmar  Vestweber (Clinical Immunology, MPI)",NULL,NULL,"1. Orlova VV, Chavakis T (2007). Regulation of vascular endothelial permeability by junctional adhesion molecules (JAM). Thromb Haemost  98, 327-32.|2. Sachs UJ, Andrei-Selmer CL, Maniar A, Weiss T, Paddock C, Orlova VV, Choi EY, Newman PJ, Preissner KT, Chavakis T, Santoso S (2007). The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). J Biol Chem  282, 23603-12.   https://doi.org/10.1074/jbc.M701120200",https://intramural.nih.gov/search/searchview.taf?ipid=50766
284,BC010664-04,"October 01, 2007 -  September 30, 2008",Crosstalk Between Inflammation and Angiogenesis,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Andre A Nussenzweig; PhD (National Cancer Institute)|Giovanna  Tosato; PhD (National Cancer Institute),Manfred  Boehm; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50767
285,BC010666-04,"October 01, 2007 -  September 30, 2008",Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines,"James L Gulley; MD, PhD|IRP Faculty Profile",Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Sandra  Doren|Mary P Pazdur|Theresa A Ferrara|Jacquin L Jones|Natasha  Brunson|Ravi  Madan|Show all 7,"William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Robert  DiPaola (Medicine, Cancer Institute of New Jersey)|John  Marshall",William Laurence Dahut; MD (National Cancer Institute)|William Marston Linehan; MD (National Cancer Institute)|Kevin A Camphausen; MD (National Cancer Institute)|Peter A Pinto; MD (National Cancer Institute)|William D Figg; PharmD (National Cancer Institute)|Jeffrey  Schlom; PhD (National Cancer Institute),NULL,"1. Cheever MA, Schlom J, Weiner LM, Lyerly HK, Disis ML, Greenwood A, Grad O, Nelson WG, Translational Research Working Group (2008). Translational Research Working Group developmental pathway for immune response modifiers. Clin Cancer Res  14, 5692-9.   https://doi.org/10.1158/1078-0432.CCR-08-1266|2. Dahut WL, Scripture C, Posadas E, Jain L, Gulley JL, Arlen PM, Wright JJ, Yu Y, Cao L, Steinberg SM, Aragon-Ching JB, Venitz J, Jones E, Chen CC, Figg WD (2008). A phase II clinical trial of sorafenib in androgen-independent prostate cancer. Clin Cancer Res  14, 209-14.   https://doi.org/10.1158/1078-0432.CCR-07-1355|3. Sharifi N, Hamada A, Sissung T, Danesi R, Venzon D, Baum C, Gulley JL, Price DK, Dahut WL, Figg WD (2008). A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer. BJU Int  102, 617-21.   https://doi.org/10.1111/j.1464-410X.2008.07629.x",https://intramural.nih.gov/search/searchview.taf?ipid=50792
286,BC010668-04,"October 01, 2007 -  September 30, 2008",Instrumentation for microSPECT and microPET imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Jurgen  Seidel; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50768
287,BC010670-04,"October 01, 2007 -  September 30, 2008",Molecular-Targeted Radiation Therapy,Norman Norman Coleman; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Sanjeewani T Palayoor|David  Cerna,NULL,James B Mitchell; PhD (National Cancer Institute)|Stephen  Yoo (National Cancer Institute),NULL,"1. Tsai MH, Cook JA, Chandramouli GV, DeGraff W, Yan H, Zhao S, Coleman CN, Mitchell JB, Chuang EY (2007). Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res  67, 3845-52.   https://doi.org/10.1158/0008-5472.CAN-06-4250",https://intramural.nih.gov/search/searchview.taf?ipid=50752
288,BC010671-04,"October 01, 2007 -  September 30, 2008",Genetic Analysis of T-cell Differentiation,"Remy J Bosselut; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI",Kathryn F Wildt|Lie  Wang|Monica B Zamisch|Yumei  Xiong; PhD|Catherine Severine Bauge,"Albert  Bendelac (University of Chicago)|Marc  Ehlers (Tolerance & auto-immunity, DRFZ)|I-Cheng  Ho (Rheumatology, Immunology and Allergy, Harvard (Brigham and Women's))",Lionel  Feigenbaum (Office Of The Director)|Lino  Tessarollo (National Cancer Institute),William E Paul; MD (NIAID) |B. J. Fowlkes; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50750
289,BC010675-04,"October 01, 2007 -  September 30, 2008",Development of a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Laboratory of Medicinal Chemistry, NCI",Oyindasola O Oyelaran|Qian  Li|David W Farnsworth,NULL,John T. Simpson; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50774
290,BC010677-04,"October 01, 2007 -  September 30, 2008",NADPH Oxidase 1: A Novel Target for Colon Cancer Therapy,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI","Yun  Ge|Agnes  Juhasz|Jiamo  Lu; MD, MPH, MHS",NULL,NULL,NULL,"1. Gajewski E, Gaur S, Akman SA, Matsumoto L, van Balgooy JN, Doroshow JH (2007). Oxidative DNA base damage in MCF-10A breast epithelial cells at clinically achievable concentrations of doxorubicin. Biochem Pharmacol  73, 1947-56.   https://doi.org/10.1016/j.bcp.2007.03.022",https://intramural.nih.gov/search/searchview.taf?ipid=50773
291,BC010678-04,"October 01, 2007 -  September 30, 2008",Keratinocyte Growth Factor (KGF): Clinical Applications,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50795
292,BC010680-04,"October 01, 2007 -  September 30, 2008",Characterization of the hCenexin-Plk1 interaction at the centrosomes,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Kyung Ho  Lee,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50783
293,BC010681-04,"October 01, 2007 -  September 30, 2008",Development of anti-polo-box therapeutic agents,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Jung Eun  Park,NULL,Marc C Nicklaus (National Cancer Institute)|James  McMahon; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50784
294,BC010683-04,"October 01, 2007 -  September 30, 2008",Role of FH loss in development of HLRCC heriditary kidney cancer,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Hye-Sik  Kong|Shinji  Tsutsumi|Mehdi  Mollapour,NULL,William Marston Linehan; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50786
295,BC010684-04,"October 01, 2007 -  September 30, 2008",Anatomic Pathology Residency Program,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Kant  Matsuda|George  Miles|Deqin  Ma|Qingyan  Liu|Haresh  Mani|Jason Dean Hipp; MD, PhD|Show all 10",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50777
296,BC010685-04,"October 01, 2007 -  September 30, 2008",Postmortem Pathology,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI","David  Levens; PhD|Susan  Mackem; MD|Martha Maria Nicacio Quezado; MD|Stephen M Hewitt; MD, PhD|Willie J Young",NULL,NULL,"Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Kenneth  Olivier; MD, MPH (NIAID)","1. Feld JJ, Hussain N, Wright EC, Kleiner DE, Hoofnagle JH, Ahlawat S, Anderson V, Hilligoss D, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T (2008). Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology  134, 1917-26.   https://doi.org/10.1053/j.gastro.2008.02.081",https://intramural.nih.gov/search/searchview.taf?ipid=50779
297,BC010686-04,"October 01, 2007 -  September 30, 2008",Clinical Operations for Laboratory of Pathology,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Earle J Barnes|Joseph  Chinquee|Ellen M Mann|Silke  Williams,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50780
298,BC010687-04,"October 01, 2007 -  September 30, 2008",Histology Core Laboratory,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Helen G Lynch|Martha A Pruden|John A Polite|Judith C Horn,NULL,"Steven  Pavletic; MD, MS (National Cancer Institute)","Jay  Hoofnagle; MD (NIDDK) |Theo  Heller; MD (NIDDK) |Gabor  Illei; MD, PhD (NIDCR) |Marc Gregory Ghany; MD (NIDDK) |Steven M Holland; MD (NIAID) |Michael  Polis; MD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50781
299,BC010688-04,"October 01, 2007 -  September 30, 2008",Dermatology Consultation Clinic and Clinical Research,Maria L Turner; MD,Mark  Udey; MD,"Dermatology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50751
300,BC010692-04,"October 01, 2007 -  September 30, 2008",Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes,Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Shannon I Skarshaug|Valerie M Zgonc,NULL,Blanche P Alter (National Cancer Institute)|Neelam K Giri; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50755
301,BC010694-04,"October 01, 2007 -  September 30, 2008",Clinical Cancer Cytogenetics,Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Shannon I Skarshaug|Valerie M Zgonc|Veronica  Krevinko,NULL,"Wyndham H Wilson; MD, PhD (National Cancer Institute)|Blanche P Alter (National Cancer Institute)|Michael R Bishop; MD (National Cancer Institute)|Daniel H Fowler (National Cancer Institute)|Elaine S Jaffe; MD (National Cancer Institute)|Stefania  Pittaluga (National Cancer Institute)","Gerald Ernest Marti (OD) |Adrian U Wiestner; MD, PhD (NHLBI)","1. Lahortiga I, Akin C, Cools J, Wilson TM, Mentens N, Arthur DC, Maric I, Noel P, Kocabas C, Marynen P, Lessin LS, Wlodarska I, Robyn J, Metcalfe DD (2008). Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion. Haematologica  93, 49-56.   https://doi.org/10.3324/haematol.11836|2. Mrózek K, Carroll AJ, Maharry K, Rao KW, Patil SR, Pettenati MJ, Watson MS, Arthur DC, Tantravahi R, Heerema NA, Koduru PR, Block AW, Qumsiyeh MB, Edwards CG, Sterling LJ, Holland KB, Bloomfield CD (2008). Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: the Cancer and Leukemia Group B experience. Int J Oncol  33, 239-44.|3. Mussai FJ, Cunningham LC, Rezvani G, Stratakis CA, Reynolds JC, Nesterova G, Henshaw RM, Levine JE, Helman LJ, Arthur DC, Kim SY (2008). Hypocalcemia in a patient with osteosarcoma and 22q11.2 deletion syndrome. J Pediatr Hematol Oncol  30, 612-7.   https://doi.org/10.1097/MPH.0b013e318168f072",https://intramural.nih.gov/search/searchview.taf?ipid=50756
302,BC010695-04,"October 01, 2007 -  September 30, 2008",Prostate stem cells and cancer stem cells,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI",Carole L Yee|Atsushi  Terunuma|Renuka  Pudi,NULL,"Lionel  Feigenbaum (Office Of The Director)|William G Telford (National Cancer Institute)|Michael R Emmert-Buck; MD, PhD (National Cancer Institute)|Kathleen  Kelly; PhD (National Cancer Institute)",Rocky S Tuan; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50796
303,BC010696-04,"October 01, 2007 -  September 30, 2008",Study of Hereditary Renal Syndromes,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Linda S Wrathall,NULL,NULL,NULL,"1. Signoretti S, Bratslavsky G, Waldman FM, Reuter VE, Haaga J, Merino M, Thomas GV, Pins MR, Libermann T, Gillespie J, Tomaszewski JE, Compton CC, Hruszkewycz A, Linehan WM, Atkins MB (2008). Tissue-based research in kidney cancer: current challenges and future directions. Clin Cancer Res  14, 3699-705.   https://doi.org/10.1158/1078-0432.CCR-07-4733|2. Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM (2008). BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet  45, 321-31.   https://doi.org/10.1136/jmg.2007.054304|3. Yang Y, Padilla-Nash HM, Vira MA, Abu-Asab MS, Val D, Worrell R, Tsokos M, Merino MJ, Pavlovich CP, Ried T, Linehan WM, Vocke CD (2008). The UOK 257 cell line: a novel model for studies of the human Birt-Hogg-Dubé gene pathway. Cancer Genet Cytogenet  180, 100-9.   https://doi.org/10.1016/j.cancergencyto.2007.10.010",https://intramural.nih.gov/search/searchview.taf?ipid=50785
304,BC010698-04,"October 01, 2007 -  September 30, 2008",Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI",Nancy M Hardy,NULL,Daniel H Fowler (National Cancer Institute)|Ronald E Gress; MD (National Cancer Institute)|Terry J Fry (National Cancer Institute)|Crystal L. Mackall; MD (National Cancer Institute)|Frances  Hakim; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50757
305,BC010701-03,"October 01, 2007 -  September 30, 2008",Human Monoclonal Antibodies and Antibody-Guided Nanoparticles,Dimiter Stanchev Dimitrov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Yang  Feng|Xiaodong  Xiao|Mei-Yun  Zhang|Zhongyu  Zhu|Bang K Vu|Weizao  Chen|Show all 11,"Christopher  Broder (Immunology and Microbiology, Uniformed Services University of the Health Sciences)|Barton  Haynes (Preventive Medicine, Duke University)|Shibo  Jiang (Virology, New York Blood Center)|Gerald  Quinnan (Uniformed Services University of the Health Sciences)|George  Shaw (Microbiology, University of Alabama at Birmingham)|Steven  Weitman (Systems Medicine Inc.)",Xinhua  Ji; PhD (National Cancer Institute)|Robert  Blumenthal; PhD (National Cancer Institute)|Ira H Pastan; MD (National Cancer Institute),Peter D Kwong; PhD (NIAID),"1. Bossart KN, Tachedjian M, McEachern JA, Crameri G, Zhu Z, Dimitrov DS, Broder CC, Wang LF (2008). Functional studies of host-specific ephrin-B ligands as Henipavirus receptors. Virology  372, 357-71.   https://doi.org/10.1016/j.virol.2007.11.011|2. Polonis VR, Brown BK, Rosa Borges A, Zolla-Pazner S, Dimitrov DS, Zhang MY, Barnett SW, Ruprecht RM, Scarlatti G, Fenyö EM, Montefiori DC, McCutchan FE, Michael NL (2008). Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination. Virology  375, 315-20.   https://doi.org/10.1016/j.virol.2008.02.007|3. Zhang MY, Vu BK, Choudhary A, Lu H, Humbert M, Ong H, Alam M, Ruprecht RM, Quinnan G, Jiang S, Montefiori DC, Mascola JR, Broder CC, Haynes BF, Dimitrov DS (2008). Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens. J Virol  82, 6869-79.   https://doi.org/10.1128/JVI.00033-08|4. Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, McEachern JA, Feng Y, Middleton D, Wang LF, Broder CC, Dimitrov DS (2008). Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. J Infect Dis  197, 846-53.   https://doi.org/10.1086/528801|5. Dimitrov DS, Chen WS (submitted in 2008) Anti-hiv Domain Antibodies And Methods Of Making And Using Same. Patents issued: 9,181,327 (US in 2016); 602009045945 (DE in 2017); 2238165 (EP in 2017); 2238165 (FR in 2017); 2238165 (GB in 2017). Patent pending: 14/867,793 (US application).|6. Dimitrov DS, Feng YS, Pastan IS (submitted in 2008) Human Anti-mesothelin Monoclonal Antibodies. Patent issued: 8,357,783 (US in 2013). Patents pending: 09726082.2 (EP application); PCT/US2009/038228 (PC application); 2009228361 (AU application); 2,718,321 (CA application).|7. Dimitrov DS, Pastan IS, Xiao XS (submitted in 2008) Human Monoclonal Antibodies Specific For Cd22. Patents issued: 8,591,889 (US in 2014); 9,279,019 (US in 2016); 9,598,492 (US in 2017). Patents pending: 15/424,238 (US application); PCT/US2009/039080 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=50804
306,BC010707-03,"October 01, 2007 -  September 30, 2008",Role of T regulatory suppression in autoimmunity and cancer,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Xin  Chen|Ola Mae Zack Howard,NULL,Jeffrey J Subleski (National Cancer Institute)|Robert  Wiltrout; PhD (National Cancer Institute),NULL,"1. Chen X, Subleski JJ, Kopf H, Howard OM, Männel DN, Oppenheim JJ (2008). Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J Immunol  180, 6467-71.   https://doi.org/10.4049/jimmunol.180.10.6467",https://intramural.nih.gov/search/searchview.taf?ipid=50810
307,BC010708-03,"October 01, 2007 -  September 30, 2008",Consequences of receptor cross talk on inflammation and algesia,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Ola Mae Zack Howard|De  Yang|Poonam  Tewary|Gonzalo  De La Rosa,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50811
308,BC010709-03,"October 01, 2007 -  September 30, 2008",An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Laurie  Steffen|Robyn S Bent,NULL,"Paul Stuart Albert (National Cancer Institute)|Pamela  Wolters (National Cancer Institute)|Kevin A Camphausen; MD (National Cancer Institute)|Stephen J Chanock; MD, PhD (National Cancer Institute)|Steven  Libutti; MD (National Cancer Institute)|Deborah E Citrin (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50848
309,BC010714-03,"October 01, 2007 -  September 30, 2008",Angiogenesis imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Hisataka  Kobayashi|Marcelino  Bernardo|Karen A Kurdziel; MD|Celeste A Regino|Mark  Williams|Noriko  Sato; PhD|Show all 7,NULL,William Marston Linehan; MD (National Cancer Institute)|William Laurence Dahut; MD (National Cancer Institute),David M Thomasson; PhD (CC),"1. Giesel FL, Mehndiratta A, Locklin J, McAuliffe MJ, White S, Choyke PL, Knopp MV, Wood BJ, Haberkorn U, von Tengg-Kobligk H (2009). Image fusion using CT, MRI and PET for treatment planning, navigation and follow up in percutaneous RFA. Exp Oncol  31, 106-14.",https://intramural.nih.gov/search/searchview.taf?ipid=50826
310,BC010715-03,"October 01, 2007 -  September 30, 2008",Phase II study of flavopiridol in mantle cell lymphoma and DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,Elaine S Jaffe; MD (National Cancer Institute)|John  Janik; MD (National Cancer Institute)|Stefania  Pittaluga (National Cancer Institute),"Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50849
311,BC010716-03,"October 01, 2007 -  September 30, 2008",Phase III study of BCL-family inhibitors in lymphoma,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (National Cancer Institute)|John  Janik; MD (National Cancer Institute)|Stefania  Pittaluga (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50850
312,BC010717-03,"October 01, 2007 -  September 30, 2008",Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (National Cancer Institute)|Stefania  Pittaluga (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50851
313,BC010719-03,"October 01, 2007 -  September 30, 2008",Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,Elaine S Jaffe; MD (National Cancer Institute)|John  Janik; MD (National Cancer Institute)|Stefania  Pittaluga (National Cancer Institute),"Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50852
314,BC010720-03,"October 01, 2007 -  September 30, 2008","Isolation, Characterization, and Behavior of Melanocyte Stem Cells",Thomas J Hornyak,NULL,"Dermatology Branch, NCI",Shunlin  Jiang|Ha-Young  Hwang,NULL,Glenn  Merlino; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50831
315,BC010721-03,"October 01, 2007 -  September 30, 2008",Modeling of the structure and functional mechanisms of voltage-gated channels,Homer Robert Guy; PhD,NULL,"Laboratory of Cell Biology, NCI",Adina L Milac,"Angie  Gelli (Dept of Pharmacology, School of Medicine, Univ Calif, Davis)|Steffen  Hering (Institut für Pharmakologie und Toxikologie, Universität Wien)|Gea-Ny  Tseng (Physiology, Virginia Commonwealth Univ)",NULL,NULL,"1. Guy H, Beyl S, Stary A, Kudrnac M, Hohaus A, Timin E (2008) Pore stability and gating in voltage-activated calcium channels. Channels 61-69.|2. Guy H, Kudrnac M, Beyl S, Hohaus A, Timin E, Wolschann P, Hering S (2008) Molecular Dynamics and Mutational Analysis of a Channelopathy mutation in the IIS6 Helix of CaV1.2. Channels 216-223.|3. Guy H, Shafrir Y, Hering S, Wolschann P (2008) Structural model of the CaV1.2 pore. Channels 210-215.|4. Shafrir Y, Durell SR, Guy HR (2008). Models of the structure and gating mechanisms of the pore domain of the NaChBac ion channel. Biophys J  95, 3650-62.   https://doi.org/10.1529/biophysj.108.135327|5. Shafrir Y, Durell SR, Guy HR (2008). Models of voltage-dependent conformational changes in NaChBac channels. Biophys J  95, 3663-76.   https://doi.org/10.1529/biophysj.108.135335",https://intramural.nih.gov/search/searchview.taf?ipid=50829
316,BC010722-03,"October 01, 2007 -  September 30, 2008",Modeling of amyloid peptides and proteins,Homer Robert Guy; PhD,NULL,"Laboratory of Cell Biology, NCI",Daniel T Flatow|Sijung  Yun,"Andriy  Anishkin (Biology, Univ Maryland, College Park)|Nelson  Arispe (Anat/Physiol/Genet, Uniformed Serv Univ Hlth Sci)|Harvey  Pollard (Anat/Physiol/Genet, Uniformed Serv Univ Hlth Sci)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50830
317,BC010725-03,"October 01, 2007 -  September 30, 2008",Role of Formylpeptide Receptors in Host Defense,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",Nancy M Dunlop|Wang-Hua  Gong|Jian  Huang,NULL,NULL,Philip M Murphy; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50820
318,BC010727-03,"October 01, 2007 -  September 30, 2008",Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers,Jacek  Capala; PhD,NULL,"Radiation Oncology Branch, NCI",Alesia J Holly|Gabriela  Kramer-Marek|Rafal Jerzy Zielinski,"Wei  Chen (Department of Physics, The University of Texas at Arlington)|Peter  Chumachov (Lerner Research Institute)|John  Dagata (NIST)|R.  Downing (NIST)|Peter  Lassota (Caliper Life Sciences)|Fredrik  Nilsson (Affibody AB)|Show all 7",Robert  Blumenthal; PhD (National Cancer Institute)|Peter L Choyke; MD (National Cancer Institute)|Barbara V Vonderhaar; PhD (National Cancer Institute),"Dale Oscar Kiesewetter; BS, PhD (NIBIB) |Amir Hossein Gandjbakhche; PhD (NICHD) |Gary Leonard Griffiths; BSc, PhD (NHLBI)","1. Capala J, Kramer-Marek G, Ma Y (2008) Radiolabeling of HER2-specific Affibody molecule with F-18. Journal of Fluorine Chemistry 799-809.|2. Hassan M, Chernomordik V, Zielinski R, Ardeshirpour Y, Capala J, Gandjbakhche A (2012). In vivo method to monitor changes in HER2 expression using near-infrared fluorescence imaging. Mol Imaging  11, 177-86.",https://intramural.nih.gov/search/searchview.taf?ipid=50824
319,BC010728-03,"October 01, 2007 -  September 30, 2008",Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (National Cancer Institute)|John  Janik; MD (National Cancer Institute)|Stefania  Pittaluga (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50853
320,BC010729-03,"October 01, 2007 -  September 30, 2008",Technology Development,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Rodrigo F Chuaqui|Gallya  Gannot|Michael  Tangrea|Sumana  Mukherjee|Jaime  Rodriguez,"Jon  Cohen (Diagnostics, 2020 GeneSystems, Inc)|Benjamin  Shapiro (Engineering, University of Maryland)|Elisabeth  Smela (Engineering, University of Maryland)",NULL,Robert F Bonner; PhD (NICHD),"1. Erickson HS, Gillespie JW, Emmert-Buck MR (2008). Tissue microdissection. Methods Mol Biol  424, 433-48.   https://doi.org/10.1007/978-1-60327-064-9_34|2. Xiao Y, Gao X, Gannot G, Emmert-Buck MR, Srivastava S, Wagner PD, Amos MD, Barker PE (2008). Quantitation of HER2 and telomerase biomarkers in solid tumors with IgY antibodies and nanocrystal detection. Int J Cancer  122, 2178-86.   https://doi.org/10.1002/ijc.23320|3. Shapiro B, Emmert-Buck M (submitted in 2008) Methods And Systems Using Therapeutic, Diagnostic, Or Prophylactic Magnetic Agents. Patent issued: 8,579,787 (US in 2014). Patent pending: 12/468,746 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=50805
321,BC010731-03,"October 01, 2007 -  September 30, 2008",In Vivo MRI imaging of single metastatic cells,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Ivy (Juan Juan)  Yin|Luhua  Zhang,NULL,NULL,Alan Paul Koretsky; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50807
322,BC010733-03,"October 01, 2007 -  September 30, 2008",Dermatoscopy in the Evaluation of Pigmented Lesions,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",NULL,NULL,Kenneth H Kraemer; MD (National Cancer Institute)|John  Digiovanna (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50832
323,BC010734-03,"October 01, 2007 -  September 30, 2008",Cutaneous Lesions in Neurofibromatosis Type I and Other Pre-cancerous Syndromes,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",NULL,NULL,Brigitte  Widemann; MD (National Cancer Institute),"Douglas Russell Stewart; BA, MD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50833
324,BC010735-03,"October 01, 2007 -  September 30, 2008",Structural studies of fimbriae of enterotoxigenic E. coli (ETEC),"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50822
325,BC010736-03,"October 01, 2007 -  September 30, 2008",Using mouse knockouts to unravel endothelial gene function,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50847
326,BC010737-03,"October 01, 2007 -  September 30, 2008",IFN-Lambda Signal Transduction,Ana M Gamero,Giorgio  Trinchieri,"Laboratory of Experimental Immunology, NCI",NULL,NULL,Paul  Goldsmith; PhD (National Cancer Institute)|Howard A Young; PhD (National Cancer Institute),Raymond  Donnelly (OD),"1. Maher SG, Sheikh F, Scarzello AJ, Romero-Weaver AL, Baker DP, Donnelly RP, Gamero AM (2008). IFN-alpha and IFN-lambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol Ther  7, nihpa47781.",https://intramural.nih.gov/search/searchview.taf?ipid=50827
327,BC010738-03,"October 01, 2007 -  September 30, 2008","Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging",Steven X Hou|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Grace Zhiyu  Zheng|Satyanarayana  Ande|Xiankun  Zeng,NULL,Lino  Tessarollo (National Cancer Institute)|Jonathan  Keller; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50834
328,BC010739-03,"October 01, 2007 -  September 30, 2008",Structural Studies of Drug Agents by Nuclear Magnetic Resonance Spectroscopy,Joseph John Barchi|IRP Faculty Profile,Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI",NULL,"Susan  Keay|Burkhard  Luy (Chemistry, Technische Universitt Mnchen)","Sandra  Smith-Gill; MS, PhD, BS (National Cancer Institute)",Adriaan  Bax; PhD (NIDDK),"1. Acchione M, Lee YC, DeSantis ME, Lipschultz CA, Wlodawer A, Li M, Shanmuganathan A, Walter RL, Smith-Gill S, Barchi JJ (2012). Specific fluorine labeling of the HyHEL10 antibody affects antigen binding and dynamics. Biochemistry  51, 6017-27.   https://doi.org/10.1021/bi300455t|2. Barchi JJ, Karki RG, Nicklaus MC, Siddiqui MA, George C, Mikhailopulo IA, Marquez VE (2008). Comprehensive structural studies of 2',3'-difluorinated nucleosides: comparison of theory, solution, and solid state. J Am Chem Soc  130, 9048-57.   https://doi.org/10.1021/ja800964g|3. Kaczmarek P, Keay SK, Tocci GM, Koch KR, Zhang CO, Barchi JJ, Grkovic D, Guo L, Michejda CJ (2008). Structure-activity relationship studies for the peptide portion of the bladder epithelial cell antiproliferative factor from interstitial cystitis patients. J Med Chem  51, 5974-83.   https://doi.org/10.1021/jm8002763|4. Marquez VE, Sun G, Siddiqui MA, Lee YC, Barchi JJ, Filippov IV, Landsman NA, Kelley JA (2008). What are the consequences of freezing the anomeric effect in nucleosides? Nucleic Acids Symp Ser (Oxf)   543-4  https://doi.org/10.1093/nass/nrn275",https://intramural.nih.gov/search/searchview.taf?ipid=50823
329,BC010740-03,"October 01, 2007 -  September 30, 2008",Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Laboratory of Medicinal Chemistry, NCI",Oyindasola O Oyelaran|Qian  Li,"Amit  Basu (Center for Microbial Pathogenesis, Brown University)|Uwe  Karsten (Toxicology and Chemotherapy, Glycotope, GmbH)|Lara  Mahal (Chemistry, University of Texas at Austin)|Robert  Munson (The Research Institute at Nationwide Children's Hospital)|Cristina  Voss (Department of Chemistry, German Cancer Research Center)|Mai  Xu; PhD",Christoph  Rader; PhD (National Cancer Institute)|Miriam R Anver (National Cancer Institute),NULL,"1. Gildersleeve JC, Oyelaran O, Simpson JT, Allred B (2008). Improved procedure for direct coupling of carbohydrates to proteins via reductive amination. Bioconjug Chem  19, 1485-90.   https://doi.org/10.1021/bc800153t",https://intramural.nih.gov/search/searchview.taf?ipid=50828
330,BC010742-03,"October 01, 2007 -  September 30, 2008",Utilizing Glycosyltransferases for Bioconjugation,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Elizabeth  Boeggeman|Boopathy  Ramakrishna|Marta  Pasek|Maria Rita Manzoni,NULL,NULL,NULL,"1. Qasba PK, Ramakrishnan B, Boeggeman E (2008). Structure and function of beta -1,4-galactosyltransferase. Curr Drug Targets  9, 292-309.   https://doi.org/10.2174/138945008783954943",https://intramural.nih.gov/search/searchview.taf?ipid=50842
331,BC010743-03,"October 01, 2007 -  September 30, 2008",Metabolic Mechanisms for Programmed Cell Death,James Ming Phang; MD|IRP Faculty Profile,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Gregory L Borchert|Yongmin  Liu|Olga  Zabirnyk|Anit  Sharma,NULL,Lucy M Anderson; PhD (National Cancer Institute)|Bhalchandra A Diwan; PhD (National Cancer Institute)|Eva  Szabo; MD (National Cancer Institute),NULL,"1. Cooper SK, Pandhare J, Donald SP, Phang JM (2008). A novel function for hydroxyproline oxidase in apoptosis through generation of reactive oxygen species. J Biol Chem  283, 10485-92.   https://doi.org/10.1074/jbc.M702181200",https://intramural.nih.gov/search/searchview.taf?ipid=50814
332,BC010744-03,"October 01, 2007 -  September 30, 2008",Regulation of Proline Oxidase for Bioenergetics during Nutrient Stress,James Ming Phang; MD|IRP Faculty Profile,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Olga  Zabirnyk,NULL,Lucy M Anderson; PhD (National Cancer Institute),Donna Day Baird; PhD (NIEHS),"1. Phang JM, Donald SP, Pandhare J, Liu Y (2008). The metabolism of proline, a stress substrate, modulates carcinogenic pathways. Amino Acids  35, 681-90.   https://doi.org/10.1007/s00726-008-0063-4",https://intramural.nih.gov/search/searchview.taf?ipid=50815
333,BC010746-03,"October 01, 2007 -  September 30, 2008",Extracellular Matrix and Stress Substrates: the Role of Prolidase,James Ming Phang; MD|IRP Faculty Profile,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Gregory L Borchert|Yongmin  Liu,NULL,Bhalchandra A Diwan; PhD (National Cancer Institute),NULL,"1. Phang JM, Donald SP, Pandhare J, Liu Y (2008). The metabolism of proline, a stress substrate, modulates carcinogenic pathways. Amino Acids  35, 681-90.   https://doi.org/10.1007/s00726-008-0063-4",https://intramural.nih.gov/search/searchview.taf?ipid=50816
334,BC010747-03,"October 01, 2007 -  September 30, 2008",Charaterization of the Expression and Ligands of KIR3DS1,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Geraldine Martina O'Connor,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50809
335,BC010748-03,"October 01, 2007 -  September 30, 2008",Clinical Investigation of Signal Transduction Inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI",Gideon Michael Blumenthal|Wendy B Bernstein,NULL,"Ilona  Linnoila; MD (National Cancer Institute)|Stephen M Hewitt; MD, PhD (National Cancer Institute)|William D Figg; PharmD (National Cancer Institute)|Seth M Steinberg; PhD (National Cancer Institute)|Joanna H Shih (National Cancer Institute)|Frederic  Kaye; MD (National Cancer Institute)",NULL,"1. LoPiccolo J, Blumenthal GM, Bernstein WB, Dennis PA (2008). Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updat  11, 32-50.   https://doi.org/10.1016/j.drup.2007.11.003",https://intramural.nih.gov/search/searchview.taf?ipid=50803
336,BC010749-03,"October 01, 2007 -  September 30, 2008",DNA Vaccines,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Agneta S Von Gegerfelt|Margherita  Rosati|Antonio L Valentin|Cristina  Bergamaschi|Gen-Mu  Zhang|Osamu  Usami,NULL,Barbara K Felber (National Cancer Institute)|Marjorie  Robert-Guroff; PhD (National Cancer Institute)|Samir N. Khleif; MD (National Cancer Institute)|Claes  Ohlen (National Cancer Institute)|Jeffrey D Lifson; MD (National Cancer Institute)|Giorgio  Trinchieri (National Cancer Institute),NULL,"1. Pavlakis GN, Felber BN (submitted in 2008) Expression Of Il-12 Family Heterodimers. Patents issued: 8,715,964 (US in 2014); 9,546,202 (US in 2017).",https://intramural.nih.gov/search/searchview.taf?ipid=50812
337,BC010750-03,"October 01, 2007 -  September 30, 2008",HIV Molecular Biology and Pathogenic Mechanisms of AIDS,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Margherita  Rosati|Antonio L Valentin|Cristina  Bergamaschi|Gen-Mu  Zhang|Osamu  Usami|Brunda  Ganneru; PhD,NULL,Barbara K Felber (National Cancer Institute)|Giorgio  Trinchieri (National Cancer Institute),NULL,"1. Pavlakis GN, Felber BN, Finkielsztein SN, Vournakis JN (submitted in 2008) Complexes Of Il-15 And Il-15r Aipha And Uses Thereof. Patents issued: 2173378 (DE in 2014); 2173378 (DK in 2014); 2173378 (EP in 2014); 2173378 (ES in 2014); 2173378 (FR in 2014); 2173378 (GB in 2014); 2173378 (IE in 2014); 2173378 (IT in 2014); 2173378 (NL in 2014); 2008269032 (AU in 2014); 599338 (NZ in 2014); 2173378 (SE in 2014); 1143084 (HK in 2015); 616254 (NZ in 2015); 2013203204 (AU in 2016); 2016206235 (AU in 2017); 2691785 (CA in 2017); 202997 (IL in 2017); 703668 (NZ in 2017). Patents pending: 13195499.2 (EP application); 14110832.5 (HK application); 14110833.4 (HK application); 2010514839 (JP application); 2014-001373 (JP application); 2015-115431 (JP application); 2016-226503 (JP application); 582330 (NZ application); 12/666,052 (US application); 15/424,621 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=50813
338,BC010752-03,"October 01, 2007 -  September 30, 2008",Anti-angiogenesis targeted vaccine therapy,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",Yufei  Jiang,NULL,Michael  Birrer (National Cancer Institute)|Steven  Libutti; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50835
339,BC010755-03,"October 01, 2007 -  September 30, 2008",Enhancing immune response strategies:,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",Raed Nabil Samara,NULL,Yuk Ying S Pang (National Cancer Institute)|Franklin R Grollman (National Cancer Institute)|David J Venzon; PhD (National Cancer Institute)|John  Schiller; PhD (National Cancer Institute)|Masaki  Terabe (National Cancer Institute),Francesco M. Marincola; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50836
340,BC010756-03,"October 01, 2007 -  September 30, 2008",Development a combined prophylactic and therapeutic cervical cancer vaccine u,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",NULL,NULL,"Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)|John  Schiller; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50837
341,BC010757-03,"October 01, 2007 -  September 30, 2008",Clinical trial development in cancer vaccines,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",NULL,NULL,"Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)|Franklin R Grollman (National Cancer Institute)|David J Venzon; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50838
342,BC010758-03,"October 01, 2007 -  September 30, 2008",Monitoring of Basic Biochemical Processes at Single Molecule Level Using Light-e,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Vitaly  Chasov,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50806
343,BC010759-03,"October 01, 2007 -  September 30, 2008",Functional Genomics of Sarcoma,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD|Robert L Walker; BS|Arthur A Glatfelter; MS|Francesca  Scrimieri|Yuelin  Zhu|Princy  Francis|Show all 8",NULL,Chand  Khanna; MD (National Cancer Institute),NULL,"1. Amundson SA, Do KT, Vinikoor LC, Lee RA, Koch-Paiz CA, Ahn J, Reimers M, Chen Y, Scudiero DA, Weinstein JN, Trent JM, Bittner ML, Meltzer PS, Fornace AJ (2008). Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res  68, 415-24.   https://doi.org/10.1158/0008-5472.CAN-07-2120",https://intramural.nih.gov/search/searchview.taf?ipid=50840
344,BC010761-03,"October 01, 2007 -  September 30, 2008",Studies of Proteins with Important Roles in Immunology andor Cancer Biology,Jacek Tadeusz Lubkowski,NULL,"Macromolecular Crystallography Laboratory, NCI",Cyril  Barinka,NULL,"Daniel  McVicar; PhD (National Cancer Institute)|Paul A Randazzo; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50839
345,BC010762-03,"October 01, 2007 -  September 30, 2008",Molecular Alterations of Primary Breast Cancer and Metastasis,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Linda S Wrathall,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50841
346,BC010763-03,"October 01, 2007 -  September 30, 2008",Building on the success of the adoptive immunotherapy of cancer,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Zhiya  Yu|Douglas  Palmer|Luca  Gattinoni|Claudia  Wrzesinski|Lindsay Marie Garvin|Yun  Ji,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50843
347,BC010764-03,"October 01, 2007 -  September 30, 2008",Pediatric Oncology Branch Clinical Care and Education,Alan S Wayne; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",Joanne A Derdak|Barbara V Wise|Vicki  Richmond|Sherri L Depollar,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50821
348,BC010766-02,"October 01, 2007 -  September 30, 2008",High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy,Udai S Kammula,NULL,"Surgery Branch, NCI",Baiqin  Teng|Roozbeh  Razmpour|Anran  Wang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50939
349,BC010767-02,"October 01, 2007 -  September 30, 2008",Biosynthesis of Selenocysteine and Its Incorporation into Protein,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Bradley A Carlson|Xueming  Xu,"Marla  Berry (Molecular Biology, U of Hawaii)|Vadim  Gladyshev (Department of Biochemistry, University of Nebraska)|Ulrich  Schweizer (Neuroscience Research Center and, Charit-Universittsmedizin Berlin)|Markus  Wahl (X-Ray Crystallography, Max-Planck-Institute for Biophysical Chemistry)",NULL,NULL,"1. Hatfield D, Berry M, Block E, Boayke H, Carlson B, Gailer J, George G, Gladyshev V, Jacobsen N, Johnson S, Kahakachchi C, Kaminski R, Manley S, Mix H, Pickering I, Prenner E, Saira K, Skowronska A, Tyson J, Uden P, Wu O, Xu X, Yamdagni R, Zhang Y (2008) Insights into the chemical biology of selenium. Phosphorous, Sulfur, and Silicon and the Relat Elem 924-930.",https://intramural.nih.gov/search/searchview.taf?ipid=50941
350,BC010768-02,"October 01, 2007 -  September 30, 2008","Isolation, Propagation and Characterization of Breast Stem Cells",Barbara V Vonderhaar; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI",Erika P Ginsburg|Matthew J Meyer|Jodie  Fleming|Tyler C Miller|Syed  Hussnain,NULL,Michael  Dean; PhD (National Cancer Institute)|Suparna B Wedam (National Cancer Institute)|David  Danforth (National Cancer Institute)|Gilbert  Smith; PhD (National Cancer Institute)|David  Salomon; PhD (National Cancer Institute)|Jacek  Capala; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50942
351,BC010769-02,"October 01, 2007 -  September 30, 2008",Protein Evolution by in Vitro Compartmentalization,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jason William Rausch,NULL,Vineet Narain KewalRamani; PhD (National Cancer Institute),Robert Joseph Crouch; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50940
352,BC010770-02,"October 01, 2007 -  September 30, 2008",Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Ofelia  Olivero; PhD|Tracey L Einem|Mia  Yu|Rao L Divi,NULL,Gene  Shearer; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50946
353,BC010771-02,"October 01, 2007 -  September 30, 2008",Medusa(TM) Sequencer,Thomas Dana Schneider; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Danielle  Needle,"James  Adair (www.keystonenano.com, Keystone Nano)|Raul Eduardo Cachau|Joseph  Lakowicz (Department of Biochemistry, Center for Fluorescence Spectroscopy, University of Maryland School of Medicine)|Stephen  Lockett (Image Analysis Laboratory, SAIC Frederick, Inc.)|Chandran  Sabanayagam (Department of Physics and Pre-engineering, Delaware State University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50943
354,BC010772-02,"October 01, 2007 -  September 30, 2008",Rod-Tether Nanoprobe,Thomas Dana Schneider; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Ilya  Lyakhov,"James  Adair (www.keystonenano.com, Keystone Nano)|Raul Eduardo Cachau|Neil  Zimmerman (College of Medicine, NIST)",Jacek  Capala; PhD (National Cancer Institute)|Robert J Fisher (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50944
355,BC010773-02,"October 01, 2007 -  September 30, 2008",Interactions of APOBEC3 Proteins with Murine Leukemia Virus,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Demetria P Harvin|Jane  Mirro,NULL,David  Derse; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50945
356,BC010774-02,"October 01, 2007 -  September 30, 2008",T Cell Alternative p38 Activation Pathway,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Paul  Mittelstadt; PhD|Bei  Dong|Ludmila  Jirmanova,NULL,Ettore  Appella; MD (National Cancer Institute),"David Harvey Margulies; MD, PhD (NIAID)","1. Ashwell J, Sarma D, Jankovic D, Mittelstadt P (2008) Genetic disruption of p38α Tyr-323 phosphorylation prevents TCR-mediated p38α activation and impairs IFN-γ production. Blood, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50854
357,BC010775-02,"October 01, 2007 -  September 30, 2008","Retroviral Gag Trafficking, Env Incorporation, and Virus Assembly",Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Abdul Latheef Abdul Waheed|Benjamin G Luttge|Ken  Fujii|Anjali  Joshi|Kayoko  Waki|Muthukumar  Balasubramaniam,"Akira  Ono (University of Michigan)|Jamil  Saad (University of Alabama)|Michael  Summers (University of Maryland, Baltimore County)",David E Ott (National Cancer Institute),Juan S Bonifacino; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50870
358,BC010776-02,"October 01, 2007 -  September 30, 2008",Retrovirus Budding and Endosomal Sorting,Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Catherine  Adamson|Abdul Latheef Abdul Waheed|Benjamin G Luttge|Ken  Fujii|Anjali  Joshi|Kayoko  Waki|Show all 7,"Tim  Veenstra (Laboratory of Systems Biology, SAIC Frederick)|Miranda  Shehu-Xhilaga; PhD",Terrence R Burke; PhD (National Cancer Institute),James H Hurley; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50871
359,BC010777-02,"October 01, 2007 -  September 30, 2008",Lipid Microdomains and HIV-1 Replication,Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Abdul Latheef Abdul Waheed|Kayoko  Waki,NULL,Elena  Chertova (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50868
360,BC010778-02,"October 01, 2007 -  September 30, 2008",Inhibition of HIV-1 Maturation,Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Catherine  Adamson|Kayoko  Waki,Michael  Sakalian (University of Oklahoma)|Karl  Salzwedel; PhD,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50869
361,BC010779-02,"October 01, 2007 -  September 30, 2008",Regulation and Consequences of Ubiquitination,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Dietrich B Conze|Bei  Dong|Guozhi  Zhu|Rocio Aguado  Alvarez,NULL,NULL,John Allan Hanover; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50855
362,BC010780-02,"October 01, 2007 -  September 30, 2008",Structural studies of molecular cancer targets and drug development,David S Waugh; PhD|IRP Faculty Profile,NULL,"Macromolecular Crystallography Laboratory, NCI",George T Lountos|Di  Zhang,NULL,Robert  Shoemaker (National Cancer Institute)|Yves  Pommier; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50877
363,BC010782-02,"October 01, 2007 -  September 30, 2008",Study of the Roles of SDF1 and CXCR4 in Hematopoiesis,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Paola  Gasperini|Peter J Mccormick|Shuhei  Sakakibara; PhD|Matina  Economopoulou,NULL,David  Levens; PhD (National Cancer Institute)|Stefania  Pittaluga (National Cancer Institute)|Douglas  Lowy; MD (National Cancer Institute),Dragan  Maric; PhD (NINDS) |William E Paul; MD (NIAID) |Jinfang  Zhu; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50878
364,BC010783-02,"October 01, 2007 -  September 30, 2008",The Molecular Mechanism of TNF-induced Necrotic Cell Death,Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Swati Suresh Choksi|You Sun  Kim|Michael J Morgan|Tao  Li,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50879
365,BC010784-02,"October 01, 2007 -  September 30, 2008",Biochemistry of Melanins and Photoprotection of the Skin,Vincent J. Hearing; PhD,NULL,"Laboratory of Cell Biology, NCI",Yoshinori  Miyamura|Sergio  Coelho,"Janusz  Beer (Center for Devices & Radiological Health, Food & Drug Administration)|Shosuke  Ito (Department of Chemistry, Fujita Health University)|Mauro  Picardo (Laboratory of Cutaneous Physiopathology, Istituto Dermatologica San Gallicano)|Rainer  Wolber (Dept Skin Research, Beiersdorf AG)|Yuji  Yamaguchi",NULL,NULL,"1. Hearing V, Coelho S, Beer J, Miller S, Wolber R, Smuda C (2008) Long-term molecular changes in human skin after repetitive in situ UV irradiation. J. Invest. Dermatol, in press.|2. Passeron T, Namiki T, Passeron HJ, Le Pape E, Hearing VJ (2009). Forskolin protects keratinocytes from UVB-induced apoptosis and increases DNA repair independent of its effects on melanogenesis. J Invest Dermatol  129, 162-6.   https://doi.org/10.1038/jid.2008.182",https://intramural.nih.gov/search/searchview.taf?ipid=50880
366,BC010785-02,"October 01, 2007 -  September 30, 2008",Characterization of Pigmentary Disorders and Melanoma Targeting,Vincent J. Hearing; PhD,NULL,"Laboratory of Cell Biology, NCI",Julio C Valencia; MD|Takeshi  Namiki,"Robert  Ballotti (Faculte de Medecine, Inserm U597)|Dorothy  Bennett (Centre for Molecular Signaling, St. George's University of London)|Mauro  Picardo (Laboratory of Cutaneous Physiopathology, Istituto Dermatologica San Gallicano)|Michael  Pickart (Department of Biology, University of Wisconsin)|Yuji  Yamaguchi",Michael Marc Gottesman; MD (National Cancer Institute)|Ettore  Appella; MD (National Cancer Institute),Kevin G Chen; MD (NINDS),"1. Hearing V (2008) Melanocyte biology and metastasis, in Cutaneous Melanoma. Balch C, Houghton A, Sober A, Soong S, Atkins M, Thompson J, eds, Quality Medical Publ (St. Louis), in press.|2. Hearing V, Valencia J, Hall M (2008) A novel approach to enhance antibody specificity and sensitivity by peptide cross-linking. Anal. Biochem, in press.|3. Yamaguchi Y, Passeron T, Hoashi T, Watabe H, Rouzaud F, Yasumoto K, Hara T, Tohyama C, Katayama I, Miki T, Hearing VJ (2008). Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/beta-catenin signaling in keratinocytes. FASEB J  22, 1009-20.   https://doi.org/10.1096/fj.07-9475com",https://intramural.nih.gov/search/searchview.taf?ipid=50881
367,BC010786-02,"October 01, 2007 -  September 30, 2008",The Regulation of Mammalian Pigmentation,Vincent J. Hearing; PhD,NULL,"Laboratory of Cell Biology, NCI",Elodie  Le Pape|Sergio  Coelho,"Robert  Ballotti (Faculte de Medecine, Inserm U597)|Ancha  Baranova (Molecular and Microbiology Department, George Mason University)|Dorothy  Bennett (Centre for Molecular Signaling, St. George's University of London)|Jose Carlos  Garcia-Borron (Department of Biochemistry, University of Murcia)|Rainer  Wolber (Dept Skin Research, Beiersdorf AG)|Yuji  Yamaguchi",NULL,NULL,"1. Hearing V (2008) Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents. Drug Discovery Today - Disease Mechanisms, in press.|2. Le Pape E, Wakamatsu K, Ito S, Wolber R, Hearing VJ (2008). Regulation of eumelanin/pheomelanin synthesis and visible pigmentation in melanocytes by ligands of the melanocortin 1 receptor. Pigment Cell Melanoma Res  21, 477-86.   https://doi.org/10.1111/j.1755-148X.2008.00479.x|3. Passeron T, Namiki T, Passeron HJ, Le Pape E, Hearing VJ (2009). Forskolin protects keratinocytes from UVB-induced apoptosis and increases DNA repair independent of its effects on melanogenesis. J Invest Dermatol  129, 162-6.   https://doi.org/10.1038/jid.2008.182|4. Wolber R, Schlenz K, Wakamatsu K, Smuda C, Nakanishi Y, Hearing VJ, Ito S (2008). Pigmentation effects of solar-simulated radiation as compared with UVA and UVB radiation. Pigment Cell Melanoma Res  21, 487-91.   https://doi.org/10.1111/j.1755-148X.2008.00470.x|5. Yamaguchi Y, Passeron T, Hoashi T, Watabe H, Rouzaud F, Yasumoto K, Hara T, Tohyama C, Katayama I, Miki T, Hearing VJ (2008). Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/beta-catenin signaling in keratinocytes. FASEB J  22, 1009-20.   https://doi.org/10.1096/fj.07-9475com",https://intramural.nih.gov/search/searchview.taf?ipid=50882
368,BC010787-02,"October 01, 2007 -  September 30, 2008",Redox Imaging using Nitroxides and MRI,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|William  Degraff|Anastasia L Sowers,NULL,Murali  Krishna; PhD (National Cancer Institute),"Bruce J Baum; DMD, PhD (NIDCR)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50883
369,BC010788-02,"October 01, 2007 -  September 30, 2008",Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Zhi-Jie  Li|Lauren  Marks,NULL,Javed  Khan; MD (National Cancer Institute)|Chand  Khanna; MD (National Cancer Institute),NULL,"1. Wei JS, Song YK, Durinck S, Chen QR, Cheuk AT, Tsang P, Zhang Q, Thiele CJ, Slack A, Shohet J, Khan J (2008). The MYCN oncogene is a direct target of miR-34a. Oncogene  27, 5204-13.   https://doi.org/10.1038/onc.2008.154",https://intramural.nih.gov/search/searchview.taf?ipid=50884
370,BC010789-02,"October 01, 2007 -  September 30, 2008",Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Zhi-Jie  Li|Lauren  Marks,NULL,"Stephen M Hewitt; MD, PhD (National Cancer Institute)|Javed  Khan; MD (National Cancer Institute)|Chand  Khanna; MD (National Cancer Institute)|Giovanni  Melillo (National Cancer Institute)",NULL,"1. Ahmed F, Tessarollo L, Thiele C, Mocchetti I (2008). Brain-derived neurotrophic factor modulates expression of chemokine receptors in the brain. Brain Res  1227, 1-11.   https://doi.org/10.1016/j.brainres.2008.05.086",https://intramural.nih.gov/search/searchview.taf?ipid=50885
371,BC010790-02,"October 01, 2007 -  September 30, 2008",Regulation of Leukocyte Integrins in Inflammatory Cell Recruitment,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI",Valeria  Orlova|Eun-Young  Choi|Sunil  Kaul,"Stefanie  Dimmeler (Cardiology, University Frankfurt)|Carl  Gahmberg (Biochemistry, University of Helsinki)|Tom  Quertermous (Cardiovascular Medicine, Stanford University)|Christian  Weber (RWTH University Aachen)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50862
372,BC010791-02,"October 01, 2007 -  September 30, 2008","Effects of genetic polymorphism in MHC, KIR, and related loci on human disease","Mary  Carrington; MS, PhD",NULL,"Laboratory of Experimental Immunology, NCI",Maureen P Martin|Darlene M Marti|Xiaojiang  Gao|Fuh-Mei  Duh|Rasmi  Thomas; PhD|Yuko  Yuki,"Marcus  Altfeld (Infectious Disease Unit, Partners AIDS Research Center)|Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)|James  Elder (University of Michigan)|Carey  Farquhar (Epidemiology and Medicine, University of Washington)|Michael  Knowles (Cystic Fibrosis Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill)|Ashley  Moffett (Pathology, University of Cambridge)|Show all 16","Allan  Hildesheim; PhD (National Cancer Institute)|Maria Teresa Pia Landi; MD, PhD (National Cancer Institute)|Ramaprasad  Srinivasan; MD, PhD (National Cancer Institute)|Sophia S Wang; PhD (National Cancer Institute)|Daniel  McVicar; PhD (National Cancer Institute)","Terrance P O'Hanlon; PhD (NIEHS) |Frederick W Miller; MD, PhD (NIEHS) |Richard  Childs; MD (NHLBI) |Barbara  Rehermann; MD (NIDDK)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50861
373,BC010792-02,"October 01, 2007 -  September 30, 2008",Molecular genetics and population studies of the KIR and HLA gene complexes,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Experimental Immunology, NCI",Maureen P Martin|Darlene M Marti|Xiaojiang  Gao|Fuh-Mei  Duh|Rasmi  Thomas; PhD|Yuko  Yuki,"Marcus  Altfeld (Infectious Disease Unit, Partners AIDS Research Center)|Kidd  Judith (Department of Genetics, Yale University)|Kenneth  Kidd (Yale University)|Diogo  Meyer (Genetics and evolutionary biology, University of Sao Paulo)|Richard  Single (Department of Mathematics and Statistics, University of Vermont)|Judith  Torimiro (Johns Hopkins School of Public Health)|Show all 8",Daniel  McVicar; PhD (National Cancer Institute)|Stephen K Anderson; PhD (National Cancer Institute),NULL,"1. Carrington M, Single R, Wilson M, Trowsdale J (2008) KIR haplotypes defined by segregation analysis in 59 Centre da€™Etude Polymorphisme Humain (CEPH) families. Immunogenetics In Press.",https://intramural.nih.gov/search/searchview.taf?ipid=50860
374,BC010793-02,"October 01, 2007 -  September 30, 2008","Role of inflammation, innate resistance, and immunity in carcinogenesis.",Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Anna T Mason|Robin T Winkler Pickett|Alessandra  Mazzoni|Lyudmila A Lyakh|Zsofia  Gyulai|Elena  Riboldi|Show all 10,NULL,"Nancy H Colburn; PhD (National Cancer Institute)|Glenn  Merlino; PhD (National Cancer Institute)|Barbara K Felber (National Cancer Institute)|George N Pavlakis; MD, PhD (National Cancer Institute)|Stuart H Yuspa; MD (National Cancer Institute)",Alan  Sher; PhD (NIAID) |Francesco M. Marincola; MD (CC),"1. Gerosa F, Baldani-Guerra B, Lyakh LA, Batoni G, Esin S, Winkler-Pickett RT, Consolaro MR, De Marchi M, Giachino D, Robbiano A, Astegiano M, Sambataro A, Kastelein RA, Carra G, Trinchieri G (2008). Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J Exp Med  205, 1447-61.   https://doi.org/10.1084/jem.20071450",https://intramural.nih.gov/search/searchview.taf?ipid=50886
375,BC010794-02,"October 01, 2007 -  September 30, 2008",Characterization of Cancer Stem Cells,William  Farrar,NULL,"Laboratory of Cancer Prevention, NCI",Xiaohu  Zhang|Suneethe  Thomas|Elaine M Hurt|Haiyan  Qin|Suresh R Volate|Francesco  Crea|Show all 7,NULL,Nadya I Tarasova; PhD (National Cancer Institute)|Timothy D Veenstra (National Cancer Institute),NULL,"1. Sharifi N, Hurt EM, Farrar WL (2008). Androgen receptor expression in prostate cancer stem cells: is there a conundrum? Cancer Chemother Pharmacol  62, 921-3.   https://doi.org/10.1007/s00280-007-0659-5",https://intramural.nih.gov/search/searchview.taf?ipid=50864
376,BC010795-02,"October 01, 2007 -  September 30, 2008",Mechanisms of transcription fidelity in prokaryotes and eukaryotes,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Maria L Kireeva|Lucyna E Lubkowska|Celine Marguerite Paulette Walmacq|Vitaly  Chasov,NULL,Jeffrey N Strathern (National Cancer Institute)|Donald L Court; PhD (National Cancer Institute),NULL,"1. Tchernaenko V, Halvorson HR, Kashlev M, Lutter LC (2008). DNA bubble formation in transcription initiation. Biochemistry  47, 1871-84.   https://doi.org/10.1021/bi701289g|2. Tchernaenko V, Radlinska M, Lubkowska L, Halvorson HR, Kashlev M, Lutter LC (2008). DNA bending in transcription initiation. Biochemistry  47, 1885-95.   https://doi.org/10.1021/bi7012883",https://intramural.nih.gov/search/searchview.taf?ipid=50887
377,BC010796-02,"October 01, 2007 -  September 30, 2008",Differentiation of tissue- and devlopment of tumor stem cells,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Christina  Stuelten,NULL,Robert  Shoemaker (National Cancer Institute)|Susan  Mertins (National Cancer Institute)|Lalage  Wakefield; PhD (National Cancer Institute),Ronald  McKay; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50876
378,BC010797-02,"October 01, 2007 -  September 30, 2008",Mechanisms of Stromal Cell Activation by the Developing Tumor,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Olga  Aprelikova; PhD|Xiang  Yu,NULL,"Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50888
379,BC010798-02,"October 01, 2007 -  September 30, 2008",Genetic Investigation of NPC and HCC in a Chinese Population,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI",Elizabeth  Binns-Roemer|Xiuchan  Guo|Benton  Wachter,NULL,Stephen J O'Brien; PhD (National Cancer Institute)|Tao  Peng (National Cancer Institute),NULL,"1. Zeng Z, Guan L, An P, Sun S, O'Brien SJ, Winkler CA, HBV study consortium (2008). A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population. BMC Infect Dis  8, 1.   https://doi.org/10.1186/1471-2334-8-1",https://intramural.nih.gov/search/searchview.taf?ipid=50889
380,BC010800-02,"October 01, 2007 -  September 30, 2008",Convection enhanced delivery of agents into the brainstem of patients with diff,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,NULL,Russell R Lonser; MD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50890
381,BC010801-02,"October 01, 2007 -  September 30, 2008",Development of Therapies for Neurofibromatosis Type 1 Related Tumors and other G,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Aerang  Kim|Eva  Dombi,NULL,"Katherine Elizabeth Warren; MD (National Cancer Institute)|Pamela  Wolters (National Cancer Institute)|Thomas J Hornyak (National Cancer Institute)|Karlyne M Reilly; BS, PhD (National Cancer Institute)|Seth M Steinberg; PhD (National Cancer Institute)","Douglas Russell Stewart; BA, MD (NHGRI) |Constantine Argyrios Stratakis; MD, DSc (NICHD) |Jeffrey M Solomon; BS, MS, PhD (CC) |Ann M Cohen-Berger; MD (CC) |Nicholas  Patronas; MD (CC) |Scott Mitchell Paul; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50891
382,BC010802-02,"October 01, 2007 -  September 30, 2008",Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Paul Gerard Hynes|Philip L Martin,NULL,Jonathan  Vogel; MD (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50892
383,BC010803-02,"October 01, 2007 -  September 30, 2008",Characterizing a novel tumor recognition mechanism,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Qiong J Wang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50893
384,BC010804-02,"October 01, 2007 -  September 30, 2008",Using Glycosyltransferases for the Development of Targeted Drug Delivery System,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Elizabeth  Boeggeman|Boopathy  Ramakrishna|Marta  Pasek|Maria Rita Manzoni|Holly M Roumeliotis|Christina J Randall|Show all 7,NULL,Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)|Robert  Blumenthal; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50894
385,BC010805-02,"October 01, 2007 -  September 30, 2008",Using Glycosyltransferases for Conjugation of Single-Chain Antibodies and Lipids,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Elizabeth  Boeggeman|Boopathy  Ramakrishna|Maria Rita Manzoni,NULL,Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)|Robert  Blumenthal; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50895
386,BC010806-02,"October 01, 2007 -  September 30, 2008",Targeting High-risk Neuroblastoma using high through put siRNA screening,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Patricia S Tsang; PhD|Qingrong  Chen|Jharna  Barman|Xiang  Guo|Natarjan  Ganesan,NULL,Malcolm A Smith (National Cancer Institute)|Carol J Thiele (National Cancer Institute)|Lee Jay Helman; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50896
387,BC010807-02,"October 01, 2007 -  September 30, 2008",Mechanisms of Cell-to-Cell Infection with HTLV-1 and HIV-1,David  Derse; PhD,NULL,"Retroviral Replication Laboratory, NCI",Gisela H Fanning-Heidecker|Patricia A Lloyd|Batsukh  Dorjbal,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50863
388,BC010808-02,"October 01, 2007 -  September 30, 2008",Nucleosome Dynamics,Yawen  Bai; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Hanqiao  Feng|Hidenori  Kato|Bing-Rui  Zhou,NULL,Carl  Wu; PhD (National Cancer Institute),NULL,"1. Zhou Z, Feng H, Hansen DF, Kato H, Luk E, Freedberg DI, Kay LE, Wu C, Bai Y (2008). NMR structure of chaperone Chz1 complexed with histones H2A.Z-H2B. Nat Struct Mol Biol  15, 868-9.   https://doi.org/10.1038/nsmb.1465",https://intramural.nih.gov/search/searchview.taf?ipid=50856
389,BC010809-02,"October 01, 2007 -  September 30, 2008",NCI-Frederick Support and Technical Services,Craig W Reynolds,NULL,"Office Of The Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50947
390,BC010811-02,"October 01, 2007 -  September 30, 2008",Combination of TNF-Gold Nanoparticles with Radiation,Jacek  Capala; PhD,NULL,"Radiation Oncology Branch, NCI",Alesia J Holly|Gabriela  Kramer-Marek,"R.  Downing (NIST)|Giulio  Paciotti (CytImmune, Ltd.)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50859
391,BC010812-02,"October 01, 2007 -  September 30, 2008",Time-dependent receptor-target interactions in molecular interaction networks,"Sandra  Smith-Gill; MS, PhD, BS",NULL,"Structural Biophysics Laboratory, NCI",Claudia A Lipschultz|Mauro  Acchione|Warren W Kretzschmar,NULL,Yun  Wang (Nucleic Acid NMR Section)|Matthew  Fivash (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50898
392,BC010814-02,"October 01, 2007 -  September 30, 2008",Understanding the Pseudodiploidy of the Retroviral Genome,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Olga A Nikolaitchik|Vitaly P Boyko|Islam T Mohammad Hussein|Na  Ni,NULL,Vinay K Pathak; PhD (National Cancer Institute)|Alan  Rein; PhD (National Cancer Institute),NULL,"1. Hu W   (2008) HIV-1 RNA dimerization: It takes two to tango.  AIDS Rev, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50900
393,BC010815-02,"October 01, 2007 -  September 30, 2008",Regulation of Hypoxia-Inducible Factors in Pluripotent Cancer Cells.,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Olga  Aprelikova; PhD,NULL,"Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50901
394,BC010816-02,"October 01, 2007 -  September 30, 2008",Immunotherapy for Malignant Mesothelioma,Raffit  Hassan|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Linda  Ellison-Dejewski|Jingli  Zhang|Elizabeth J Maestri|Kun Frank Lu|Barbara S Schuler,NULL,Ira H Pastan; MD (National Cancer Institute),NULL,"1. Hassan R, Ho M (2008). Mesothelin targeted cancer immunotherapy. Eur J Cancer  44, 46-53.   https://doi.org/10.1016/j.ejca.2007.08.028",https://intramural.nih.gov/search/searchview.taf?ipid=50902
395,BC010817-02,"October 01, 2007 -  September 30, 2008",Role of normal cervical stem cells in the HPV induced initiation of cervical can,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Xiang  Yu,NULL,John  Schiller; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50903
396,BC010818-02,"October 01, 2007 -  September 30, 2008",Replication Dynamics in Patients on Suppressive Antiretroviral Therapy,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",NULL,NULL,NULL,Michael  Polis; MD (NIAID),"1. Ramanathan R, Pau AK, Busse KH, Zemskova M, Nieman L, Kwan R, Hammer JH, Mican JM, Maldarelli F (2008). Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir. Clin Infect Dis  47, e97-9.   https://doi.org/10.1086/593314",https://intramural.nih.gov/search/searchview.taf?ipid=50904
397,BC010819-02,"October 01, 2007 -  September 30, 2008",HIV-1 Genetic Variation in Infected Individuals,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",NULL,NULL,Eric O Freed; PhD (National Cancer Institute)|Vinay K Pathak; PhD (National Cancer Institute),Joann  Mican; MD (NIAID) |Michael  Polis; MD (NIAID),"1. Ramanathan R, Pau AK, Busse KH, Zemskova M, Nieman L, Kwan R, Hammer JH, Mican JM, Maldarelli F (2008). Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir. Clin Infect Dis  47, e97-9.   https://doi.org/10.1086/593314",https://intramural.nih.gov/search/searchview.taf?ipid=50905
398,BC010820-02,"October 01, 2007 -  September 30, 2008",Appearance and Disappearance of Drug Resistance Mutations,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",NULL,NULL,Eric O Freed; PhD (National Cancer Institute)|Vineet Narain KewalRamani; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50906
399,BC010821-02,"October 01, 2007 -  September 30, 2008",Role of Specific Drugs and Mutations in Partial Suppression of Viremia,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",NULL,NULL,Vinay K Pathak; PhD (National Cancer Institute),Richard T Davey; MD (NIAID) |Irini  Sereti; MD (NIAID) |Alice K Pau; PharmD (CC),"1. Maldarelli F, Pau A, Busse K, Zemskova M, Nieman L, Kwan R, Hammer J, Mican J   (2008) Iatrogenic Cushing's syndrome following epidural triamcinolone in an HIV-1  infected patient undergoing therapy with ritonavir-lopinavir.  Clin Infect Dis, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50907
400,BC010822-02,"October 01, 2007 -  September 30, 2008",Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation,Munira A Basrai; PhD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Wei-Chun  Au|Suveena  Sharma; PhD|John S Choy|Prashant  Mishra|Yoshimitsu  Takahashi|David W Rawson|Show all 7,"Richard  Baker (Molecular Genetics & Microbiology, Univ. of Massachusetts, Amherst)|Kenneth  Belanger (Biology, Colgate University)|Kerry  Bloom (University of North Carolina (UNC) @ Chapel HIll)|Valeria  Culotta; PhD (Environmental Health Sciences, Johns Hopkins University)|Maitreya  Dunham (Genome Sciences, Univ of Washington,)|Grant  Hartzog (MCD Biology, Univ. of California, Santa Cruz)|Show all 7","Anna V Roschke (National Cancer Institute)|Paul S Meltzer; MD, PhD (National Cancer Institute)",Alexander V Strunnikov; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50857
401,BC010823-02,"October 01, 2007 -  September 30, 2008",Asparagine Synthetase as a Biomarker for L-asparaginase Rx of Ovarian Cancer,"John N Weinstein; MD, PhD",NULL,"Developmental Therapeutics Branch, NCI",William Curtis Reinhold|David  Kane|Philip L Lorenzi,NULL,"Natasha  Caplen (National Cancer Institute)|Paul  Goldsmith; PhD (National Cancer Institute)|Frank Jess Gonzalez; PhD (National Cancer Institute)|Satoshi  Nishizuka (National Cancer Institute)|Stephen M Hewitt; MD, PhD (National Cancer Institute)","Peter Jonathan Munson; BA, MA, PhD (CIT)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50908
402,BC010824-02,"October 01, 2007 -  September 30, 2008",Molecular structure of the bacterial chemotaxis apparatus,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI","Martin  Kessel; BSc, PhD|Jonathan A Lefman|Cezar  Khursigara","Jerry  Hazelbauer (Biochemistry, University of Missouri)|Sandy  Parkinson (Biochemistry, University of Utah)",NULL,NULL,"1. Subramaniam S, Wu X, Zhang P   (2008) Role of HAMP domains in chemotaxis signaling by bacterial chemoreceptors.  Proc. Natl. Acad. Sci. USA, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50909
403,BC010825-02,"October 01, 2007 -  September 30, 2008",HIV neutralization and mechanisms of cellular entry,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alberto  Bartesaghi|Adam  Bennett|Lisa M. Hartnell|Audray  Harris; PhD|Kedar  Narayan|Michael Jason de la Cruz,NULL,Jeffrey D Lifson; MD (National Cancer Institute)|Robert  Blumenthal; PhD (National Cancer Institute)|Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)|Eric O Freed; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50910
404,BC010826-02,"October 01, 2007 -  September 30, 2008",Technology Development for 3D Electron Microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI","Martin  Kessel; BSc, PhD|Jonathan A Lefman|Alberto  Bartesaghi|Adam  Bennett|Lisa M. Hartnell|Jing  Fu","Steve  McLaughlin (Georgia Tech)|Robert  Morrison (GATAN Inc.)|Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|John Henry  Scott (NIST)",NULL,NULL,"1. Subramaniam S, Ouyang H, Gray A, McLaughllin S   (2008) Automatic mining of 3D images of whole cells.  Pattern Recognition, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50911
405,BC010827-02,"October 01, 2007 -  September 30, 2008",Structural Studies of Bacterial Architecture Using Electron Tomography,Jacqueline L Milne,NULL,"Laboratory of Cell Biology, NCI",Mario J Borgnia; PhD|Dan  Shi,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50912
406,BC010828-02,"October 01, 2007 -  September 30, 2008",STAT2 Role in Inflammation and Cancer,Ana M Gamero,Giorgio  Trinchieri,"Laboratory of Experimental Immunology, NCI",NULL,NULL,Nancy H Colburn; PhD (National Cancer Institute),NULL,"1. Maher SG, Sheikh F, Scarzello AJ, Romero-Weaver AL, Baker DP, Donnelly RP, Gamero AM (2008). IFN-alpha and IFN-lambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol Ther  7, nihpa47781.",https://intramural.nih.gov/search/searchview.taf?ipid=50872
407,BC010830-02,"October 01, 2007 -  September 30, 2008",Mechanisms of non-classical multidrug resistance in cancer,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Carol O Cardarelli|Ding wu  Shen; PhD|Wilfred D Vieira|Rajalakshm L Padmanabhan|Matthew David Hall|Jean-Pierre  Gillet|Show all 7,"Ram  Ganapathy (Cleveland Clinic)|Michael  Seiden (Hematology Oncology, Dana-Farber/Partners Cancer Care Program)|Brian P. Sorrentino; MD (Div of Experimental Hematology, St Jude Children's Research Hosp)",Vincent J. Hearing; PhD (National Cancer Institute)|Anna Maria Calcagno (Transport Biochemistry Section),Kevin G Chen; MD (NINDS),"1. Elbaz B, Alperovitch A, Gottesman MM, Kimchi-Sarfaty C, Rahamimoff H (2008). Modulation of Na+-Ca2+ exchanger expression by immunosuppressive drugs is isoform-specific. Mol Pharmacol  73, 1254-63.   https://doi.org/10.1124/mol.107.041582|2. Gottesman M, Szakacs G, Reimers M, Suzuki T, Hall M, Abe T, Weinstein J (2008) Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters. Mol Cancer Ther, in press.|3. Hall MD, Okabe M, Shen DW, Liang XJ, Gottesman MM (2008). The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol  48, 495-535.   https://doi.org/10.1146/annurev.pharmtox.48.080907.180426|4. Liang XJ, Yin JJ, Taylor B, Winkovitch SM, Garfield SH, Shen DW, Gottesman MM, Aszalos A (2008). Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell lines. Cancer Chemother Pharmacol  62, 977-84.   https://doi.org/10.1007/s00280-008-0687-9",https://intramural.nih.gov/search/searchview.taf?ipid=50914
408,BC010831-02,"October 01, 2007 -  September 30, 2008",Characterization of Small Open Reading Frames (sORFs) that Encode for Proteins,Munira A Basrai; PhD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Wei-Chun  Au,"Jef  Boeke (Molecular Biology and Genetics, The Johns Hopkins School of Medicine)|Ron  Davis (Biochemistry and Genome Technology Center, Stanford University)|Michael  Snyder (Molecular, Cellular and Developmental Biology, Yale University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50858
409,BC010832-02,"October 01, 2007 -  September 30, 2008",Fundamentals of Ligand-Protein Interactions,Marc C Nicklaus|IRP Faculty Profile,Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI",Igor V Filippov|Markus  Sitzmann,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50915
410,BC010833-02,"October 01, 2007 -  September 30, 2008",Identification and functional characterization of colorectal cancer genes,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Michael John Difilippantonio; PhD|Buddy  Chen|Nicole E Mcneil|Chi Chung  Cheng|Marian  Grade|Amanda  Hummon|Show all 9,NULL,Natasha  Caplen (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50916
411,BC010834-02,"October 01, 2007 -  September 30, 2008","Identifying Diagnostic Markers for Cervical Cancer, Breast Cancer, and Prostate",Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Buddy  Chen|Damrong M Wangsa|Kerstin  Heselmeyer|Chi Chung  Cheng|Clarymar  Ortiz-Melendez|Jana  Kinder,Gert  Auer|Elisabeth  Unger,NULL,NULL,"1. Martin CL, Reshmi SC, Ried T, Gottberg W, Wilson JW, Reddy JK, Khanna P, Johnson JT, Myers EN, Gollin SM (2008). Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. Oral Oncol  44, 369-82.   https://doi.org/10.1016/j.oraloncology.2007.05.003|2. Ried KT, Auer GT, Guo NT, Habermann JT (submitted in 2008) Gene Expression Signature Of Genomic Instability In Breast Cancer. Patents issued: 8,741,574 (US in 2014); 2737382 (CA in 2017); 2344675 (EP in 2017). Patents pending: 09792535.8 (GB application); PCT/US09/56931 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=50917
412,BC010835-02,"October 01, 2007 -  September 30, 2008",Consequences of Genomic Instability and Aneuploidy on the Colorectal Cancer,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Michael John Difilippantonio; PhD|Buddy  Chen|Nicole E Mcneil|Hesed M Padilla Nash|Damrong M Wangsa|Chi Chung  Cheng|Show all 9,NULL,Andre A Nussenzweig; PhD (National Cancer Institute),NULL,"1. Habermann JK, Bader FG, Franke C, Zimmermann K, Gemoll T, Fritzsche B, Ried T, Auer G, Bruch HP, Roblick UJ (2008). From the genome to the proteome--biomarkers in colorectal cancer. Langenbecks Arch Surg  393, 93-104.   https://doi.org/10.1007/s00423-007-0230-1",https://intramural.nih.gov/search/searchview.taf?ipid=50918
413,BC010836-02,"October 01, 2007 -  September 30, 2008",Cancer Genomics,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Michael John Difilippantonio; PhD|Buddy  Chen|Damrong M Wangsa|Chi Chung  Cheng|Marian  Grade|Jana  Kinder,"Gert  Auer|Michael  Ghadimi (Surgery, U. of Goettingen)",NULL,NULL,"1. Camps J, Grade M, Nguyen QT, Hörmann P, Becker S, Hummon AB, Rodriguez V, Chandrasekharappa S, Chen Y, Difilippantonio MJ, Becker H, Ghadimi BM, Ried T (2008). Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. Cancer Res  68, 1284-95.   https://doi.org/10.1158/0008-5472.CAN-07-2864|2. Habermann JK, Bader FG, Franke C, Zimmermann K, Gemoll T, Fritzsche B, Ried T, Auer G, Bruch HP, Roblick UJ (2008). From the genome to the proteome--biomarkers in colorectal cancer. Langenbecks Arch Surg  393, 93-104.   https://doi.org/10.1007/s00423-007-0230-1|3. Martin CL, Reshmi SC, Ried T, Gottberg W, Wilson JW, Reddy JK, Khanna P, Johnson JT, Myers EN, Gollin SM (2008). Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. Oral Oncol  44, 369-82.   https://doi.org/10.1016/j.oraloncology.2007.05.003",https://intramural.nih.gov/search/searchview.taf?ipid=50919
414,BC010837-02,"October 01, 2007 -  September 30, 2008",Prediction of Therapy Response in Colorectal Cancer,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Michael John Difilippantonio; PhD|Buddy  Chen|Chi Chung  Cheng|Marian  Grade|Jana  Kinder|Feng  Tian; PhD,NULL,NULL,NULL,"1. Camps J, Grade M, Nguyen QT, Hörmann P, Becker S, Hummon AB, Rodriguez V, Chandrasekharappa S, Chen Y, Difilippantonio MJ, Becker H, Ghadimi BM, Ried T (2008). Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. Cancer Res  68, 1284-95.   https://doi.org/10.1158/0008-5472.CAN-07-2864|2. Habermann JK, Bader FG, Franke C, Zimmermann K, Gemoll T, Fritzsche B, Ried T, Auer G, Bruch HP, Roblick UJ (2008). From the genome to the proteome--biomarkers in colorectal cancer. Langenbecks Arch Surg  393, 93-104.   https://doi.org/10.1007/s00423-007-0230-1|3. Raphael BJ, Volik S, Yu P, Wu C, Huang G, Linardopoulou EV, Trask BJ, Waldman F, Costello J, Pienta KJ, Mills GB, Bajsarowicz K, Kobayashi Y, Sridharan S, Paris PL, Tao Q, Aerni SJ, Brown RP, Bashir A, Gray JW, Cheng JF, de Jong P, Nefedov M, Ried T, Padilla-Nash HM, et al. [1 more author] (2008). A sequence-based survey of the complex structural organization of tumor genomes. Genome Biol  9, R59.   https://doi.org/10.1186/gb-2008-9-3-r59",https://intramural.nih.gov/search/searchview.taf?ipid=50921
415,BC010838-02,"October 01, 2007 -  September 30, 2008",NCI Enterprise caCORE,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50928
416,BC010839-02,"October 01, 2007 -  September 30, 2008",Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Wei  Zhang|Jean-Claude  Zenklusen; PhD|Jeongwu  Lee|Yuri  Kotliarov|Svetlana  Kotliarova|Aiguo  Li|Show all 18,NULL,NULL,NULL,"1. Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, Kotliarova S, Kotliarov Y, Walling J, Ahn S, Kim M, Totonchy M, Cusack T, Ene C, Ma H, Su Q, Zenklusen JC, Zhang W, Maric D, Fine HA (2008). Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell  13, 69-80.   https://doi.org/10.1016/j.ccr.2007.12.005",https://intramural.nih.gov/search/searchview.taf?ipid=50865
417,BC010840-02,"October 01, 2007 -  September 30, 2008",Elucidation and Exploitation of GSK3 as a Novel Glioma Therapeutic Target,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Wei  Zhang|Jean-Claude  Zenklusen; PhD|Jeongwu  Lee|Yuri  Kotliarov|Svetlana  Kotliarova|Aiguo  Li|Show all 17,NULL,NULL,NULL,"1. Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, Zhang W, Bailey R, Maric D, Zenklusen JC, Lee J, Fine HA (2008). Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Res  68, 6643-51.   https://doi.org/10.1158/0008-5472.CAN-08-0850",https://intramural.nih.gov/search/searchview.taf?ipid=50866
418,BC010841-02,"October 01, 2007 -  September 30, 2008",ROLE OF NONCANONICAL WNT PATHWAYS IN TISSUE MORPHOGENESIS.,Terence P Yamaguchi; PhD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Kristin K Biris|William C Dunty|Rieko  Ajima|Kenya  Lyons,NULL,NULL,NULL,"1. Yamaguchi T, Prakash N, Cajanek L, Minina E, Bryja V, Bryjova L, Hall A, Wurst W, Arenas E   (2008) Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10  dopaminergic cells in vivo.  PLoS One, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50923
419,BC010842-02,"October 01, 2007 -  September 30, 2008",The Miner Suite: State of the Art Bioinformatic Tools and Data Resources,"John N Weinstein; MD, PhD",NULL,"Developmental Therapeutics Branch, NCI",Margot  Sunshine|Hong  Cao|David  Kane|Barry R Zeeberg; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50924
420,BC010843-02,"October 01, 2007 -  September 30, 2008",Medical Oncology Fellowship Program,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Janet A Edds,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50867
421,BC010844-02,"October 01, 2007 -  September 30, 2008",DNA Folding in Chromatin and Interaction with Transcription Factors,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Feng  Cui|Difei  Wang,NULL,Sankar  Adhya; PhD (National Cancer Institute),NULL,"1. Zhurkin V, Timoshin V, Borisova O, Florentiev V, Shchyolkina A   (2008) Intramolecular recombination R-triplex in solution: Stabilization by  bis-intercalator YOYO.  J. Biomol. Struct. Dyn, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50925
422,BC010845-02,"October 01, 2007 -  September 30, 2008",p53-induced Regulation of Transcription in the Chromatin Context,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Feng  Cui|Difei  Wang,NULL,Curtis  Harris; MD (National Cancer Institute)|Ettore  Appella; MD (National Cancer Institute),Ronald D Neumann; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50875
423,BC010846-02,"October 01, 2007 -  September 30, 2008",Mechanisms of Transcriptional Control by p300,"Kevin  Gardner; MD, PhD",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Jesse F Quintero|Cynthia  Haggerty|Jung Shin  Byun|Alfonso  Fernandez; PhD|Madeline Mei Fong Wong; PhD,NULL,NULL,Dan L Longo; MD (NIA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50873
424,BC010847-02,"October 01, 2007 -  September 30, 2008",Gene-specific Mechanisms of BRCA1 transcriptional Control,"Kevin  Gardner; MD, PhD",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Jesse F Quintero|Cynthia  Haggerty|Lijun  Di,NULL,Kent W Hunter; PhD (National Cancer Institute)|Kevin A Camphausen; MD (National Cancer Institute)|Charles  Vinson; PhD (National Cancer Institute),Dan L Longo; MD (NIA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50874
425,BC010849-02,"October 01, 2007 -  September 30, 2008",Evaluation of Novel Radiation Modifiers,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50929
426,BC010850-02,"October 01, 2007 -  September 30, 2008",Mechanisms of Normal Tissue Toxicity,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,James B Mitchell; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50930
427,BC010852-02,"October 01, 2007 -  September 30, 2008",Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI",Lev  Petrenko|Debra  Tross|Sven  Klaschik|Koji  Tomaru; MD|Masaki  Yamamoto|Hidekazu  Shirota|Show all 7,NULL,Howard A Young; PhD (National Cancer Institute)|Joost J Oppenheim; MD (National Cancer Institute)|Giorgio  Trinchieri (National Cancer Institute),Igal  Gery; PhD (NEI),"1. Sato T, Shimosato T, Alvord WG, Klinman DM (2008). Suppressive oligodeoxynucleotides inhibit silica-induced pulmonary inflammation. J Immunol  180, 7648-54.   https://doi.org/10.4049/jimmunol.180.11.7648",https://intramural.nih.gov/search/searchview.taf?ipid=50936
428,BC010853-02,"October 01, 2007 -  September 30, 2008",Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI",Debra  Tross|Sven  Klaschik|Koji  Tomaru; MD|Masaki  Yamamoto|Hidekazu  Shirota|Hidekazu  Ikeuchi,NULL,Giorgio  Trinchieri (National Cancer Institute),Igal  Gery; PhD (NEI),"1. Klinman DM, Ikeuchi HM (submitted in 2008) Anti-cancer Oligodeoxynucleotides. Patents issued: 8,053,422 (US in 2012); 8,697,666 (US in 2014).|2. Klinman DM, Sato TM (submitted in 2008) Method Of Treating Pneumoconiosis With Oligodeoxynecleotides. Patent issued: 8,222,225 (US in 2012). Patents pending: 09751520.9 (EP application); PCT/US2009/044739 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=50937
429,BC010854-02,"October 01, 2007 -  September 30, 2008",Lung Cancer Program,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",Maria  Zajac-Kaye; PhD|Arlene Wendy Berman|Donna M Voeller|Min  Chen|Jin-Hyeok  Hwang|Trung C Pham|Show all 8,"M  Gallegos-Ruiz (Afdeling Geneeskundige Oncologie, VU Medisch Centrum)|Yong  Kim (Department of Internal Medicine, Seoul National University College of Medicine)|Jose  Rodriguez (Medical Oncology, University of Bilbao)",NULL,NULL,"1. Barlési F, Giaccone G, Gallegos-Ruiz MI, Span SW, Lefesvre P, Kruyt FA, Rodriguez JA (2008). Genotype analysis of the VNTR polymorphism in the SMYD3 histone methyltransferase gene: lack of correlation with the level of histone H3 methylation in NSCLC tissues or with the risk of NSCLC. Int J Cancer  122, 1441-2.   https://doi.org/10.1002/ijc.23227|2. Eberhard DA, Giaccone G, Johnson BE, Non-Small-Cell Lung Cancer Working Group (2008). Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting. J Clin Oncol  26, 983-94.   https://doi.org/10.1200/JCO.2007.12.9858|3. Gallegos Ruiz MI, Floor K, Roepman P, Rodriguez JA, Meijer GA, Mooi WJ, Jassem E, Niklinski J, Muley T, van Zandwijk N, Smit EF, Beebe K, Neckers L, Ylstra B, Giaccone G (2008). Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target. PLoS One  3, e0001722.   https://doi.org/10.1371/journal.pone.0001722|4. Giaccone G, Zucali PA (2008). Src as a potential therapeutic target in non-small-cell lung cancer. Ann Oncol  19, 1219-23.   https://doi.org/10.1093/annonc/mdn048|5. Giovannetti E, Lemos C, Tekle C, Smid K, Nannizzi S, Rodriguez JA, Ricciardi S, Danesi R, Giaccone G, Peters GJ (2008). Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells. Mol Pharmacol  73, 1290-300.   https://doi.org/10.1124/mol.107.042382|6. Gutierrez M, Giaccone G (2008). Antiangiogenic therapy in nonsmall cell lung cancer. Curr Opin Oncol  20, 176-82.   https://doi.org/10.1097/CCO.0b013e3282f4e55e|7. Kelly RJ, Giaccone G (2011). Lung cancer vaccines. Cancer J  17, 302-8.   https://doi.org/10.1097/PPO.0b013e318233e6b4",https://intramural.nih.gov/search/searchview.taf?ipid=50933
430,BC010855-02,"October 01, 2007 -  September 30, 2008",caBIG Enterprise,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50927
431,BC010856-02,"October 01, 2007 -  September 30, 2008",Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,Mary C Custer,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50931
432,BC010857-02,"October 01, 2007 -  September 30, 2008",Science and Technology Partnerships,David Jay Goldstein,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50934
433,BC010858-02,"October 01, 2007 -  September 30, 2008",CCR Confocal Microscopy Core,Susan H Garfield,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",Poonam  Mannan|Langston  Lim,NULL,"Adorjan  Aszalos (National Cancer Institute)|Peter  Blumberg; PhD (National Cancer Institute)|Kundan  Sengupta; MS, PhD (National Cancer Institute)|Srinivasa M Srinivasula (National Cancer Institute)|Daniel  Fitzgerald (National Cancer Institute)|Benu Brata  Das (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50932
434,BC010859-02,"October 01, 2007 -  September 30, 2008",CCR DNA Sequencing MiniCore,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",Steven W Shema|Kathleen D Hartman,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50935
435,BC010867-01,"October 01, 2007 -  September 30, 2008",Genetically Modifying Lactobacillus to Alter Gut Inflammation and Pathogens,Howard A Young; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Adelle P McFarland,NULL,Nancy H Colburn; PhD (National Cancer Institute),Brian  Kelsall; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56606
436,BC010870-01,"October 01, 2007 -  September 30, 2008",Hematopoietic Stem Cell Transplant for Immunodeficiency with MDS,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56468
437,BC010871-01,"October 01, 2007 -  September 30, 2008",Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yanlin  Yu|Richard D Sharp,NULL,"Paul S Meltzer; MD, PhD (National Cancer Institute)|Nealapheur L Khan (National Cancer Institute)|Javed  Khan; MD (National Cancer Institute)|Miriam R Anver (National Cancer Institute)|Melinda  Hollingshead (National Cancer Institute)",NULL,"1. Calvo A, Catena R, Noble MS, Carbott D, Gil-Bazo I, Gonzalez-Moreno O, Huh JI, Sharp R, Qiu TH, Anver MR, Merlino G, Dickson RB, Johnson MD, Green JE (2008). Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene  27, 5373-84.   https://doi.org/10.1038/onc.2008.155",https://intramural.nih.gov/search/searchview.taf?ipid=56738
438,BC010872-01,"October 01, 2007 -  September 30, 2008",High troughput screen for small molecule inhibitors of Ran regulated functions,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56650
439,BC010873-01,"October 01, 2007 -  September 30, 2008",Underlying Cause of Radiation-induced Fibrosis,Nicole L Simone; MD,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Anthony D Saleh|Jason E Savage,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56497
440,BC010874-01,"October 01, 2007 -  September 30, 2008",Biomarkers of Human Lung Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Elise Dawn Bowman|Elisa A Spillare|Masahiro  Seike|Rosemary Irene Braun|Akiteru  Goto|Ewy A Mathe|Show all 7,NULL,NULL,NULL,"1. Mathe EA, Croce CA, Harris CA (submitted in 2008) Mirna Biomarkers Predict Esophageal Carcinoma Diagnosis And Barrett's Esophagus Status. Patents issued: 200880116343 (CN in 2014); 2008310704 (AU in 2014); 103937876 (CN in 2016). Patents pending: 08838376.5 (EP application); 2010-529072 (JP application); PCT/US2008/079482 (PC application); 12/682,318 (US application); 2,702,241 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=56463
441,BC010875-01,"October 01, 2007 -  September 30, 2008",Inhibitor of Normal Growth (ING),Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Elisa A Spillare|Motoko  Unoki|Motonobu  Saito,NULL,Ettore  Appella; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56464
442,BC010876-01,"October 01, 2007 -  September 30, 2008",The role of cancer stem cells in liver cancer heterogeneity and subtypes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Zhipeng  Yu|Taro  Yamashita|Stephanie  Roessler|Junfang  Ji,NULL,"Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)|Robert  Wiltrout; PhD (National Cancer Institute)|Howard A Young; PhD (National Cancer Institute)|Paul S Meltzer; MD, PhD (National Cancer Institute)","Paul P. Liu; MD, PhD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56550
443,BC010877-01,"October 01, 2007 -  September 30, 2008",The identification of human hepatocellular carcinoma metastasis genes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Zhipeng  Yu|Junfang  Ji|Lei  Zhao|Guoling  Lin|Show all 7,NULL,Paul  Goldsmith; PhD (National Cancer Institute)|Udai S Kammula (National Cancer Institute)|Richard  Simon (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56548
444,BC010878-01,"October 01, 2007 -  September 30, 2008",Human Colon Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Elise Dawn Bowman|Mohammed A. Khan; PhD|Elisa A Spillare|Aaron Joseph Schetter|Akiteru  Goto|Giang Huong Nguyen,Carlo M Croce|Suet  Leung (Hong Kong University),NULL,NULL,"1. Fujita K, Mondal AM, Horikawa I, Nguyen GH, Kumamoto K, Sohn JJ, Bowman ED, Mathe EA, Schetter AJ, Pine SR, Ji H, Vojtesek B, Bourdon JC, Lane DP, Harris CC (2009). p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat Cell Biol  11, 1135-42.   https://doi.org/10.1038/ncb1928|2. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC (2008). MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA  299, 425-36.   https://doi.org/10.1001/jama.299.4.425",https://intramural.nih.gov/search/searchview.taf?ipid=56465
445,BC010879-01,"October 01, 2007 -  September 30, 2008",Role of Toll-like receptors in the generation of acquired immunity,David M Segal; PhD,NULL,"Experimental Immunology Branch, NCI",Anna K Manlapat|Yan  Wang|Ivett  Jelinek,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56491
446,BC010880-01,"October 01, 2007 -  September 30, 2008",Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Yurong  Song; PhD|Terry Anne Van Dyke,NULL,Jonathan  Keller; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56538
447,BC010881-01,"October 01, 2007 -  September 30, 2008",Development of TGF-beta antagonists for cancer therapy,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Misako  Sato|Yu-an  Yang,NULL,"Scott M Lawrence (National Cancer Institute)|Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)|John Charles Morris; MD (National Cancer Institute)",Arian  Laurence (NIAMS),"1. Nam JS, Terabe M, Kang MJ, Chae H, Voong N, Yang YA, Laurence A, Michalowska A, Mamura M, Lonning S, Berzofsky JA, Wakefield LM (2008). Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res  68, 3915-23.   https://doi.org/10.1158/0008-5472.CAN-08-0206|2. Nam JS, Terabe M, Mamura M, Kang MJ, Chae H, Stuelten C, Kohn E, Tang B, Sabzevari H, Anver MR, Lawrence S, Danielpour D, Lonning S, Berzofsky JA, Wakefield LM (2008). An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments. Cancer Res  68, 3835-43.   https://doi.org/10.1158/0008-5472.CAN-08-0215",https://intramural.nih.gov/search/searchview.taf?ipid=56544
448,BC010882-01,"October 01, 2007 -  September 30, 2008",Clinical Trials Support,"Frank M Balis; MD, PhD",NULL,"Pediatric Oncology Branch, NCI",Martha B Shaw|Linda F Adams|Elizabeth A Ness|Susan G Mcmullen|Allison P Wise|Patricia A Klevins|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56514
449,BC010885-01,"October 01, 2007 -  September 30, 2008",Study of tumor pathogenesis and development of therapies for AIDS-malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Muzammel  Haque|David A Davis; MD|Victoria Y Wang|Kazushi  Nakano|Paula  Velasco|Sarah  Daniels,NULL,"Stefania  Pittaluga (National Cancer Institute)|Giovanna  Tosato; PhD (National Cancer Institute)|Denise  Whitby (National Cancer Institute)|Zhi Ming  Zheng; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56604
450,BC010886-01,"October 01, 2007 -  September 30, 2008",Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Robert Scott Hudson,NULL,Robert H Stephens (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56354
451,BC010887-01,"October 01, 2007 -  September 30, 2008",Novel Markers for Disease Outcome in Breast Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Sharon  Glynn,NULL,"Stephen J Chanock; MD, PhD (National Cancer Institute)|David Anderson Wink (National Cancer Institute)|Kent W Hunter; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56355
452,BC010888-01,"October 01, 2007 -  September 30, 2008",Clinical trials of patients with AIDS-related malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI","Richard  Little; MD, PhD|Victoria Y Wang|Kathleen M Wyvill|Deirdre  O'Mahony|Thomas S Uldrick",NULL,"Stefania  Pittaluga (National Cancer Institute)|Frank  Maldarelli (National Cancer Institute)|Giovanna  Tosato; PhD (National Cancer Institute)|Wyndham H Wilson; MD, PhD (National Cancer Institute)|Denise  Whitby (National Cancer Institute)|Seth M Steinberg; PhD (National Cancer Institute)",Moinuddin  Hassan; PhD (NICHD) |H. Clifford  Lane; MD (NIAID) |Joseph A Kovacs; MD (CC) |Amir Hossein Gandjbakhche; PhD (NICHD) |Jeffrey  Cohen; MD (NIAID),"1. Yarchoan R, Gandjbakhche A, Hassan M, Vogel A   (2008) Imaging Techniques for Kaposi Sarcoma (KS)., in Kaposi sarcoma. A Model of Oncogenesis. Pantanowitz L, Stebbing J, Dezube B, eds., Research Signpost (Kerela, India), in press.|2. Yarchoan R, Little R   (2008) AIDS and cancer, in Cancer - The Outlaw Cell. LaFond R, ed., American Chemical Society and Oxford University Press USA (New York), in press.",https://intramural.nih.gov/search/searchview.taf?ipid=56602
453,BC010889-01,"October 01, 2007 -  September 30, 2008",Role of Selenium-containing Proteins in Cancer and Development,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Bradley A Carlson|Min-Hyuk  Yoo|Xueming  Xu,NULL,NULL,NULL,"1. Le DT, Liang X, Fomenko DE, Raza AS, Chong CK, Carlson BA, Hatfield DL, Gladyshev VN (2008). Analysis of methionine/selenomethionine oxidation and methionine sulfoxide reductase function using methionine-rich proteins and antibodies against their oxidized forms. Biochemistry  47, 6685-94.   https://doi.org/10.1021/bi800422s|2. Lobanov AV, Hatfield DL, Gladyshev VN (2008). Reduced reliance on the trace element selenium during evolution of mammals. Genome Biol  9, R62.   https://doi.org/10.1186/gb-2008-9-3-r62|3. Lobanov AV, Hatfield DL, Gladyshev VN (2008). Selenoproteinless animals: selenophosphate synthetase SPS1 functions in a pathway unrelated to selenocysteine biosynthesis. Protein Sci  17, 176-82.   https://doi.org/10.1110/ps.073261508|4. Yoo MH, Hatfield DL (2008). The cancer stem cell theory: is it correct? Mol Cells  26, 514-6.",https://intramural.nih.gov/search/searchview.taf?ipid=56466
454,BC010891-01,"October 01, 2007 -  September 30, 2008",Antibody Therapy of Cancer,Mitchell  Ho|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Lucy  Gong|Heungnam  Kim,Steven M Albelda|Itai  Benhar (Tel Aviv University),Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)|Byungkook  Lee; PhD (National Cancer Institute)|Raffit  Hassan (National Cancer Institute)|Ira H Pastan; MD (National Cancer Institute)|David J Fitzgerald; PhD (National Cancer Institute),NULL,"1. Hassan R, Ho M (2008). Mesothelin targeted cancer immunotherapy. Eur J Cancer  44, 46-53.   https://doi.org/10.1016/j.ejca.2007.08.028",https://intramural.nih.gov/search/searchview.taf?ipid=56469
455,BC010892-01,"October 01, 2007 -  September 30, 2008",Characterization of the interaction between inflammation and cancer progression,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Jeffrey J Subleski|Jonathan  Weiss|Tim  Chan|Jimmy  Stauffer|Anthony J Scarzello|Show all 7,NULL,John R Ortaldo; PhD (National Cancer Institute)|Howard A Young; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56560
456,BC010893-01,"October 01, 2007 -  September 30, 2008",Tumor models for the study of inflammation and oncogenesis,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Jeffrey J Subleski|Jimmy  Stauffer,NULL,"John R Ortaldo; PhD (National Cancer Institute)|Howard A Young; PhD (National Cancer Institute)|Curtis  Harris; MD (National Cancer Institute)|Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)|William Marston Linehan; MD (National Cancer Institute)|Xin Wei Wang; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56562
457,BC010895-01,"October 01, 2007 -  September 30, 2008",The cell biology of the calcium release-activated calcium channel in T cells,Lawrence Elliot Samelson; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Valarie  Barr; PhD|Connie  Sommers; PhD|Kelsie M Bernot,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56486
458,BC010898-01,"October 01, 2007 -  September 30, 2008",Redox Mechanism Process of Angiogenesis and Wound Healing,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",NULL,NULL,Murali  Krishna; PhD (National Cancer Institute)|Curtis  Harris; MD (National Cancer Institute)|Stefan  Ambs (National Cancer Institute),NULL,"1. Isenberg JS, Hyodo F, Ridnour LA, Shannon CS, Wink DA, Krishna MC, Roberts DD (2008). Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow. Neoplasia  10, 886-96.   https://doi.org/10.1593/neo.08264",https://intramural.nih.gov/search/searchview.taf?ipid=56568
459,BC010899-01,"October 01, 2007 -  September 30, 2008",Properties of redox modified NSAIDs in cancer prevention and treatment,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",NULL,NULL,James B Mitchell; PhD (National Cancer Institute)|Murali  Krishna; PhD (National Cancer Institute)|Larry K Keefer; PhD (National Cancer Institute)|Grace  Yeh; PhD (National Cancer Institute),NULL,"1. Dai S, Jia Y, Wu SL, Isenberg JS, Ridnour LA, Bandle RW, Wink DA, Roberts DD, Karger BL (2008). Comprehensive characterization of heat shock protein 27 phosphorylation in human endothelial cells stimulated by the microbial dithiole thiolutin. J Proteome Res  7, 4384-95.   https://doi.org/10.1021/pr800376w|2. Switzer CH, Ridnour LA, Cheng RY, Sparatore A, Del Soldato P, Moody TW, Vitek MP, Roberts DD, Wink DA (2009). Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity. Oncogene  28, 3837-46.   https://doi.org/10.1038/onc.2009.244",https://intramural.nih.gov/search/searchview.taf?ipid=56570
460,BC010900-01,"October 01, 2007 -  September 30, 2008",DNA Extraction Service,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",David  Winkler,NULL,James Stephen Shaw; PhD (National Cancer Institute)|Paul A Roche; PhD (National Cancer Institute)|Dinah  Singer; PhD (National Cancer Institute)|Andre A Nussenzweig; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56572
461,BC010901-01,"October 01, 2007 -  September 30, 2008",Hollow Fiber Production of Monoclonal Antibodies,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",David  Winkler,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56574
462,BC010903-01,"October 01, 2007 -  September 30, 2008",Transgenic Core Facility,Deborah A Swing,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Robert H Koogle|Holly Marie Morris,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56522
463,BC010904-01,"October 01, 2007 -  September 30, 2008",Generation of Targeted Mutation in Mice,Vincenzo  Coppola,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Jodi L Becker|Susan W Reid,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56393
464,BC010905-01,"October 01, 2007 -  September 30, 2008",Cell Prep Core,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Azam V Nahvi|Linda L Parker|Thomas E Shelton|Michelle  Pelletier|John R Wunderlich,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56600
465,BC010906-01,"October 01, 2007 -  September 30, 2008",Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Liyanage P Perera; PhD|Yutaka  Tagaya; MD, PhD|Carolyn  Goldman|Ping  Yu",NULL,"Jason L Yovandich (National Cancer Institute)|John  Janik; MD (National Cancer Institute)|Stephen  Creekmore; PhD (National Cancer Institute)|John Charles Morris; MD (National Cancer Institute)|Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)",Mario  Roederer; PhD (NIAID),"1. Dubois S, Patel HJ, Zhang M, Waldmann TA, Müller JR (2008). Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action. J Immunol  180, 2099-106.   https://doi.org/10.4049/jimmunol.180.4.2099",https://intramural.nih.gov/search/searchview.taf?ipid=56546
466,BC010907-01,"October 01, 2007 -  September 30, 2008",Papillomavirus Infectious Entry,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana|Adam  Moyer|Rachel  Schowalter; PhD,NULL,NULL,Benes L Trus; PhD (CIT) |David Eric Anderson; PhD (NIDDK) |Alasdair C Steven; PhD (NIAMS),"1. Buck CB (2008). Defensins' offensive play: exploiting a viral achilles' heel. Cell Host Microbe  3, 3-4.   https://doi.org/10.1016/j.chom.2007.12.006|2. Buck CB, Cheng N, Thompson CD, Lowy DR, Steven AC, Schiller JT, Trus BL (2008). Arrangement of L2 within the papillomavirus capsid. J Virol  82, 5190-7.   https://doi.org/10.1128/JVI.02726-07|3. Talwar GP, Dar SA, Rai MK, Reddy KV, Mitra D, Kulkarni SV, Doncel GF, Buck CB, Schiller JT, Muralidhar S, Bala M, Agrawal SS, Bansal K, Verma JK (2008). A novel polyherbal microbicide with inhibitory effect on bacterial, fungal and viral genital pathogens. Int J Antimicrob Agents  32, 180-5.   https://doi.org/10.1016/j.ijantimicag.2008.03.004",https://intramural.nih.gov/search/searchview.taf?ipid=56373
467,BC010908-01,"October 01, 2007 -  September 30, 2008",Role of MxA in Human Prostate Cancer,J. Frederic Mushinski; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",James D Owens,NULL,Jane Beth Trepel (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56758
468,BC010909-01,"October 01, 2007 -  September 30, 2008",Use of Mouse Gene Expression Profiles to Predict Human Breast Cancer Prognosis,J. Frederic Mushinski; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",NULL,NULL,Joanna H Shih (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56760
469,BC010910-01,"October 01, 2007 -  September 30, 2008",Genomic Rearrangements in Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI",Oleg K Glebov|Leslie Ann Brents|Yulia  Demchenko|Edward S Ramsay,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56680
470,BC010911-01,"October 01, 2007 -  September 30, 2008",Role of Novel MicroRNAs in the PVT-1 Locus,J. Frederic Mushinski; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",NULL,NULL,"Natasha  Caplen (National Cancer Institute)|Konrad  Huppi; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56756
471,BC010912-01,"October 01, 2007 -  September 30, 2008",Novel role of an aquaporin in endosome biogenesis and Notch signaling,Mark E Fortini,NULL,"Cancer and Developmental Biology Laboratory, NCI",Mary K Ernst|Ritu  Kanwar|Nikolaos  Tountas,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56440
472,BC010913-01,"October 01, 2007 -  September 30, 2008",Identification and characterization of new mutants affecting Notch trafficking,Mark E Fortini,NULL,"Cancer and Developmental Biology Laboratory, NCI",Mary K Ernst|Casper  Groth|Nikolaos  Tountas|Takeshi  Sasamura,NULL,NULL,NULL,"1. Fortini ME (2007). Medicine. Anticipating trouble from gene transcription. Science  315, 1800-1.   https://doi.org/10.1126/science.1141279|2. Lu Y, Lv Y, Ye Y, Wang Y, Hong Y, Fortini ME, Zhong Y, Xie Z (2007). A role for presenilin in post-stress regulation: effects of presenilin mutations on Ca2+ currents in Drosophila. FASEB J  21, 2368-78.   https://doi.org/10.1096/fj.06-6380com",https://intramural.nih.gov/search/searchview.taf?ipid=56441
473,BC010914-01,"October 01, 2007 -  September 30, 2008",Gene Expression Profiling and Clinical Characterization of Phototoxicity,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Elizabeth Ravenna Bassett,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56668
474,BC010915-01,"October 01, 2007 -  September 30, 2008",EIB Microscopy Core Facility,Michael John Kruhlak; PhD,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",NULL,NULL,"Thomas J. Walsh; MD (National Cancer Institute)|Zhi Ming  Zheng; MD, PhD (National Cancer Institute)|Thomas A Misteli; PhD (National Cancer Institute)|James Stephen Shaw; PhD (National Cancer Institute)|Gene  Shearer; PhD (National Cancer Institute)|David M Segal; PhD (National Cancer Institute)","Elissa P Lei; BS, PhD (NIDDK) |Richard D Leapman; PhD (NIBIB)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56678
475,BC010923-01,"October 01, 2007 -  September 30, 2008",Tissue Array Research Program,John Carl Oberholtzer,NULL,"Laboratory of Pathology, NCI","Joon Yong Chung|Mikiko  Takikita|Stephen M Hewitt; MD, PhD",NULL,"Philip  Taylor; MD, ScD (National Cancer Institute)|Nealapheur L Khan (National Cancer Institute)|Mark E Sherman; MD (National Cancer Institute)|Montserrat  Garcia-Closas; MD, PhD (National Cancer Institute)|Lee Elizabeth Moore; PhD, MD (National Cancer Institute)|Sanford Martin Dawsey; MD (National Cancer Institute)","Ashani T Weeraratna; PhD (NIA) |Yoke Peng  Loh; PhD (NICHD) |Ira W Levin; PhD (NIDDK) |Alfredo A Molinolo; MD, PhD (NIDCR)","1. Jiao W, Lin HM, Datta J, Braunschweig T, Chung JY, Hewitt SM, Rane SG (2008). Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiation. Oncogene  27, 3156-64.   https://doi.org/10.1038/sj.onc.1210970",https://intramural.nih.gov/search/searchview.taf?ipid=56467
476,BC010924-01,"October 01, 2007 -  September 30, 2008",Pathogenesis of cutaneous T cell lymphoma,"Sam  Hwang; MD, PhD",NULL,"Dermatology Branch, NCI",Xuesong  Wu,NULL,"Chyi-Chia Richard Lee (National Cancer Institute)|Gordon  Whiteley (National Cancer Institute)|Mark  Udey; MD (National Cancer Institute)|Wolfgang W Leitner; MS, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56644
477,BC010925-01,"October 01, 2007 -  September 30, 2008",Phase I Study of Topical Romidepsin in Early Stage Cutaneous T-cell Lymphoma,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Elizabeth Ravenna Bassett,NULL,Susan  Bates; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56670
478,BC010926-01,"October 01, 2007 -  September 30, 2008",Bioinformatics Analysis of Mouse Cancer Model,Keiko  Akagi,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",NULL,"Neal  Copeland (Department of Environmental Medicine, Institute of Molecular and Cell Biology)|Kyoji  Horie (Osaka University)","Shyam K Sharan (National Cancer Institute)|David E Symer (National Cancer Institute)|Karlyne M Reilly; BS, PhD (National Cancer Institute)|Robert  Stephens (National Cancer Institute)",NULL,"1. Akagi K, Li J, Stephens RM, Volfovsky N, Symer DE (2008). Extensive variation between inbred mouse strains due to endogenous L1 retrotransposition. Genome Res  18, 869-80.   https://doi.org/10.1101/gr.075770.107",https://intramural.nih.gov/search/searchview.taf?ipid=56353
479,BC010927-01,"October 01, 2007 -  September 30, 2008",Role of Chromatin Structure in Regulating MHC Class I Expression,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Anne G M Gegonne Bosselut|Jocelyn D Weissman|Aparna  Kotekar,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56500
480,BC010928-01,"October 01, 2007 -  September 30, 2008",Boundary Elements Regulate MHC Class I Expression In Vivo,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Anne G M Gegonne Bosselut|Jocelyn D Weissman|Aparna  Kotekar|Palak Rajendra Parekh|Jie  Mu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56501
481,BC010929-01,"October 01, 2007 -  September 30, 2008",Tumor Stroma Interactions: Wound Promoted Tumor Growth,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Christina  Stuelten,NULL,Kent W Hunter; PhD (National Cancer Institute)|Lalage  Wakefield; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56764
482,BC010930-01,"October 01, 2007 -  September 30, 2008",Molecular Cytogenetics Core,Anna V Roschke,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Ken  Nakahara,NULL,"Natasha  Caplen (National Cancer Institute)|Liang  Cao (National Cancer Institute)|Peter D Aplan; MD (National Cancer Institute)|Walter M Kuehl; MD, PhD (National Cancer Institute)|Munira A Basrai; PhD (National Cancer Institute)|Louis  Staudt; MD (Lymphoid Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56480
483,BC010931-01,"October 01, 2007 -  September 30, 2008",Comparative Biomedical Scientist Training Program,"Robert Mark Simpson; DVM, PhD",Stuart H Yuspa; MD,"Laboratory of Cancer Biology and Genetics, NCI",David L Caudell|Philip L Martin|Kevin D Woolard|Yava  Jones|Tanasa S Osborne|Schantel  Hayes|Show all 10,"John M Cullen; VMD, PhD|Thomas  Mullaney (Pathobiology and Diagnostic Investigtion, Michigan State University)|Siba  Samal; PhD (Virginia-Maryland Regional College of Vet Med, University of Maryland)","Peter D Aplan; MD (National Cancer Institute)|Howard A Fine; MD, PhD (National Cancer Institute)|Jeffrey E Green; MD (National Cancer Institute)",NULL,"1. Caudell D, Aplan PD (2008). The role of CALM-AF10 gene fusion in acute leukemia. Leukemia  22, 678-85.   https://doi.org/10.1038/sj.leu.2405074|2. Higgins MA, Rossmeisl JH, Saunders GK, Hayes S, Kiupel M (2008) B-cell lymphoma in the peripheral nerves of a cat. Vet Pathol 45:54-7|3. Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, Kotliarova S, Kotliarov Y, Walling J, Ahn S, Kim M, Totonchy M, Cusack T, Ene C, Ma H, Su Q, Zenklusen JC, Zhang W, Maric D, Fine HA (2008). Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell  13, 69-80.   https://doi.org/10.1016/j.ccr.2007.12.005",https://intramural.nih.gov/search/searchview.taf?ipid=56498
484,BC010932-01,"October 01, 2007 -  September 30, 2008",T Cell Memory,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Atef  Allam; PhD|Maria Letizia  Giardino Torchia,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56359
485,BC010933-01,"October 01, 2007 -  September 30, 2008",Costimulation Enhances Murine T Cells in Cancer Vaccine Development,Helen B Sabzevari,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Benedetto Paolo Farsaci; PhD|Shinji  Takai,NULL,"Diane E Milenic (National Cancer Institute)|Marta Liliana Catalfamo; PhD (Lymphocyte Cytotoxicity Section)|Yutaka  Tagaya; MD, PhD (National Cancer Institute)|Jeffrey  Schlom; PhD (National Cancer Institute)",Roshanak  Tolouei Semnani; PhD (NIAID),"1. Bernstein MB, Chakraborty M, Wansley EK, Guo Z, Franzusoff A, Mostböck S, Sabzevari H, Schlom J, Hodge JW (2008). Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells. Vaccine  26, 509-21.   https://doi.org/10.1016/j.vaccine.2007.11.033|2. Hu P, Arias RS, Sadun RE, Nien YC, Zhang N, Sabzevari H, Lutsiak ME, Khawli LA, Epstein AL (2008). Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer. Clin Cancer Res  14, 579-88.   https://doi.org/10.1158/1078-0432.CCR-07-0940|3. Lutsiak ME, Tagaya Y, Adams AJ, Schlom J, Sabzevari H (2008). Tumor-induced impairment of TCR signaling results in compromised functionality of tumor-infiltrating regulatory T cells. J Immunol  180, 5871-81.   https://doi.org/10.4049/jimmunol.180.9.5871|4. Mostböck S, Lutsiak ME, Milenic DE, Baidoo K, Schlom J, Sabzevari H (2008). IL-2/anti-IL-2 antibody complex enhances vaccine-mediated antigen-specific CD8+ T cell responses and increases the ratio of effector/memory CD8+ T cells to regulatory T cells. J Immunol  180, 5118-29.   https://doi.org/10.4049/jimmunol.180.7.5118|5. Nam JS, Terabe M, Mamura M, Kang MJ, Chae H, Stuelten C, Kohn E, Tang B, Sabzevari H, Anver MR, Lawrence S, Danielpour D, Lonning S, Berzofsky JA, Wakefield LM (2008). An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments. Cancer Res  68, 3835-43.   https://doi.org/10.1158/0008-5472.CAN-08-0215|6. Sadun RE, Hsu WE, Zhang N, Nien YC, Bergfeld SA, Sabzevari H, Lutsiak ME, Khawli L, Hu P, Epstein AL (2008). Fc-mOX40L fusion protein produces complete remission and enhanced survival in 2 murine tumor models. J Immunother  31, 235-45.   https://doi.org/10.1097/CJI.0b013e31816a88e0|7. Semnani RT, Venugopal PG, Leifer CA, Mostböck S, Sabzevari H, Nutman TB (2008). Inhibition of TLR3 and TLR4 function and expression in human dendritic cells by helminth parasites. Blood  112, 1290-8.   https://doi.org/10.1182/blood-2008-04-149856",https://intramural.nih.gov/search/searchview.taf?ipid=56484
486,BC010934-01,"October 01, 2007 -  September 30, 2008",Immune reconstitution following autologous and allogeneic stem cell transplant,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",David  Justus|Sarah E Lafond,NULL,"Steven  Pavletic; MD, MS (National Cancer Institute)|Alan S Wayne; MD (National Cancer Institute)|Claude  Sportes (National Cancer Institute)|Michael R Bishop; MD (National Cancer Institute)|Daniel H Fowler (National Cancer Institute)|Ronald E Gress; MD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56461
487,BC010935-01,"October 01, 2007 -  September 30, 2008",Regulation of Metastasis and Angiogenesis by Autotaxin and its Products,Mary  Stracke,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Elliott  Schiffman,NULL,Malgorzata  Ptaszynska (National Cancer Institute)|Russell William Bandle (National Cancer Institute),NULL,"1. Ptaszynska MM, Pendrak ML, Bandle RW, Stracke ML, Roberts DD (2008). Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells. Mol Cancer Res  6, 352-63.   https://doi.org/10.1158/1541-7786.MCR-07-0143|2. Zhao C, Fernandes MJ, Prestwich GD, Turgeon M, Di Battista J, Clair T, Poubelle PE, Bourgoin SG (2008) Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis? Mol Pharmacol 73:587-600",https://intramural.nih.gov/search/searchview.taf?ipid=56520
488,BC010936-01,"October 01, 2007 -  September 30, 2008",CCR VB FACS CORE,Katherine M McKinnon,"Jay Arthur Berzofsky; MD, PhD","Vaccine Branch, NCI",NULL,NULL,"Kevin  Gardner; MD, PhD (National Cancer Institute)|Marjorie  Robert-Guroff; PhD (National Cancer Institute)|John N Brady; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56732
489,BC010937-01,"October 01, 2007 -  September 30, 2008",Novel Targets for Vaccine Therapy,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Marjorie P Duberstein|Mary T Litzinger|Romaine Ingrid Fernando|Bruce K Huang|Marianne Devilla Castillo|Duane Howard Hamilton|Show all 7,NULL,NULL,NULL,"1. Gulley JL, Arlen PM, Tsang KY, Yokokawa J, Palena C, Poole DJ, Remondo C, Cereda V, Jones JL, Pazdur MP, Higgins JP, Hodge JW, Steinberg SM, Kotz H, Dahut WL, Schlom J (2008). Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma. Clin Cancer Res  14, 3060-9.   https://doi.org/10.1158/1078-0432.CCR-08-0126",https://intramural.nih.gov/search/searchview.taf?ipid=56770
490,BC010938-01,"October 01, 2007 -  September 30, 2008",Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Elizabeth Ravenna Bassett,NULL,NULL,Julia A Segre; PhD (NHGRI) |Hirsh David Komarow; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56672
491,BC010939-01,"October 01, 2007 -  September 30, 2008",RNAi Analysis and Screening for Study of Genes and Anti-Cancer Treatments,Natasha  Caplen|IRP Faculty Profile,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Scott E Martin|Tamara L Jones,"Shigeki  Miyamoto (University of Wisconsin)|John  Weinstein (Bioinformatics and Computational Biology, MD Anderson)",Yves  Pommier; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56387
492,BC010940-01,"October 01, 2007 -  September 30, 2008",Cutaneous Adverse Drug Reactions,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56666
493,BC010941-01,"October 01, 2007 -  September 30, 2008",CCR FACS Core Laboratory,Barbara J Taylor,Stuart H Yuspa; MD,"Laboratory of Cancer Biology and Genetics, NCI",Subhadra  Banerjee,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56524
494,BC010942-01,"October 01, 2007 -  September 30, 2008",Diacylglycerol Lactones as C1 Ligands for Protein Kinase C and Related Proteins,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Said  El Kazzouli,NULL,Peter  Blumberg; PhD (National Cancer Institute)|Howard A Young; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56726
495,BC010943-01,"October 01, 2007 -  September 30, 2008",DNA Methylase Inhibitors,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",NULL,NULL,William  Farrar (National Cancer Institute),NULL,"1. Marquez V, Chung J, Byun H, Egger G, Young A, Dubeau L, Long T, Laird P, Jones P   (2008) Long-term epigenetic therapy with oral zebularine has minimal side effects and  prevents intestinal tumors in mice.  Cancer Prevention Research  233-240 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=56728
496,BC010944-01,"October 01, 2007 -  September 30, 2008",Control of the immune response for cancer vaccine development,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Judith M Dipietro,NULL,Marta Liliana Catalfamo; PhD (Lymphocyte Cytotoxicity Section)|Claudia Mercedes Palena (National Cancer Institute)|Helen B Sabzevari (National Cancer Institute)|James W Hodge; PhD (National Cancer Institute)|John  Greiner; PhD (National Cancer Institute),Roshanak  Tolouei Semnani; PhD (NIAID),"1. Schlom J, Arlen P, Hodge J   (2008) Vaccines and Immunostimulants., in Cancer Medicine 8. Kufe D, ed.,  BC Decker, in press.|2. Bernstein MB, Chakraborty M, Wansley EK, Guo Z, Franzusoff A, Mostböck S, Sabzevari H, Schlom J, Hodge JW (2008). Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells. Vaccine  26, 509-21.   https://doi.org/10.1016/j.vaccine.2007.11.033|3. Chakraborty M, Gelbard A, Carrasquillo JA, Yu S, Mamede M, Paik CH, Camphausen K, Schlom J, Hodge JW (2008). Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects. Cancer Immunol Immunother  57, 1173-83.   https://doi.org/10.1007/s00262-008-0449-x|4. Chakraborty M, Wansley EK, Carrasquillo JA, Yu S, Paik CH, Camphausen K, Becker MD, Goeckeler WF, Schlom J, Hodge JW (2008). The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing. Clin Cancer Res  14, 4241-9.   https://doi.org/10.1158/1078-0432.CCR-08-0335|5. Garnett CT, Schlom J, Hodge JW (2008). Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement. Clin Cancer Res  14, 3536-44.   https://doi.org/10.1158/1078-0432.CCR-07-4025|6. Gulley JL, Arlen PM, Tsang KY, Yokokawa J, Palena C, Poole DJ, Remondo C, Cereda V, Jones JL, Pazdur MP, Higgins JP, Hodge JW, Steinberg SM, Kotz H, Dahut WL, Schlom J (2008). Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma. Clin Cancer Res  14, 3060-9.   https://doi.org/10.1158/1078-0432.CCR-08-0126|7. Lechleider RJ, Arlen PM, Tsang KY, Steinberg SM, Yokokawa J, Cereda V, Camphausen K, Schlom J, Dahut WL, Gulley JL (2008). Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant. Clin Cancer Res  14, 5284-91.   https://doi.org/10.1158/1078-0432.CCR-07-5162|8. Madan RA, Gulley JL, Schlom J, Steinberg SM, Liewehr DJ, Dahut WL, Arlen PM (2008). Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, nilutamide, and combination therapy. Clin Cancer Res  14, 4526-31.   https://doi.org/10.1158/1078-0432.CCR-07-5048|9. Rogers CJ, Berrigan D, Zaharoff DA, Hance KW, Patel AC, Perkins SN, Schlom J, Greiner JW, Hursting SD (2008). Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in mice. J Nutr  138, 115-22.   https://doi.org/10.1093/jn/138.1.115|10. Rogers CJ, Zaharoff DA, Hance KW, Perkins SN, Hursting SD, Schlom J, Greiner JW (2008). Exercise enhances vaccine-induced antigen-specific T cell responses. Vaccine  26, 5407-15.   https://doi.org/10.1016/j.vaccine.2008.07.081|11. Schlom J, Gulley JL, Arlen PM (2008). Paradigm shifts in cancer vaccine therapy. Exp Biol Med (Maywood)  233, 522-34.   https://doi.org/10.3181/0708-MR-226|12. Wansley EK, Chakraborty M, Hance KW, Bernstein MB, Boehm AL, Guo Z, Quick D, Franzusoff A, Greiner JW, Schlom J, Hodge JW (2008). Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin Cancer Res  14, 4316-25.   https://doi.org/10.1158/1078-0432.CCR-08-0393|13. Yang S, Schlom J (2009). Antigen-presenting cells containing multiple costimulatory molecules promote activation and expansion of human antigen-specific memory CD8+ T cells. Cancer Immunol Immunother  58, 503-15.   https://doi.org/10.1007/s00262-008-0572-8|14. Yokokawa J, Cereda V, Remondo C, Gulley JL, Arlen PM, Schlom J, Tsang KY (2008). Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer. Clin Cancer Res  14, 1032-40.   https://doi.org/10.1158/1078-0432.CCR-07-2056|15. Zeytin H, Reali E, Zaharoff DA, Rogers CJ, Schlom J, Greiner JW (2008). Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity. J Interferon Cytokine Res  28, 73-87.   https://doi.org/10.1089/jir.2007.0063",https://intramural.nih.gov/search/searchview.taf?ipid=56488
497,BC010945-01,"October 01, 2007 -  September 30, 2008",Clinical trials employing cancer vaccine combination therapies,"James L Gulley; MD, PhD|IRP Faculty Profile",Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Sandra  Doren|Mary P Pazdur|Theresa A Ferrara|Jacquin L Jones|Natasha  Brunson|Ravi  Madan|Show all 7,"William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Robert  DiPaola (Medicine, Cancer Institute of New Jersey)|John  Marshall",William Laurence Dahut; MD (National Cancer Institute)|William Marston Linehan; MD (National Cancer Institute)|Kevin A Camphausen; MD (National Cancer Institute)|Peter A Pinto; MD (National Cancer Institute)|William D Figg; PharmD (National Cancer Institute)|Jeffrey  Schlom; PhD (National Cancer Institute),NULL,"1. Cheever MA, Schlom J, Weiner LM, Lyerly HK, Disis ML, Greenwood A, Grad O, Nelson WG, Translational Research Working Group (2008). Translational Research Working Group developmental pathway for immune response modifiers. Clin Cancer Res  14, 5692-9.   https://doi.org/10.1158/1078-0432.CCR-08-1266|2. Dahut WL, Scripture C, Posadas E, Jain L, Gulley JL, Arlen PM, Wright JJ, Yu Y, Cao L, Steinberg SM, Aragon-Ching JB, Venitz J, Jones E, Chen CC, Figg WD (2008). A phase II clinical trial of sorafenib in androgen-independent prostate cancer. Clin Cancer Res  14, 209-14.   https://doi.org/10.1158/1078-0432.CCR-07-1355|3. Sharifi N, Hamada A, Sissung T, Danesi R, Venzon D, Baum C, Gulley JL, Price DK, Dahut WL, Figg WD (2008). A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer. BJU Int  102, 617-21.   https://doi.org/10.1111/j.1464-410X.2008.07629.x",https://intramural.nih.gov/search/searchview.taf?ipid=56459
498,BC010946-01,"October 01, 2007 -  September 30, 2008",Protection against Radiation-Induced Carcinogenesis,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|Anastasia L Sowers|Maria E Figueroa,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56740
499,BC010947-01,"October 01, 2007 -  September 30, 2008",Cell and Cancer Biology Branch Confocal Microscopy Core,Yvona  Ward; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Ross G Lake,NULL,"Susan  Bates; MD (National Cancer Institute)|Antonio  Fojo; MD, PhD (National Cancer Institute)|Zhenggang  Liu; PhD (National Cancer Institute)|Marianne  Poruchynsky (National Cancer Institute)|Miriam Christine Poirier; PhD (National Cancer Institute)|Edina M Komlodi-pasztor (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56552
500,BC010948-01,"October 01, 2007 -  September 30, 2008",DNA Sequencing and FACS Core Facilities,Paul  Robbins,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Mona E El gamil|Yili  Li|Arnold L Mixon,NULL,NULL,NULL,"1. Wargo JA, Robbins PF, Li Y, Zhao Y, El-Gamil M, Caragacianu D, Zheng Z, Hong JA, Downey S, Schrump DS, Rosenberg SA, Morgan RA (2009). Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression. Cancer Immunol Immunother  58, 383-94.   https://doi.org/10.1007/s00262-008-0562-x",https://intramural.nih.gov/search/searchview.taf?ipid=56474
501,BC010949-01,"October 01, 2007 -  September 30, 2008",GI Tumor Program,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",Austin Gerard Duffy,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56446
502,BC010950-01,"October 01, 2007 -  September 30, 2008",Research Nursing,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",Arlene Wendy Berman|Suzanne E Fioravanti|Nancy A Harold|Moira G Mcguire|Nancy  Mansell|Lisa R King|Show all 19,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56447
503,BC010951-01,"October 01, 2007 -  September 30, 2008",Medical Directors Office,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",Herbert L Kotz|George L Carter|Kerry  Ryan; MPAS|Kathryn G Trewhitt|Jane L Blash|Margarita R Velarde; CRNP|Show all 9,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56444
504,BC010952-01,"October 01, 2007 -  September 30, 2008",Cytokines to control the immune response in cancer vaccine development,Helen B Sabzevari,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Benedetto Paolo Farsaci; PhD|Shinji  Takai,NULL,"Diane E Milenic (National Cancer Institute)|Marta Liliana Catalfamo; PhD (Lymphocyte Cytotoxicity Section)|Yutaka  Tagaya; MD, PhD (National Cancer Institute)|Jeffrey  Schlom; PhD (National Cancer Institute)",Roshanak  Tolouei Semnani; PhD (NIAID),"1. Bernstein MB, Chakraborty M, Wansley EK, Guo Z, Franzusoff A, Mostböck S, Sabzevari H, Schlom J, Hodge JW (2008). Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells. Vaccine  26, 509-21.   https://doi.org/10.1016/j.vaccine.2007.11.033|2. Hu P, Arias RS, Sadun RE, Nien YC, Zhang N, Sabzevari H, Lutsiak ME, Khawli LA, Epstein AL (2008). Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer. Clin Cancer Res  14, 579-88.   https://doi.org/10.1158/1078-0432.CCR-07-0940|3. Lutsiak ME, Tagaya Y, Adams AJ, Schlom J, Sabzevari H (2008). Tumor-induced impairment of TCR signaling results in compromised functionality of tumor-infiltrating regulatory T cells. J Immunol  180, 5871-81.   https://doi.org/10.4049/jimmunol.180.9.5871|4. Mostböck S, Lutsiak ME, Milenic DE, Baidoo K, Schlom J, Sabzevari H (2008). IL-2/anti-IL-2 antibody complex enhances vaccine-mediated antigen-specific CD8+ T cell responses and increases the ratio of effector/memory CD8+ T cells to regulatory T cells. J Immunol  180, 5118-29.   https://doi.org/10.4049/jimmunol.180.7.5118|5. Nam JS, Terabe M, Mamura M, Kang MJ, Chae H, Stuelten C, Kohn E, Tang B, Sabzevari H, Anver MR, Lawrence S, Danielpour D, Lonning S, Berzofsky JA, Wakefield LM (2008). An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments. Cancer Res  68, 3835-43.   https://doi.org/10.1158/0008-5472.CAN-08-0215|6. Sadun RE, Hsu WE, Zhang N, Nien YC, Bergfeld SA, Sabzevari H, Lutsiak ME, Khawli L, Hu P, Epstein AL (2008). Fc-mOX40L fusion protein produces complete remission and enhanced survival in 2 murine tumor models. J Immunother  31, 235-45.   https://doi.org/10.1097/CJI.0b013e31816a88e0|7. Semnani RT, Venugopal PG, Leifer CA, Mostböck S, Sabzevari H, Nutman TB (2008). Inhibition of TLR3 and TLR4 function and expression in human dendritic cells by helminth parasites. Blood  112, 1290-8.   https://doi.org/10.1182/blood-2008-04-149856",https://intramural.nih.gov/search/searchview.taf?ipid=56485
505,BC010953-01,"October 01, 2007 -  September 30, 2008",Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"Robert Mark Simpson; DVM, PhD",Stuart H Yuspa; MD,"Laboratory of Cancer Biology and Genetics, NCI",Shelley B Hoover|Bih-Rong  Wei|Azalia  Zandieh,"Lance  Liotta (Center for Applied Proteomics and Molecular Medicine, George Mason University)|Emanuel  Petricoin, III (Food and Drug Administration)",Charles  Vinson; PhD (National Cancer Institute)|Samir N. Khleif; MD (National Cancer Institute)|Michael Q Bailey (National Cancer Institute)|David A Berrigan (National Cancer Institute),"Robert Carlton Sills; DVM, PhD (NIEHS) |Jeeva P Munasinghe (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56499
506,BC010954-01,"October 01, 2007 -  September 30, 2008",Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI",Jami D Willette brown|Terri L Stull|Stephanie K Watkins,NULL,Stefan  Ambs (National Cancer Institute),NULL,"1. Mazzucchelli R, Hixon JA, Spolski R, Chen X, Li WQ, Hall VL, Willette-Brown J, Hurwitz AA, Leonard WJ, Durum SK (2008). Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP. Blood  112, 3283-92.   https://doi.org/10.1182/blood-2008-02-137414",https://intramural.nih.gov/search/searchview.taf?ipid=56642
507,BC010955-01,"October 01, 2007 -  September 30, 2008",The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI",Jami D Willette brown|Terri L Stull,NULL,Lionel  Feigenbaum (Office Of The Director)|Scott K Durum; PhD (National Cancer Institute)|Lino  Tessarollo (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56640
508,BC010956-01,"October 01, 2007 -  September 30, 2008",EpCAM (CD326) Function in Epithelial Cell BIology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Xu  Feng; PhD,NULL,Susan  Mackem; MD (National Cancer Institute)|Lino  Tessarollo (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56534
509,BC010957-01,"October 01, 2007 -  September 30, 2008",Transplant Models,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Philip J Lucas; PhD|Yu-Waye (Wayne)  Chu|Catherine Virginia Bare|Jiun  Wang|Kirsten  Williams|Shirin  Treadwell|Show all 8,"Gregory  Hadley (Immunology, University of Maryland)|Robert  Korngold (Cancer Center, Hackensack University)",Alfred  Singer; MD (National Cancer Institute)|James Stephen Shaw; PhD (National Cancer Institute)|Richard J Hodes; MD (National Cancer Institute),Arya  Biragyn; PhD (NIA),"1. Williams KM, Lucas PJ, Bare CV, Wang J, Chu YW, Tayler E, Kapoor V, Gress RE (2008). CCL25 increases thymopoiesis after androgen withdrawal. Blood  112, 3255-63.   https://doi.org/10.1182/blood-2008-04-153627",https://intramural.nih.gov/search/searchview.taf?ipid=56457
510,BC010958-01,"October 01, 2007 -  September 30, 2008","Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion",Ira  Daar; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Kathleen T Soria|Hyun-Shik  Lee|Yon Ju  Ji|Arvinder J Singh,NULL,Lino  Tessarollo (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56395
511,BC010959-01,"October 01, 2007 -  September 30, 2008",Relationship between DNA damage detection and signaling,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Jeremy A Daniel|Maria Elsa  Callen Moreu,NULL,NULL,NULL,"1. Schotta G, Sengupta R, Kubicek S, Malin S, Kauer M, Callén E, Celeste A, Pagani M, Opravil S, De La Rosa-Velazquez IA, Espejo A, Bedford MT, Nussenzweig A, Busslinger M, Jenuwein T (2008). A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev  22, 2048-61.   https://doi.org/10.1101/gad.476008",https://intramural.nih.gov/search/searchview.taf?ipid=56766
512,BC010960-01,"October 01, 2007 -  September 30, 2008",Clinical Trials,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Sarfraz A Memon|Francis  Flomerfelt; PhD|Philip J Lucas; PhD|Yu-Waye (Wayne)  Chu|Catherine Virginia Bare|Jiun  Wang|Show all 10,"Robert  Korngold (Cancer Center, Hackensack University)|Andrew  Pecora (Cancer Center, Hackensack University)","Martin  Gutierrez (National Cancer Institute)|Shivaani  Kummar; PhD (National Cancer Institute)|Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)",NULL,"1. Bishop MR, Dean RM, Steinberg SM, Odom J, Pavletic SZ, Chow C, Pittaluga S, Sportes C, Hardy NM, Gea-Banacloche J, Kolstad A, Gress RE, Fowler DH (2008). Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation. Ann Oncol  19, 1935-40.   https://doi.org/10.1093/annonc/mdn404|2. Sportès C, Hakim FT, Memon SA, Zhang H, Chua KS, Brown MR, Fleisher TA, Krumlauf MC, Babb RR, Chow CK, Fry TJ, Engels J, Buffet R, Morre M, Amato RJ, Venzon DJ, Korngold R, Pecora A, Gress RE, Mackall CL (2008). Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med  205, 1701-14.   https://doi.org/10.1084/jem.20071681",https://intramural.nih.gov/search/searchview.taf?ipid=56458
513,BC010961-01,"October 01, 2007 -  September 30, 2008",High-throughput screen for activators of DNA strand break repair,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Nancy  Wong,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56768
514,BC010962-01,"October 01, 2007 -  September 30, 2008",Cytidine deaminase inhibitors,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Olaf R Ludek,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56730
515,BC010963-01,"October 01, 2007 -  September 30, 2008",Branch Clinical Research Core,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI","Juan Carlos Gea-Banacloche; MD|Claude  Sportes|Steven  Pavletic; MD, MS|Michael Charles Krumlauf|Daniele N Avila|Kelly E Snow|Show all 7",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56456
516,BC010964-01,"October 01, 2007 -  September 30, 2008",Trans-NIH Angiogenesis Core Facility,Frank  Cuttitta; PhD,Robert  Wiltrout; PhD,"Office of the Director, NCI",Ingalill R Avis|Enrique  Zudaire Ubani; PhD|Changge  Fang; PhD|Marta  Aparicio Miguel,"Martin  Friedlander (Dept Cell Biology, Scripps Research Institute)|Norma  Javitt (Dept Pediatric Medicine, New York University Medical Center)|Charles  Keese (Electric Cell Impedance System, Applied Biophysics)|Jil  Siegfried (Pharmacology, University of Pittsburgh)|Mary  Sunday (Dept Pathology, Duke University)|Stefanie  Vogel (Dept Microbiol & Immunol, University of Maryland)|Show all 7","Steven  Libutti; MD (National Cancer Institute)|William G Stetler-Stevenson; MD, PhD (National Cancer Institute)|David  Salomon; PhD (National Cancer Institute)|Patricia  Steeg; PhD (National Cancer Institute)","David A Schwartz; MD, MPH (NHLBI) |Joel  Moss; MD, PhD (NHLBI) |Lisa Georgianne Rider; MD (NIEHS)","1. Fernández AP, Serrano J, Tessarollo L, Cuttitta F, Martínez A (2008). Lack of adrenomedullin in the mouse brain results in behavioral changes, anxiety, and lower survival under stress conditions. Proc Natl Acad Sci U S A  105, 12581-6.   https://doi.org/10.1073/pnas.0803174105|2. Sackett DL, Ozbun L, Zudaire E, Wessner L, Chirgwin JM, Cuttitta F, Martínez A (2008). Intracellular proadrenomedullin-derived peptides decorate the microtubules and contribute to cytoskeleton function. Endocrinology  149, 2888-98.   https://doi.org/10.1210/en.2007-1763|3. Cuttitta F, Avis I, Salomon D (submitted in 2008) Apelin Peptides And Methods Of Use. Patent issued: 8,946,382 (US in 2015). Patent pending: 14/593,099 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=56394
517,BC010965-01,"October 01, 2007 -  September 30, 2008",CCR Biophysics Resource Core,Sergey G Tarasov,Robert Andrew Byrd,"Structural Biophysics Laboratory, NCI",NULL,"Jose  Casas-Finet|Zigmund  Gryczynski (University of North Texas)|Wuyuan  Lu (Institute of Virology, University of Maryland)","Marc C Nicklaus (National Cancer Institute)|Xinhua  Ji; PhD (National Cancer Institute)|Stuart F J Le Grice; PhD (National Cancer Institute)|Sandra  Smith-Gill; MS, PhD, BS (National Cancer Institute)|Anil K Patri (Office Of The Director)|Anu  Puri; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56523
518,BC010967-01,"October 01, 2007 -  September 30, 2008",The role of exercise in vaccine-mediated immunity,John  Greiner; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Garland M Davis|Kenneth W Hance|Bertina L Gibbs|Lajuan  Chase,"Stephen D Hursting; PhD, MPH (Epidemiology and Carcinogenesis, NCI)|Susan N Perkins; PhD (NCI)",Jeffrey  Schlom; PhD (National Cancer Institute),NULL,"1. Wansley EK, Chakraborty M, Hance KW, Bernstein MB, Boehm AL, Guo Z, Quick D, Franzusoff A, Greiner JW, Schlom J, Hodge JW (2008). Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin Cancer Res  14, 4316-25.   https://doi.org/10.1158/1078-0432.CCR-08-0393|2. Zeytin H, Reali E, Zaharoff DA, Rogers CJ, Schlom J, Greiner JW (2008). Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity. J Interferon Cytokine Res  28, 73-87.   https://doi.org/10.1089/jir.2007.0063",https://intramural.nih.gov/search/searchview.taf?ipid=56453
519,BC010969-01,"October 01, 2007 -  September 30, 2008",The use of chitosan for cancer vaccine delivery,John  Greiner; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Garland M Davis|David A Zaharoff|Bertina L Gibbs|Lajuan  Chase|Michael  Heffernan,NULL,Jeffrey  Schlom; PhD (National Cancer Institute)|William Marston Linehan; MD (National Cancer Institute)|Peter A Pinto; MD (National Cancer Institute),NULL,"1. Rogers CJ, Berrigan D, Zaharoff DA, Hance KW, Patel AC, Perkins SN, Schlom J, Greiner JW, Hursting SD (2008). Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in mice. J Nutr  138, 115-22.   https://doi.org/10.1093/jn/138.1.115|2. Rogers CJ, Colbert LH, Greiner JW, Perkins SN, Hursting SD (2008). Physical activity and cancer prevention : pathways and targets for intervention. Sports Med  38, 271-96.   https://doi.org/10.2165/00007256-200838040-00002|3. Rogers CJ, Zaharoff DA, Hance KW, Perkins SN, Hursting SD, Schlom J, Greiner JW (2008). Exercise enhances vaccine-induced antigen-specific T cell responses. Vaccine  26, 5407-15.   https://doi.org/10.1016/j.vaccine.2008.07.081|4. Wansley EK, Chakraborty M, Hance KW, Bernstein MB, Boehm AL, Guo Z, Quick D, Franzusoff A, Greiner JW, Schlom J, Hodge JW (2008). Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin Cancer Res  14, 4316-25.   https://doi.org/10.1158/1078-0432.CCR-08-0393|5. Zeytin H, Reali E, Zaharoff DA, Rogers CJ, Schlom J, Greiner JW (2008). Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity. J Interferon Cytokine Res  28, 73-87.   https://doi.org/10.1089/jir.2007.0063",https://intramural.nih.gov/search/searchview.taf?ipid=56454
520,BC010970-01,"October 01, 2007 -  September 30, 2008",The connection of innate and adaptive anti-cancer immunity,John  Greiner; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Garland M Davis|Kenneth W Hance|Bertina L Gibbs|Lajuan  Chase,NULL,Jeffrey  Schlom; PhD (National Cancer Institute),NULL,"1. Rogers CJ, Berrigan D, Zaharoff DA, Hance KW, Patel AC, Perkins SN, Schlom J, Greiner JW, Hursting SD (2008). Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in mice. J Nutr  138, 115-22.   https://doi.org/10.1093/jn/138.1.115|2. Rogers CJ, Colbert LH, Greiner JW, Perkins SN, Hursting SD (2008). Physical activity and cancer prevention : pathways and targets for intervention. Sports Med  38, 271-96.   https://doi.org/10.2165/00007256-200838040-00002|3. Rogers CJ, Zaharoff DA, Hance KW, Perkins SN, Hursting SD, Schlom J, Greiner JW (2008). Exercise enhances vaccine-induced antigen-specific T cell responses. Vaccine  26, 5407-15.   https://doi.org/10.1016/j.vaccine.2008.07.081",https://intramural.nih.gov/search/searchview.taf?ipid=56455
521,BC010972-01,"October 01, 2007 -  September 30, 2008",Identification of human tumor-associated antigens,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Vittore  Cereda|Matteo  Vergati,NULL,"Ira H Pastan; MD (National Cancer Institute)|Tapan K Bera (National Cancer Institute)|Claudia Mercedes Palena (National Cancer Institute)|Philip M Arlen; MD (National Cancer Institute)|James L Gulley; MD, PhD (National Cancer Institute)|Jeffrey  Schlom; PhD (National Cancer Institute)",NULL,"1. Yokokawa J, Cereda V, Remondo C, Gulley JL, Arlen PM, Schlom J, Tsang KY (2008). Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer. Clin Cancer Res  14, 1032-40.   https://doi.org/10.1158/1078-0432.CCR-07-2056",https://intramural.nih.gov/search/searchview.taf?ipid=56530
522,BC010973-01,"October 01, 2007 -  September 30, 2008",Analyses of human T regulatory cells,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Vittore  Cereda|Matteo  Vergati,NULL,"Philip M Arlen; MD (National Cancer Institute)|James L Gulley; MD, PhD (National Cancer Institute)|Jeffrey  Schlom; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56532
523,BC010974-01,"October 01, 2007 -  September 30, 2008",The development of Saccharomyces (yeast) vaccines for cancer therapy,James W Hodge; PhD|IRP Faculty Profile,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Marion G Taylor|Amanda L Boehm; PhD|Jack P Higgins|Anais  Kasten-sportes|Sofia Ribeiro Gameiro,NULL,Jeffrey  Schlom; PhD (National Cancer Institute)|John  Greiner; PhD (National Cancer Institute)|Kenneth W Hance (National Cancer Institute),NULL,"1. Hodge J, Arlen P, Schlom J   (2008) Vaccines and immunostimulants., in Cancer Medicine 8. Kufe D, ed., BC Decker (Philadelphia, PA), in press.|2. Ardiani A, Farsaci B, Rogers CJ, Protter A, Guo Z, King TH, Apelian D, Hodge JW (2013). Combination therapy with a second-generation androgen receptor antagonist and a metastasis vaccine improves survival in a spontaneous prostate cancer model. Clin Cancer Res  19, 6205-18.   https://doi.org/10.1158/1078-0432.CCR-13-1026|3. Ardiani A, Gameiro SR, Palena C, Hamilton DH, Kwilas A, King TH, Schlom J, Hodge JW (2014). Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process. Cancer Res  74, 1945-57.   https://doi.org/10.1158/0008-5472.CAN-13-2045|4. Chakraborty M, Gelbard A, Carrasquillo JA, Yu S, Mamede M, Paik CH, Camphausen K, Schlom J, Hodge JW (2008). Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects. Cancer Immunol Immunother  57, 1173-83.   https://doi.org/10.1007/s00262-008-0449-x|5. Chakraborty M, Wansley EK, Carrasquillo JA, Yu S, Paik CH, Camphausen K, Becker MD, Goeckeler WF, Schlom J, Hodge JW (2008). The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing. Clin Cancer Res  14, 4241-9.   https://doi.org/10.1158/1078-0432.CCR-08-0335|6. Garnett CT, Schlom J, Hodge JW (2008). Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement. Clin Cancer Res  14, 3536-44.   https://doi.org/10.1158/1078-0432.CCR-07-4025|7. Gulley JL, Arlen PM, Tsang KY, Yokokawa J, Palena C, Poole DJ, Remondo C, Cereda V, Jones JL, Pazdur MP, Higgins JP, Hodge JW, Steinberg SM, Kotz H, Dahut WL, Schlom J (2008). Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma. Clin Cancer Res  14, 3060-9.   https://doi.org/10.1158/1078-0432.CCR-08-0126|8. Kwilas AR, Donahue RN, Tsang KY, Hodge JW (2015). Immune consequences of tyrosine kinase inhibitors that synergize with cancer immunotherapy. Cancer Cell Microenviron  2.   https://doi.org/10.14800/ccm.677|9. Remondo C, Cereda V, Mostböck S, Sabzevari H, Franzusoff A, Schlom J, Tsang KY (2009). Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen. Vaccine  27, 987-94.   https://doi.org/10.1016/j.vaccine.2008.12.002",https://intramural.nih.gov/search/searchview.taf?ipid=56634
524,BC010975-01,"October 01, 2007 -  September 30, 2008",Vaccine and radiation for the therapy of human cancers,James W Hodge; PhD|IRP Faculty Profile,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Marion G Taylor|Amanda L Boehm; PhD|Jack P Higgins|Anais  Kasten-sportes|Sofia Ribeiro Gameiro,NULL,Kevin A Camphausen; MD (National Cancer Institute)|Jeffrey  Schlom; PhD (National Cancer Institute),NULL,"1. Hodge J, Arlen P, Schlom J   (2008) Vaccines and immunostimulants., in Cancer Medicine 8. Kufe D, ed., BC Decker (Philadelphia, PA), in press.|2. Bernstein MB, Chakraborty M, Wansley EK, Guo Z, Franzusoff A, Mostböck S, Sabzevari H, Schlom J, Hodge JW (2008). Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells. Vaccine  26, 509-21.   https://doi.org/10.1016/j.vaccine.2007.11.033|3. Garnett CT, Schlom J, Hodge JW (2008). Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement. Clin Cancer Res  14, 3536-44.   https://doi.org/10.1158/1078-0432.CCR-07-4025|4. Gulley JL, Arlen PM, Tsang KY, Yokokawa J, Palena C, Poole DJ, Remondo C, Cereda V, Jones JL, Pazdur MP, Higgins JP, Hodge JW, Steinberg SM, Kotz H, Dahut WL, Schlom J (2008). Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma. Clin Cancer Res  14, 3060-9.   https://doi.org/10.1158/1078-0432.CCR-08-0126|5. Wansley EK, Chakraborty M, Hance KW, Bernstein MB, Boehm AL, Guo Z, Quick D, Franzusoff A, Greiner JW, Schlom J, Hodge JW (2008). Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin Cancer Res  14, 4316-25.   https://doi.org/10.1158/1078-0432.CCR-08-0393",https://intramural.nih.gov/search/searchview.taf?ipid=56636
525,BC010976-01,"October 01, 2007 -  September 30, 2008",Role of MFG-E8 in Tumor Biology ans Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Xu  Feng; PhD|Michael C Lu|Christine A Dewitt; MD|Olga  Milgrom|Sei-Ichiro  Motegi,NULL,James B Mitchell; PhD (National Cancer Institute)|Triantafyllos  Chavakis (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56536
526,BC010977-01,"October 01, 2007 -  September 30, 2008",Cbl Proteins as Regulators of Tyrosine Kinase Signaling,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Marion M Nau|Philip  Ryan|Stephen Charles Kales,NULL,Raul Eduardo Cachau (National Cancer Institute)|Allan M Weissman; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56706
527,BC010978-01,"October 01, 2007 -  September 30, 2008",Confocal Core for the Laboratory of Cellular and Molecular Biology,Valarie  Barr; PhD,Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,"Paul A Randazzo; MD, PhD (National Cancer Institute)|Carole A Parent; PhD (National Cancer Institute)","Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56365
528,BC010980-01,"October 01, 2007 -  September 30, 2008",Identification of Molecular Targets in Triple-Negative Breast Cancer,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Sireesha  Garimella,NULL,Natasha  Caplen (National Cancer Institute)|Jeffrey E Green; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56708
529,BC010981-01,"October 01, 2007 -  September 30, 2008","Design, Develop, Validate, and Implement Biomarkers for Clinical Investigations",Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Yunkai  Yu|Linnia  Mayeenuddin,NULL,William Laurence Dahut; MD (National Cancer Institute)|William D Figg; PharmD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56385
530,BC010982-01,"October 01, 2007 -  September 30, 2008",Collaborative Pathways that Lead to Leukemia,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Christopher  Slape|David L Caudell|Yang-Jo  Chung|Helge  Hartung|David P Harper|Sarah H Beachy; PhD|Show all 8,NULL,"Lino  Tessarollo (National Cancer Institute)|Linda  Wolff; PhD (National Cancer Institute)|Paul S Meltzer; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56357
531,BC010983-01,"October 01, 2007 -  September 30, 2008",Pre-clinical Studies of Therapy for Myelodysplastic Syndrome,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Christopher  Slape|Yang-Jo  Chung|Chul Won  Choi|Sarah H Beachy; PhD|Sheryl Maxine Gough|Rachel  Novak,NULL,Terry J Fry (National Cancer Institute),"Perry Justin Blackshear; MD, DPhil (NIEHS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56358
532,BC010984-01,"October 01, 2007 -  September 30, 2008",Adoptive Cell Transfer Immunotherapy of Cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Mark E Dudley|Richard A Morgan; PhD|John R Wunderlich,NULL,"Marybeth S Hughes (National Cancer Institute)|Udai S Kammula (National Cancer Institute)|James Chung-Yin Yang; MD, PhD (National Cancer Institute)|Nicholas Phillip Restifo; MD (National Cancer Institute)|Richard Eldon Royal (National Cancer Institute)|Richard  Sherry; MD (National Cancer Institute)",NULL,"1. Abad JD, Wrzensinski C, Overwijk W, De Witte MA, Jorritsma A, Hsu C, Gattinoni L, Cohen CJ, Paulos CM, Palmer DC, Haanen JB, Schumacher TN, Rosenberg SA, Restifo NP, Morgan RA (2008). T-cell receptor gene therapy of established tumors in a murine melanoma model. J Immunother  31, 1-6.   https://doi.org/10.1097/CJI.0b013e31815c193f|2. Heemskerk B, Liu K, Dudley ME, Johnson LA, Kaiser A, Downey S, Zheng Z, Shelton TE, Matsuda K, Robbins PF, Morgan RA, Rosenberg SA (2008). Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2. Hum Gene Ther  19, 496-510.   https://doi.org/10.1089/hum.2007.0171|3. Robbins PF, Li YF, El-Gamil M, Zhao Y, Wargo JA, Zheng Z, Xu H, Morgan RA, Feldman SA, Johnson LA, Bennett AD, Dunn SM, Mahon TM, Jakobsen BK, Rosenberg SA (2008). Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions. J Immunol  180, 6116-31.   https://doi.org/10.4049/jimmunol.180.9.6116|4. Wargo JA, Robbins PF, Li Y, Zhao Y, El-Gamil M, Caragacianu D, Zheng Z, Hong JA, Downey S, Schrump DS, Rosenberg SA, Morgan RA (2009). Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression. Cancer Immunol Immunother  58, 383-94.   https://doi.org/10.1007/s00262-008-0562-x|5. Yang S, Cohen CJ, Peng PD, Zhao Y, Cassard L, Yu Z, Zheng Z, Jones S, Restifo NP, Rosenberg SA, Morgan RA (2008). Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition. Gene Ther  15, 1411-23.   https://doi.org/10.1038/gt.2008.90|6. Harris C, Bourdon J, Fujita K, Horikawa I, Lane D, Vojtesek B (submitted in 2008) Therapeutic Applications Of P53 Isoforms In Regenerative Medicine, Aging And Cancer. Patents issued: 8,575,121 (US in 2014); 2008321253 (AU in 2014); 602008038364 (DE in 2015); 2217706 (EP in 2015); 2217706 (FR in 2015); 2217706 (GB in 2015); 9,068,165 (US in 2015); 2705488 (CA in 2018). Patents pending: PCT/US2008/080648 (PC application); 14/754,000 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=56482
533,BC010985-01,"October 01, 2007 -  September 30, 2008",Gene therapy of cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Mark E Dudley|Marybeth S Hughes|Richard A Morgan; PhD|John R Wunderlich,NULL,"Udai S Kammula (National Cancer Institute)|James Chung-Yin Yang; MD, PhD (National Cancer Institute)|Nicholas Phillip Restifo; MD (National Cancer Institute)|Richard Eldon Royal (National Cancer Institute)|Richard  Sherry; MD (National Cancer Institute)",NULL,"1. Breunis WB, Tarazona-Santos E, Chen R, Kiley M, Rosenberg SA, Chanock SJ (2008). Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade. J Immunother  31, 586-90.   https://doi.org/10.1097/CJI.0b013e31817fd8f3|2. Hinrichs CS, Spolski R, Paulos CM, Gattinoni L, Kerstann KW, Palmer DC, Klebanoff CA, Rosenberg SA, Leonard WJ, Restifo NP (2008). IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood  111, 5326-33.   https://doi.org/10.1182/blood-2007-09-113050|3. Klapper JA, Downey SG, Smith FO, Yang JC, Hughes MS, Kammula US, Sherry RM, Royal RE, Steinberg SM, Rosenberg S (2008). High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006. Cancer  113, 293-301.   https://doi.org/10.1002/cncr.23552|4. Palmer DC, Chan CC, Gattinoni L, Wrzesinski C, Paulos CM, Hinrichs CS, Powell DJ, Klebanoff CA, Finkelstein SE, Fariss RN, Yu Z, Nussenblatt RB, Rosenberg SA, Restifo NP (2008). Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity. Proc Natl Acad Sci U S A  105, 8061-6.   https://doi.org/10.1073/pnas.0710929105|5. Powell DJ, Attia P, Ghetie V, Schindler J, Vitetta ES, Rosenberg SA (2008). Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration. J Immunother  31, 189-98.   https://doi.org/10.1097/CJI.0b013e31815dc0e8|6. Rosenberg SA (2008). Why perform sentinel-lymph-node biopsy in patients with melanoma? Nat Clin Pract Oncol  5, 1.   https://doi.org/10.1038/ncponc1022|7. Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME (2008). Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer  8, 299-308.   https://doi.org/10.1038/nrc2355",https://intramural.nih.gov/search/searchview.taf?ipid=56481
534,BC010986-01,"October 01, 2007 -  September 30, 2008",Allele-specific gene expression and epigenetic information,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI",Sheryl A Gere|Mitsutaka  Kadota|Howard H Yang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56690
535,BC010987-01,"October 01, 2007 -  September 30, 2008",Center for Cancer Research Patient Travel,"Frank M Balis; MD, PhD",NULL,"Pediatric Oncology Branch, NCI","Martha B Shaw|Patricia A Klevins|Caryn  Steakley; BA, BSN, MSW",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56515
536,BC010988-01,"October 01, 2007 -  September 30, 2008",Center for Cancer Research Clinical Trials Data Management Service,"Frank M Balis; MD, PhD",NULL,"Pediatric Oncology Branch, NCI","Martha B Shaw|Allison P Wise|Patricia A Klevins|Caryn  Steakley; BA, BSN, MSW",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56516
537,BC010989-01,"October 01, 2007 -  September 30, 2008",Clinical production of viral vectors for cancer gene therapy,Steven A Feldman,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Mary Alexandra Black,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56423
538,BC010990-01,"October 01, 2007 -  September 30, 2008",Radiation Oncology Branch - Radiation Clinic,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Anurag  Singh|Sharon L Smith|John R Mansueti,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56384
539,BC010991-01,"October 01, 2007 -  September 30, 2008",Radiation Oncology Branch - Microarray Facility,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Hailing  Yan|Shuping  Zhao,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56383
540,BC010992-01,"October 01, 2007 -  September 30, 2008",Fidelity of Transcription,Jeffrey N Strathern,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Alison J Rattray|Brenda K Shafer|Deanna R Gotte|Jordan D Irvin|Yan Ning H Zhou|Rita  Grantner,NULL,Stephen H Hughes; PhD (National Cancer Institute)|Mikhail V Kashlev (National Cancer Institute)|Ding Jun Jin (National Cancer Institute),NULL,"1. Santoyo G, Strathern JN (2008). Non-homologous end joining is important for repair of Cr(VI)-induced DNA damage in Saccharomyces cerevisiae. Microbiol Res  163, 113-9.   https://doi.org/10.1016/j.micres.2007.09.001",https://intramural.nih.gov/search/searchview.taf?ipid=56521
541,BC010993-01,"October 01, 2007 -  September 30, 2008",Molecular architecture of lymphocyte cortex,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Jian-Jiang  Hao|Khadija  Ben-aissa|Isaac  Shomer,"E. Michael  Ostap (Pennsylvania Muscle Institute, University of Pennsylvania)|Edward  Weinman (Department of Physiology, University of Maryland School of Medicine)",Michael John Kruhlak; PhD (National Cancer Institute),Rong-Fong  Shen (NHLBI) |Guanghui  Wang; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56496
542,BC010994-01,"October 01, 2007 -  September 30, 2008",Lymphocyte membrane-proximal basophilic kinases,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Yin  Liu,NULL,Alfred  Singer; MD (National Cancer Institute)|Philip J Lucas; PhD (National Cancer Institute),Lauren Redding Brinster (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56493
543,BC010995-01,"October 01, 2007 -  September 30, 2008",ERM phosphorylation in lymphocytes,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Yin  Liu|Natalya  Belkina,NULL,NULL,Alan  Sher; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56494
544,BC010996-01,"October 01, 2007 -  September 30, 2008",Molecular mechanisms of ERM regulation,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Natalya  Belkina|Jian-Jiang  Hao,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56495
545,BC010997-01,"October 01, 2007 -  September 30, 2008",Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells,Itzhak  Avital,NULL,"Surgery Branch, NCI",Hongwu  Xin,NULL,"Paul  Goldsmith; PhD (National Cancer Institute)|Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56361
546,BC010998-01,"October 01, 2007 -  September 30, 2008",Identification of Novel Mutations In Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Young K Song|Patricia S Tsang; PhD|James  Badgett|Xinyu  Wen|Peter  Johansson|Show all 9,NULL,"Paul S Meltzer; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56658
547,BC010999-01,"October 01, 2007 -  September 30, 2008",Characterization of FGFR4 mutations in Rhabdomyosarcoma,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Young K Song|Patricia S Tsang; PhD|Qingrong  Chen,NULL,"Chand  Khanna; MD (Pediatric Oncology Br)|Stephen J Chanock; MD, PhD (National Cancer Institute)|Glenn  Merlino; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56660
548,BC011000-01,"October 01, 2007 -  September 30, 2008",Protein Structure,Byungkook  Lee; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Chin-Hsien  Tai|Changhoon  Kim|Jodi  Basner,NULL,NULL,"Peter Jonathan Munson; BA, MA, PhD (CIT)","1. Goonesekere NC, Lee B (2008). Context-specific amino acid substitution matrices and their use in the detection of protein homologs. Proteins  71, 910-9.   https://doi.org/10.1002/prot.21775|2. Sam V, Tai CH, Garnier J, Gibrat JF, Lee B, Munson PJ (2008). Towards an automatic classification of protein structural domains based on structural similarity. BMC Bioinformatics  9, 74.   https://doi.org/10.1186/1471-2105-9-74",https://intramural.nih.gov/search/searchview.taf?ipid=56686
549,BC011001-01,"October 01, 2007 -  September 30, 2008",Micro RNA Profiling in Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Young K Song|James  Badgett|Qingrong  Chen|Xinyu  Wen|Peter  Johansson|Show all 7,NULL,Malcolm A Smith (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56662
550,BC011002-01,"October 01, 2007 -  September 30, 2008",BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Qingrong  Chen|Xinyu  Wen|Peter  Johansson|Wesley  Beckstead|Xiang  Guo|Natarjan  Ganesan,NULL,Timothy D Veenstra (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56654
551,BC011003-01,"October 01, 2007 -  September 30, 2008",Asymmetric Division and Self Renewal of Cancer Stem Cells,Itzhak  Avital,NULL,"Surgery Branch, NCI",Hongwu  Xin,NULL,"Paul  Goldsmith; PhD (National Cancer Institute)|Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56362
552,BC011004-01,"October 01, 2007 -  September 30, 2008",Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis,Itzhak  Avital,NULL,"Surgery Branch, NCI",Hongwu  Xin,NULL,"Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56363
553,BC011005-01,"October 01, 2007 -  September 30, 2008",Isolation and Purification of Cancer Stem Cells Based on Functional Appraoch,Itzhak  Avital,NULL,"Surgery Branch, NCI",Hongwu  Xin,NULL,"Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56360
554,BC011006-01,"October 01, 2007 -  September 30, 2008",Molecular diagnosis and outcome prediction in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Hong  Zhao|Georg  Lenz|Weihong  Xu,"Elias  Campo (Pathology, University of Barcelona)|John  Chan (Univ. of Nebraska Medical Center)|Joseph  Connors (British Columbia Cancer Agency)|Richard  Fisher (Medicine, University of Rochester School of Medicine)|Randy  Gascoyne (British Columbia Cancer Center)|T. Andrew  Lister (St. Bartholomew Hospital)|Show all 9","Wyndham H Wilson; MD, PhD (National Cancer Institute)|Elaine S Jaffe; MD (National Cancer Institute)",NULL,"1. Staudt L, Braziel R, Campo Guerri E, Chan W, Connors J, Dave S, Delabie J, Fisher R, Gascoyne R, Holte H, Jaffe E, Jares P, Kvaloy S, Lenz G, Lister T, Lopez-guillermo A, Muller-hermelink H, Ott G, Rimsza L, Rosenwald A, Smeland E, Weisenburger D, Wilson W, Wright G (submitted in 2008) Survival Predictor For Diffuse Large B Cell Lymphoma. Patents issued: 2294420 (EP in 2015); 2294420 (ES in 2015); 2294420 (FR in 2015); 2294420 (GB in 2015); 2294420 (IT in 2015); 602009032854 (DE in 2015). Patents pending: 15180558.7 (EP application); PCT/US2009/046421 (PC application); 12/996,489 (US application); 14/540,302 (US application); 2726811 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=56512
555,BC011007-01,"October 01, 2007 -  September 30, 2008",RNA interference-based screens for molecular targets in cancer,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Hong  Zhao|Vu  Ngo|Laurence  Lamy|Yandan  Yang; PhD|Weihong  Xu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56513
556,BC011008-01,"October 01, 2007 -  September 30, 2008",Oncogenic mechanisms and molecular targets in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Arthur L Shaffer|Richard E Davis|Georg  Lenz|Lloyd T Lam|Cailin T Collins,"Elias  Campo (Pathology, University of Barcelona)|John  Chan (Univ. of Nebraska Medical Center)|Joseph  Connors (British Columbia Cancer Agency)|Lenny  Dang (Millennium Pharmaceuticals)|Richard  Fisher (Medicine, University of Rochester School of Medicine)|Randy  Gascoyne (British Columbia Cancer Center)|Show all 10","Wyndham H Wilson; MD, PhD (National Cancer Institute)|Elaine S Jaffe; MD (National Cancer Institute)",NULL,"1. Xie Y, Deng S, Thomas CJ, Liu Y, Zhang YQ, Rinderspacher A, Huang W, Gong G, Wyler M, Cayanis E, Aulner N, Többen U, Chung C, Pampou S, Southall N, Vidović D, Schürer S, Branden L, Davis RE, Staudt LM, Inglese J, Austin CP, Landry DW, Smith DH, Auld DS (2008). Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation. Bioorg Med Chem Lett  18, 329-35.   https://doi.org/10.1016/j.bmcl.2007.10.100",https://intramural.nih.gov/search/searchview.taf?ipid=56510
557,BC011010-01,"October 01, 2007 -  September 30, 2008",Oncogenic mechanisms and molecular targets in myeloma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Arthur L Shaffer|Laurence  Lamy,Bart  Barlogie (Univ. of Arkansas for Medical Sciences)|John  Shaughnessy (Univ. of Arkansas for Medical Sciences),"Walter M Kuehl; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56511
558,BC011011-01,"October 01, 2007 -  September 30, 2008",The genome-wide function of supercoiling and alternative DNA conformations,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Larry  Benjamin|Matthew  Vogt|Ashutosh  Gupta,NULL,"Paul S Meltzer; MD, PhD (National Cancer Institute)",Keji  Zhao; PhD (NHLBI),"1. Kouzine F, Sanford S, Elisha-Feil Z, Levens D (2008). The functional response of upstream DNA to dynamic supercoiling in vivo. Nat Struct Mol Biol  15, 146-54.   https://doi.org/10.1038/nsmb.1372",https://intramural.nih.gov/search/searchview.taf?ipid=56694
559,BC011012-01,"October 01, 2007 -  September 30, 2008",Study of Hepatic Arterial Infusion of Melphalan for Malignancy in the liver,Marybeth S Hughes,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Brian David Emery|Caroline C Webb,NULL,William D Figg; PharmD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56638
560,BC011013-01,"October 01, 2007 -  September 30, 2008",Mesothelin Structural Modeling,Byungkook  Lee; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Bangalore K Sathyanarayana,NULL,Mitchell  Ho (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56688
561,BC011016-01,"October 01, 2007 -  September 30, 2008",Protein Production,Joseph Edward Tropea,Alexander  Wlodawer; PhD,"Macromolecular Crystallography Laboratory, NCI",Scott R Cherry; BS,NULL,Xinhua  Ji; PhD (National Cancer Institute)|David S Waugh; PhD (Protein Engineering Section)|Jacek Tadeusz Lubkowski (National Cancer Institute)|Donald L Court; PhD (National Cancer Institute)|Terrence R Burke; PhD (National Cancer Institute)|Robert  Shoemaker (National Cancer Institute),NULL,"1. Tropea J, Waugh D   (2008) Expression and purification of the soluble His6-tagged TEV protease.  Methods Mol. Biol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=56528
562,BC011017-01,"October 01, 2007 -  September 30, 2008",The study of underlying mechanism of EGFR-Ras signaling in glioblastoma,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Qian  Zhang|Teresa L Sullivan|Terry Anne Van Dyke,NULL,"Karlyne M Reilly; BS, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56540
563,BC011018-01,"October 01, 2007 -  September 30, 2008",Differential Gene Expression and Targeting of Gliomas Using Radiation,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,Kevin A Camphausen; MD (National Cancer Institute),Russell R Lonser; MD (NINDS) |Marsha J Merrill; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56556
564,BC011019-01,"October 01, 2007 -  September 30, 2008",Diffuse Intrinsic Pontine Glioma Genomic Study,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,"Paul S Meltzer; MD, PhD (National Cancer Institute)|Martha Maria Nicacio Quezado; MD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56554
565,BC011020-01,"October 01, 2007 -  September 30, 2008",Cell Production Facility Core,Mark E Dudley,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Azam V Nahvi|Linda L Parker|Thomas E Shelton|Michelle  Pelletier,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56416
566,BC011023-01,"October 01, 2007 -  September 30, 2008",Clinical Fellowship Training Program,Peter A Pinto; MD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Adam R Metwalli|Inger  Rosner|Compton  Benjamin; MD, PhD|Gopal N Gupta|Angelo A Baccala|Ronald S Boris|Show all 10",NULL,"Maria  Merino; PhD (National Cancer Institute)|Peter L Choyke; MD (National Cancer Institute)|Michael R Emmert-Buck; MD, PhD (National Cancer Institute)",Bradford J Wood; MD (CC),"1. Benhammou JN, Vocke CD, Santani A, Schmidt LS, Baba M, Seyama K, Wu X, Korolevich S, Nathanson KL, Stolle CA, Linehan WM (2011). Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome. Genes Chromosomes Cancer  50, 466-77.   https://doi.org/10.1002/gcc.20872|2. Bratslavsky G, Linehan WM (2010). Long-term management of bilateral, multifocal, recurrent renal carcinoma. Nat Rev Urol  7, 267-75.   https://doi.org/10.1038/nrurol.2010.44|3. Bratslavsky G, Linehan WM (2011). Surgery: Routine adrenalectomy in renal cancer--an antiquated practice. Nat Rev Urol  8, 534-6.   https://doi.org/10.1038/nrurol.2011.136|4. Brooks S, Linehan WM, Srinivasan R, Kong HH (2011). Successful laser treatment of vandetanib-associated cutaneous pigmentation. Arch Dermatol  147, 364-5.   https://doi.org/10.1001/archdermatol.2011.30|5. Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K (2011). Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem  57, 411-20.   https://doi.org/10.1373/clinchem.2010.153320|6. Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, Linehan WM, Mannelli M, Friberg P, Grebe SK, Timmers HJ, Bornstein SR, Lenders JW (2011). Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer  18, 97-111.   https://doi.org/10.1677/ERC-10-0211|7. Hong SB, Oh H, Valera VA, Baba M, Schmidt LS, Linehan WM (2010). Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS One  5, e15793.   https://doi.org/10.1371/journal.pone.0015793|8. Hong SB, Oh H, Valera VA, Stull J, Ngo DT, Baba M, Merino MJ, Linehan WM, Schmidt LS (2010). Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling. Mol Cancer  9, 160.   https://doi.org/10.1186/1476-4598-9-160|9. Johann DJ, Wei BR, Prieto DA, Chan KC, Ye X, Valera VA, Simpson RM, Rudnick PA, Xiao Z, Issaq HJ, Linehan WM, Stein SE, Veenstra TD, Blonder J (2010). Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma. Anal Chem  82, 1584-8.   https://doi.org/10.1021/ac902204k|10. Linehan WM, Ricketts CJ (2013). The metabolic basis of kidney cancer. Semin Cancer Biol  23, 46-55.   https://doi.org/10.1016/j.semcancer.2012.06.002|11. Shuch B, Bratslavsky G, Linehan WM, Srinivasan R (2012). Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist  17, 46-54.   https://doi.org/10.1634/theoncologist.2011-0227|12. Shuch B, Bratslavsky G, Shih J, Vourganti S, Finley D, Castor B, Treat E, Linehan WM, Pantuck AJ, Said JW, Belldegrun AS (2012). Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int  109, 1600-6.   https://doi.org/10.1111/j.1464-410X.2011.10785.x|13. Shuch B, Linehan WM, Bratslavsky G (2011). Repeat partial nephrectomy: surgical, functional and oncological outcomes. Curr Opin Urol  21, 368-75.   https://doi.org/10.1097/MOU.0b013e32834964ea|14. Shuch B, Vourganti S, Friend JC, Zehngebot LM, Linehan WM, Srinivasan R (2012). Targeting the mTOR pathway in Chromophobe Kidney Cancer. J Cancer  3, 152-7.   https://doi.org/10.7150/jca.4378|15. Singer EA, Bratslavsky G, Middelton L, Srinivasan R, Linehan WM (2011). Impact of genetics on the diagnosis and treatment of renal cancer. Curr Urol Rep  12, 47-55.   https://doi.org/10.1007/s11934-010-0156-y|16. Singer EA, Gupta GN, Srinivasan R (2012) Targeted therapeutic strategies for the management of renal cell carcinoma. Curr Opin Oncol 24:284-90.|17. Singer EA, Srinivasan R (2012). Intravenous therapies for castration-resistant prostate cancer: toxicities and adverse events. Urol Oncol  30, S15-9.   https://doi.org/10.1016/j.urolonc.2011.09.003|18. Tong WH, Sourbier C, Kovtunovych G, Jeong SY, Vira M, Ghosh M, Romero VV, Sougrat R, Vaulont S, Viollet B, Kim YS, Lee S, Trepel J, Srinivasan R, Bratslavsky G, Yang Y, Linehan WM, Rouault TA (2011). The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels. Cancer Cell  20, 315-27.   https://doi.org/10.1016/j.ccr.2011.07.018|19. Yang Y, Valera V, Sourbier C, Vocke CD, Wei M, Pike L, Huang Y, Merino MA, Bratslavsky G, Wu M, Ricketts CJ, Linehan WM (2012). A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer. Cancer Genet  205, 377-90.   https://doi.org/10.1016/j.cancergen.2012.05.001",https://intramural.nih.gov/search/searchview.taf?ipid=56774
567,BC011024-01,"October 01, 2007 -  September 30, 2008",Tumor and Metastasis Therapy,Chand  Khanna; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",Ling  Ren|Sung-Hyeok  Hong|Joseph  Briggs|Lauren E Buquo|Anita C Epps,NULL,"Lee Jay Helman; MD (National Cancer Institute)|Joseph John Barchi (National Cancer Institute)|Steven  Libutti; MD (National Cancer Institute)|John A Beutler (National Cancer Institute)|Stephen M Hewitt; MD, PhD (National Cancer Institute)|Paul S Meltzer; MD, PhD (National Cancer Institute)",NULL,"1. Guimond M, Freud AG, Mao HC, Yu J, Blaser BW, Leong JW, Vandeusen JB, Dorrance A, Zhang J, Mackall CL, Caligiuri MA (2010). In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. J Immunol  184, 2769-75.   https://doi.org/10.4049/jimmunol.0900685",https://intramural.nih.gov/search/searchview.taf?ipid=56664
568,BC011025-01,"October 01, 2007 -  September 30, 2008",Regulation of RANTES expression in T lymphocytes,Alan M Krensky,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Carol  Clayberger|Donovan Roderick Unks|Byung Joon  Hwang|Dong Seok  Kim; PhD,NULL,NULL,Keji  Zhao; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56674
569,BC011026-01,"October 01, 2007 -  September 30, 2008",Function of granulysin,Alan M Krensky,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Carol  Clayberger|Michael Wehren Finn; PhD|Donovan Roderick Unks|Christine  Wilson,NULL,Joost J Oppenheim; MD (National Cancer Institute),NULL,"1. da Silva AP, Unks D, Lyu SC, Ma J, Zbozien-Pacamaj R, Chen X, Krensky AM, Clayberger C (2008). In vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae. J Antimicrob Chemother  61, 1103-9.   https://doi.org/10.1093/jac/dkn058|2. Zheng CF, Jones GJ, Shi M, Wiseman JC, Marr KJ, Berenger BM, Huston SM, Gill MJ, Krensky AM, Kubes P, Mody CH (2008). Late expression of granulysin by microbicidal CD4+ T cells requires PI3K- and STAT5-dependent expression of IL-2Rbeta that is defective in HIV-infected patients. J Immunol  180, 7221-9.   https://doi.org/10.4049/jimmunol.180.11.7221",https://intramural.nih.gov/search/searchview.taf?ipid=56676
570,BC011027-01,"October 01, 2007 -  September 30, 2008",Animal models to study the role of INK4b loss in human acute myeloid leukemia,Linda  Wolff; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Juraj  Bies|Richard P Koller|Rita  Humeniuk,NULL,Peter D Aplan; MD (National Cancer Institute),NULL,"1. Ko RM, Kim HG, Wolff L, Klug CA (2008). Roles of p15Ink4b and p16Ink4a in myeloid differentiation and RUNX1-ETO-associated acute myeloid leukemia. Leuk Res  32, 1101-11.   https://doi.org/10.1016/j.leukres.2007.10.012|2. Mizuno T, Yamasaki N, Miyazaki K, Tazaki T, Koller R, Oda H, Honda ZI, Ochi M, Wolff L, Honda H (2008). Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice. Oncogene  27, 3465-74.   https://doi.org/10.1038/sj.onc.1211007|3. Rosu-Myles M, Wolff L (2008). p15Ink4b: dual function in myelopoiesis and inactivation in myeloid disease. Blood Cells Mol Dis  40, 406-9.   https://doi.org/10.1016/j.bcmd.2007.09.005",https://intramural.nih.gov/search/searchview.taf?ipid=56596
571,BC011028-01,"October 01, 2007 -  September 30, 2008",Clinical Studies of the Molecular Genetic Basis of Kidney Cancer,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",NULL,NULL,"Steven  Libutti; MD (National Cancer Institute)|Gladys M. Glenn; MD, PhD (National Cancer Institute)|Jorge R Toro (National Cancer Institute)|Wong H Chow (National Cancer Institute)|Leonard  Neckers; PhD (National Cancer Institute)|Donald P Bottaro; PhD (National Cancer Institute)","Karel  Pacak; MD, PhD (NICHD) |Richard  Childs; MD (NHLBI) |Emily Y Chew; MD (NEI) |Pamela  Stratton; MD (NICHD) |Bradford J Wood; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56702
572,BC011029-01,"October 01, 2007 -  September 30, 2008",Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Vicki  Fellowes|David  Justus|Sarah E Lafond,NULL,Nancy M Hardy (National Cancer Institute)|Michael R Bishop; MD (National Cancer Institute)|Daniel H Fowler (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56462
573,BC011030-01,"October 01, 2007 -  September 30, 2008",Peptide Synthesis Core Faciity and Peptide Epitope Identification,Maria  Parkhurst,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",John P Riley,NULL,"Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)|Nicholas Phillip Restifo; MD (National Cancer Institute)|Steven A Feldman (National Cancer Institute)|Richard A Morgan; PhD (National Cancer Institute)|Paul  Robbins (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56772
574,BC011031-01,"October 01, 2007 -  September 30, 2008",Cancer stem cells and human liver cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Timothy V Benjamin|Elizabeth A Conner|Marian E Durkin|Anita  Ton|Joe W Grisham|Daekwan  Seo; PhD, MS, BA|Show all 10",NULL,Valentina  Factor (Cellular and Molecular Biology Section)|Xin Wei Wang; PhD (National Cancer Institute)|Itzhak  Avital (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56526
575,BC011032-01,"October 01, 2007 -  September 30, 2008",Post-translational modifications of Hsp90 that impact drug efficacy,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Wanping  Xu|Shinji  Tsutsumi|Mehdi  Mollapour,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56762
576,BC011033-01,"October 01, 2007 -  September 30, 2008",Mechanisms of MHC Class II Association with Plasma Membrane Microdomains,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Sanjay  Khandelwal|Berta  Bosch Pages,Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering),Lionel  Feigenbaum (Office Of The Director),NULL,"1. Puri N, Roche PA (2008). Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc Natl Acad Sci U S A  105, 2580-5.   https://doi.org/10.1073/pnas.0707854105",https://intramural.nih.gov/search/searchview.taf?ipid=56479
577,BC011034-01,"October 01, 2007 -  September 30, 2008",. Methylation and silencing of human p15INK4b in acute myeloid leukemia,Linda  Wolff; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Jan  Markus|Thomas  Paul,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56598
578,BC011035-01,"October 01, 2007 -  September 30, 2008",Regulation of Exocytosis from Immune Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Even  Walseng|Karis  Faust|Kazuyuki  Furuta,"Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering)|Sidney  Whiteheart (Mol. and Cellular Biochemistry, Univ. of Kentucky)",Lionel  Feigenbaum (Office Of The Director),Katherine Walton Roche; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56478
579,BC011036-01,"October 01, 2007 -  September 30, 2008",NanoBioSensor Initiative,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Belhu  Metaferia; PhD|Peter  Johansson|Jharna  Barman,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56656
580,BC011037-01,"October 01, 2007 -  September 30, 2008",Developing new immunotherapies based of CD4 T cells,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Andrea  Boni|Lydie  Cassard,NULL,NULL,NULL,"1. Abad JD, Wrzensinski C, Overwijk W, De Witte MA, Jorritsma A, Hsu C, Gattinoni L, Cohen CJ, Paulos CM, Palmer DC, Haanen JB, Schumacher TN, Rosenberg SA, Restifo NP, Morgan RA (2008). T-cell receptor gene therapy of established tumors in a murine melanoma model. J Immunother  31, 1-6.   https://doi.org/10.1097/CJI.0b013e31815c193f|2. Hinrichs CS, Spolski R, Paulos CM, Gattinoni L, Kerstann KW, Palmer DC, Klebanoff CA, Rosenberg SA, Leonard WJ, Restifo NP (2008). IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood  111, 5326-33.   https://doi.org/10.1182/blood-2007-09-113050|3. Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, Kaiser A, Paulos CM, Palmer DC, Touloukian CE, Ptak K, Gattinoni L, Wrzesinski C, Hinrichs CS, Kerstann KW, Feigenbaum L, Chan CC, Restifo NP (2008). Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood  112, 362-73.   https://doi.org/10.1182/blood-2007-11-120998|4. Palmer DC, Chan CC, Gattinoni L, Wrzesinski C, Paulos CM, Hinrichs CS, Powell DJ, Klebanoff CA, Finkelstein SE, Fariss RN, Yu Z, Nussenblatt RB, Rosenberg SA, Restifo NP (2008). Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity. Proc Natl Acad Sci U S A  105, 8061-6.   https://doi.org/10.1073/pnas.0710929105|5. Palmer DC, Restifo NP (2009). Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol  30, 592-602.   https://doi.org/10.1016/j.it.2009.09.009|6. Rosenberg SA, Dudley ME, Restifo NP (2008). Cancer immunotherapy. N Engl J Med  359, 1072.   https://doi.org/10.1056/NEJMc081511|7. Roychoudhuri R, Hirahara K, Mousavi K, Clever D, Klebanoff CA, Bonelli M, Sciumè G, Zare H, Vahedi G, Dema B, Yu Z, Liu H, Takahashi H, Rao M, Muranski P, Crompton JG, Punkosdy G, Bedognetti D, Wang E, Hoffmann V, Rivera J, Marincola FM, Nakamura A, Sartorelli V, Kanno Y, et al. [5 more authors] (2013). BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature  498, 506-10.   https://doi.org/10.1038/nature12199|8. Smith FO, Downey SG, Klapper JA, Yang JC, Sherry RM, Royal RE, Kammula US, Hughes MS, Restifo NP, Levy CL, White DE, Steinberg SM, Rosenberg SA (2008). Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines. Clin Cancer Res  14, 5610-8.   https://doi.org/10.1158/1078-0432.CCR-08-0116",https://intramural.nih.gov/search/searchview.taf?ipid=56473
581,BC011038-01,"October 01, 2007 -  September 30, 2008",Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI","Vladmir Alexander Valera Romero; MD, PhD",NULL,"Steven  Libutti; MD (National Cancer Institute)|Gladys M. Glenn; MD, PhD (National Cancer Institute)|Jorge R Toro (National Cancer Institute)|Wong H Chow (National Cancer Institute)|Leonard  Neckers; PhD (National Cancer Institute)|Donald P Bottaro; PhD (National Cancer Institute)","Karel  Pacak; MD, PhD (NICHD) |Richard  Childs; MD (NHLBI) |Emily Y Chew; MD (NEI) |Pamela  Stratton; MD (NICHD) |Bradford J Wood; MD (CC)","1. Butman JA, Linehan WM, Lonser RR (2008). Neurologic manifestations of von Hippel-Lindau disease. JAMA  300, 1334-42.   https://doi.org/10.1001/jama.300.11.1334|2. Finley DS, Narula N, Valera VA, Merino MJ, Fruehauf J, Wu ML, Linehan WM, Clayman RV (2011). Immunohistochemical basis for adjuvant anti-angiogenic targeted therapy for renal carcinoid: initial case report. Urol Oncol  29, 85-9.   https://doi.org/10.1016/j.urolonc.2008.10.017",https://intramural.nih.gov/search/searchview.taf?ipid=56704
582,BC011039-01,"October 01, 2007 -  September 30, 2008",Long distant regulation of c-myb in normal cells and acute myeloid leukemia,Linda  Wolff; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Jan  Markus,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56594
583,BC011040-01,"October 01, 2007 -  September 30, 2008",Molecular Profiling of Clinical Specimens,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",Yonghong  Wang|Audrey N Player|David  Petersen|Robert Peter Chang|Miia  Suuriniemi; PhD|Jonathan Keith Killian|Show all 9,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56420
584,BC011041-01,"October 01, 2007 -  September 30, 2008",Technical Development of Molecular Profiling Technologies,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",Jason  Kralj|Yonghong  Wang|Audrey N Player|David  Petersen|Robert Peter Chang|Miia  Suuriniemi; PhD|Show all 10,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56421
585,BC011042-01,"October 01, 2007 -  September 30, 2008",Global changes in specific histone modifications in cancer,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Alexandra E Kovach|Russell William Bandle|Christopher  Devor,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Katherine Rainsford Calvo (National Cancer Institute)|Elaine S Jaffe; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56692
586,BC011043-01,"October 01, 2007 -  September 30, 2008",Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI","Ramaprasad  Srinivasan; MD, PhD|Gennady  Bratslavsky",NULL,"Gladys M. Glenn; MD, PhD (National Cancer Institute)|Jorge R Toro (National Cancer Institute)|Leonard  Neckers; PhD (National Cancer Institute)|Donald P Bottaro; PhD (National Cancer Institute)|Maria  Merino; PhD (National Cancer Institute)|Peter L Choyke; MD (National Cancer Institute)",David R Davies; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56696
587,BC011044-01,"October 01, 2007 -  September 30, 2008",Clinical Tissue Procurement and Sequencing Core,Cathy  Vocke; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Youfeng  Yang|Catherine  Wells,NULL,"Paul S Meltzer; MD, PhD (National Cancer Institute)|Ester K Rozenblum (National Cancer Institute)|James Chung-Yin Yang; MD, PhD (National Cancer Institute)|William  Farrar (National Cancer Institute)|Stefan  Ambs (National Cancer Institute)|Maria  Merino; PhD (National Cancer Institute)","Karel  Pacak; MD, PhD (NICHD)","1. Vocke C, Bratslavsky G, Linehan W   (2008) Molecular Genetics in Inherited Renal Cell Carcinoma: Identification of  Targets in the Hereditary Syndromes., in Renal Cancer: Molecular Targets & Clinical Applications.  Humana Press, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=56542
588,BC011046-01,"October 01, 2007 -  September 30, 2008",Mechanisms of apoptosis regulation which impede cancer cell death in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI",Jianhui  Yang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56682
589,BC011047-01,"October 01, 2007 -  September 30, 2008",Animal Model and Genotyping Core Support Facility,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI",Marta  Custer|Maudeline  Etienne|Kelly  Nelson|Susan  Walters|Tina M Wellington|Hao The Du|Show all 11,NULL,"Michael  Potter; MD (National Cancer Institute)|J. Frederic Mushinski; MD (National Cancer Institute)|Beverly  Mock; PhD (National Cancer Institute)|Lalage  Wakefield; PhD (National Cancer Institute)|Konrad  Huppi; MD, PhD (National Cancer Institute)|David  Levens; PhD (National Cancer Institute)","Pamela Lee Schwartzberg; MD, PhD (NHGRI) |Alasdair M Gilfillan; PhD (NIAID)","1. Takizawa M, Tolarová H, Li Z, Dubois W, Lim S, Callen E, Franco S, Mosaico M, Feigenbaum L, Alt FW, Nussenzweig A, Potter M, Casellas R (2008). AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J Exp Med  205, 1949-57.   https://doi.org/10.1084/jem.20081007",https://intramural.nih.gov/search/searchview.taf?ipid=56415
590,BC011048-01,"October 01, 2007 -  September 30, 2008",Predictive Biomarkers and Mechanism of Action for Anti-IGF1R Agents for Cancer,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Yunkai  Yu|Linnia  Mayeenuddin,NULL,Lee Jay Helman; MD (National Cancer Institute),NULL,"1. Cao L (2008) Addiction to Elevated Insulin-like Growth Factor I Receptor and Initial Modulation of the AKT Pathway Define the Responsiveness of Rhabdomyosarcoma to the Targeting Antibody. Cancer Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=56386
591,BC011049-01,"October 01, 2007 -  September 30, 2008",Development and evaluation of apoptosis targeted therapies in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI",Jianhui  Yang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56684
592,BC011050-01,"October 01, 2007 -  September 30, 2008",Wnt Antagonist Gene Hypermethylation in Circulating DNA: Cancer Biomarker,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Nancy  Anoruo,"Terri  Burgess (Department Cancer Biology, Amgen)|John  Copland (Mayo Clinic College of Medicine)|Susan  Cottrell (Oncology Research, Amgen, Inc.)","Donald P Bottaro; PhD (National Cancer Institute)|Deborah E Citrin (National Cancer Institute)|Lee Elizabeth Moore; PhD, MD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56483
593,BC011051-01,"October 01, 2007 -  September 30, 2008",Lung Cancer Stem Cell Core,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",Ana  Robles|Lyuba  Varticovski,NULL,NULL,NULL,"1. Barlési F, Giaccone G, Gallegos-Ruiz MI, Span SW, Lefesvre P, Kruyt FA, Rodriguez JA (2008). Genotype analysis of the VNTR polymorphism in the SMYD3 histone methyltransferase gene: lack of correlation with the level of histone H3 methylation in NSCLC tissues or with the risk of NSCLC. Int J Cancer  122, 1441-2.   https://doi.org/10.1002/ijc.23227|2. Eberhard DA, Giaccone G, Johnson BE, Non-Small-Cell Lung Cancer Working Group (2008). Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting. J Clin Oncol  26, 983-94.   https://doi.org/10.1200/JCO.2007.12.9858|3. Gallegos Ruiz MI, Floor K, Roepman P, Rodriguez JA, Meijer GA, Mooi WJ, Jassem E, Niklinski J, Muley T, van Zandwijk N, Smit EF, Beebe K, Neckers L, Ylstra B, Giaccone G (2008). Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target. PLoS One  3, e0001722.   https://doi.org/10.1371/journal.pone.0001722|4. Giaccone G, Zucali PA (2008). Src as a potential therapeutic target in non-small-cell lung cancer. Ann Oncol  19, 1219-23.   https://doi.org/10.1093/annonc/mdn048|5. Giovannetti E, Lemos C, Tekle C, Smid K, Nannizzi S, Rodriguez JA, Ricciardi S, Danesi R, Giaccone G, Peters GJ (2008). Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells. Mol Pharmacol  73, 1290-300.   https://doi.org/10.1124/mol.107.042382|6. Gutierrez M, Giaccone G (2008). Antiangiogenic therapy in nonsmall cell lung cancer. Curr Opin Oncol  20, 176-82.   https://doi.org/10.1097/CCO.0b013e3282f4e55e",https://intramural.nih.gov/search/searchview.taf?ipid=56445
594,BC011052-01,"October 01, 2007 -  September 30, 2008",Cytopathology Core,Armando  Filie,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Patricia A Fetsch|Anna-Maria  Wilder|Keith R Brosky|Dana K Erickson,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56433
595,BC011053-01,"October 01, 2007 -  September 30, 2008",TMPRSS2-ERG chromosomal translocations and prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Orla Majella Casey,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56652
596,BC011054-01,"October 01, 2007 -  September 30, 2008",Nuclear Factor-kappaB in Ovarian Cancer,Christina M Annunziata|IRP Faculty Profile,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Sarah C Hsu|Lidia F Hernandez|James J Driscoll; MD|Jonathan S Gootenberg,NULL,Michael  Birrer (National Cancer Institute)|Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,"1. Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, Lenz G, Hanamura I, Wright G, Xiao W, Dave S, Hurt EM, Tan B, Zhao H, Stephens O, Santra M, Williams DR, Dang L, Barlogie B, Shaughnessy JD, Kuehl WM, Staudt LM (2007). Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell  12, 115-30.   https://doi.org/10.1016/j.ccr.2007.07.004",https://intramural.nih.gov/search/searchview.taf?ipid=56356
597,BC011055-01,"October 01, 2007 -  September 30, 2008",Serum Antibody Profiling with a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Laboratory of Medicinal Chemistry, NCI",Oyindasola O Oyelaran|Qian  Li,NULL,Christoph  Rader; PhD (National Cancer Institute)|Kevin A Camphausen; MD (National Cancer Institute)|Lori E Dodd (Biometrics Research Branch)|Lisa  Mcshane (National Cancer Institute),NULL,"1. Oyelaran O, Gildersleeve JC (2007). Application of carbohydrate array technology to antigen discovery and vaccine development. Expert Rev Vaccines  6, 957-69.   https://doi.org/10.1586/14760584.6.6.957",https://intramural.nih.gov/search/searchview.taf?ipid=56448
598,BC011056-01,"October 01, 2007 -  September 30, 2008",Promoting tumor cell apoptosis by death ligands,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Alan  Brooks|Anil  Shanker|Kristen M Jacobsen,"Mark  Smyth (Cancer Immunology Program, Peter McCallum Cancer Center)|Hideo  Yagita (Immunology, Juntendo University)",NULL,William T Murphy (OD),"1. Hallett WH, Ames E, Motarjemi M, Barao I, Shanker A, Tamang DL, Sayers TJ, Hudig D, Murphy WJ (2008). Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition. J Immunol  180, 163-70.   https://doi.org/10.4049/jimmunol.180.1.163|2. Sayers T (2008). Productively combining proteasome inhibition with the immunotherapy of cancer. J Mol Med (Berl)  86, 857-60.   https://doi.org/10.1007/s00109-008-0384-5|3. Shanker A, Brooks AD, Tristan CA, Wine JW, Elliott PJ, Yagita H, Takeda K, Smyth MJ, Murphy WJ, Sayers TJ (2008). Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody. J Natl Cancer Inst  100, 649-62.   https://doi.org/10.1093/jnci/djn113|4. Sun K, Li M, Sayers TJ, Welniak LA, Murphy WJ (2008). Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation. Blood  112, 1522-9.   https://doi.org/10.1182/blood-2008-03-143461",https://intramural.nih.gov/search/searchview.taf?ipid=56487
599,BC011058-01,"October 01, 2007 -  September 30, 2008",Development of a Vaccine for HIVAIDS: Humoral Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Peng  Xiao; PhD|Jun  Zhao|Lakeisha E Summers|Seraphin  Kuate; PhD|Egidio  Brocca-Cofano|Thorsten  Demberg|Show all 11,"Susan  Barnett (Chiron Corporation)|Willy  Bogers (Biomedical Primate Research Centre)|Barbara  Ensoli (Istituto Superiore di Sanita)|Jonathan  Heeney (University of Cambridge)|David C Montefiori; PhD (Department of Surgery, NIAID)|David  O'Conner (Wisconsin National Primate Research Center)|Show all 8","Barbara K Felber (National Cancer Institute)|George N Pavlakis; MD, PhD (National Cancer Institute)|David J Venzon; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56476
600,BC011059-01,"October 01, 2007 -  September 30, 2008",Biologic Pathway Analysis,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Sharon I Greenblum,NULL,Sol  Efroni (National Cancer Institute)|Carl F Schaefer (National Cancer Institute),NULL,"1. Efroni S, Carmel L, Schaefer CG, Buetow KH (2008). Superposition of transcriptional behaviors determines gene state. PLoS One  3, e2901.   https://doi.org/10.1371/journal.pone.0002901",https://intramural.nih.gov/search/searchview.taf?ipid=56375
601,BC011060-01,"October 01, 2007 -  September 30, 2008",Developing Improved Methods for Modeling and Simulating Protein Structures,Homer Robert Guy; PhD,NULL,"Laboratory of Cell Biology, NCI",Daniel T Flatow|Sijung  Yun|Adina L Milac,"Andriy  Anishkin (Biology, Univ Maryland, College Park)|Sergei  Sukharev (Biology, Univ Maryland, College Park)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56460
602,BC011061-01,"October 01, 2007 -  September 30, 2008",Computational RNA Nanodesign,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Kazimierz Wojcieck Kasprzak|Eckart  Bindewald|Brett  Boyle,"Gregory  Chirikjian (Mechanical Engineering, Johns Hopkins University)|Luc  Jaeger (University of California Santa Barbara)|Robert L Jernigan; PhD (NCI)|Jim  Maher (Biochemistry, Mayo Clinic College of Medicine)|Hugo  Martinez (Consultant, SAIC)|Roderick  Melnik (M2Net Laboratory, Wilfrid Laurier University)",Shu Yun  Le (National Cancer Institute)|Yun  Wang (Nucleic Acid NMR Section)|Victor  Marquez; PhD (National Cancer Institute),NULL,"1. Shapiro B, Geary C, Jaeger L, Bindewald E, Kasprzak W   (2008) Computational and Experimental RNA Nanoparticle Design., in Automation in Genomics and Proteomics: An Engineering Case-Based Approach. Alterovitz G, Ramoni M, Benson R, eds., Wiley Publishing (Hoboken), in press.|2. Shapiro B, Kasprzak W, Yingling Y   (2008) Protocols for the In silico Design of RNA Nanostructures., in Nanostructure Design Methods and Protocols. Gazit E, Nussinov R, eds., Humana Press (Totowa, NJ), pp. 93-115.",https://intramural.nih.gov/search/searchview.taf?ipid=56492
603,BC011062-01,"October 01, 2007 -  September 30, 2008",Development of a Vaccine for HIVAIDS: Cellular Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Peng  Xiao; PhD|Jun  Zhao|Lakeisha E Summers|Seraphin  Kuate; PhD|Egidio  Brocca-Cofano|Thorsten  Demberg|Show all 11,"Satya  Dandekar (University of California, Davis)|Michael G. Katze; PhD (University of Washington)|Norman  Letvin (Harvard University)|David  O'Conner (Wisconsin National Primate Research Center)|Ruth  Ruprecht (Dana Farber Cancer Institute)|David  Weiner (University of Pennsylvania)",David J Venzon; PhD (National Cancer Institute),NULL,"1. Robert-Guroff M, Shiver J   (2008) Replication-defective and competent adenovirus recombinants as vaccine  vectors., in New Generation Vaccines, 4th Edition. Levine M, ed., Informa Healthcare (New York), in press.|2. Robert-Guroff M   (2008) Replicating adenovirus vector prime/protein boost strategies for HIV vaccine  development.  Exp. Opin. Biol. Ther, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=56477
604,BC011063-01,"October 01, 2007 -  September 30, 2008",Development of a Vaccine for HIVAIDS: Translation to the Clinic,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Seraphin  Kuate; PhD|Janet M Dipasquale|Lois Jean Patterson|Rachmat  Hidajat,NULL,NULL,NULL,"1. Robert-Guroff M, Nabel G, Shiver J (2008) Replication-defective and competent adenovirus recombinants as vaccine vectors, in New Generation Vaccines, 4th Edition. Informa Healthcare (New York), in press.|2. Robert-Guroff M, Shiver J   (2008) Replication-defective and competent adenovirus recombinants as vaccine  vectors., in New Generation Vaccines, 4th Edition. Levine M, ed., Informa Healthcare (New York), in press.|3. Robert-Guroff M, Marthas M, Miller C, Duerr A, Cheng-Mayer C, Desrosiers R, Flores J, Haigwood N, Hu S, Johnson R, Lifson J, Montefiori D, Moore J, Robinson H, Self S, Corey L   (2008) The use of nonhuman primate models in HIV vaccine development.  PLos Med, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=56475
605,BC011064-01,"October 01, 2007 -  September 30, 2008",A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Jyoti  Patel|Laura A Roth|Shuling  Zhang; MD, PhD|Richard C Robinson",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56746
606,BC011065-01,"October 01, 2007 -  September 30, 2008",Preclinical Testing of HDAC and mTOR Inhibitors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Shuling  Zhang; MD, PhD|Jyoti  Patel",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56748
607,BC011066-01,"October 01, 2007 -  September 30, 2008",Genetic Pathways Altered by MMTV in Mouse Mammary Tumors,Robert  Callahan; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI",David M Mccurdy|Ahmed M Raafat|Idean  Amirjazil,NULL,Gilbert  Smith; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56382
608,BC011068-01,"October 01, 2007 -  September 30, 2008",Laser Capture Microdissection Core Laboratory,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Rodrigo F Chuaqui,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56422
609,BC011069-01,"October 01, 2007 -  September 30, 2008",Biology of T Cell Depletion,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Joanna L Meadors|Martin  Guimond|Christian  Capitini|Yongzhi  Cui; MD,NULL,Robert  Yarchoan; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56716
610,BC011070-01,"October 01, 2007 -  September 30, 2008",Hematopathology diagnosis and education,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Girish  Venkataraman; MD|Jacquelyn E Grays|Armin G Jegalian; MD, PhD|Haipeng  Shao; MD|Stefania  Pittaluga|Katherine Rainsford Calvo",NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)|Wyndham H Wilson; MD, PhD (National Cancer Institute)|Sam  Hwang; MD, PhD (National Cancer Institute)|Kieron Michael Dunleavy (National Cancer Institute)|Robert  Yarchoan; MD (National Cancer Institute)|Richard  Little; MD, PhD (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Feldman AL, Arber DA, Pittaluga S, Martinez A, Burke JS, Raffeld M, Camos M, Warnke R, Jaffe ES (2008). Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood  111, 5433-9.   https://doi.org/10.1182/blood-2007-11-124792|2. Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM (2008). Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science  319, 1676-9.   https://doi.org/10.1126/science.1153629|3. Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM (2008). Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A  105, 13520-5.   https://doi.org/10.1073/pnas.0804295105|4. Martinez A, Pittaluga S, Rudelius M, Davies-Hill T, Sebasigari D, Fountaine TJ, Hewitt S, Jaffe ES, Raffeld M (2008). Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker. Am J Surg Pathol  32, 1190-200.   https://doi.org/10.1097/PAS.0b013e318166f46a|5. Thieblemont C, Rolland D, Baseggio L, Felman P, Gazzo S, Callet-Bauchu E, Traverse-Glehen A, Houlgatte R, Fu K, Weisenburger D, De Jong D, Jaffe ES, Rosenwald A, Ott G, Coiffier B, Berger F (2008). Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival. Leuk Lymphoma  49, 1403-6.   https://doi.org/10.1080/10428190802094245|6. Young KH, Leroy K, Møller MB, Colleoni GW, Sánchez-Beato M, Kerbauy FR, Haioun C, Eickhoff JC, Young AH, Gaulard P, Piris MA, Oberley TD, Rehrauer WM, Kahl BS, Malter JS, Campo E, Delabie J, Gascoyne RD, Rosenwald A, Rimsza L, Huang J, Braziel RM, Jaffe ES, Wilson WH, Staudt LM, et al. [4 more authors] (2008). Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood  112, 3088-98.   https://doi.org/10.1182/blood-2008-01-129783",https://intramural.nih.gov/search/searchview.taf?ipid=56646
611,BC011071-01,"October 01, 2007 -  September 30, 2008",Molecular Modeling of Ion Channel and Other Membrane Proteins,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Homer Robert Guy; PhD (National Cancer Institute),NULL,"1. Shafrir Y, Durell SR, Guy HR (2008). Models of the structure and gating mechanisms of the pore domain of the NaChBac ion channel. Biophys J  95, 3650-62.   https://doi.org/10.1529/biophysj.108.135327|2. Shafrir Y, Durell SR, Guy HR (2008). Models of voltage-dependent conformational changes in NaChBac channels. Biophys J  95, 3663-76.   https://doi.org/10.1529/biophysj.108.135335",https://intramural.nih.gov/search/searchview.taf?ipid=56417
612,BC011072-01,"October 01, 2007 -  September 30, 2008",Developing Immune Based Therapies,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Hua  Zhang|Christian  Capitini|Jeremy V Edwards,NULL,"Ronald E Gress; MD (National Cancer Institute)|Claude  Sportes (National Cancer Institute)|Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)|Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)|Christoph  Rader; PhD (National Cancer Institute)",NULL,"1. Sportès C, Hakim FT, Memon SA, Zhang H, Chua KS, Brown MR, Fleisher TA, Krumlauf MC, Babb RR, Chow CK, Fry TJ, Engels J, Buffet R, Morre M, Amato RJ, Venzon DJ, Korngold R, Pecora A, Gress RE, Mackall CL (2008). Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med  205, 1701-14.   https://doi.org/10.1084/jem.20071681",https://intramural.nih.gov/search/searchview.taf?ipid=56710
613,BC011073-01,"October 01, 2007 -  September 30, 2008",Immunobiology of Pediatric Tumors,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Aviva  Krauss|Haiying  Qin,NULL,Javed  Khan; MD (National Cancer Institute)|Carol J Thiele (National Cancer Institute)|Maria  Tsokos; MD (National Cancer Institute)|Chand  Khanna; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56712
614,BC011074-01,"October 01, 2007 -  September 30, 2008",Clinical Program in Pediatric Sarcomas,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Donna B Bernstein|Christian  Capitini,NULL,"Lee Jay Helman; MD (National Cancer Institute)|Ronald E Gress; MD (National Cancer Institute)|Michael R Bishop; MD (National Cancer Institute)|Alan S Wayne; MD (National Cancer Institute)|Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)|Maria  Tsokos; MD (National Cancer Institute)",Patrick J Mansky; MD (NCCIH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56714
615,BC011075-01,"October 01, 2007 -  September 30, 2008",Molecular Modeling of the Human P-glycoprotein Transporter Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Homer Robert Guy; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56418
616,BC011076-01,"October 01, 2007 -  September 30, 2008",Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Smitha  Antony|Yongzhong  Wu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56413
617,BC011077-01,"October 01, 2007 -  September 30, 2008",Modeling Molecular of Interactions Regulating the Activity of the p53 Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,NULL,Daniel  Appella; PhD (NIDDK),"1. Bang J, Yamaguchi H, Durell SR, Appella E, Appella DH (2008). A small molecular scaffold for selective inhibition of Wip1 phosphatase. ChemMedChem  3, 230-2.   https://doi.org/10.1002/cmdc.200700281",https://intramural.nih.gov/search/searchview.taf?ipid=56419
618,BC011078-01,"October 01, 2007 -  September 30, 2008",Phase 01 Clinical Trials,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,Joseph E Tomaszewski (National Cancer Institute)|Yves  Pommier; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56414
619,BC011079-01,"October 01, 2007 -  September 30, 2008",Molecular Diagnostics Core Laboratory,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Liqiang  Xi; MD,NULL,NULL,NULL,"1. Hardy NM, Grady C, Pentz R, Stetler-Stevenson M, Raffeld M, Fontaine LS, Babb R, Bishop MR, Caporaso N, Marti GE (2007). Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation. Br J Haematol  139, 824-31.   https://doi.org/10.1111/j.1365-2141.2007.06862.x|2. Manosca F, Schinstine M, Fetsch PA, Sorbara L, Maria Wilder A, Brosky K, Erickson D, Raffeld M, Filie AC, Abati A (2007). Diagnostic effects of prolonged storage on fresh effusion samples. Diagn Cytopathol  35, 6-11.   https://doi.org/10.1002/dc.20587|3. Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, Burek C, Hartmann E, Rudiger T, Jaffe ES, Müller-Hermelink HK, Ott G, Fend F, Rosenwald A (2007). IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol  31, 1605-14.   https://doi.org/10.1097/PAS.0b013e31804bdaf8",https://intramural.nih.gov/search/searchview.taf?ipid=56814
620,BC011080-01,"October 01, 2007 -  September 30, 2008",Clinical Pharmacology of Anticancer Drugs,"Frank M Balis; MD, PhD",NULL,"Pediatric Oncology Branch, NCI",Robert F Murphy|Wendy J Goodspeed|Anne D Goodwin|Nalini M Jayaprakash|Alberta A Aikin|Patricia O Whitcomb|Show all 8,"Eliel  Bayever (Oncology, Johnson & Johnson)|Stacey  Berg (Pediatric Oncology, Baylor Univ.)|Susan  Blaney (Pediatric Oncology, Baylor)|Gregory  Curt (NCI)|Merrill  Egorin (Oncology, Univ of Pittsburgh)|Juan  Tercero (Molecular Medicine, Pharma-Mar)|Show all 7","Kenneth H Kraemer; MD (National Cancer Institute)|Yves  Pommier; PhD (National Cancer Institute)|Antonio  Fojo; MD, PhD (National Cancer Institute)|Wyndham H Wilson; MD, PhD (National Cancer Institute)|Katherine Elizabeth Warren; MD (National Cancer Institute)|Paul S Meltzer; MD, PhD (National Cancer Institute)","Clara Chi Chen; MD (NIDDK) |Danny L Sackett; PhD (NICHD) |John D. Bacher; BS, DVM, MS (OD) |Raphaela  Goldbach-Mansky; MD, MHS (NIAMS)","1. Bernardi RJ, Bomgaars L, Fox E, Balis FM, Egorin MJ, Lagattuta TF, Aikin A, Whitcomb P, Renbarger J, Lieberman FS, Berg SL, Blaney SM (2008). Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis. Cancer Chemother Pharmacol  62, 355-61.   https://doi.org/10.1007/s00280-007-0601-x|2. Fox E, Razzouk BI, Widemann BC, Xiao S, O'Brien M, Goodspeed W, Reaman GH, Blaney SM, Murgo AJ, Balis FM, Adamson PC (2008). Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma. Blood  111, 566-73.   https://doi.org/10.1182/blood-2007-08-107839",https://intramural.nih.gov/search/searchview.taf?ipid=56364
621,BC011081-01,"October 01, 2007 -  September 30, 2008",Prostate Section,Peter A Pinto; MD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Benjamin Robert Mchone|Compton  Benjamin; MD, PhD|Mohamed Awny Atalla|Hal B Hooper",NULL,"Maria  Merino; PhD (National Cancer Institute)|Peter L Choyke; MD (National Cancer Institute)|Michael R Emmert-Buck; MD, PhD (National Cancer Institute)",Bradford J Wood; MD (CC),"1. Singer EA, Srinivasan R (2012). Intravenous therapies for castration-resistant prostate cancer: toxicities and adverse events. Urol Oncol  30, S15-9.   https://doi.org/10.1016/j.urolonc.2011.09.003",https://intramural.nih.gov/search/searchview.taf?ipid=56776
622,BC011082-01,"October 01, 2007 -  September 30, 2008",The National Cancer Institute�s Office of Cancer Genomics,Daniela S Gerhard,NULL,"Office Of The Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56815
623,BC011084-01,"October 01, 2007 -  September 30, 2008",Cellular functions of Ran GTPase,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56648
624,BC011085-01,"October 01, 2007 -  September 30, 2008",Binding Kinetics of LRP Protein with Receptor Related Protein,"Sandra  Smith-Gill; MS, PhD, BS",NULL,"Structural Biophysics Laboratory, NCI",Claudia A Lipschultz|Aranganathan  Shanmuganathan,NULL,Yun  Wang (Nucleic Acid NMR Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56509
625,BC011086-01,"October 01, 2007 -  September 30, 2008",Brain Tumor Animal Therapeutics Core,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Wei  Zhang|Hua  Song,NULL,"Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)",Robert  Innis; MD (NIMH),"1. Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, Zhang W, Bailey R, Maric D, Zenklusen JC, Lee J, Fine HA (2008). Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Res  68, 6643-51.   https://doi.org/10.1158/0008-5472.CAN-08-0850|2. Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, Kotliarova S, Kotliarov Y, Walling J, Ahn S, Kim M, Totonchy M, Cusack T, Ene C, Ma H, Su Q, Zenklusen JC, Zhang W, Maric D, Fine HA (2008). Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell  13, 69-80.   https://doi.org/10.1016/j.ccr.2007.12.005|3. Purow BW, Sundaresan TK, Burdick MJ, Kefas BA, Comeau LD, Hawkinson MP, Su Q, Kotliarov Y, Lee J, Zhang W, Fine HA (2008). Notch-1 regulates transcription of the epidermal growth factor receptor through p53. Carcinogenesis  29, 918-25.   https://doi.org/10.1093/carcin/bgn079",https://intramural.nih.gov/search/searchview.taf?ipid=56437
626,BC011087-01,"October 01, 2007 -  September 30, 2008",Immunohistochemistry Core Laboratory,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Cynthia A Harris|Hong  Jin,NULL,Gisela Esta Sterneck; PhD (National Cancer Institute)|Giovanni  Melillo (National Cancer Institute)|David  Vistica; PhD (National Cancer Institute)|Elaine S Jaffe; MD (National Cancer Institute)|Stefania  Pittaluga (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56780
627,BC011088-01,"October 01, 2007 -  September 30, 2008",Functional genomics of breast cancer,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",Yuelin  Zhu|Ogan D Abaan|Yevgeniy  Gindin|Arthur A Glatfelter; MS|Holly S Stevenson|Fan  Yang|Show all 12,NULL,"Stanley  Lipkowitz; MD, PhD (National Cancer Institute)|Mark E Sherman; MD (National Cancer Institute)|Montserrat  Garcia-Closas; MD, PhD (National Cancer Institute)",NULL,"1. Amundson SA, Do KT, Vinikoor LC, Lee RA, Koch-Paiz CA, Ahn J, Reimers M, Chen Y, Scudiero DA, Weinstein JN, Trent JM, Bittner ML, Meltzer PS, Fornace AJ (2008). Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res  68, 415-24.   https://doi.org/10.1158/0008-5472.CAN-07-2120|2. Fleming JM, Long EL, Ginsburg E, Gerscovich D, Meltzer PS, Vonderhaar BK (2008). Interlobular and intralobular mammary stroma: genotype may not reflect phenotype. BMC Cell Biol  9, 46.   https://doi.org/10.1186/1471-2121-9-46|3. Rahman M, Davis SR, Pumphrey JG, Bao J, Nau MM, Meltzer PS, Lipkowitz S (2009). TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype. Breast Cancer Res Treat  113, 217-30.   https://doi.org/10.1007/s10549-008-9924-5",https://intramural.nih.gov/search/searchview.taf?ipid=56734
628,BC011089-01,"October 01, 2007 -  September 30, 2008",Clinical Nursing and Data Management Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Fanny C Gabela|Donna  Drake|Martha A Ninos|Geri L Hawks|Nana  Yaqub-Ogun|Cris  Leite|Show all 10,NULL,"Steven  Libutti; MD (National Cancer Institute)|Gladys M. Glenn; MD, PhD (National Cancer Institute)|Jorge R Toro (National Cancer Institute)|Donald P Bottaro; PhD (National Cancer Institute)|Maria  Merino; PhD (National Cancer Institute)|Peter L Choyke; MD (National Cancer Institute)","Karel  Pacak; MD, PhD (NICHD) |Richard  Childs; MD (NHLBI) |Emily Y Chew; MD (NEI) |Bradford J Wood; MD (CC) |Russell R Lonser; MD (NINDS)","1. Bratslavsky G, Liu JJ, Johnson AD, Sudarshan S, Choyke PL, Linehan WM, Pinto PA (2008). Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes. J Urol  179, 67-70.   https://doi.org/10.1016/j.juro.2007.08.150|2. Butman JA, Linehan WM, Lonser RR (2008). Neurologic manifestations of von Hippel-Lindau disease. JAMA  300, 1334-42.   https://doi.org/10.1001/jama.300.11.1334|3. Finley DS, Narula N, Valera VA, Merino MJ, Fruehauf J, Wu ML, Linehan WM, Clayman RV (2011). Immunohistochemical basis for adjuvant anti-angiogenic targeted therapy for renal carcinoid: initial case report. Urol Oncol  29, 85-9.   https://doi.org/10.1016/j.urolonc.2008.10.017|4. Johnson A, Sudarshan S, Liu J, Linehan WM, Pinto PA, Bratslavsky G (2008). Feasibility and outcomes of repeat partial nephrectomy. J Urol  180, 89-93; discussion 93.   https://doi.org/10.1016/j.juro.2008.03.030|5. Nickerson ML, Jaeger E, Shi Y, Durocher JA, Mahurkar S, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Schmidt LS, Toro JR, Karami S, Hung R, Gerard GF, Linehan WM, Merino M, Zbar B, Boffetta P, Brennan P, et al. [4 more authors] (2008). Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res  14, 4726-34.   https://doi.org/10.1158/1078-0432.CCR-07-4921|6. Pfaffenroth EC, Linehan WM (2008). Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy. Expert Opin Biol Ther  8, 779-90.   https://doi.org/10.1517/14712598.8.6.779|7. Rogers CG, Singh A, Blatt AM, Linehan WM, Pinto PA (2008). Robotic partial nephrectomy for complex renal tumors: surgical technique. Eur Urol  53, 514-21.   https://doi.org/10.1016/j.eururo.2007.09.047|8. Rosner I, Bratslavsky G, Pinto PA, Linehan WM (2009). The clinical implications of the genetics of renal cell carcinoma. Urol Oncol  27, 131-6.   https://doi.org/10.1016/j.urolonc.2008.11.001|9. Signoretti S, Bratslavsky G, Waldman FM, Reuter VE, Haaga J, Merino M, Thomas GV, Pins MR, Libermann T, Gillespie J, Tomaszewski JE, Compton CC, Hruszkewycz A, Linehan WM, Atkins MB (2008). Tissue-based research in kidney cancer: current challenges and future directions. Clin Cancer Res  14, 3699-705.   https://doi.org/10.1158/1078-0432.CCR-07-4733|10. Singer EA, Gupta GN, Srinivasan R (2012) Targeted therapeutic strategies for the management of renal cell carcinoma. Curr Opin Oncol 24:284-90.|11. Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM (2008). BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet  45, 321-31.   https://doi.org/10.1136/jmg.2007.054304",https://intramural.nih.gov/search/searchview.taf?ipid=56698
629,BC011090-01,"October 01, 2007 -  September 30, 2008",Merkel Cell Carcinoma Polyomavirus,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana,"Yuan  Chang (Cancer Institute, University of Pittsburgh)|Patrick  Moore (Cancer Institute, University of Pittsburgh)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56374
630,BC011091-01,"October 01, 2007 -  September 30, 2008",Cancer Genomics Technology Development,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",Manuel  Valenzuela|Fan  Yang|Ogan D Abaan|Yevgeniy  Gindin|Yuan  Jiang; MD|John R Cornelison|Show all 10,NULL,Gordon Lee Hager; PhD (National Cancer Institute)|Glenn  Merlino; PhD (National Cancer Institute)|Kenneth H Kraemer; MD (National Cancer Institute),Judith L Rapoport; MD (NIMH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56736
631,BC011092-01,"October 01, 2007 -  September 30, 2008",Consult Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI","Peter A Pinto; MD|Ramaprasad  Srinivasan; MD, PhD|Gennady  Bratslavsky",NULL,William Laurence Dahut; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56700
632,BC011093-01,"October 01, 2007 -  September 30, 2008",FLow Cytometric Detection of Malignant Cells in Body Fluids,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Alexander  Ponomarev|Catharine S Mccoy|Linda Shonk Weaver,NULL,"Richard  Little; MD, PhD (National Cancer Institute)|Wyndham H Wilson; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56518
633,BC011094-01,"October 01, 2007 -  September 30, 2008",Detection of Circulating Endothelial Cells,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Catharine S Mccoy,NULL,Steven  Libutti; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56519
634,BC011095-01,"October 01, 2007 -  September 30, 2008",Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Alena  Naumova,NULL,"Ramaprasad  Srinivasan; MD, PhD (National Cancer Institute)|Leonard  Neckers; PhD (National Cancer Institute)|Peter A Pinto; MD (National Cancer Institute)|Tawnya Carlene McKee; BA, PhD (National Cancer Institute)",NULL,"1. Bottaro D, Linehan W (2008) Regulation of Angiogenesis by von Hippel Lindau Protein and Hypoxia Inducible Factor 2, in Angiogenesis: An Integrative Approach from Science to Medicine. Figg W, Folkman J, eds, Springer (Boston), pp. 181-191.|2. Bottaro D, Rubin J (2008) Signaling Networks in Focus: VHL Loss of Function and Its Impact on Oncogenic Signaling Networks in Clear Cell Renal Cell Carcinoma. International Journal of Biochemistry and Cell Biology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=56366
635,BC011098-01,"October 01, 2007 -  September 30, 2008",Brain Tumor Clinical and Clinical Research Program,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Tendai  Kajese|Tracy L Cropper|Mabel  Cruz|Alexandra  Morehouse|Colleen Adris Livingstone|Leslie S Moses|Show all 20,NULL,NULL,NULL,"1. Fine H, Kim L, Moore K, Duic J, Royce C, Stroud I, Garren N, Mackey M, Butman J, Camphausen K, Park J, Albert P (2008) A Phase II Trial of Single Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Patients with Recurrent Glioblastoma. Journal of Clinical Oncology, in press.|2. Li A, Walling J, Ahn S, Kotliarov Y, Su Q, Quezado M, Oberholtzer JC, Park J, Zenklusen JC, Fine HA (2009). Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res  69, 2091-9.   https://doi.org/10.1158/0008-5472.CAN-08-2100",https://intramural.nih.gov/search/searchview.taf?ipid=56438
636,BC011099-01,"October 01, 2007 -  September 30, 2008",Canine Glioma and Embryonic Neural Stem Cell Project,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Kevin D Woolard,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56439
637,BC011100-01,"October 01, 2007 -  September 30, 2008",SCF as a Novel CNS and Glioma-Derived Angiogenic Factor and SC Chemotaxic Factor,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Maureen R Beederman|Kevin D Woolard|Carolyn A Bryant|Galina Ivanovna Belova|Emely  Castro-Rivera|Natalia N Ogurtsova|Show all 19,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56434
638,BC011101-01,"October 01, 2007 -  September 30, 2008",Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Maureen R Beederman|Kevin D Woolard|Carolyn A Bryant|Galina Ivanovna Belova|Emely  Castro-Rivera|Natalia N Ogurtsova|Show all 19,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56435
639,BC011102-01,"October 01, 2007 -  September 30, 2008",The Role of miRNAs in Glioma Stem Cell and Glioma Biology,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Maureen R Beederman|Kevin D Woolard|Carolyn A Bryant|Galina Ivanovna Belova|Emely  Castro-Rivera|Natalia N Ogurtsova|Show all 19,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56436
640,BC011104-01,"October 01, 2007 -  September 30, 2008",Flow Cytometric Evaluation of Biomarkers,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Linda Shonk Weaver,NULL,"Robert J Kreitman; MD, PhD (National Cancer Institute)|Ira H Pastan; MD (National Cancer Institute)|John  Janik; MD (National Cancer Institute)|John Charles Morris; MD (National Cancer Institute)|Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)|Alan S Wayne; MD (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56517
641,BC011105-01,"October 01, 2007 -  September 30, 2008",Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",NULL,NULL,Debananda  Das; PhD (National Cancer Institute)|Hirotomo  Nakata (National Cancer Institute)|Robert  Yarchoan; MD (National Cancer Institute)|David A Davis; MD (National Cancer Institute)|Shintaro  Matsumi (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56742
642,BC011106-01,"October 01, 2007 -  September 30, 2008",Specification of T cell function during development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Stanley  Adoro|Motoko  Kimura|Amala Shenai Alag|Terry I Guinter|Jung-Hyun  Park,Batu M Erman|Sophia D Sarafova (NCI),Lionel  Feigenbaum (Office Of The Director),"Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56507
643,BC011107-01,"October 01, 2007 -  September 30, 2008",Function and Regulation of Scaffold Proteins in Signal Transduction,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Junghwa  Lim|Melissa M Mckay,NULL,Timothy D Veenstra (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56754
644,BC011108-01,"October 01, 2007 -  September 30, 2008",MAP Kinase signal transduction disruption in cancer,Jonathan S Wiest; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Tejaswini Satya Reddi,NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56558
645,BC011109-01,"October 01, 2007 -  September 30, 2008",Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Hirotomo  Nakata|Yasuhiro  Hayashi|Kenji  Maeda|Kiyoto  Tsuchiya|Debananda  Das; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56744
646,BC011110-01,"October 01, 2007 -  September 30, 2008",caBIG Affiliates,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50926
647,BC011111-01,"October 01, 2007 -  September 30, 2008",Cytokine signaling in developing thymocytes and T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Motoko  Kimura|Amala Shenai Alag|Jung-Hyun  Park|Stanley  Adoro,NULL,NULL,NULL,"1. Singer A, Adoro S, Park JH (2008). Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat Rev Immunol  8, 788-801.   https://doi.org/10.1038/nri2416",https://intramural.nih.gov/search/searchview.taf?ipid=56508
648,BC011112-01,"October 01, 2007 -  September 30, 2008",Development and function of regulatory T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Xuguang C Tai|Gil  Katz|Amala Shenai Alag|Terry I Guinter|Jung-Hyun  Park,NULL,Lionel  Feigenbaum (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56504
649,BC011113-01,"October 01, 2007 -  September 30, 2008",T cell survival,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Motoko  Kimura|Xuguang C Tai|Francois  Van Laethem|Amala Shenai Alag|Terry I Guinter|Jung-Hyun  Park,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56505
650,BC011114-01,"October 01, 2007 -  September 30, 2008",Role of microRNAs in T cell development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Amala Shenai Alag|Terry I Guinter|Francois  Van Laethem,NULL,NULL,"Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56506
651,BC011115-01,"October 01, 2007 -  September 30, 2008",Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Julie A Hong|Mahadev  Rao|Mary R Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56489
652,BC011116-01,"October 01, 2007 -  September 30, 2008",MHC-independent T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Amala Shenai Alag|Terry I Guinter|Francois  Van Laethem,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56502
653,BC011117-01,"October 01, 2007 -  September 30, 2008",T cell receptor regulation of cytokine signaling,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Amala Shenai Alag|Terry I Guinter|Gil  Katz,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56503
654,BC011118-01,"October 01, 2007 -  September 30, 2008",Role of Shh in developmental patterning and proliferation of digit skeleton,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Jianjian  Zhu|Junming  Yang,NULL,NULL,Cecilia W. Lo; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56722
655,BC011119-01,"October 01, 2007 -  September 30, 2008",Hoxd gene functions in digit morphogenesis and role of Gli3-Hoxd interaction,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Junming  Yang|Hai  Huang|Aki  Furusawa,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56724
656,BC011120-01,"October 01, 2007 -  September 30, 2008",Genome-wide identification of target promoters of developmental regulators,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Hai  Huang|Junming  Yang,NULL,NULL,Keji  Zhao; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56718
657,BC011121-01,"October 01, 2007 -  September 30, 2008",RNA interference approach to dissect roles of notochord regulators,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Jianjian  Zhu|Junming  Yang,NULL,Mark B Lewandoski (National Cancer Institute)|Terence P Yamaguchi; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56720
658,BC011122-01,"October 01, 2007 -  September 30, 2008",Epigenetic Alterations Induced by Tobacco Smoke,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Maocheng  Yang|Fang  Liu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56490
659,BC011123-01,"October 01, 2007 -  September 30, 2008",Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Alessio  Giubellino,NULL,Ettore  Appella; MD (National Cancer Institute)|Jane Beth Trepel (National Cancer Institute)|Terrence R Burke; PhD (National Cancer Institute)|Peter A Pinto; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56367
660,BC011124-01,"October 01, 2007 -  September 30, 2008",Oncogenic Met Signaling in Urologic Malignancies,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Fabiola  Cecchi|Alena  Naumova,"Stuart  Aaronson (Research, Mount Sinai Medical Center)|Teresa  Burgess (Preclinical Development, Amgen)|Ascoli  Carl (Clinical Development Oncology, Rockland Immunologicals, Inc)|James  Christensen (Oncology Research, Pfizer)|Angela  Coxon (Amgen)|Regina  Day (NCI)|Show all 25","Laura  Schmidt (National Cancer Institute)|Maria  Merino; PhD (National Cancer Institute)|Patricia  Steeg; PhD (National Cancer Institute)|Kevin A Camphausen; MD (National Cancer Institute)|Cathy  Vocke; PhD (National Cancer Institute)|Ramaprasad  Srinivasan; MD, PhD (National Cancer Institute)",NULL,"1. Bottaro D, Linehan W (2008) Regulation of Angiogenesis by von Hippel Lindau Protein and Hypoxia Inducible Factor 2, in Angiogenesis: An Integrative Approach from Science to Medicine. Figg W, Folkman J, eds, Springer (Boston), pp. 181-191.",https://intramural.nih.gov/search/searchview.taf?ipid=56368
661,BC011125-01,"October 01, 2007 -  September 30, 2008",Inhibition of Type 1 Interferon During SIV Infection,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Anna  Hryniewicz|Wen-Po  Tsai|Vibeke  Andresen|Shari  Gordon; PhD,"Jacob D Estes (Office Of The Director)|Ashley  Haase (Microbiology, Columbia College of Physicians and Surgeons)|Chris  Miller; MS",Gene  Shearer; PhD (National Cancer Institute)|Adriano  Boasso (National Cancer Institute)|Howard A Young; PhD (National Cancer Institute)|Giorgio  Trinchieri (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56443
662,BC011126-01,"October 01, 2007 -  September 30, 2008",Preventive Vaccines for HIV,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Anna  Hryniewicz|Melvin Nelson Doster|Lorenzo  Zaffiri|Wen-Po  Tsai|Monica  Vaccari|Izabela  Bialuk,"Dan  Barouch (Harvard University)|Donald  Forthal (School of Medicine, Univ of CA)|Ditemar  Fuchs (Innsbruck Medical University)|Ashley  Haase (Microbiology, Columbia College of Physicians and Surgeons)|Chris  Miller; MS|Eckhard  Podack (Department of Microbiology, University of Miami)|Show all 7",Marjorie  Robert-Guroff; PhD (National Cancer Institute)|Christopher  Buck (National Cancer Institute)|Jeffrey  Roberts (National Cancer Institute)|John  Schiller; PhD (National Cancer Institute),"Nancy R Miller (NIAID) |Vanessa  Hirsch (NIAID) |Barney S Graham; MD, PhD (NIAID)","1. Franchini G, Boasso A, Ma Z, Cecchinato V, Venzon D, Doster M, Tsai W, Shearer G, Fuchs D, Felber B, Pavlakis G, Miller J (2008) CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIVmac251 infection. Mucosal Immunology Online.|2. Kaufman DR, Goudsmit J, Holterman L, Ewald BA, Denholtz M, Devoy C, Giri A, Grandpre LE, Heraud JM, Franchini G, Seaman MS, Havenga MJ, Barouch DH (2008). Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice. J Virol  82, 6829-37.   https://doi.org/10.1128/JVI.00353-08|3. Vaccari M, Mattapallil J, Song K, Tsai WP, Hryniewicz A, Venzon D, Zanetti M, Reimann KA, Roederer M, Franchini G (2008). Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency. J Virol  82, 9629-38.   https://doi.org/10.1128/JVI.00893-08",https://intramural.nih.gov/search/searchview.taf?ipid=56442
663,BC011127-01,"October 01, 2007 -  September 30, 2008",Structural Biology of the Antitermination Process Regulating Transcription,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Amanda S Altieri; PhD|Jess R Li|Ranabir  Das,NULL,Donald L Court; PhD (National Cancer Institute)|Xinhua  Ji; PhD (National Cancer Institute),NULL,"1. Das R, Loss S, Li J, Waugh DS, Tarasov S, Wingfield PT, Byrd RA, Altieri AS (2008). Structural biophysics of the NusB:NusE antitermination complex. J Mol Biol  376, 705-20.   https://doi.org/10.1016/j.jmb.2007.11.022",https://intramural.nih.gov/search/searchview.taf?ipid=56380
664,BC011129-01,"October 01, 2007 -  September 30, 2008",Structural Biology of an Antiviral Entry Inhibitor,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Jess R Li|Robert L Mcfeeters,NULL,Barry R O'Keefe (National Cancer Institute),NULL,"1. McFeeters RL, Xiong C, O'Keefe BR, Bokesch HR, McMahon JB, Ratner DM, Castelli R, Seeberger PH, Byrd RA (2007). The novel fold of scytovirin reveals a new twist for antiviral entry inhibitors. J Mol Biol  369, 451-61.   https://doi.org/10.1016/j.jmb.2007.03.030",https://intramural.nih.gov/search/searchview.taf?ipid=56377
665,BC011130-01,"October 01, 2007 -  September 30, 2008",Investigation of the Hepatocyte Growth FactorMet Pathway,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,NULL,Donald P Bottaro; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56378
666,BC011131-01,"October 01, 2007 -  September 30, 2008",Investigation of Protein-protein interactions in the ERAD ubiquitylation pathway,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Amanda S Altieri; PhD|Jess R Li|Ranabir  Das,NULL,Allan M Weissman; MD (National Cancer Institute)|Xinhua  Ji; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56379
667,BC011132-01,"October 01, 2007 -  September 30, 2008",Methods Development,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Jess R Li|Catherine L Deatherage,NULL,Yun  Wang (Nucleic Acid NMR Section),John J Kuszewski; PhD (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56376
668,BC011135-01,"October 01, 2007 -  September 30, 2008",Molecular Mechanism of Lymphomagenesis,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Yoko  Tabe,NULL,Stefania  Pittaluga (National Cancer Institute),NULL,"1. Raffeld M, Sebasigari D, Jin L, Rudelius M, Theresa D, Miyake K, Miida T, Pittaluga S   (2008) The MDM2 Antagonist Nutlin-3 Displays Anti-Proliferative and Pro-Apoptotic  Activity in Mantle Cell Lymphoma.  Clinical Cancer Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=56782
669,BC011138-01,"October 01, 2007 -  September 30, 2008",FACS Core Facility,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Veena N Kapoor|Nga  Voong,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56784
670,BC011139-01,"October 01, 2007 -  September 30, 2008",Application of novel laser technology for flow cytometric analysis.,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Veena N Kapoor,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56786
671,CP000101-04,"October 01, 2007 -  September 30, 2008",Human Studies of Diet and Nutrition,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,NULL,Blossom  Patterson (Biometry Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51005
672,CP000112-04,"October 01, 2007 -  September 30, 2008",Nutrition Intervention Trials in Linxian China,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile  |Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,NULL,Farin  Kamangar (Nutritional Epidemiology Branch)|Mark J Roth (Nutritional Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51003
673,CP000150-04,"October 01, 2007 -  September 30, 2008",UGI Cancer Genetic Studies,"Sanford Martin Dawsey; MD|IRP Faculty Profile  | |Alisa  Goldstein; PhD|IRP Faculty Profile  |Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI","Chaoyu C Wang|David  Ng; AB, MD",NULL,"Christian Cormac Abnet; PhD, MPH (Nutritional Epidemiology Branch)|Mark J Roth (Nutritional Epidemiology Branch)|Maxwell P Lee; PhD (Laboratory of Population Genetics)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,"1. Li WQ, Hu N, Burton VH, Yang HH, Su H, Conway CM, Wang L, Wang C, Ding T, Xu Y, Giffen C, Abnet CC, Goldstein AM, Hewitt SM, Taylor PR (2014). PLCE1 mRNA and protein expression and survival of patients with esophageal squamous cell carcinoma and gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev  23, 1579-1588.   https://doi.org/10.1158/1055-9965.EPI-13-1329|2. Yang H, Taylor P, Lee M, Wang C, Ng D, Hu N (2008) A statistical reappraisal of the findings of an Esophageal cancer  genome-wide association study-Response (Letter). Cancer Res 3075-3075.",https://intramural.nih.gov/search/searchview.taf?ipid=51004
674,CP000176-04,"October 01, 2007 -  September 30, 2008",Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,NULL,Ping  Hu; MS (Biometry Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51006
675,CP000185-04,"October 01, 2007 -  September 30, 2008",Upper Gastrointestinal Cancer Studies,Sanford Martin Dawsey; MD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",Farin  Kamangar|Mark J Roth|Neal David Freedman,NULL,Edward L Korn (Clinical Trials Section),NULL,"1. (2008) Cytologic detection of esophageal squamous cell carcinoma and its precursor lesions using balloon samplers and liquid-based cytology in asymptomatic adults in Linxian, China. Acta Cytol 52:14-23.|2. (2008) Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. BRIT J CANCER 98:1857-1863.|3. (2008) Promoter Methylation in Balloon Cytology Specimens as an Early Detection Marker for Esophageal Squamous Dysplasia and Early Esophageal Squamous Cell Carcinoma. Cancer Prevention Research 1:357-61.|4. Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, Merat S, Pourshams A, Marjani HA, Ebadati A, Sotoudeh M, Boffetta P, Malekzadeh R, Dawsey SM (2008). Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev  17, 3062-8.   https://doi.org/10.1158/1055-9965.EPI-08-0558|5. Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Islami F, Li S, Zandvakili I, Shakeri R, Sotoudeh M, Aghcheli K, Salahi R, Pourshams A, Semnani S, Boffetta P, Dawsey SM, Ghadirian P, Narod SA (2008). Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma. Oncogene  27, 1290-6.   https://doi.org/10.1038/sj.onc.1210739|6. Dawsey S (2008) Germline BRCA2 mutations and the risk of esophageal squamous cell  carcinoma. Oncogene 1290-1296.|7. Dawsey SP, Roth MJ, Adams L, Hu N, Wang QH, Taylor PR, Woodson K (2008). COX-2 (PTGS2) gene methylation in epithelial, subepithelial lymphocyte and stromal tissue compartments in a spectrum of esophageal squamous neoplasia. Cancer Detect Prev  32, 135-9.   https://doi.org/10.1016/j.cdp.2008.05.001|8. Kamangar F (2008) Dietary intake of benzo(a)pyrene and risk of esophageal cancer in  North of Iran. Archives of Iranian Medicine 216-221.|9. Kamangar F (2008) Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a  meta-analysis. Int J Epidemiol 1443-1451.|10. Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, Shakeri R, Pourshams A, Marjani HA, Nouraie M, Khatibian M, Semnani S, Ye W, Boffetta P, Dawsey SM, Malekzadeh R (2008). Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer  98, 1857-63.   https://doi.org/10.1038/sj.bjc.6604369|11. Pan QJ, Roth MJ, Guo HQ, Kochman ML, Wang GQ, Henry M, Wei WQ, Giffen CA, Lu N, Abnet CC, Hao CQ, Taylor PR, Qiao YL, Dawsey SM (2008). Cytologic detection of esophageal squamous cell carcinoma and its precursor lesions using balloon samplers and liquid-based cytology in asymptomatic adults in Llinxian, China. Acta Cytol  52, 14-23.   https://doi.org/10.1159/000325430|12. Shou JZ, Hu N, Takikita M, Roth MJ, Johnson LL, Giffen C, Wang QH, Wang C, Wang Y, Su H, Kong LH, Emmert-Buck MR, Goldstein AM, Hewitt SM, Taylor PR (2008). Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell carcinomas and premalignant lesions in subjects from a high-risk population in China. Cancer Epidemiol Biomarkers Prev  17, 1424-35.   https://doi.org/10.1158/1055-9965.EPI-06-0666",https://intramural.nih.gov/search/searchview.taf?ipid=51007
676,CP004410-32,"October 01, 2007 -  September 30, 2008",Family Studies,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Alisa  Goldstein; PhD|IRP Faculty Profile  | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  |Jorge R Toro| | |Margaret Anne Tucker|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI","David  Ng; AB, MD|Dilys  Parry; PhD|Gladys M. Glenn; MD, PhD|Mary C Fraser|Mary Louise McMaster; MD|Xiaohong Rose Yang; PhD|Show all 7",NULL,June  Peters (Clinical Genetics Branch)|Kenneth H Kraemer; MD (DNA Repair Section),NULL,"1. Abbasi F, Longo NS, Lipsky PE, Raveche E, Schleinitz TA, Stetler-Stevenson M, Caporaso N, Marti G (2007). B-cell repertoire and clonal analysis in unaffected first degree relatives in familial chronic lymphocytic leukaemia kindred. Br J Haematol  139, 820-3.   https://doi.org/10.1111/j.1365-2141.2007.06857.x|2. Goldin LR, Caporaso NE (2007). Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours. Br J Haematol  139, 774-9.   https://doi.org/10.1111/j.1365-2141.2007.06810.x|3. Kristinsson SY, Fears TR, Gridley G, Turesson I, Mellqvist UH, Björkholm M, Landgren O (2008). Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Blood  112, 3582-6.   https://doi.org/10.1182/blood-2008-04-151076|4. McMaster ML, Caporaso N (2007). Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition. Br J Haematol  139, 663-71.   https://doi.org/10.1111/j.1365-2141.2007.06845.x|5. McMaster ML, Csako G (2008). Protein electrophoresis, immunoelectrophoresis and immunofixation electrophoresis as predictors for high-risk phenotype in familial Waldenström macroglobulinemia. Int J Cancer  122, 1183-8.   https://doi.org/10.1002/ijc.23229|6. Stewart L, Glenn GM, Stratton P, Goldstein AM, Merino MJ, Tucker MA, Linehan WM, Toro JR (2008). Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer. Arch Dermatol  144, 1584-92.   https://doi.org/10.1001/archdermatol.2008.517|7. Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM (2008). BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet  45, 321-31.   https://doi.org/10.1136/jmg.2007.054304|8. Tucker MA (2008). Is sunlight important to melanoma causation? Cancer Epidemiol Biomarkers Prev  17, 467-8.   https://doi.org/10.1158/1055-9965.EPI-07-2743",https://intramural.nih.gov/search/searchview.taf?ipid=50964
677,CP005782-14,"October 01, 2007 -  September 30, 2008",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,NULL,"Kai  Yu (Biostatistics Branch)|Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,"1. Bacchetti P, Tien PC, Seaberg EC, O'Brien TR, Augenbraun MH, Kral AH, Busch MP, Edlin BR (2007). Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression. BMC Infect Dis  7, 145.   https://doi.org/10.1186/1471-2334-7-145|2. Brown EE, Zhang M, Zarin-Pass R, Bernig T, Tseng FC, Xiao N, Yeager M, Edlin BR, Chanock SJ, O'Brien TR (2008). MBL2 and hepatitis C virus infection among injection drug users. BMC Infect Dis  8, 57.   https://doi.org/10.1186/1471-2334-8-57|3. Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan SM, Flanders WD, Higgins JP, McCarthy MI, McDermott DH, Page GP, Rebbeck TR, Seminara D, Khoury MJ (2008). Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol  37, 120-32.   https://doi.org/10.1093/ije/dym159|4. Mizukoshi E, Eisenbach C, Edlin BR, Newton KP, Raghuraman S, Weiler-Normann C, Tobler LH, Busch MP, Carrington M, McKeating JA, O'Brien TR, Rehermann B (2008). Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. J Infect Dis  198, 203-12.   https://doi.org/10.1086/589510|5. Page-Shafer K, Pappalardo BL, Tobler LH, Phelps BH, Edlin BR, Moss AR, Wright TL, Wright DJ, O'Brien TR, Caglioti S, Busch MP (2008). Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol  46, 499-506.   https://doi.org/10.1128/JCM.01229-07|6. Truelove AL, Oleksyk TK, Shrestha S, Thio CL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ, Smith MW (2008). Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Int J Immunogenet  35, 255-64.   https://doi.org/10.1111/j.1744-313X.2008.00770.x|7. Tseng FC, Edlin BR, Zhang M, Kral A, Busch MP, Ortiz-Conde BA, Welzel TM, O'Brien TR (2008). The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use. J Viral Hepat  15, 690-8.   https://doi.org/10.1111/j.1365-2893.2008.01005.x",https://intramural.nih.gov/search/searchview.taf?ipid=50963
678,CP005803-14,"October 01, 2007 -  September 30, 2008",Genetic Epidemiology,Alisa  Goldstein; PhD|IRP Faculty Profile,NULL,"Genetic Epidemiology Branch, NCI","David  Ng; AB, MD|Dilys  Parry; PhD|Gladys M. Glenn; MD, PhD|Jorge R Toro|Lynn Rachel Goldin; PhD|Maria Teresa Pia Landi; MD, PhD|Show all 12",NULL,"Gloria L Gridley (Biostatistics Branch)|Margaret Anne Tucker (Human Genetics Program)|Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)",NULL,"1. Gao Y, Linet MS, Gridley G, Mellemkjaer L, Hemminki K, Goldin LR, Landgren O (2008). Shared susceptibility for celiac disease and inflammatory bowel disease? Scand J Gastroenterol  43, 1279-80.   https://doi.org/10.1080/00365520802158630|2. Landgren O, Caporaso NE (2007). New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin's lymphoma. Hematol Oncol Clin North Am  21, 825-40.   https://doi.org/10.1016/j.hoc.2007.07.001|3. Landgren O, Goldin LR, Kristinsson SY, Helgadottir EA, Samuelsson J, Björkholm M (2008). Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden. Blood  112, 2199-204.   https://doi.org/10.1182/blood-2008-03-143602|4. Landgren O, Kyle RA (2007). Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases. Br J Haematol  139, 717-23.   https://doi.org/10.1111/j.1365-2141.2007.06866.x|5. Landgren O, Tilly H (2008). Epidemiology, pathology and treatment of non-follicular indolent lymphomas. Leuk Lymphoma  49 Suppl 1, 35-42.   https://doi.org/10.1080/10428190802311425|6. Linet M, Engels E, Gridley G, Landgren O, Pfeiffer R, Goldin L (2008) Autoimmune disease in individuals and close family members and  susceptibility to non-Hodgkin's lymphoma. Arthritis Rheum 657-666.|7. Mellemkjaer L, Pfeiffer RM, Engels EA, Gridley G, Wheeler W, Hemminki K, Olsen JH, Dreyer L, Linet MS, Goldin LR, Landgren O (2008). Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis Rheum  58, 657-66.   https://doi.org/10.1002/art.23267|8. Moschovi M, Stavrou T, Dessypris N, Skalkidis I, Karalis D, Reaman GH, Goldstein AM, Prodromou N, Tzortzatou-Stathopoulou F, Petridou ET (2007). Survival among children with medulloblastoma in Greece: gains from transition to chemotherapy and socio-economic differentials. Eur J Cancer Prev  16, 460-5.   https://doi.org/10.1097/01.cej.0000243848.74609.9a|9. Turesson I, Linet MS, Björkholm M, Kristinsson SY, Goldin LR, Caporaso NE, Landgren O (2007). Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. Int J Cancer  121, 2260-6.   https://doi.org/10.1002/ijc.22912|10. Wild P, Andrieu N, Goldstein AM, Schill W (2008). Flexible Two-Phase studies for rare exposures: Feasibility, planning and efficiency issues of a new variant. Epidemiol Perspect Innov  5, 4.   https://doi.org/10.1186/1742-5573-5-4|11. Yang H, Taylor P, Lee M, Wang C, Ng D, Hu N (2008) A statistical reappraisal of the findings of an Esophageal cancer  genome-wide association study-Response (Letter). Cancer Res 3075-3075.|12. Yang XR, Pfeiffer RM, Garcia-Closas M, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Cartun RW, Mandich D, Sasano H, Evans DB, Sutter TR, Sherman ME (2007). Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study. Cancer Res  67, 10608-17.   https://doi.org/10.1158/0008-5472.CAN-07-2142",https://intramural.nih.gov/search/searchview.taf?ipid=50962
679,CP005804-14,"October 01, 2007 -  September 30, 2008",Pharmacogenetic Studies,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI","Alisa  Goldstein; PhD|Lynn Rachel Goldin; PhD|Maria Teresa Pia Landi; MD, PhD",NULL,Margaret Anne Tucker (Human Genetics Program)|Anil Kumar Chaturvedi (Infection & Immunoepidemiology Branch),NULL,"1. Landgren O, Katzmann JA, Hsing AW, Pfeiffer RM, Kyle RA, Yeboah ED, Biritwum RB, Tettey Y, Adjei AA, Larson DR, Dispenzieri A, Melton LJ, Goldin LR, McMaster ML, Caporaso NE, Rajkumar SV (2007). Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc  82, 1468-73.   https://doi.org/10.1016/S0025-6196(11)61089-6|2. Landi MT, Consonni D, Rotunno M, Bergen AW, Goldstein AM, Lubin JH, Goldin L, Alavanja M, Morgan G, Subar AF, Linnoila I, Previdi F, Corno M, Rubagotti M, Marinelli B, Albetti B, Colombi A, Tucker M, Wacholder S, Pesatori AC, Caporaso NE, Bertazzi PA (2008). Environment And Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health  8, 203.   https://doi.org/10.1186/1471-2458-8-203",https://intramural.nih.gov/search/searchview.taf?ipid=50961
680,CP010119-13,"October 01, 2007 -  September 30, 2008",Studies of Occupational Cancer (Pesticides),Michael  Alavanja; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Debra  Silverman; ScD, ScM|Gabriella  Andreotti|Joanne S Colt|Kenneth  Cantor; PhD|Mary Helen Ward; MS, PhD|Show all 8",NULL,"Jay  Lubin; PhD (Biostatistics Branch)|Ola Anders Landgren (Genetic Epidemiology Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Shelia K Zahm; ScM, ScD (Office of the Director)",NULL,"1. Alavanja M (2008) Personal and family medical history correlates of rheumatoid  arthritis. Ann Epidemiol (Epub) na.|2. Beseler CL, Stallones L, Hoppin JA, Alavanja MC, Blair A, Keefe T, Kamel F (2008). Depression and pesticide exposures among private pesticide applicators enrolled in the Agricultural Health Study. Environ Health Perspect  116, 1713-9.   https://doi.org/10.1289/ehp.11091|3. Bonner MR, Coble J, Blair A, Beane Freeman LE, Hoppin JA, Sandler DP, Alavanja MC (2007). Malathion exposure and the incidence of cancer in the agricultural health study. Am J Epidemiol  166, 1023-34.   https://doi.org/10.1093/aje/kwm182|4. Coble J, Alavanja M, Lubin J, Blair A, Beane Freeman L (2008) Cancer incidence among pesticide applicators exposed to trifluralin  in the Agricultural Health Study. Environ Res (epub) na.|5. Crawford JM, Hoppin JA, Alavanja MC, Blair A, Sandler DP, Kamel F (2008). Hearing loss among licensed pesticide applicators in the agricultural health study. J Occup Environ Med  50, 817-26.   https://doi.org/10.1097/JOM.0b013e31816a8caf|6. Curwin BD, Hein MJ, Sanderson WT, Striley C, Heederik D, Kromhout H, Reynolds SJ, Alavanja MC (2007). Pesticide dose estimates for children of Iowa farmers and non-farmers. Environ Res  105, 307-15.   https://doi.org/10.1016/j.envres.2007.06.001|7. de Roos AJ, Cooper GS, Alavanja MC, Sandler DP (2008). Personal and family medical history correlates of rheumatoid arthritis. Ann Epidemiol  18, 433-9.   https://doi.org/10.1016/j.annepidem.2007.12.011|8. Hoppin JA, Umbach DM, London SJ, Henneberger PK, Kullman GJ, Alavanja MC, Sandler DP (2008). Pesticides and atopic and nonatopic asthma among farm women in the Agricultural Health Study. Am J Respir Crit Care Med  177, 11-8.   https://doi.org/10.1164/rccm.200706-821OC|9. Hoppin JA, Valcin M, Henneberger PK, Kullman GJ, Umbach DM, London SJ, Alavanja MC, Sandler DP (2007). Pesticide use and chronic bronchitis among farmers in the Agricultural Health Study. Am J Ind Med  50, 969-79.   https://doi.org/10.1002/ajim.20523|10. Kang D, Park SK, Beane-Freeman L, Lynch CF, Knott CE, Sandler DP, Hoppin JA, Dosemeci M, Coble J, Lubin J, Blair A, Alavanja M (2008). Cancer incidence among pesticide applicators exposed to trifluralin in the Agricultural Health Study. Environ Res  107, 271-6.   https://doi.org/10.1016/j.envres.2008.01.010|11. Mozzachio AM, Rusiecki JA, Hoppin JA, Mahajan R, Patel R, Beane-Freeman L, Alavanja MC (2008). Chlorothalonil exposure and cancer incidence among pesticide applicator participants in the agricultural health study. Environ Res  108, 400-3.   https://doi.org/10.1016/j.envres.2008.07.018|12. van Bemmel DM, Visvanathan K, Beane Freeman LE, Coble J, Hoppin JA, Alavanja MC (2008). S-ethyl-N,N-dipropylthiocarbamate exposure and cancer incidence among male pesticide applicators in the agricultural health study: a prospective cohort. Environ Health Perspect  116, 1541-6.   https://doi.org/10.1289/ehp.11371",https://intramural.nih.gov/search/searchview.taf?ipid=50956
681,CP010120-13,"October 01, 2007 -  September 30, 2008",Studies of Occupational Cancer,"Michael  Alavanja; PhD| |Kenneth  Cantor; PhD| |Wong H Chow| |Mustafa  Dosemeci; PhD| | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  |Richard  Hayes; PhD",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji|Claudine M Samanic|Dalsu  Baris|Joanne S Colt|Joseph B Coble|Lee Elizabeth Moore; PhD, MD|Show all 12",NULL,"Jay  Lubin; PhD (Biostatistics Branch)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)",NULL,"1. Backer LC, Lan Q, Blount BC, Nuckols JR, Branch R, Lyu CW, Kieszak SM, Brinkman MC, Gordon SM, Flanders WD, Romkes M, Cantor KP (2008). Exogenous and endogenous determinants of blood trihalomethane levels after showering. Environ Health Perspect  116, 57-63.   https://doi.org/10.1289/ehp.10049|2. Blair A, Purdue MP, Weisenburger DD, Baris D (2007). Chemical exposures and risk of chronic lymphocytic leukaemia. Br J Haematol  139, 753-61.   https://doi.org/10.1111/j.1365-2141.2007.06874.x|3. Brennan P, van der Hel O, Moore LE, Zaridze D, Matveev V, Holcatova I, Janout V, Kollarova H, Foretova L, Szeszenia-Dabrowska N, Mates D, Rothman N, Boffetta P, Chow WH (2008). Tobacco smoking, body mass index, hypertension, and kidney cancer risk in central and eastern Europe. Br J Cancer  99, 1912-5.   https://doi.org/10.1038/sj.bjc.6604761|4. Chiu BC, Lan Q, Dave BJ, Blair A, Zahm SH, Weisenburger DD (2008). The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma. J Natl Cancer Inst Monogr   69-73  https://doi.org/10.1093/jncimonographs/lgn018|5. Moore LE, Hung R, Karami S, Boffetta P, Berndt S, Hsu CC, Zaridze D, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Yeager M, Chanock S, Garcia-Closas M, Rothman N, Chow WH, Brennan P (2008). Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int J Cancer  122, 1710-5.   https://doi.org/10.1002/ijc.23318|6. Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, García-Closas R, Chanock S, Tardón A, Serra C, Carrato A, Dosemeci M, García-Closas M, Esteller M, Fraga M, Rothman N, Malats N (2008). Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol  9, 359-66.   https://doi.org/10.1016/S1470-2045(08)70038-X|7. Rothman N, Cantor K, Silverman D, Vermeulen R (2008) Air pollution and risk of urinary bladder cancer in a case-control  study in Spain. Occup Environ Med 56-60.|8. Rothman N, Garcia Closas M, Silverman D (2008) Micronuclei assessment in the urothelial cells of women using hair  dyes and its modulation by genetic polymorphisms. Cancer Letters 259-266.|9. Samanic CM, Kogevinas M, Silverman DT, Tardón A, Serra C, Malats N, Real FX, Carrato A, García-Closas R, Sala M, Lloreta J, Rothman N, Dosemeci M (2008). Occupation and bladder cancer in a hospital-based case-control study in Spain. Occup Environ Med  65, 347-53.   https://doi.org/10.1136/oem.2007.035816|10. Shen M, Chapman RS, He X, Liu LZ, Lai H, Chen W, Lan Q (2008). Dietary factors, food contamination and lung cancer risk in Xuanwei, China. Lung Cancer  61, 275-82.   https://doi.org/10.1016/j.lungcan.2007.12.024|11. Wilson RT, Donahue M, Gridley G, Adami J, El Ghormli L, Dosemeci M (2008). Shared occupational risks for transitional cell cancer of the bladder and renal pelvis among men and women in Sweden. Am J Ind Med  51, 83-99.   https://doi.org/10.1002/ajim.20522",https://intramural.nih.gov/search/searchview.taf?ipid=50958
682,CP010121-13,"October 01, 2007 -  September 30, 2008",Molecular Epidemiology Studies of Occupational and Environmental Exposures,Nathaniel C Rothman; MD|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Kenneth  Cantor; PhD|Laura Elizabeth Beane Freeman|Mark  Purdue|Mary Helen Ward; MS, PhD|Michael  Alavanja; PhD|Show all 10",NULL,"Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Shelia K Zahm; ScM, ScD (Office of the Director)",NULL,"1. Castaño-Vinyals G, Cantor KP, Malats N, Tardon A, Garcia-Closas R, Serra C, Carrato A, Rothman N, Vermeulen R, Silverman D, Dosemeci M, Kogevinas M (2008). Air pollution and risk of urinary bladder cancer in a case-control study in Spain. Occup Environ Med  65, 56-60.   https://doi.org/10.1136/oem.2007.034348|2. Castaño-Vinyals G, Talaska G, Rothman N, Alguacil J, Garcia-Closas M, Dosemeci M, Cantor KP, Malats N, Real FX, Silverman D, Serra C, Carrato A, Tardon A, Garcia-Closas R, Kogevinas M, Vermeulen R (2007). Bulky DNA adduct formation and risk of bladder cancer. Cancer Epidemiol Biomarkers Prev  16, 2155-9.   https://doi.org/10.1158/1055-9965.EPI-07-0184|3. Espinoza F, Silverman D, Kogevinas M, Creus A, Fernández F, García-Closas M, Tardon A, García-Closas R, Serra C, Carrato A, Rothman N, Dosemeci M, Malats N, Marcos R (2008). Micronuclei assessment in the urothelial cells of women using hair dyes and its modulation by genetic polymorphisms. Cancer Lett  263, 259-66.   https://doi.org/10.1016/j.canlet.2008.01.010|4. Kim S, Lan Q, Waidyanatha S, Chanock S, Johnson BA, Vermeulen R, Smith MT, Zhang L, Li G, Shen M, Yin S, Rothman N, Rappaport SM (2007). Genetic polymorphisms and benzene metabolism in humans exposed to a wide range of air concentrations. Pharmacogenet Genomics  17, 789-801.   https://doi.org/10.1097/FPC.0b013e3280128f77|5. Liu Y, Lan Q, Shen M, Jin J, Mumford J, Ren D, Keohavong P (2008). Aberrant gene promoter methylation in sputum from individuals exposed to smoky coal emissions. Anticancer Res  28, 2061-6.|6. Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, García-Closas R, Chanock S, Tardón A, Serra C, Carrato A, Dosemeci M, García-Closas M, Esteller M, Fraga M, Rothman N, Malats N (2008). Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol  9, 359-66.   https://doi.org/10.1016/S1470-2045(08)70038-X|7. Rothman N, Cantor K, Silverman D, Vermeulen R (2008) Air pollution and risk of urinary bladder cancer in a case-control  study in Spain. Occup Environ Med 56-60.|8. Rothman N, Garcia Closas M, Silverman D (2008) Micronuclei assessment in the urothelial cells of women using hair  dyes and its modulation by genetic polymorphisms. Cancer Letters 259-266.|9. Samanic CM, Kogevinas M, Silverman DT, Tardón A, Serra C, Malats N, Real FX, Carrato A, García-Closas R, Sala M, Lloreta J, Rothman N, Dosemeci M (2008). Occupation and bladder cancer in a hospital-based case-control study in Spain. Occup Environ Med  65, 347-53.   https://doi.org/10.1136/oem.2007.035816|10. Shen M, Zhang L, Bonner MR, Liu CS, Li G, Vermeulen R, Dosemeci M, Yin S, Lan Q (2008). Association between mitochondrial DNA copy number, blood cell counts, and occupational benzene exposure. Environ Mol Mutagen  49, 453-7.   https://doi.org/10.1002/em.20402|11. Varela-Lema L, Taioli E, Ruano-Ravina A, Barros-Dios JM, Anantharaman D, Benhamou S, Boccia S, Bhisey RA, Cadoni G, Capoluongo E, Chen CJ, Foulkes W, Goloni-Bertollo EM, Hatagima A, Hayes RB, Katoh T, Koifman S, Lazarus P, Manni JJ, Mahimkar M, Morita S, Park J, Park KK, Pavarino Bertelli EC, de Souza Fonseca Ribeiro EM, et al. [5 more authors] (2008). Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med  10, 369-84.   https://doi.org/10.1097/GIM.0b013e3181770196",https://intramural.nih.gov/search/searchview.taf?ipid=50959
683,CP010122-13,"October 01, 2007 -  September 30, 2008",Occupational Exposure Assessment,Mustafa  Dosemeci; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji|Claudine M Samanic|Dalsu  Baris|Debra  Silverman; ScD, ScM|John R Nuckols|Joanne S Colt|Show all 16",NULL,"Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Gloria L Gridley (Biostatistics Branch)|Jay  Lubin; PhD (Biostatistics Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)|Nilanjan  Chatterjee (Biostatistics Branch)",NULL,"1. Marehbian J, Colt JS, Baris D, Stewart P, Stukel TA, Spencer SK, Karagas MR (2007). Occupation and keratinocyte cancer risk: a population-based case-control study. Cancer Causes Control  18, 895-908.   https://doi.org/10.1007/s10552-007-9034-4",https://intramural.nih.gov/search/searchview.taf?ipid=50957
684,CP010123-13,"October 01, 2007 -  September 30, 2008",Occupational and Environmental Determinants of Cancer among Women and Minorities,"Michael  Alavanja; PhD| |Kenneth  Cantor; PhD| |Mustafa  Dosemeci; PhD| |Richard  Hayes; PhD| | |Qing  Lan|IRP Faculty Profile  |Jay  Lubin; PhD| |Lee Elizabeth Moore; PhD, MD| | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  |Wong H Chow",NULL,"Occupational and Environmental Epidemiology Branch, NCI",Bu Tian  Ji|Dalsu  Baris|Joanne S Colt,NULL,"Gloria L Gridley (Biostatistics Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Shelia K Zahm; ScM, ScD (Office of the Director)",NULL,"1. Chow W, Rothman N, Lubin J, Blair A, Ji B (2008) Occupation and chronic bronchitis among Chinese women. Journal of Occupational and Environmental Medicine 64-71.|2. Freedman ND, Chow WH, Gao YT, Shu XO, Ji BT, Yang G, Lubin JH, Li HL, Rothman N, Zheng W, Abnet CC (2007). Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut  56, 1671-7.   https://doi.org/10.1136/gut.2007.129411|3. Hosgood HD, Baris D, Zhang Y, Zhu Y, Zheng T, Yeager M, Welch R, Zahm S, Chanock S, Rothman N, Lan Q (2008). Caspase polymorphisms and genetic susceptibility to multiple myeloma. Hematol Oncol  26, 148-51.   https://doi.org/10.1002/hon.852|4. Ji BT, Blair A, Shu XO, Chow WH, Hauptmann M, Dosemeci M, Yang G, Lubin J, Gao YT, Rothman N, Zheng W (2008). Occupation and breast cancer risk among Shanghai women in a population-based cohort study. Am J Ind Med  51, 100-10.   https://doi.org/10.1002/ajim.20507|5. Johnson DC, Corthals S, Ramos C, Hoering A, Cocks K, Dickens NJ, Haessler J, Goldschmidt H, Child JA, Bell SE, Jackson G, Baris D, Rajkumar SV, Davies FE, Durie BG, Crowley J, Sonneveld P, Van Ness B, Morgan GJ (2008). Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping. Blood  112, 4924-34.   https://doi.org/10.1182/blood-2008-02-140434|6. Weiss JM, Lacey JV, Shu XO, Ji BT, Hou L, Yang G, Li H, Rothman N, Blair A, Gao YT, Chow WH, Zheng W (2008). Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol  168, 1319-25.   https://doi.org/10.1093/aje/kwn257|7. Zhang X, Shu XO, Chow WH, Yang G, Li H, Gao J, Gao YT, Zheng W (2008). Body mass index at various ages and mortality in Chinese women: impact of potential methodological biases. Int J Obes (Lond)  32, 1130-6.   https://doi.org/10.1038/ijo.2008.63|8. Zhang Y, Shu XO, Gao YT, Ji BT, Yang G, Li HL, Kilfoy B, Rothman N, Zheng W, Chow WH (2007). Family history of cancer and risk of lung cancer among nonsmoking Chinese women. Cancer Epidemiol Biomarkers Prev  16, 2432-5.   https://doi.org/10.1158/1055-9965.EPI-07-0398",https://intramural.nih.gov/search/searchview.taf?ipid=50960
685,CP010124-13,"October 01, 2007 -  September 30, 2008",Cervical cancer and human papillomavirus (HPV) infection,"Philip E Castle; PhD, MPH| | |Allan  Hildesheim; PhD|IRP Faculty Profile  |Sophia S Wang; PhD| | |Mark  Schiffman; MD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","James V Lacey; MPH, PhD|Joseph  Carreon|Mahboobeh  Safaeian|Mark E Sherman; MD|Louise  Brinton; PhD",NULL,"Aimee Rebecca Kreimer (Early Detection Research Group)|Diane  Solomon; PhD (Breast and Gynecologic Cancer Research Group)|Douglas  Lowy; MD (Laboratory of Cellular Oncology)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Kenneth  Chu (Integrated Networks Branch)|Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)",NULL,"1. Castle P (2008) A Comparison of Depth of Necrosis for CO2- and N20-Cryotherapy:  Implications for Treatment of Cervical Precancer in Low-Resource  Settings. Int J Gynaecol Obstet 24-26.|2. Castle PE (2008). How does tobacco smoke contribute to cervical carcinogenesis? J Virol  82, 6084-5; author reply 6085-6.   https://doi.org/10.1128/JVI.00103-08|3. Castle PE (2008). Human papillomavirus (HPV) genotype 84 infection of the male genitalia: further evidence for HPV tissue tropism? J Infect Dis  197, 776-8.   https://doi.org/10.1086/527398|4. Castle PE (2008). The potential utility of HPV genotyping in screening and clinical management. J Natl Compr Canc Netw  6, 83-95.   https://doi.org/10.6004/jnccn.2008.0008|5. Castle PE, Cox JT, Jeronimo J, Solomon D, Wheeler CM, Gravitt PE, Schiffman M (2008). An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS). Obstet Gynecol  111, 847-56.   https://doi.org/10.1097/AOG.0b013e318168460b|6. Castle PE, Gage JC, Wheeler CM, Schiffman M (2011). The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy. Obstet Gynecol  118, 1222-9.   https://doi.org/10.1097/AOG.0b013e318237caf4|7. Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M (2008). Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol  46, 109-17.   https://doi.org/10.1128/JCM.01667-07|8. Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Schiffman M (2008). Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol  46, 2595-604.   https://doi.org/10.1128/JCM.00824-08|9. Gage J, Safaeian M (2008) Spectroscopic imaging as triage test for cervical disease  (Correspondence). Journal of Lower Genital Tract Diseases 52-53.|10. Gravitt PE, Schiffman M, Solomon D, Wheeler CM, Castle PE (2008). A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiol Biomarkers Prev  17, 1248-54.   https://doi.org/10.1158/1055-9965.EPI-07-2904|11. Hildesheim A (2008) MicroRNA 29c is down-regulated in nasopharyngeal carcinomas,  up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A 5874-5878.|12. Jeronimo J, Massad LS, Castle PE, Wacholder S, Schiffman M, National Institutes of Health (NIH)-American Society for Colposcopy and Cervical Pathology (ASCCP) Research Group (2007). Interobserver agreement in the evaluation of digitized cervical images. Obstet Gynecol  110, 833-40.   https://doi.org/10.1097/01.AOG.0000281665.63550.8f|13. Kovacic MB, Katki HA, Kreimer AR, Sherman ME (2008). Epidemiologic analysis of histologic cervical inflammation: relationship to human papillomavirus infections. Hum Pathol  39, 1088-95.   https://doi.org/10.1016/j.humpath.2007.12.002|14. Mariategui J, Santos C, Taxa L, Jeronimo J, Castle PE (2008). Comparison of depth of necrosis achieved by CO2- and N2O-cryotherapy. Int J Gynaecol Obstet  100, 24-6.   https://doi.org/10.1016/j.ijgo.2007.07.009|15. Schiffman M (2008) Heterogeneity in CIN3 diagnosis (Editorial Material). Lancet Oncology 404-406.|16. Schiffman M, Wacholder S (2008) Rapid Clearance of Human Papillomavirus and Implications for Clinical  Focus on Persistent Infections. J Natl Cancer Inst 513-517.|17. Seamans Y, Loesel C, Jeronimo J, Sellors J, Castle PE (2007). Effect of cough technique and cryogen gas on temperatures achieved during simulated cryotherapy. BMC Womens Health  7, 16.   https://doi.org/10.1186/1472-6874-7-16|18. Sherman M, Kreimer A (2008) Epidemiologic analysis of histologic cervical inflammation:  relationship to human papillomavirus infections. Hum Pathol na.|19. Wang SS, Smiraglia DJ, Wu YZ, Ghosh S, Rader JS, Cho KR, Bonfiglio TA, Nayar R, Plass C, Sherman ME (2008). Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Res  68, 2489-97.   https://doi.org/10.1158/0008-5472.CAN-07-3194",https://intramural.nih.gov/search/searchview.taf?ipid=50949
686,CP010125-13,"October 01, 2007 -  September 30, 2008",Cancer Risk and Environmental Exposures,"Mary Helen Ward; MS, PhD|IRP Faculty Profile  |Kenneth  Cantor; PhD",NULL,"Occupational and Environmental Epidemiology Branch, NCI","An-Tsun  Huang|Bu Tian  Ji|Claudine M Samanic|Dalsu  Baris|Debra  Silverman; ScD, ScM|John R Nuckols|Show all 13",NULL,"Jay  Lubin; PhD (Biostatistics Branch)|Peter D Inskip; ScD (Radiation Epidemiology Branch)|Shelia K Zahm; ScM, ScD (Office of the Director)",NULL,"1. Cantor K (2008) Disinfection byproducts in drinking water and skin cancer? A  hypothesis (Letter to Editor). Cancer Causes Control 547-548.|2. Cantor K, Nuckols J, Lan Q (2008) Exogenous and endogenous determinants of blood trihalomethane levels  after showering. Environ Health Perspect 57-63.|3. Colt J (2008) Household vacuum cleaners vs. the high-volume surface sampler for  collection of carpet dust samples in epidemiologic studies of children. Journal of Exposure Analysis and Environmental Epidemiology na.|4. Karagas MR, Villanueva CM, Nieuwenhuijsen M, Weisel CP, Cantor KP, Kogevinas M (2008). Disinfection byproducts in drinking water and skin cancer? A hypothesis. Cancer Causes Control  19, 547-8.   https://doi.org/10.1007/s10552-008-9116-y|5. Moore LE, Hung R, Karami S, Boffetta P, Berndt S, Hsu CC, Zaridze D, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Yeager M, Chanock S, Garcia-Closas M, Rothman N, Chow WH, Brennan P (2008). Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int J Cancer  122, 1710-5.   https://doi.org/10.1002/ijc.23318|6. Ward MH, Rusiecki JA, Lynch CF, Cantor KP (2007). Nitrate in public water supplies and the risk of renal cell carcinoma. Cancer Causes Control  18, 1141-51.   https://doi.org/10.1007/s10552-007-9053-1",https://intramural.nih.gov/search/searchview.taf?ipid=50965
687,CP010126-13,"October 01, 2007 -  September 30, 2008",Hormone-Related Cancers,"Montserrat  Garcia-Closas; MD, PhD|IRP Faculty Profile  |James V Lacey; MPH, PhD| | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  |Louise  Brinton; PhD",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Gretchen L Gierach|Kim N Danforth|Mark E Sherman; MD|Michael Blaise Cook|Patricia  Madigan|Roni T Falk,NULL,"Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Barry Ira Graubard; PhD (Biostatistics Branch)|Nilanjan  Chatterjee (Biostatistics Branch)|Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|William Frederick Anderson (Biostatistics Branch)",NULL,"1. (2008) Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status. Breast Cancer Research and Treatment 1:113-117.|2. (2008) Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China. Carcinogenesis 5:944-948.|3. (2008) Risk of testicular germ-cell tumours in relation to childhood physical activity. Br J Cancer 1:174-178.|4. (2008) The association between oral contraceptive use and lobular and ductal breast cancer in young women. Int J Cancer 4:936-941.|5. Andreotti G, Chen J, Gao YT, Rashid A, Chang SC, Shen MC, Wang BS, Han TQ, Zhang BH, Danforth KN, Althuis MD, Hsing AW (2008). Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in China. Int J Cancer  122, 2322-9.   https://doi.org/10.1002/ijc.23307|6. Andreotti G, Hsing A, Chanock S, Fraumeni J, Rosenberg P (2008) Polymorphisms of genes in the lipid metabolism pathway and risk of  biliary tract cancers and stones: A population-based case-control study  in Shanghai, China. Cancer Epidemiol Biomarkers 525-534.|7. Brinton L (2008) Ovarian cancer and oral contraceptives: Collaborative reanalysis of  data from 45 epidemiological studies including 23257 women with ovarian  cancer and 87303 controls. Lancet 303-314.|8. Brinton L (2008) Ovarian cancer and oral contraceptives: Collaborative reanalysis of data from 45 epidemiological studies including 23257 women with ovarian cancer and 87303 controls. Lancet 371:303-314|9. Chia VM, Sakoda LC, Graubard BI, Rubertone MV, Chanock SJ, Erickson RL, McGlynn KA (2008). Risk of testicular germ cell tumors and polymorphisms in the insulin-like growth factor genes. Cancer Epidemiol Biomarkers Prev  17, 721-6.   https://doi.org/10.1158/1055-9965.EPI-07-0768|10. Cook MB, Graubard BI, Quraishi SM, Yeager M, Chanock SJ, Crenshaw A, Erickson RL, Rubertone MV, Thomas G, McGlynn KA (2008). Genetic variants in the 8q24 locus and risk of testicular germ cell tumors. Hum Genet  123, 409-18.   https://doi.org/10.1007/s00439-008-0491-y|11. Cook MB, Graubard BI, Rubertone MV, Erickson RL, McGlynn KA (2008). Perinatal factors and the risk of testicular germ cell tumors. Int J Cancer  122, 2600-6.   https://doi.org/10.1002/ijc.23424|12. Cook MB, Zhang Y, Graubard BI, Rubertone MV, Erickson RL, McGlynn KA (2008). Risk of testicular germ-cell tumours in relation to childhood physical activity. Br J Cancer  98, 174-8.   https://doi.org/10.1038/sj.bjc.6604109|13. Danforth KN, Gierach GL, Brinton LA, Hollenbeck AR, Katki HA, Leitzmann MF, Schatzkin A, Lacey JV (2009). Nonsteroidal anti-inflammatory drug use and endometrial cancer risk in the NIH-AARP Diet and Health Study. Cancer Prev Res (Phila)  2, 466-72.   https://doi.org/10.1158/1940-6207.CAPR-08-0239|14. Falk RT, Gentzschein E, Stanczyk FZ, Brinton LA, Garcia-Closas M, Ioffe OB, Sherman ME (2008). Measurement of sex steroid hormones in breast adipocytes: methods and implications. Cancer Epidemiol Biomarkers Prev  17, 1891-5.   https://doi.org/10.1158/1055-9965.EPI-08-0119|15. Figueroa J, McGlynn K, Chanock S (2008) Genetic variation in hormone metabolizing genes and risk of  testicular germ cell tumors. Cancer Causes Control (Epub) na.|16. Gaudet MM, Lacey JV, Lissowska J, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M (2008). Genetic variation in CYP17 and endometrial cancer risk. Hum Genet  123, 155-62.   https://doi.org/10.1007/s00439-007-0454-8|17. Graubard B, McGlynn K, Chanock S (2008) Risk of testicular germ cell tumors and polymorphisms in the  insulin-like growth factor genes. Cancer Epidemiology Biomarkers and Prevention 721-726.|18. Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, Ortiz-Conde BA, Goedert JJ, Fraumeni JF, O'Brien TR, Gao YT (2008). Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer  122, 1849-53.   https://doi.org/10.1002/ijc.23251|19. Huang WY, Gao YT, Rashid A, Sakoda LC, Deng J, Shen MC, Wang BS, Han TQ, Zhang BH, Chen BE, Rosenberg PS, Chanock SJ, Hsing AW (2008). Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. Carcinogenesis  29, 100-5.   https://doi.org/10.1093/carcin/bgm247|20. Lacey JV, Ioffe OB, Ronnett BM, Rush BB, Richesson DA, Chatterjee N, Langholz B, Glass AG, Sherman ME (2008). Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan. Br J Cancer  98, 45-53.   https://doi.org/10.1038/sj.bjc.6604102|21. Lissowska J, Gaudet MM, Brinton LA, Peplonska B, Sherman M, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M (2008). Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status. Breast Cancer Res Treat  107, 113-7.   https://doi.org/10.1007/s10549-007-9524-9|22. McGlynn K (2008) Title: Re: Nguyen MM, Ellison LM: Testicular cancer patterns in  Asian-American males: an opportunity for public health education to  impact outcomes (Urology 66: 606-609, 2005) and Gajendran VK, Nguyen M,  Ellison LM: Testicular cancer patterns in Afri. Urology 356-357.|23. McGlynn K, Quraishi S (2008) Persistent organochlorine pesticides and risk of testicular germ  cell tumors. J Natl Cancer Inst 663-671.|24. Nyante SJ, Gammon MD, Malone KE, Daling JR, Brinton LA (2008). The association between oral contraceptive use and lobular and ductal breast cancer in young women. Int J Cancer  122, 936-41.   https://doi.org/10.1002/ijc.23163|25. Pearce CL, Wu AH, Gayther SA, Bale AE, Australian Cancer Study (Ovarian Cancer) and Australian Cancer Study Group, Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, Garcia-Closas M, Goode EL, Green AC, Hartmann LC, Hogdall E, Kjaer SK, Lissowska J, McGuire V, Modugno F, Moysich K, Ness RB, Ramus SJ, Risch HA, Sellers TA, Ovarian Cancer Association Consortium, et al. [12 more authors] (2008). Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. Br J Cancer  98, 282-8.   https://doi.org/10.1038/sj.bjc.6604170|26. Peplonska B, Lissowska J, Hartman TJ, Szeszenia-Dabrowska N, Blair A, Zatonski W, Sherman ME, Garcia-Closas M, Brinton LA (2008). Adulthood lifetime physical activity and breast cancer. Epidemiology  19, 226-36.   https://doi.org/10.1097/EDE.0b013e3181633bfb|27. Purdue MP, Graubard BI, Chanock SJ, Rubertone MV, Erickson RL, McGlynn KA (2008). Genetic variation in the inhibin pathway and risk of testicular germ cell tumors. Cancer Res  68, 3043-8.   https://doi.org/10.1158/0008-5472.CAN-07-5852|28. Sherman ME, Madigan MP, Lacey JV, Garcia-Closas M, Potischman N, Carreon JD, Hartge P, Brinton LA (2007). Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones. Gynecol Oncol  107, 431-5.   https://doi.org/10.1016/j.ygyno.2007.07.061",https://intramural.nih.gov/search/searchview.taf?ipid=50966
688,CP010127-13,"October 01, 2007 -  September 30, 2008",Etiologic Studies of Diet and Cancer,Rashmi P Sinha; PhD|IRP Faculty Profile  |Arthur  Schatzkin; PhD,NULL,"Nutritional Epidemiology Branch, NCI","Amanda  Cross|Christian Cormac Abnet; PhD, MPH|Demetrius  Albanes; MD|Farin  Kamangar|Jiyoung  Ahn|Mark J Roth|Show all 11",NULL,Amy F Subar (Risk Factor Monitoring and Methods Branch)|Douglas N Midthune (Biometry Research Group)|Frances E Thompson (Risk Factor Monitoring and Methods Branch)|Richard P Troiano (Risk Factor Monitoring and Methods Branch)|Victor  Kipnis (Biometry Research Group),NULL,"1. (2008) Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial. Cancer Causes Control (Epub) na:na.|2. Abnet C, Fraumeni J (2008) A prospective study of BMI and risk of oesophageal and gastric  adenocarcinoma. Eur J Cancer 465-471.|3. Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni JF, Leitzmann M, Schatzkin A (2008). A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer  44, 465-71.   https://doi.org/10.1016/j.ejca.2007.12.009|4. Albanes D, Taylor P, Solomon R, Weinstein S (2008) Flavonoid intake and risk of pancreatic cancer in male smokers  (Finland). Cancer Epidemiol Biomarkers Prev 553-562.|5. Freedman ND, Park Y, Subar AF, Hollenbeck AR, Leitzmann MF, Schatzkin A, Abnet CC (2008). Fruit and vegetable intake and head and neck cancer risk in a large United States prospective cohort study. Int J Cancer  122, 2330-6.   https://doi.org/10.1002/ijc.23319|6. Freedman ND, Subar AF, Hollenbeck AR, Leitzmann MF, Schatzkin A, Abnet CC (2008). Fruit and vegetable intake and gastric cancer risk in a large United States prospective cohort study. Cancer Causes Control  19, 459-67.   https://doi.org/10.1007/s10552-007-9107-4|7. Gierach GL, Lacey JV, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA (2008). Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res  10, R38.   https://doi.org/10.1186/bcr2089|8. Murphy G, Sansbury L, Lanza E, Laiyemo A, Wang Z, Solomon R, Cross A, Albert P   (2008) Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention 							Trial.  Cancer Causes Control (Epub)  na pp.|9. Peters TM, Ekelund U, Leitzmann M, Easton D, Warren R, Luben R, Bingham S, Khaw KT, Wareham NJ (2008). Physical activity and mammographic breast density in the EPIC-Norfolk cohort study. Am J Epidemiol  167, 579-85.   https://doi.org/10.1093/aje/kwm350|10. Pfeiffer R, Lanza E, McShane L (2008) The effects of a high-fruit and -vegetable, high-fiber, low-fat  dietary intervention on serum concentrations of insulin, glucose, IGF-I  and IGFBP-3. Eur J Clin Nutr 186-196.|11. Schatzkin A, Dodd K, Subar A (2008) Using Biomarker Data to Adjust Estimates of the Distribution of Usual  Intakes for Misreporting: Application to Energy Intake in the US  Population. J Am Diet Assoc 455-464.|12. Schatzkin A, Freedman L (2008) The role of dietary measurement error in investigating the  hypothesized link between dietary fat intake and breast cancer--a story  with twists and turns. Cancer Invest 68-73.|13. Schatzkin A, Lanza E, Pfeiffer R (2008) Insulin resistance and colorectal adenomas-Reply (Letter). Gastroenterology 1269-1270.|14. Schatzkin A, Lanza E, Wang Z, Murphy G (2008) Polynucleotide kinase 3' phosphatase variant, dietary variables and  risk of adenoma recurrence in the Polyp Prevention Trial. Eur J Cancer Prev 287-290.|15. Schatzkin A, Potischman N (2008) Methods of Epidemiology: Evaluating the Fat-Breast Cancer Hypothesis  - Comparing Dietary Instruments and Other Developments. Cancer J 69-74.|16. Schatzkin A, Sinha R, Albanes D, Solomon R, Cross A (2008) Genomic methylation of leukocyte DNA in relation to colorectal  adenoma among asymptomatic women. CANCER RES 47-55.|17. Stolzenberg-Solomon RZ, Adams K, Leitzmann M, Schairer C, Michaud DS, Hollenbeck A, Schatzkin A, Silverman DT (2008). Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am J Epidemiol  167, 586-97.   https://doi.org/10.1093/aje/kwm361",https://intramural.nih.gov/search/searchview.taf?ipid=50997
689,CP010128-13,"October 01, 2007 -  September 30, 2008",Therapeutic and Diagnostic Factors as Related to Cancer Risk,"James V Lacey; MPH, PhD| |Louise  Brinton; PhD",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Mark E Sherman; MD,NULL,"Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Arthur  Schatzkin; PhD (Nutritional Epidemiology Branch)|Catherine G Schairer (Biostatistics Branch)|Jay  Lubin; PhD (Biostatistics Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,"1. Brinton LA (2007). The relationship of silicone breast implants and cancer at other sites. Plast Reconstr Surg  120, 94S-102S.   https://doi.org/10.1097/01.prs.0000286573.72187.6e",https://intramural.nih.gov/search/searchview.taf?ipid=50967
690,CP010131-13,"October 01, 2007 -  September 30, 2008",Studies of Medical Radiation and Other Therapeutic Agents,Peter D Inskip; ScD| |Elaine  Ron; PhD,NULL,"Radiation Epidemiology Branch, NCI","Alice  Sigurdson; PhD|Alina V Brenner|Andre  Bouville|Charles E. Land; PhD|Kiyohiko  Mabuchi; MD, DPhil|Martha S Linet; PhD|Show all 12",NULL,Margaret Anne Tucker (Human Genetics Program),NULL,"1. Amy S, Kleinerman R, Abramson D (2008) Genes and Environment: Effects on the development of second malignancies in retinoblastoma survivors. Expert Reviews in Ophthalmology 3:51-61|2. Bluhm EC, Ronckers C, Hayashi RJ, Neglia JP, Mertens AC, Stovall M, Meadows AT, Mitby PA, Whitton JA, Hammond S, Barker JD, Donaldson SS, Robison LL, Inskip PD (2008). Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood  111, 4014-21.   https://doi.org/10.1182/blood-2007-08-106021|3. Chodick G, Kim KP, Shwarz M, Horev G, Shalev V, Ron E (2009). Radiation risks from pediatric computed tomography scanning. Pediatr Endocrinol Rev  7, 29-36.|4. Inskip P (2008) Cause-specific mortality and second cancer incidence after  non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. J CLIN ONCOL 4014-4021.|5. Inskip PD, Curtis RE (2007). New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer  121, 2233-40.   https://doi.org/10.1002/ijc.22827|6. Kim KP, Miller DL, Balter S, Kleinerman RA, Linet MS, Kwon D, Simon SL (2008). Occupational radiation doses to operators performing cardiac catheterization procedures. Health Phys  94, 211-27.   https://doi.org/10.1097/01.HP.0000290614.76386.35|7. Land CE, Zhumadilov Z, Gusev BI, Hartshorne MH, Wiest PW, Woodward PW, Crooks LA, Luckyanov NK, Fillmore CM, Carr Z, Abisheva G, Beck HL, Bouville A, Langer J, Weinstock R, Gordeev KI, Shinkarev S, Simon SL (2008). Ultrasound-detected thyroid nodule prevalence and radiation dose from fallout. Radiat Res  169, 373-83.   https://doi.org/10.1667/RR1063.1|8. Linet MS, Kim KP, Rajaraman P (2008) Childrens exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric. Pediatr Radiol 39:S4-S26|9. Little MP (2010) Do non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model? Mutat Res 687:17-27.|10. Little MP, Tawn EJ, Tzoulaki I, Wakeford R, Hildebrandt G, Paris F, Tapio S, Elliott P (2010) Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms. Radiat Environ Biophys 49:139-53.|11. Schefler A, Kleinerman R, Abramson D (2008) Genes and Environment: Effects on the development of second malignancies in retinoblastoma survivors. Expert Reviews in Ophthalmology 3:51-61|12. Schneider AB, Ron E, Lubin J, Stovall M, Shore-Freedman E, Tolentino J, Collins BJ (2008). Acoustic neuromas following childhood radiation treatment for benign conditions of the head and neck. Neuro Oncol  10, 73-8.   https://doi.org/10.1215/15228517-2007-047|13. Sheen V, Tucker MA, Abramson DH, Seddon JM, Kleinerman RA (2008). Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers. Cancer  113, 434-41.   https://doi.org/10.1002/cncr.23564",https://intramural.nih.gov/search/searchview.taf?ipid=50968
691,CP010132-13,"October 01, 2007 -  September 30, 2008",Studies of Populations Exposed to Environmental Sources of Radiation,Charles E. Land; PhD| |Elaine  Ron; PhD| | |Martha S Linet; PhD|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI","Alice  Sigurdson; PhD|Alina V Brenner|Andre  Bouville|Ihor  Masnyk|Kiyohiko  Mabuchi; MD, DPhil|Maureen Cusack Hatch; MD|Show all 10",NULL,Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Freedman D (2008) Response: Re: Prospective study of Vitamin D and cancer mortality in  the United States (Letter to Editor). J Natl Canc I na.|2. Freedman D, Looker A, Chang S, Graubard B (2008) Response: Re: Prospective study of Vitamin D and cancer mortality in the United States (Letter to Editor). J Natl Canc I na:na|3. Freedman DM (2008). Commentary: The complexities of minimizing risks due to UV exposures. Int J Epidemiol  37, 667-8.   https://doi.org/10.1093/ije/dyn061|4. Freedman DM, Looker AC, Chang SC, Graubard BI (2007). Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst  99, 1594-602.   https://doi.org/10.1093/jnci/djm204|5. Karagas MR, Nelson HH, Zens MS, Linet M, Stukel TA, Spencer S, Applebaum KM, Mott L, Mabuchi K (2007). Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure. Epidemiology  18, 776-84.   https://doi.org/10.1097/EDE.0b013e3181567ebe|6. Land CE, Zhumadilov Z, Gusev BI, Hartshorne MH, Wiest PW, Woodward PW, Crooks LA, Luckyanov NK, Fillmore CM, Carr Z, Abisheva G, Beck HL, Bouville A, Langer J, Weinstock R, Gordeev KI, Shinkarev S, Simon SL (2008). Ultrasound-detected thyroid nodule prevalence and radiation dose from fallout. Radiat Res  169, 373-83.   https://doi.org/10.1667/RR1063.1|7. Luckyanov N, Bouville A (2008) Credibility of Chernobyl thyroid doses exceeding 10 Gy based on  in-vivo measurements OF 131I in Belarus. Health Physics 180-187.|8. Ron E (2007). Thyroid cancer incidence among people living in areas contaminated by radiation from the Chernobyl accident. Health Phys  93, 502-11.   https://doi.org/10.1097/01.HP.0000279018.93081.29|9. Ron E, Masnyk I, Brenner A, Bouville A, Hatch M (2008) A cohort study of thyroid cancer and other thyroid diseases after the  Chornobyl accident: dose-response analysis of thyroid follicular  adenomas detected during first screening in Ukraine (1998-2000). American Journal of Epidemiology 305-312.|10. Shinkarev SM, Voillequé PG, Gavrilin YI, Khrouch VT, Bouville A, Hoshi M, Meckbach R, Minenko VF, Ulanovsky AV, Luckyanov N (2008). Credibility of Chernobyl thyroid doses exceeding 10 Gy based on in-vivo measurements of 131I in Belarus. Health Phys  94, 180-7.   https://doi.org/10.1097/01.HP.0000288044.73410.6b|11. Zablotska LB, Bogdanova TI, Ron E, Epstein OV, Robbins J, Likhtarev IA, Hatch M, Markov VV, Bouville AC, Olijnyk VA, McConnell RJ, Shpak VM, Brenner A, Terekhova GN, Greenebaum E, Tereshchenko VP, Fink DJ, Brill AB, Zamotayeva GA, Masnyk IJ, Howe GR, Tronko MD (2008). A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: dose-response analysis of thyroid follicular adenomas detected during first screening in Ukraine (1998-2000). Am J Epidemiol  167, 305-12.   https://doi.org/10.1093/aje/kwm301",https://intramural.nih.gov/search/searchview.taf?ipid=50950
692,CP010133-13,"October 01, 2007 -  September 30, 2008",Studies of Populations Exposed to Occupational Sources of Radiation,Elaine  Ron; PhD| | |Martha S Linet; PhD|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",Alice  Sigurdson; PhD|Alina V Brenner|Andre  Bouville|Ethel S Gilbert|Maureen Cusack Hatch; MD|Daryl  Freedman|Show all 9,NULL,NULL,NULL,"1. Bhatti P, Doody MM, Alexander BH, Yuenger J, Simon SL, Weinstock RM, Rosenstein M, Stovall M, Abend M, Preston DL, Pharoah P, Struewing JP, Sigurdson AJ (2008). Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists. Cancer Epidemiol Biomarkers Prev  17, 2007-11.   https://doi.org/10.1158/1055-9965.EPI-08-0300|2. Bhatti P, Doody MM, Preston DL, Kampa D, Ron E, Weinstock RW, Simon S, Edwards AA, Sigurdson AJ (2008). Increased frequency of chromosome translocations associated with diagnostic x-ray examinations. Radiat Res  170, 149-55.   https://doi.org/10.1667/RR1422.1|3. Bhatti P, Sigurdson AJ, Thomas CB, Iwan A, Alexander BH, Kampa D, Bowen L, Doody MM, Jones IM (2008). No evidence for differences in DNA damage assessed before and after a cancer diagnosis. Cancer Epidemiol Biomarkers Prev  17, 990-4.   https://doi.org/10.1158/1055-9965.EPI-07-2871|4. Bhatti P, Struewing JP, Alexander BH, Hauptmann M, Bowen L, Mateus-Pereira LH, Pineda MA, Simon SL, Weinstock RM, Rosenstein M, Stovall M, Preston DL, Linet MS, Doody MM, Sigurdson AJ (2008). Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists. Int J Cancer  122, 177-82.   https://doi.org/10.1002/ijc.23066|5. Bozhok Y, Greenebaum E, Bogdanova TI, McConnell RJ, Zelinskaya A, Brenner AV, Zurnadzhy LY, Zablotska L, Tronko MD, Hatch M (2009). NA cohort study of thyroid cancer and other thyroid diseases after the Chernobyl accident: cytohistopathologic correlation and accuracy of fine-needle aspiration biopsy in nodules detected during the first screening in Ukraine (1998-2000). Cancer  117, 73-81.   https://doi.org/10.1002/cncy.20002|6. Chodick G, Bekiroglu N, Hauptmann M, Alexander BH, Freedman DM, Doody MM, Cheung LC, Simon SL, Weinstock RM, Bouville A, Sigurdson AJ (2008). Risk of cataract after exposure to low doses of ionizing radiation: a 20-year prospective cohort study among US radiologic technologists. Am J Epidemiol  168, 620-31.   https://doi.org/10.1093/aje/kwn171|7. Freedman DM, Rajaraman P, Fuhrman B, Hoffbeck R, Alexander BH (2010). Sunlight, hormone replacement status and colorectal cancer risk in postmenopausal women. Int J Cancer  126, 1997-2001.   https://doi.org/10.1002/ijc.24903|8. Johnson KJ, Alexander BH, Doody MM, Sigurdson AJ, Linet MS, Spector LG, Hoffbeck W, Simon SL, Weinstock RM, Ross JA (2008). Childhood cancer in the offspring born in 1921-1984 to US radiologic technologists. Br J Cancer  99, 545-50.   https://doi.org/10.1038/sj.bjc.6604516|9. Kesminiene A, Evrard AS, Ivanov VK, Malakhova IV, Kurtinaitis J, Stengrevics A, Tekkel M, Anspaugh LR, Bouville A, Chekin S, Chumak VV, Drozdovitch V, Gapanovich V, Golovanov I, Hubert P, Illichev SV, Khait SE, Kryuchkov VP, Maceika E, Maksyoutov M, Mirkhaidarov AK, Polyakov S, Shchukina N, Tenet V, Tserakhovich TI, et al. [3 more authors] (2008). Risk of hematological malignancies among Chernobyl liquidators. Radiat Res  170, 721-35.   https://doi.org/10.1667/RR1231.1|10. Romanenko A, Bebeshko V, Hatch M, Bazyka D, Finch S, Dyagil I, Reiss R, Chumak V, Bouville A, Gudzenko N, Zablotska L, Pilinskaya M, Lyubarets T, Bakhanova E, Babkina N, Trotsiuk N, Ledoschuk B, Belayev Y, Dybsky SS, Ron E, Howe G (2008). The Ukrainian-American study of leukemia and related disorders among Chornobyl cleanup workers from Ukraine: I. Study methods. Radiat Res  170, 691-7.   https://doi.org/10.1667/RR1402.1|11. Romanenko AY, Finch SC, Hatch M, Lubin JH, Bebeshko VG, Bazyka DA, Gudzenko N, Dyagil IS, Reiss RF, Bouville A, Chumak VV, Trotsiuk NK, Babkina NG, Belyayev Y, Masnyk I, Ron E, Howe GR, Zablotska LB (2008). The Ukrainian-American study of leukemia and related disorders among Chornobyl cleanup workers from Ukraine: III. Radiation risks. Radiat Res  170, 711-20.   https://doi.org/10.1667/RR1404.1|12. Sigurdson AJ, Bhatti P, Doody MM, Hauptmann M, Bowen L, Simon SL, Weinstock RM, Linet MS, Rosenstein M, Stovall M, Alexander BH, Preston DL, Struewing JP, Rajaraman P (2007). Polymorphisms in apoptosis- and proliferation-related genes, ionizing radiation exposure, and risk of breast cancer among U.S. Radiologic Technologists. Cancer Epidemiol Biomarkers Prev  16, 2000-7.   https://doi.org/10.1158/1055-9965.EPI-07-0282",https://intramural.nih.gov/search/searchview.taf?ipid=50969
693,CP010134-13,"October 01, 2007 -  September 30, 2008",Studies of Atomic Bomb Survivors,Charles E. Land; PhD,NULL,"Radiation Epidemiology Branch, NCI","Alina V Brenner|Elaine  Ron; PhD|Kiyohiko  Mabuchi; MD, DPhil|Martha S Linet; PhD",NULL,NULL,NULL,"1. Kocher DC, Apostoaei AI, Henshaw RW, Hoffman FO, Schubauer-Berigan MK, Stancescu DO, Thomas BA, Trabalka JR, Gilbert ES, Land CE (2008). Interactive RadioEpidemiological Program (IREP): a web-based tool for estimating probability of causation/assigned share of radiogenic cancers. Health Phys  95, 119-47.   https://doi.org/10.1097/01.HP.0000291191.49583.f7|2. Nishi N, Sugiyama H, Hsu WL, Soda M, Kasagi F, Mabuchi K, Kodama K (2008). Differences in mortality and incidence for major sites of cancer by education level in a Japanese population. Ann Epidemiol  18, 584-91.   https://doi.org/10.1016/j.annepidem.2008.02.003|3. Preston DL, Cullings H, Suyama A, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K, Kasagi F, Shore RE (2008). Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst  100, 428-36.   https://doi.org/10.1093/jnci/djn045|4. Ron E, Mabuchi K (2008) Solid cancer incidence in atomic bomb survivors exposed in utero or  as young children. J Natl Cancer Inst (epub) 428-436.",https://intramural.nih.gov/search/searchview.taf?ipid=51009
694,CP010135-13,"October 01, 2007 -  September 30, 2008",Studies of Non-Ionizing Radiation-Related Cancer,Martha S Linet; PhD|IRP Faculty Profile  |Peter D Inskip; ScD,NULL,"Radiation Epidemiology Branch, NCI",Alina V Brenner|Daryl  Freedman|Preetha  Rajaraman|Ruth Anne Kleinerman; MPH|Steven L Simon,NULL,Joseph B Coble (Occupational and Environmental Epidemiology Branch)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Sholom  Wacholder; PhD (Biostatistics Branch)|Thomas  Fears; PhD (Genetic Epidemiology Branch),NULL,"1. Brenner AV, Butler MA, Wang SS, Ruder AM, Rothman N, Schulte PA, Chanock SJ, Fine HA, Linet MS, Inskip PD (2007). Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis  28, 2543-7.   https://doi.org/10.1093/carcin/bgm210|2. Kwok RK, Linet MS, Chodick G, Kleinerman RA, Freedman DM, Fears T, Johnson RE, Alexander BH (2009). Simplified categorization of outdoor activities for male and female U.S. indoor workers-a feasibility study to improve assessment of ultraviolet radiation exposures in epidemiologic study questionnaires. Photochem Photobiol  85, 45-9.   https://doi.org/10.1111/j.1751-1097.2008.00393.x|3. Lönn S, Rothman N, Shapiro WR, Fine HA, Selker RG, Black PM, Loeffler JS, Hutchinson AA, Inskip PD (2008). Genetic variation in insulin-like growth factors and brain tumor risk. Neuro Oncol  10, 553-9.   https://doi.org/10.1215/15228517-2008-026|4. Rajaraman P, Hutchinson A, Rothman N, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Linet MS, Inskip PD (2008). Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol  10, 709-15.   https://doi.org/10.1215/15228517-2008-037|5. Samanic CM, De Roos AJ, Stewart PA, Rajaraman P, Waters MA, Inskip PD (2008). Occupational exposure to pesticides and risk of adult brain tumors. Am J Epidemiol  167, 976-85.   https://doi.org/10.1093/aje/kwm401",https://intramural.nih.gov/search/searchview.taf?ipid=50970
695,CP010136-13,"October 01, 2007 -  September 30, 2008",Cancer Risk in Human Populations,"Debra  Silverman; ScD, ScM|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI",Bu Tian  Ji|Claudine M Samanic|Dalsu  Baris|Joanne S Colt|Joseph B Coble|Kenneth  Cantor; PhD|Show all 10,NULL,Mark  Schiffman; MD (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Fortuny J, Johnson CC, Bohlke K, Chow WH, Hart G, Kucera G, Mujumdar U, Ownby D, Wells K, Yood MU, Engel LS (2007). Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers. Clin Gastroenterol Hepatol  5, 1154-1159.e3.   https://doi.org/10.1016/j.cgh.2007.05.022|2. Hou L, Grillo P, Zhu ZZ, Lissowska J, Yeager M, Zatonski W, Zhu G, Baccarelli A, Chanock SJ, Fraumeni JF, Chow WH (2007). COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population. Anticancer Res  27, 4243-7.|3. Karami S, Boffetta P, Rothman N, Hung RJ, Stewart T, Zaridze D, Navritalova M, Mates D, Janout V, Kollarova H, Bencko V, Szeszenia-Dabrowska N, Holcatova I, Mukeria A, Gromiec J, Chanock SJ, Brennan P, Chow WH, Moore LE (2008). Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms. Carcinogenesis  29, 1567-71.   https://doi.org/10.1093/carcin/bgn153|4. Mahajan R, El-Omar EM, Lissowska J, Grillo P, Rabkin CS, Baccarelli A, Yeager M, Sobin LH, Zatonski W, Channock SJ, Chow WH, Hou L (2008). Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population. Jpn J Clin Oncol  38, 626-33.   https://doi.org/10.1093/jjco/hyn075|5. Silverman DT, Alguacil J, Rothman N, Real FX, Garcia-Closas M, Cantor KP, Malats N, Tardon A, Serra C, Garcia-Closas R, Carrato A, Lloreta J, Samanic C, Dosemeci M, Kogevinas M (2008). Does increased urination frequency protect against bladder cancer? Int J Cancer  123, 1644-8.   https://doi.org/10.1002/ijc.23572|6. Zhang FF, Hou L, Terry MB, Lissowska J, Morabia A, Chen J, Yeager M, Zatonski W, Chanock S, Chow WH (2007). Genetic polymorphisms in alcohol metabolism, alcohol intake and the risk of stomach cancer in Warsaw, Poland. Int J Cancer  121, 2060-4.   https://doi.org/10.1002/ijc.22973",https://intramural.nih.gov/search/searchview.taf?ipid=50971
696,CP010139-11,"October 01, 2007 -  September 30, 2008",Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Myung Soo  Lyu|Jinghui E Zhang; PhD|Michael N Edmonson|Robert  Clifford|Hongen  Zhang|Cu  Nguyen|Show all 14,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50973
697,CP010140-11,"October 01, 2007 -  September 30, 2008",Molecular Genetic Epidemiology of Leading U.S. Cancers,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Jenny M Kelley,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50974
698,CP010141-11,"October 01, 2007 -  September 30, 2008",The Cancer Genome Anatomy Projects Genetic Annotation Initiative,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Robert  Clifford|Hongen  Zhang|Cu  Nguyen|Jenny M Kelley,NULL,"Lalage  Wakefield; PhD (National Cancer Institute)|Maxwell P Lee; PhD (National Cancer Institute)|Philip  Taylor; MD, ScD (National Cancer Institute)|Dinah  Singer; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50996
699,CP010142-10,"October 01, 2007 -  September 30, 2008",Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,"Charles  Rabkin|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile  | |Regina Gale Ziegler; PhD, MPH|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI",Barbara  Dunn,NULL,"Barry Ira Graubard; PhD (Biostatistics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Kenneth  Buetow; PhD (Laboratory of Population Genetics)|Philip Samuel Rosenberg; PhD (Biostatistics Branch)|Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50975
700,CP010144-10,"October 01, 2007 -  September 30, 2008",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,Sharon Ann Savage|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Blanche P Alter|Jennifer T Loud|June  Peters|Neelam K Giri; MD|Sadie  Hutson,NULL,David  Danforth (Surgery Branch)|Diane Carol Arthur; MD (Laboratory of Pathology)|Gordon B Willis (Healthcare Delivery Research Program)|Izumi  Horikawa (Molecular Genetics and Carcinogenesis Section)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)|Margaret Anne Tucker (Human Genetics Program),NULL,"1. (2008) All in the Family: Disclosure of Unwanted Information to an Adolescent to Benifit a Relative. American Journal of Medical Genetics, Part A 146A:2719-2724.|2. (2008) An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. Br J Cancer 99:974-7.|3. (2008) Cancer risks in Fanconi anemia: Findings from the German Fanconi Anemia (GEFA) Registry. Haematologica 93:511-517.|4. (2008) Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. American Journal of Human Genetics 82:937Â948.|5. (2008) Disclosure of positive BRCA12 mutation status in young couples: The journey from uncertainty to bonding through partner support. Families, Systems Health 26:.|6. (2008) Increased Incidence of Testicular Microlithiasis in Men with Familial Testicular Cancer and their Relatives. British Journal of Cancer 99:1748-1753.|7. (2008) Survivin expression in the bone marrow of patients with severe congenital neutropenia: Comparison with other bone marrow failure syndromes. Leukemia Research 32:1793-1799.|8. (2008) TINF2, a component of the shelterin telomere protection complex, is mutated in Dyskeratosis Congenita. American Journal of Human Genetics 82:50`-509.|9. Al-Rahawan MM, Alter BP, Bryant BJ, Elghetany MT (2008). Bone marrow cell cycle markers in inherited bone marrow failure syndromes. Leuk Res  32, 1793-9.   https://doi.org/10.1016/j.leukres.2008.05.020|10. Alter BP (2007). Diagnosis, genetics, and management of inherited bone marrow failure syndromes. Hematology Am Soc Hematol Educ Program   29-39  https://doi.org/10.1182/asheducation-2007.1.29|11. Antoniou AC, Sinilnikova OM, Simard J, Léoné M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ, Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers Study (GEMO), Rebbeck TR, Wagner T, Lynch HT, Domchek SM, Nathanson KL, Garber JE, Weitzel J, Narod SA, Tomlinson G, Olopade OI, Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE), German Consortium for Hereditary Breast and Ovarian Cancer (GCHBOC), Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), et al. [54 more authors] (2007). RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet  81, 1186-200.   https://doi.org/10.1086/522611|12. Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Hofmann W, Sutter C, Niederacher D, Deissler H, Caldes T, Kämpjärvi K, Nevanlinna H, Simard J, Beesley J, Chen X, Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Neuhausen SL, Rebbeck TR, Wagner T, Lynch HT, Isaacs C, OCGN, Swedish BRCA1 and BRCA2 study collaborators, DNA-HEBON collaborators, EMBRACE, GEMO, CIMBA, et al. [61 more authors] (2008). Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet  82, 937-48.   https://doi.org/10.1016/j.ajhg.2008.02.008|13. Atkinson JC, Harvey KE, Domingo DL, Trujillo MI, Guadagnini JP, Gollins S, Giri N, Hart TC, Alter BP (2008). Oral and dental phenotype of dyskeratosis congenita. Oral Dis  14, 419-27.   https://doi.org/10.1111/j.1601-0825.2007.01394.x|14. Chen BE, Kramer JL, Greene MH, Rosenberg PS (2008). Competing risks analysis of correlated failure time data. Biometrics  64, 172-9.   https://doi.org/10.1111/j.1541-0420.2007.00868.x|15. Chia V, Goldin L, Graubard B, Greene M, Korde L, Rubertone M, Erickson R, McGlynn K (2008) Risk of cancer in first- and second-degree relatives of testicular germ cell tumor cases and controls. International Journal of Cancer 124:952-957|16. Greene M, Gail M, Mai P, Loud J (2008) GOG-199: A Prospective Study of Risk-Reducing Salpingo-Oophorectomy  and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk  of Ovarian Cancer: Design and Baseline Characteristics Â A GOG Study. Cancer Epidemiol Biomarkers Prev 594-604.|17. Hoskins L, Loud J, Greene M   (2008) Disclosure of Positive BRCA1/2-Mutation Status in Young Couples: 							Expectation, Experience, and Effect.  Families, Systems & Health  296-316 pp.|18. Koehly LM, Peters JA, Kuhn N, Hoskins L, Letocha A, Kenen R, Loud J, Greene MH (2008). Sisters in hereditary breast and ovarian cancer families: communal coping, social integration, and psychological well-being. Psychooncology  17, 812-21.   https://doi.org/10.1002/pon.1373|19. Linger R, Dudakia D, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Stoppa-Lyonnet D, Bonaïti-Pellié C, Heidenreich A, Albers P, Olah E, Geczi L, Bodrogi I, Daly PA, Guilford P, Fosså SD, Heimdal K, Tjulandin SA, Liubchenko L, et al. [12 more authors] (2008). Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors. Genes Chromosomes Cancer  47, 247-52.   https://doi.org/10.1002/gcc.20526|20. Mcmaster M, Korde L, Greene M (2008) Analysis of the DND1 gene in men with sporadic and familial  testicular germ cell tumors. Genes Chromosomes & Cancer 247-252.|21. Mueller C, Caporaso N, Greene M (2008) Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract. Urologic Oncology 26:1-14|22. Mueller C, Greene M (2008) Familial and Genetic Risk of Transitional Cell Carcinoma of the  Urinary Tract. Urologic Oncology 1-14.|23. Mueller C, Mai P, Loud J, Greene M (2008) Complementary and Alternative Medicine Use among Women at Increased  Genetic Risk of Breast and Ovarian Cancer. BMC Complementary and Alternative Medicine 17.|24. Osorio A, Pollán M, Pita G, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Preisler-Adams S, Niederacher D, Hofmann W, Gadzicki D, Jakubowska A, Hamann U, Lubinski J, Toloczko-Grabarek A, Cybulski C, Debniak T, Llort G, Yannoukakos D, Díez O, Peissel B, Peterlongo P, Radice P, Heikkinen T, CIMBA, et al. [6 more authors] (2008). An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. Br J Cancer  99, 974-7.   https://doi.org/10.1038/sj.bjc.6604624|25. Pereira L, Greene M (2008) No Association of TGFB1 Genotypes and Breast Cancer Risk in. Breast Cancer Research and Treatment 1-5.|26. Pereira L, Struewing J, Greene M (2008) Common Breast Cancer Predisposition Alleles are Associated with  Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Am J Hum Genet 1-12.|27. Pereira LH, Pineda MA, Rowe WH, Fonseca LR, Greene MH, Offit K, Ellis NA, Zhang J, Collins A, Struewing JP (2007). The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies. BMC Genet  8, 68.   https://doi.org/10.1186/1471-2156-8-68|28. Peters J, Beckjord E, Ryan D, Carr A, Vadaparampil S, Loud J, Korde L, Greene M (2008) Testicular cancer and genetics knowledge among familial testicular cancer family members. Journal of Genetic Counseling 17:1-5|29. Peters J, Greene M (2008) BRCA Mutation-Negative Women from Hereditary Breast and Ovarian  Cancer (HBOC) Families: A Qualitative Study of the BRCA-Negative  Experience. HEALTH EXPECT 220-231.|30. Peters J, Korde L, Greene M (2008) Testicular cancer and genetics knowledge among familial testicular  cancer family members. Journal of Genetic Counseling 1-5.|31. Rosenberg P, Greene M (2008) Competing Risks Analysis of Correlated Failure Time Data. Biometrics 172-179.|32. Savage S (2008) The Role of Telomere Biology in Bone Marrow Failure and Other  Disorders. Mechanisms of Ageing and Development 35-47.|33. Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP (2008). TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet  82, 501-9.   https://doi.org/10.1016/j.ajhg.2007.10.004|34. Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, Ramenghi U, Meerpohl J, Karlsson S, Liu JM, Leblanc T, Paley C, Kang EM, Leder EJ, Atsidaftos E, Shimamura A, Bessler M, Glader B, Lipton JM, Participants of Sixth Annual Daniella Maria Arturi International Consensus Conference (2008). Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol  142, 859-76.   https://doi.org/10.1111/j.1365-2141.2008.07269.x",https://intramural.nih.gov/search/searchview.taf?ipid=50976
701,CP010145-09,"October 01, 2007 -  September 30, 2008",Intervention Trials in Persons at Increased Genetic Risk of Cancer,Mark H Greene; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Blanche P Alter|Christine M Mueller|Jennifer T Loud|Neelam K Giri; MD,NULL,"Alisa  Goldstein; PhD (Genetic Epidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Margaret Anne Tucker (Human Genetics Program)|Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Paul Kj Han (Outcomes Research Branch)",NULL,"1. (2008) Disclosure of positive BRCA12 mutation status in young couples: The journey from uncertainty to bonding through partner support. Families, Systems Health 26:.|2. Alexis B, Hutson S, Peters J, Giusti R, Greene M (2008) BRCA Mutation-Negative Women from Hereditary Breast and Ovarian Cancer (HBOC) Families:  A Qualitative Study of the BRCA-Negative Experience. HEALTH EXPECT 11:220-231|3. Greene M, Gail M, Mai P, Loud J (2008) GOG-199: A Prospective Study of Risk-Reducing Salpingo-Oophorectomy  and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk  of Ovarian Cancer: Design and Baseline Characteristics Â A GOG Study. Cancer Epidemiol Biomarkers Prev 594-604.|4. Greene MH, Piedmonte M, Alberts D, Gail M, Hensley M, Miner Z, Mai PL, Loud J, Rodriguez G, Basil J, Boggess J, Schwartz PE, Kelley JL, Wakeley KE, Minasian L, Skates S (2008). A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study. Cancer Epidemiol Biomarkers Prev  17, 594-604.   https://doi.org/10.1158/1055-9965.EPI-07-2703|5. Hoskins L, Loud J, Greene M   (2008) Disclosure of Positive BRCA1/2-Mutation Status in Young Couples: 							Expectation, Experience, and Effect.  Families, Systems & Health  296-316 pp.|6. Hoskins L, Roy K, Peters J, Loud J, Greene M (2008) Disclosure of positive BRCA12 mutation status in young couples: The journey from uncertainty to bonding through partner support. Families, Systems Health 26:.|7. Hoskins LM, Roy K, Peters JA, Loud JT, Greene MH (2008). Disclosure of Positive BRCA1/2-Mutation Status in Young Couples: The Journey From Uncertainty to Bonding Through Partner Support. Fam Syst Health  26, 296-316.   https://doi.org/10.1037/a0012914|8. Koehly LM, Peters JA, Kuhn N, Hoskins L, Letocha A, Kenen R, Loud J, Greene MH (2008). Sisters in hereditary breast and ovarian cancer families: communal coping, social integration, and psychological well-being. Psychooncology  17, 812-21.   https://doi.org/10.1002/pon.1373|9. Korde LA, Micheli A, Smith AW, Venzon D, Prindiville SA, Drinkard B, Sebring N, Smith MD, Zujewski JA, Eng-Wong J (2009). Recruitment to a physical activity intervention study in women at increased risk of breast cancer. BMC Med Res Methodol  9, 27.   https://doi.org/10.1186/1471-2288-9-27|10. Laura K, Peters J, Kuhn N, Hoskins L, Letocha A, Kenen R, Loud J, Greene M (2008) Sisters in Hereditary Breast and Ovarian Cancer Families: Communal coping, social support and psychogical well-being. Psycho-Oncology 17:812-821|11. Mueller C, Mai P, Bucher J, Peters J, Loud J, Greene M (2008) Complementary and Alternative Medicine Use among Women at Increased Genetic Risk of Breast and Ovarian Cancer. BMC Complementary and Alternative Medicine 8:17|12. Mueller C, Mai P, Loud J, Greene M (2008) Complementary and Alternative Medicine Use among Women at Increased  Genetic Risk of Breast and Ovarian Cancer. BMC Complementary and Alternative Medicine 17.|13. Pereira L, Greene M (2008) No Association of TGFB1 Genotypes and Breast Cancer Risk in. Breast Cancer Research and Treatment 1-5.|14. Peters J, Greene M (2008) BRCA Mutation-Negative Women from Hereditary Breast and Ovarian  Cancer (HBOC) Families: A Qualitative Study of the BRCA-Negative  Experience. HEALTH EXPECT 220-231.|15. Timothy R, Antoniou A, CaldesLlopis T, Nevanlinna H, Aittomaki K, Simard J, Spurdle A, Couch F, Pereira L, Greene M, Andrulis I, Pasche B, Kaklamani V, Hamann U, Szabo C, Peock S, Cook M, Harrington P, Donaldson A, Male A, Gardiner C, Gregory H, Side L, Robinson A, Emmerson L, et al. [19 more authors] (2008) No Association of TGFB1 Genotypes and Breast Cancer Risk in. Breast Cancer Research and Treatment 110:1-5",https://intramural.nih.gov/search/searchview.taf?ipid=50977
702,CP010146-09,"October 01, 2007 -  September 30, 2008",Genetic Modifiers of Intitiation and Progression of Mammary Cancer,Kent W Hunter; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Jude  Alsarraj|Nigel P Crawford; MB ChB, PhD|Szu-Min  Hsieh|Nicholas  Lintell|Luanne M Lukes|Renard Cerrell Walker|Show all 10",NULL,Douglas  Lowy; MD (National Cancer Institute)|Chand  Khanna; MD (National Cancer Institute)|Stefan  Ambs (National Cancer Institute)|Lalage  Wakefield; PhD (National Cancer Institute),NULL,"1. Hunter K   (2008) Emerging concepts in metastasis: The impact of genetics, genomics and  other tools to investigate the pathobiology of secondary disease in cancer., in Genomics and Personalized Medicine.  Elsevier, in press.|2. Gordon RR, Hunter KW, Sørensen P, Pomp D (2008). Genotype X diet interactions in mice predisposed to mammary cancer. I. Body weight and fat. Mamm Genome  19, 163-78.   https://doi.org/10.1007/s00335-008-9095-z|3. Hunter K, Alsarraj J   (2008) Mechanisms of metastasis.  Breast Cancer Research, in press.|4. Hunter K, Pharoah P, Dunning A, Driver K, Lissowska J, Sherman M, Peplonska B, Brinton L, Channock S, Garcia-Closas M   (2008) Genetic variation in SIPA1 in relation to breast cancer risk and survival after  breast cancer diagnosis.  International Journal of Cancer, in press.|5. Shukla A, Alsarraj J, Hunter K (2014) Understanding susceptibility to breast cancer metastasis: the genetic approach. Breast Cancer Manag 3:165-172",https://intramural.nih.gov/search/searchview.taf?ipid=50954
703,CP010150-09,"October 01, 2007 -  September 30, 2008","Infections, immunity, and inflammation in cancer",James Jerome Goedert; MD| | |Sam  Mbulaiteye|IRP Faculty Profile  | |Charles  Rabkin|IRP Faculty Profile  | |Eric Andrew Engels; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",Anil Kumar Chaturvedi,NULL,"Demetrius  Albanes; MD (Nutritional Epidemiology Branch)|Farin  Kamangar (Nutritional Epidemiology Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Nilanjan  Chatterjee (Biostatistics Branch)",NULL,"1. Biggar R, Mbulaiteye S, Rabkin C (2008) Human herpesvirus 8 load and progression of AIDS-related Kaposi  sarcoma lesions. Cancer Lett 182-188.|2. Chaturvedi AK, Mbulaiteye SM, Engels EA (2008). Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers. Ann Epidemiol  18, 230-4.   https://doi.org/10.1016/j.annepidem.2007.10.005|3. Engels E (2008) Hepatitis C virus infection and non-Hodgkin lymphoma: interesting  association or causal relationship? (Editorial Material). International Journal of Cancer x-xii.|4. Engels E (2008) Incidence and outcomes of malignancy in the HAART era in an urban  cohort of HIV-infected individuals. AIDS 489-496.|5. Engels EA (2008). Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther  8, 605-15.   https://doi.org/10.1586/14737140.8.4.605|6. Guech-Ongey M, Engels EA, Goedert JJ, Biggar RJ, Mbulaiteye SM (2008). Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States. Int J Cancer  122, 2590-3.   https://doi.org/10.1002/ijc.23384|7. Long JL, Engels EA, Moore RD, Gebo KA (2008). Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS  22, 489-96.   https://doi.org/10.1097/QAD.0b013e3282f47082|8. Mbulaiteye S (2008) Antibodies against malaria and Epstein-Barr virus in childhood  Burkitt lymphoma: A case-control study in Uganda. Int J Cancer 1319-1323.|9. Mbulaiteye SM, Goedert JJ (2008). Transmission of Kaposi sarcoma-associated herpesvirus in sub-Saharan Africa. AIDS  22, 535-7.   https://doi.org/10.1097/QAD.0b013e3282f4352e|10. Morton L, Engels E, Hartge P (2008) Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269  controls from the International Lymphoma Epidemiology Consortium. Gastroenterology 451-458.|11. Schetter AJ, You WC, Lennette ET, Gail MT, Rabkin CS (2008). Association of Epstein-Barr virus antibody levels with precancerous gastric lesions in a high-risk cohort. Cancer Sci  99, 350-4.   https://doi.org/10.1111/j.1349-7006.2007.00668.x|12. Shebl FM, Bhatia K, Engels EA (2010). Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States. Int J Cancer  126, 2503-8.   https://doi.org/10.1002/ijc.24930",https://intramural.nih.gov/search/searchview.taf?ipid=50978
704,CP010152-09,"October 01, 2007 -  September 30, 2008",PLCO Trial Etiologic and Early Marker Study,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  |Arthur  Schatzkin; PhD| | |Regina Gale Ziegler; PhD, MPH|IRP Faculty Profile  |Richard  Hayes; PhD",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji|Wen-Yi  Huang|Sarah  Daugherty|Mark  Purdue|Lee Elizabeth Moore; PhD, MD",NULL,"Christine Dorothy Berg (Early Detection Research Group)|Rachael Zoe Solomon (Nutritional Epidemiology Branch)|Barry Ira Graubard; PhD (Biostatistics Branch)|Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)|Jorge R Toro (Genetic Epidemiology Branch)|Sharon Ann Savage (Clinical Genetics Branch)",NULL,"1. Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, Freedman M, Chatterjee N, Andriole GL, Leitzmann MF, Hayes RB, Prostate, Lung, Colorectal, and Ovarian Trial Project Team (2007). Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev  16, 2623-30.   https://doi.org/10.1158/1055-9965.EPI-07-0601|2. Ahn J, Berndt SI, Wacholder S, Kraft P, Kibel AS, Yeager M, Albanes D, Giovannucci E, Stampfer MJ, Virtamo J, Thun MJ, Feigelson HS, Cancel-Tassin G, Cussenot O, Thomas G, Hunter DJ, Fraumeni JF, Hoover RN, Chanock SJ, Hayes RB (2008). Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet  40, 1032-4; author reply 1035-6.   https://doi.org/10.1038/ng0908-1032|3. Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, Hermon C, Peto R, Reeves G (2008) Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371:303-14|4. Danforth KN, Rodriguez C, Hayes RB, Sakoda LC, Huang WY, Yu K, Calle EE, Jacobs EJ, Chen BE, Andriole GL, Figueroa JD, Yeager M, Platz EA, Michaud DS, Chanock SJ, Thun MJ, Hsing AW (2008). TNF polymorphisms and prostate cancer risk. Prostate  68, 400-7.   https://doi.org/10.1002/pros.20694|5. Daugherty SE, Shugart YY, Platz EA, Fallin MD, Isaacs WB, Pfeiffer RM, Welch R, Huang WY, Reding D, Hayes RB (2007). Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer. Prostate  67, 1487-97.   https://doi.org/10.1002/pros.20635|6. Dixon LB, Subar AF, Peters U, Weissfeld JL, Bresalier RS, Risch A, Schatzkin A, Hayes RB (2007). Adherence to the USDA Food Guide, DASH Eating Plan, and Mediterranean dietary pattern reduces risk of colorectal adenoma. J Nutr  137, 2443-50.   https://doi.org/10.1093/jn/137.11.2443|7. Freedman DM, Chang SC, Falk RT, Purdue MP, Huang WY, McCarty CA, Hollis BW, Graubard BI, Berg CD, Ziegler RG (2008). Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev  17, 889-94.   https://doi.org/10.1158/1055-9965.EPI-07-2594|8. Leitzmann MF, Ahn J, Albanes D, Hsing AW, Schatzkin A, Chang SC, Huang WY, Weiss JM, Danforth KN, Grubb RL, Andriole GL, Prostate, Lung, Colorectal, and Ovarian Trial Project Team (2008). Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control  19, 1267-76.   https://doi.org/10.1007/s10552-008-9198-6|9. Lettre G, Jackson AU, Gieger C, Schumacher FR, Berndt SI, Sanna S, Eyheramendy S, Voight BF, Butler JL, Guiducci C, Illig T, Hackett R, Heid IM, Jacobs KB, Lyssenko V, Uda M, Diabetes Genetics Initiative, FUSION, KORA, Prostate, Lung Colorectal and Ovarian Cancer Screening Trial, Nurses'' Health Study, SardiNIA, Boehnke M, Chanock SJ, Groop LC, Hu FB, Isomaa B, Kraft P, Peltonen L, Salomaa V, Schlessinger D, et al. [6 more authors] (2008). Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet  40, 584-91.   https://doi.org/10.1038/ng.125|10. Millen AE, Subar AF, Graubard BI, Peters U, Hayes RB, Weissfeld JL, Yokochi LA, Ziegler RG, PLCO Cancer Screening Trial Project Team (2007). Fruit and vegetable intake and prevalence of colorectal adenoma in a cancer screening trial. Am J Clin Nutr  86, 1754-64.   https://doi.org/10.1093/ajcn/86.5.1754|11. Schenk JM, Riboli E, Chatterjee N, Leitzmann MF, Ahn J, Albanes D, Reding DJ, Wang Y, Friesen MD, Hayes RB, Peters U (2009). Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev  18, 1227-31.   https://doi.org/10.1158/1055-9965.EPI-08-0984|12. Setiawan VW, Schumacher FR, Haiman CA, Stram DO, Albanes D, Altshuler D, Berglund G, Buring J, Calle EE, Clavel-Chapelon F, Cox DG, Gaziano JM, Hankinson SE, Hayes RB, Henderson BE, Hirschhorn J, Hoover R, Hunter DJ, Kaaks R, Kolonel LN, Kraft P, Ma J, Le Marchand L, Linseisen J, Lund E, et al. [14 more authors] (2007). CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev  16, 2237-46.   https://doi.org/10.1158/1055-9965.EPI-07-0589|13. Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, Hayes RB, Kraft P, Wacholder S, Orr N, Berndt S, Yu K, Hutchinson A, Wang Z, Amundadottir L, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, et al. [28 more authors] (2009). Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet  41, 1055-7.   https://doi.org/10.1038/ng.444",https://intramural.nih.gov/search/searchview.taf?ipid=50980
705,CP010153-09,"October 01, 2007 -  September 30, 2008","Cancer Risk and Environmental Exposures to Nitrate, Pesticides, and IndustrialCh","Kenneth  Cantor; PhD| | |Mary Helen Ward; MS, PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Debra  Silverman; ScD, ScM|Joanne S Colt",NULL,"Jay  Lubin; PhD (Biostatistics Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Shelia K Zahm; ScM, ScD (Office of the Director)",NULL,1. Colt J (2008) Household vacuum cleaners vs. the high-volume surface sampler for  collection of carpet dust samples in epidemiologic studies of children. Journal of Exposure Analysis and Environmental Epidemiology na.,https://intramural.nih.gov/search/searchview.taf?ipid=51001
706,CP010154-09,"October 01, 2007 -  September 30, 2008",Genetics and Epigenetics of Cancer,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI",Sheryl A Gere|Mitsutaka  Kadota|Howard H Yang|Beverly W Duncan,NULL,"Philip  Taylor; MD, ScD (National Cancer Institute)|Alisa  Goldstein; PhD (National Cancer Institute)|Jeffery P Struewing; MS, MD (Office of the Director)|Kent W Hunter; PhD (National Cancer Institute)|Kenneth  Buetow; PhD (National Cancer Institute)|Lalage  Wakefield; PhD (National Cancer Institute)",NULL,"1. Ng D, Hu N, Hu Y, Wang C, Giffen C, Tang ZZ, Han XY, Yang HH, Lee MP, Goldstein AM, Taylor PR (2008). Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. Int J Cancer  123, 1610-5.   https://doi.org/10.1002/ijc.23682|2. Yang HH, Hu N, Taylor PR, Lee MP (2008). Whole genome-wide association study using affymetrix SNP chip: a two-stage sequential selection method to identify genes that increase the risk of developing complex diseases. Methods Mol Med  141, 23-35.   https://doi.org/10.1007/978-1-60327-148-6_2",https://intramural.nih.gov/search/searchview.taf?ipid=50981
707,CP010155-09,"October 01, 2007 -  September 30, 2008",Informatics Solutions to Biomedical Research,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI",Howard H Yang,NULL,"Philip  Taylor; MD, ScD (National Cancer Institute)|Alisa  Goldstein; PhD (National Cancer Institute)|Dinah  Singer; PhD (National Cancer Institute)|Kenneth  Buetow; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50982
708,CP010158-08,"October 01, 2007 -  September 30, 2008",Studies of Rare Cancers,Allan  Hildesheim; PhD|IRP Faculty Profile  |Ann  Hsing; PhD| | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  |Sophia S Wang; PhD| |Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Michael Blaise Cook,NULL,Gabriella  Andreotti (Occupational and Environmental Epidemiology Branch)|Kelly Jen-Yi Yu (Infection & Immunoepidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch),NULL,"1. (2008) Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China. Carcinogenesis 5:944-948.|2. Andreotti G, Chen J, Gao YT, Rashid A, Chang SC, Shen MC, Wang BS, Han TQ, Zhang BH, Danforth KN, Althuis MD, Hsing AW (2008). Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in China. Int J Cancer  122, 2322-9.   https://doi.org/10.1002/ijc.23307|3. Andreotti G, Hsing A, Chanock S, Fraumeni J, Rosenberg P (2008) Polymorphisms of genes in the lipid metabolism pathway and risk of  biliary tract cancers and stones: A population-based case-control study  in Shanghai, China. Cancer Epidemiol Biomarkers 525-534.|4. Brinton LA, Richesson DA, Gierach GL, Lacey JV, Park Y, Hollenbeck AR, Schatzkin A (2008) Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst 100:1477-1481|5. Brinton LA, Richesson DA, Gierach GL, Lacey JV, Park Y, Hollenbeck AR, Schatzkin A (2008). Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst  100, 1477-81.   https://doi.org/10.1093/jnci/djn329|6. Hildesheim A (2008) MicroRNA 29c is down-regulated in nasopharyngeal carcinomas,  up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A 5874-5878.|7. Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, Ortiz-Conde BA, Goedert JJ, Fraumeni JF, O'Brien TR, Gao YT (2008). Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer  122, 1849-53.   https://doi.org/10.1002/ijc.23251|8. Huang WY, Gao YT, Rashid A, Sakoda LC, Deng J, Shen MC, Wang BS, Han TQ, Zhang BH, Chen BE, Rosenberg PS, Chanock SJ, Hsing AW (2008). Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. Carcinogenesis  29, 100-5.   https://doi.org/10.1093/carcin/bgm247|9. Shaib YH, Davila JA, Henderson L, McGlynn KA, El-Serag HB (2007). Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study. J Clin Gastroenterol  41, 911-7.   https://doi.org/10.1097/MCG.0b013e31802f3132",https://intramural.nih.gov/search/searchview.taf?ipid=50983
709,CP010162-08,"October 01, 2007 -  September 30, 2008",Gene Expression Profiles in Lung Cancer Using cDNA Arrays,Jin  Jen,NULL,"Laboratory of Human Carcinogenesis, NCI",Tatiana V Dracheva|Hyo-Sung  Jeon|Abbas  Shakoori,NULL,"Curtis  Harris; MD (National Cancer Institute)|Neil Edward Caporaso; MS, MD (National Cancer Institute)|Kenneth  Buetow; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50984
710,CP010163-08,"October 01, 2007 -  September 30, 2008",Genetic Analysis in Early Age of Onset Lung Cancer Patients,Jin  Jen,NULL,"Laboratory of Human Carcinogenesis, NCI",Tatiana V Dracheva|Hyo-Sung  Jeon|Abbas  Shakoori,NULL,Curtis  Harris; MD (National Cancer Institute)|Kenneth  Buetow; PhD (National Cancer Institute),NULL,"1. Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, Murphy SE, Yang P, Pesatori AC, Consonni D, Bertazzi PA, Wacholder S, Shih JH, Caporaso NE, Jen J (2008). Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One  3, e1651.   https://doi.org/10.1371/journal.pone.0001651",https://intramural.nih.gov/search/searchview.taf?ipid=50985
711,CP010164-08,"October 01, 2007 -  September 30, 2008",A Non-small Cell Lung Cancer Tissue Microarray to Analyze Protein Expression,Jin  Jen,NULL,"Laboratory of Human Carcinogenesis, NCI",Tatiana V Dracheva|Hyo-Sung  Jeon|Abbas  Shakoori,NULL,Curtis  Harris; MD (National Cancer Institute)|Kenneth  Buetow; PhD (National Cancer Institute)|Karl Thomas Ried; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50986
712,CP010165-08,"October 01, 2007 -  September 30, 2008",Mechanisms of Gene Expression Changes in Lung Cancer,Jin  Jen,NULL,"Laboratory of Human Carcinogenesis, NCI",Tatiana V Dracheva|Hyo-Sung  Jeon|Abbas  Shakoori,NULL,Ilona  Linnoila; MD (National Cancer Institute)|Kent W Hunter; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50987
713,CP010167-08,"October 01, 2007 -  September 30, 2008",General Studies of Epidemiology,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Patricia  Hartge; ScD|Rebecca  Troisi,NULL,Sharon Ann Savage (Clinical Genetics Branch),NULL,"1. Hartge P (2008) Personal sun exposure and non Hodgkin lymphoma: a pooled analysis  from the Interlymph Consortium. INT J CANCER 144-154.|2. Morton L, Hartge P (2008) Non-Hodgkin lymphoma and obesity: a pooled analysis from the  InterLymph Consortium. International Journal of Cancer 2062-2070.|3. Morton L, Hartge P, Zahm S (2008) Personal Use of Hair Dye and the Risk of Certain Subtypes of  Non-Hodgkin Lymphoma. JAMA 1321-1331.",https://intramural.nih.gov/search/searchview.taf?ipid=50988
714,CP010168-08,"October 01, 2007 -  September 30, 2008",Early Life Exposures and Subsequent Cancer Risk,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Rebecca  Troisi,NULL,NULL,NULL,"1. (2008) Cervical Screening and General Physical Exam Behaviors of Women Exposed In-utero to Diethylstilbestrol. Journal of Lower Reproductive Tract Disease 12:111-7.|2. Camp EA, Coker AL, Troisi R, Robboy SJ, Noller KL, Goodman KJ, Titus-Ernstoff LT, Hatch EE, Herbst AL, Kaufman RH, Adam E (2008). Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. J Low Genit Tract Dis  12, 111-7.   https://doi.org/10.1097/LGT.0b013e31815ae980|3. De Stavola B, McCormack V, (2008) Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med 5:e193|4. Hartge P, Hoover R, Troisi R (2008) Offspring of women exposed in utero to diethylstilbestrol (DES): a  preliminary report of benign and malignant pathology in the third  generation. Epidemiology 251-257.|5. Strohsnitter WC, Hatch EE, Hyer M, Troisi R, Kaufman RH, Robboy SJ, Palmer JR, Titus-Ernstoff L, Anderson D, Hoover RN, Noller KL (2008). The association between in utero cigarette smoke exposure and age at menopause. Am J Epidemiol  167, 727-33.   https://doi.org/10.1093/aje/kwm351|6. Titus-Ernstoff L, Troisi R, Hatch EE, Hyer M, Wise LA, Palmer JR, Kaufman R, Adam E, Noller K, Herbst AL, Strohsnitter W, Cole BF, Hartge P, Hoover RN (2008). Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation. Epidemiology  19, 251-7.   https://doi.org/10.1097/EDE.0b013e318163152a|7. Troisi R (2008) The association between in utero cigarette smoke exposure and age at  menopause. Am J Epidemiol 727-733.|8. Troisi R, Lagiou P, Trichopoulos D, Xu B, Chie L, Stanczyk FZ, Potischman N, Adami HO, Hoover RN, Hsieh CC (2008). Cord serum estrogens, androgens, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 in Chinese and U.S. Caucasian neonates. Cancer Epidemiol Biomarkers Prev  17, 224-31.   https://doi.org/10.1158/1055-9965.EPI-07-0536",https://intramural.nih.gov/search/searchview.taf?ipid=50989
715,CP010169-07,"October 01, 2007 -  September 30, 2008","Nutrition, Metabolism, and Cancer","Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Regina Gale Ziegler; PhD, MPH|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Patricia  Hartge; ScD,NULL,Blossom  Patterson (Biometry Research Group)|Catherine G Schairer (Biostatistics Branch)|Demetrius  Albanes; MD (Nutritional Epidemiology Branch)|Gloria L Gridley (Biostatistics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Brock KE, Gridley G, Chiu BC, Ershow AG, Lynch CF, Cantor KP (2009). Dietary fat and risk of renal cell carcinoma in the USA: a case-control study. Br J Nutr  101, 1228-38.   https://doi.org/10.1017/S0007114508056043|2. Falk RT, Xu X, Keefer L, Veenstra TD, Ziegler RG (2008). A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol Biomarkers Prev  17, 3411-8.   https://doi.org/10.1158/1055-9965.EPI-08-0355|3. Li Q, Yu K (2008). Improved correction for population stratification in genome-wide association studies by identifying hidden population structures. Genet Epidemiol  32, 215-26.   https://doi.org/10.1002/gepi.20296|4. Li Q, Zheng G, Li Z, Yu K (2008). Efficient approximation of P-value of the maximum of correlated tests, with applications to genome-wide association studies. Ann Hum Genet  72, 397-406.   https://doi.org/10.1111/j.1469-1809.2008.00437.x|5. Xu X, Roman JM, Issaq HJ, Keefer LK, Veenstra TD, Ziegler RG (2007). Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Anal Chem  79, 7813-21.   https://doi.org/10.1021/ac070494j",https://intramural.nih.gov/search/searchview.taf?ipid=50994
716,CP010170-08,"October 01, 2007 -  September 30, 2008",Multidisciplinary Studies of Lymphoma,Patricia  Hartge; ScD,NULL,"Epidemiology and Biostatistics Program, NCI",Lindsay Mcomber Morton,NULL,"Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Gloria L Gridley (Biostatistics Branch)|Joanne S Colt (Occupational and Environmental Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Mary Helen Ward; MS, PhD (Occupational and Environmental Epidemiology Branch)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)",NULL,"1. (2008) Antibiotic use and risk of non-Hodgkin's lymphoma: A population-based case-control study. British Journal of Cancer 1:161-164.|2. (2008) Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study. International Journal of Cancer 123:888-894.|3. (2008) Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk. Cancer Causes Control 5:491-503.|4. Anderson LA, Gridley G, Engels EA, Morton LM, Cerhan JR, Cozen W, Severson RK, Davis S, Hartge P, Linet MS (2008). Antibiotic use and risk of non-Hodgkin's lymphoma: a population-based case-control study. Br J Cancer  98, 161-4.   https://doi.org/10.1038/sj.bjc.6604127|5. Anne K, Armstrong B, Hughes A, Goumas C, Ekstrom K, Zheng T, Spinelli J, de Sanjose S, Hartge P, Melbye M, Willett E, Becker N, Chiu B, Cerhan J, Maynadie M, Staines A, Cocco P, Boffetta P (2008) Personal sun exposure and non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. INT J CANCER 122:144-154|6. Cerhan JR, Engels EA, Cozen W, Davis S, Severson RK, Morton LM, Gridley G, Hartge P, Linet M (2008). Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study. Int J Cancer  123, 888-94.   https://doi.org/10.1002/ijc.23561|7. Cozen W, Cerhan JR, Martinez-Maza O, Ward MH, Linet M, Colt JS, Davis S, Severson RK, Hartge P, Bernstein L (2007). The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk. Cancer Causes Control  18, 821-31.   https://doi.org/10.1007/s10552-007-9025-5|8. Hartge P (2008) Personal sun exposure and non Hodgkin lymphoma: a pooled analysis  from the Interlymph Consortium. INT J CANCER 144-154.|9. Kelemen LE, Wang SS, Lim U, Cozen W, Schenk M, Hartge P, Li Y, Rothman N, Davis S, Chanock SJ, Ward MH, Cerhan JR (2008). Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk. Cancer Causes Control  19, 491-503.   https://doi.org/10.1007/s10552-008-9111-3|10. Morton L, Hartge P (2008) Non-Hodgkin lymphoma and obesity: a pooled analysis from the  InterLymph Consortium. International Journal of Cancer 2062-2070.|11. Morton L, Hartge P, Zahm S (2008) Personal Use of Hair Dye and the Risk of Certain Subtypes of  Non-Hodgkin Lymphoma. JAMA 1321-1331.|12. Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD (2007). Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood  110, 695-708.   https://doi.org/10.1182/blood-2006-11-051672|13. Purdue MP, Hartge P, Davis S, Cerhan JR, Colt JS, Cozen W, Severson RK, Li Y, Chanock SJ, Rothman N, Wang SS (2007). Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control  18, 989-99.   https://doi.org/10.1007/s10552-007-9039-z|14. Wang SS, Davis S, Hartge P, Cozen W, Severson RK, Cerhan JR, Rothman N (2008). Chromosomal aberrations in peripheral blood lymphocytes and risk for non-Hodgkin lymphoma. J Natl Cancer Inst Monogr   78-82  https://doi.org/10.1093/jncimonographs/lgn016|15. Willett EV, Morton LM, Hartge P, Becker N, Bernstein L, Boffetta P, Bracci P, Cerhan J, Chiu BC, Cocco P, Dal Maso L, Davis S, De Sanjose S, Smedby KE, Ennas MG, Foretova L, Holly EA, La Vecchia C, Matsuo K, Maynadie M, Melbye M, Negri E, Nieters A, Severson R, Slager SL, Interlymph Consortium, et al. [6 more authors] (2008). Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer  122, 2062-70.   https://doi.org/10.1002/ijc.23344|16. Zahm S, Colt J, Hartge P, Wang S, Welch R (2008) Hair dye use, genetic variation in Nacetyltransferase 1 (NAT1) and 2  (NAT2), and risk of no-hodgkin lymphoma (Letter to the Editor-Response). Carcinogenesis 1084-1985.|17. Zhang Y, Sanjose SD, Bracci PM, Morton LM, Wang R, Brennan P, Hartge P, Boffetta P, Becker N, Maynadie M, Foretova L, Cocco P, Staines A, Holford T, Holly EA, Nieters A, Benavente Y, Bernstein L, Zahm SH, Zheng T (2008). Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am J Epidemiol  167, 1321-31.   https://doi.org/10.1093/aje/kwn058",https://intramural.nih.gov/search/searchview.taf?ipid=50990
717,CP010175-08,"October 01, 2007 -  September 30, 2008",Molecular Targets - Colon Cancer,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Constance M Cultraro,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50991
718,CP010176-08,"October 01, 2007 -  September 30, 2008",Epidemiology and Natural History of Cancer-Associated Viruses,"Eric Andrew Engels; PhD|IRP Faculty Profile  |James Jerome Goedert; MD| | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sam  Mbulaiteye|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",Charles  Rabkin|Anil Kumar Chaturvedi,NULL,"Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|Ola Anders Landgren (Genetic Epidemiology Branch)|Ann  Hsing; PhD (Hormonal and Reproductive Epidemiology Branch)",NULL,"1. Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW (2010). Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome. Int J Cancer  127, 1493-6.   https://doi.org/10.1002/ijc.25136|2. Biggar R, Mbulaiteye S, Rabkin C (2008) Human herpesvirus 8 load and progression of AIDS-related Kaposi  sarcoma lesions. Cancer Lett 182-188.|3. Carpenter LM, Newton R, Casabonne D, Ziegler J, Mbulaiteye S, Mbidde E, Wabinga H, Jaffe H, Beral V (2008). Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int J Cancer  122, 1319-23.   https://doi.org/10.1002/ijc.23254|4. Chaturvedi AK, Mbulaiteye SM, Engels EA (2008). Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers. Ann Epidemiol  18, 230-4.   https://doi.org/10.1016/j.annepidem.2007.10.005|5. de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM, Spinelli JJ, Zheng T, Zhang Y, Franceschi S, Talamini R, Holly EA, Grulich AE, Cerhan JR, Hartge P, Cozen W, Boffetta P, Brennan P, Maynadié M, Cocco P, Bosch R, Foretova L, Staines A, Becker N, Nieters A (2008). Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol  6, 451-8.   https://doi.org/10.1016/j.cgh.2008.02.011|6. Ekström Smedby K, Vajdic CM, Falster M, Engels EA, Martínez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjosé S, Chiu BC, Dal Maso L, Cocco P, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, et al. [6 more authors] (2008). Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood  111, 4029-38.   https://doi.org/10.1182/blood-2007-10-119974|7. Engels E (2008) Incidence and outcomes of malignancy in the HAART era in an urban  cohort of HIV-infected individuals. AIDS 489-496.|8. Gillison ML, Chaturvedi AK, Lowy DR (2008). HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer  113, 3036-46.   https://doi.org/10.1002/cncr.23764|9. Guech-Ongey M, Engels EA, Goedert JJ, Biggar RJ, Mbulaiteye SM (2008). Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States. Int J Cancer  122, 2590-3.   https://doi.org/10.1002/ijc.23384|10. Mbulaiteye S, Rabkin C (2008) Intestinal parasites in kaposi sarcoma patients in Uganda:  indication of shared risk factors or etiologic association. Am J Trop Med Hyg 409-412.|11. Mbulaiteye SM, Goedert JJ (2008). Transmission of Kaposi sarcoma-associated herpesvirus in sub-Saharan Africa. AIDS  22, 535-7.   https://doi.org/10.1097/QAD.0b013e3282f4352e|12. Mbulaiteye SM, Pfeiffer RM, Dolan B, Tsang VC, Noh J, Mikhail NN, Abdel-Hamid M, Hashem M, Whitby D, Thomas Strickland G, Goedert JJ (2008). Seroprevalence and risk factors for human herpesvirus 8 infection, rural Egypt. Emerg Infect Dis  14, 586-91.   https://doi.org/10.3201/eid1404.070935|13. Newton R, Ziegler J, Casabonne D, Beral V, Mbidde E, Carpenter L, Maxwell Parkin D, Wabinga H, Mbulaiteye S, Jaffe H, Uganda Kaposi''s Sarcoma Study Group (2007). A case-control study of cancer of the uterine cervix in Uganda. Eur J Cancer Prev  16, 555-8.   https://doi.org/10.1097/01.cej.0000243863.22137.b7|14. Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM (2008). Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer  123, 2658-63.   https://doi.org/10.1002/ijc.23800|15. Pandey JP, Namboodiri AM, Luo Y, Wu Y, Elston RC, Thomas DL, Rosen HR, Goedert JJ (2008). Genetic markers of IgG influence the outcome of infection with hepatitis C virus. J Infect Dis  198, 1334-6.   https://doi.org/10.1086/592282|16. Rabkin C (2008) Rapid and sustained clearance of circulating lymphoma cells after  chemotherapy plus rituximab: clinical significance of quantitative  t(14;18) PCR monitoring in advanced stage follicular lymphoma patients. Br J Haematol 631-640.|17. Rabkin CS, Hirt C, Janz S, Dölken G (2008). t(14;18) Translocations and risk of follicular lymphoma. J Natl Cancer Inst Monogr   48-51  https://doi.org/10.1093/jncimonographs/lgn002|18. Schetter AJ, You WC, Lennette ET, Gail MT, Rabkin CS (2008). Association of Epstein-Barr virus antibody levels with precancerous gastric lesions in a high-risk cohort. Cancer Sci  99, 350-4.   https://doi.org/10.1111/j.1349-7006.2007.00668.x|19. Truelove AL, Oleksyk TK, Shrestha S, Thio CL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ, Smith MW (2008). Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Int J Immunogenet  35, 255-64.   https://doi.org/10.1111/j.1744-313X.2008.00770.x",https://intramural.nih.gov/search/searchview.taf?ipid=50992
719,CP010177-08,"October 01, 2007 -  September 30, 2008",HPV Vaccine Trials,Mark  Schiffman; MD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Mahboobeh  Safaeian|Mark E Sherman; MD|Philip E Castle; PhD, MPH|Roni T Falk|Sophia S Wang; PhD|Diane  Solomon; PhD",NULL,"Douglas  Lowy; MD (Laboratory of Cellular Oncology)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Ligia  Pinto  (Infection & Immunoepidemiology Branch)",NULL,"1. Baker R, Dauner JG, Rodriguez AC, Williams MC, Kemp TJ, Hildesheim A, Pinto LA (2011). Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection. Cytokine  53, 282-5.   https://doi.org/10.1016/j.cyto.2010.11.014",https://intramural.nih.gov/search/searchview.taf?ipid=50993
720,CP010178-07,"October 01, 2007 -  September 30, 2008",Core Genotyping Facility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,NULL,Gilles F Thomas (Laboratory Translational Genomics),NULL,"1. Chanock S (2008) Genomics: when the smoke clears.(Editorial Material). Nature 537-538.|2. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, et al. [14 more authors] (2008). Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet  40, 310-5.   https://doi.org/10.1038/ng.91",https://intramural.nih.gov/search/searchview.taf?ipid=50995
721,CP010180-07,"October 01, 2007 -  September 30, 2008",Prostate Cancer Studies,Ann  Hsing; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Sabah  Quraishi,NULL,Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch),NULL,"1. Chu LW, Zhu Y, Yu K, Zheng T, Yu H, Zhang Y, Sesterhenn I, Chokkalingam AP, Danforth KN, Shen MC, Stanczyk FZ, Gao YT, Hsing AW (2008). Variants in circadian genes and prostate cancer risk: a population-based study in China. Prostate Cancer Prostatic Dis  11, 342-8.   https://doi.org/10.1038/sj.pcan.4501024|2. Danforth KN, Hayes RB, Rodriguez C, Yu K, Sakoda LC, Huang WY, Chen BE, Chen J, Andriole GL, Calle EE, Jacobs EJ, Chu LW, Figueroa JD, Yeager M, Platz EA, Michaud DS, Chanock SJ, Thun MJ, Hsing AW (2008). Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies. Carcinogenesis  29, 568-72.   https://doi.org/10.1093/carcin/bgm253|3. Hsing A, Chanock S (2008) Polymorphisms in angiogenesis-related genes and prostate cancer. Cancer Epidemiol Biomarkers 972-977.|4. Hsing AW, Sakoda LC, Chen J, Chokkalingam AP, Sesterhenn I, Gao YT, Xu J, Zheng SL (2007). MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China. Carcinogenesis  28, 2530-6.   https://doi.org/10.1093/carcin/bgm196",https://intramural.nih.gov/search/searchview.taf?ipid=51010
722,CP010181-06,"October 01, 2007 -  September 30, 2008",Methods for Epidemiology Studies,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  |Jay  Lubin; PhD| | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  |Nilanjan  Chatterjee",NULL,"Biostatistics Branch, NCI",Hormuzdiar Aspandiar Katki; MS|Junmo  Nam|Kai  Yu,NULL,"Edward L Korn (Clinical Trials Section)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Mark H Greene; MD (Clinical Genetics Branch)|Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Sam  Mbulaiteye (Infection & Immunoepidemiology Branch)",NULL,"1. Breslow RA, Graubard BI (2008). Prospective study of alcohol consumption in the United States: quantity, frequency, and cause-specific mortality. Alcohol Clin Exp Res  32, 513-21.   https://doi.org/10.1111/j.1530-0277.2007.00595.x|2. Chatterjee N (2008) Retrospective analysis of haplotype-based case control studies under  a flexible model for gene environment association. BIOSTATISTICS 81-99.|3. Chatterjee N, Chen YH (2007). A semiparametric pseudo-score method for analysis of two-phase studies with continuous phase-I covariates. Lifetime Data Anal  13, 607-22.   https://doi.org/10.1007/s10985-007-9066-9|4. Chen YH, Chatterjee N, Carroll RJ (2008). Retrospective analysis of haplotype-based case control studies under a flexible model for gene environment association. Biostatistics  9, 81-99.   https://doi.org/10.1093/biostatistics/kxm011|5. Efstathia B, Pfeiffer R (2008) On the distribution of the left singular vectors of a random matrix and its applications. STAT PROBABIL LETT 78:2275-558|6. Flegal KM, Graubard BI, Williamson DF, Gail MH (2008). Response to ""Biased Corrections or Biased About Corrections"" Obesity (Silver Spring)  17, 940.   https://doi.org/10.1038/oby.2009.13|7. Gail M (2008) Response: Re: Projecting individualized absolute invasive breast  cancer risk in African American women (Letter to Editor). Journal of the National Cancer Institute 684-684.|8. Gail M, Bernstein L, Costantino J, Pee D, Ursin G (2008) Response: Re: Projecting individualized absolute invasive breast cancer risk in African American women (Letter to Editor). Journal of the National Cancer Institute 100:684-684|9. Gail MH (2008). Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst  100, 1037-41.   https://doi.org/10.1093/jnci/djn180|10. Gail MH (2008). Estimation and interpretation of models of absolute risk from epidemiologic data, including family-based studies. Lifetime Data Anal  14, 18-36.   https://doi.org/10.1007/s10985-007-9070-0|11. Graubard B (2008) Ethnic and socioeconomic differences in variability in nutritional  biomarkers. AMERICAN JOURNAL OF CLINICAL NUTRITION 1464-1471.|12. Lobach I, Carroll RJ, Spinka C, Gail MH, Chatterjee N (2008). Haplotype-based regression analysis and inference of case-control studies with unphased genotypes and measurement errors in environmental exposures. Biometrics  64, 673-84.   https://doi.org/10.1111/j.1541-0420.2007.00930.x|13. Lubin JH, Virtamo J, Weinstein SJ, Albanes D (2008). Cigarette smoking and cancer: intensity patterns in the alpha-tocopherol, beta-carotene cancer prevention study in Finnish men. Am J Epidemiol  167, 970-5.   https://doi.org/10.1093/aje/kwm392|14. Menashe I, Rosenberg PS, Chen BE (2008). PGA: power calculator for case-control genetic association analyses. BMC Genet  9, 36.   https://doi.org/10.1186/1471-2156-9-36|15. Mukherjee B, Chatterjee N (2008). Exploiting gene-environment independence for analysis of case-control studies: an empirical Bayes-type shrinkage estimator to trade-off between bias and efficiency. Biometrics  64, 685-94.   https://doi.org/10.1111/j.1541-0420.2007.00953.x|16. Yu K, Wang Z, Li Q, Wacholder S, Hunter DJ, Hoover RN, Chanock S, Thomas G (2008). Population substructure and control selection in genome-wide association studies. PLoS One  3, e2551.   https://doi.org/10.1371/journal.pone.0002551",https://intramural.nih.gov/search/searchview.taf?ipid=50952
723,CP010182-06,"October 01, 2007 -  September 30, 2008",Epidemiologic Field Studies,"Nilanjan  Chatterjee| | |Barry Ira Graubard; PhD|IRP Faculty Profile  |Jay  Lubin; PhD| | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Catherine G Schairer|Gloria L Gridley,NULL,"Alina V Brenner (Radiation Epidemiology Branch)|Andre  Bouville (Radiation Epidemiology Branch)|Arthur  Schatzkin; PhD (Nutritional Epidemiology Branch)|Claudine M Samanic (Occupational and Environmental Epidemiology Branch)|Dalsu  Baris (Occupational and Environmental Epidemiology Branch)|Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)",NULL,"1. (2008) Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) program. Breast Cancer Res Treat (epub) na:na.|2. Moore SC, Mayne ST, Graubard BI, Schatzkin A, Albanes D, Schairer C, Hoover RN, Leitzmann MF (2008). Past body mass index and risk of mortality among women. Int J Obes (Lond)  32, 730-9.   https://doi.org/10.1038/sj.ijo.0803801|3. Schouten LJ, Rivera C, Hunter DJ, Spiegelman D, Adami HO, Arslan A, Beeson WL, van den Brandt PA, Buring JE, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Hankinson SE, Lacey JV, Leitzmann M, Lukanova A, Marshall JR, Miller AB, Patel AV, Rodriguez C, Rohan TE, Ross JA, Wolk A, Zhang SM, et al. [1 more author] (2008). Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev  17, 902-12.   https://doi.org/10.1158/1055-9965.EPI-07-2524|4. Strayer L, Jacobs DR, Schairer C, Schatzkin A, Flood A (2007). Dietary carbohydrate, glycemic index, and glycemic load and the risk of colorectal cancer in the BCDDP cohort. Cancer Causes Control  18, 853-63.   https://doi.org/10.1007/s10552-007-9030-8",https://intramural.nih.gov/search/searchview.taf?ipid=50998
724,CP010183-06,"October 01, 2007 -  September 30, 2008",Descriptive Studies and Record Linkage,William Frederick Anderson,NULL,"Biostatistics Branch, NCI","Catherine G Schairer|Gloria L Gridley|Jay  Lubin; PhD|Mitchell Henry Gail; PhD, MD|Nilanjan  Chatterjee|Philip Samuel Rosenberg; PhD|Show all 8",NULL,Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Ann  Hsing; PhD (Hormonal and Reproductive Epidemiology Branch)|Asad  Umar (Gastrointestinal and Other Cancer Research Group)|Charles  Rabkin (Infection & Immunoepidemiology Branch)|Claudine M Samanic (Occupational and Environmental Epidemiology Branch)|Dalsu  Baris (Occupational and Environmental Epidemiology Branch),NULL,"1. (2008) Deep vein thrombosis following monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma. Blood 112:3582-6.|2. (2008) Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) program. Breast Cancer Res Treat (epub) na:na.|3. (2008) OCCUPATIONAL PHYSICAL ACTIVITY AND RISK FOR CANCER OF THE COLON AND RECTUM AMONG MEN AND WOMEN BY ANATOMIC SUBSITE IN SWEDEN. Eur J Cancer Prev 17:201-8.|4. (2008) Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 7:3388-3394.|5. (2008) Shared occupational risks for transitional cell cancer of the bladder and renal pelvis among men and women in Sweden (Review). Amer J Ind Med 2:83-99.|6. Anderson WF (2009). Cancer surveillance research. Cancer Epidemiol Biomarkers Prev  18, 1669-71.   https://doi.org/10.1158/1055-9965.EPI-09-0318|7. Anderson WF, Jatoi I, Tse J, Rosenberg PS (2010). Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol  28, 232-9.   https://doi.org/10.1200/JCO.2009.23.8162|8. Bluhm E, McNeil DE, Cnattingius S, Gridley G, El Ghormli L, Fraumeni JF (2008). Prenatal and perinatal risk factors for neuroblastoma. Int J Cancer  123, 2885-90.   https://doi.org/10.1002/ijc.23847|9. Dores GM, Matsuno RK, Weisenburger DD, Rosenberg PS, Anderson WF (2008). Hairy cell leukaemia: a heterogeneous disease? Br J Haematol  142, 45-51.   https://doi.org/10.1111/j.1365-2141.2008.07156.x|10. Edgren G, Tran TN, Hjalgrim H, Rostgaard K, Shanwell A, Titlestad K, Wikman A, Norda R, Jersild C, Wideroff L, Gridley G, Adami J, Melbye M, Nyrén O, Reilly M (2007). Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion  47, 2017-24.   https://doi.org/10.1111/j.1537-2995.2007.01425.x|11. Hjalgrim H, Edgren G, Rostgaard K, Reilly M, Tran TN, Titlestad KE, Shanwell A, Jersild C, Adami J, Wikman A, Gridley G, Wideroff L, Nyrén O, Melbye M (2007). Cancer incidence in blood transfusion recipients. J Natl Cancer Inst  99, 1864-74.   https://doi.org/10.1093/jnci/djm248|12. Koshiol J, Gridley G, Engels EA, McMaster ML, Landgren O (2008). Chronic immune stimulation and subsequent Waldenström macroglobulinemia. Arch Intern Med  168, 1903-9.   https://doi.org/10.1001/archinternmed.2008.4|13. McGlynn KA, Gridley G, Mellemkjaer L, Brinton LA, Anderson KC, Caporaso NE, Landgren O, Olsen JH (2008). Risks of cancer among a cohort of 23,935 men and women with osteoporosis. Int J Cancer  122, 1879-84.   https://doi.org/10.1002/ijc.23290|14. Moradi T, Gridley G, Björk J, Dosemeci M, Ji BT, Berkel HJ, Lemeshow S (2008). Occupational physical activity and risk for cancer of the colon and rectum in Sweden among men and women by anatomic subsite. Eur J Cancer Prev  17, 201-8.   https://doi.org/10.1097/CEJ.0b013e3282b6fd78|15. Wilson RT, Donahue M, Gridley G, Adami J, El Ghormli L, Dosemeci M (2008). Shared occupational risks for transitional cell cancer of the bladder and renal pelvis among men and women in Sweden. Am J Ind Med  51, 83-99.   https://doi.org/10.1002/ajim.20522",https://intramural.nih.gov/search/searchview.taf?ipid=50951
725,CP010184-06,"October 01, 2007 -  September 30, 2008",Consultation and Collaboration,Barry Ira Graubard; PhD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  |Jay  Lubin; PhD,NULL,"Biostatistics Branch, NCI","Gloria L Gridley|Junmo  Nam|Mitchell Henry Gail; PhD, MD|Nilanjan  Chatterjee|Ruth  Pfeiffer; PhD",NULL,Alice  Sigurdson; PhD (Radiation Epidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Ann  Hsing; PhD (Hormonal and Reproductive Epidemiology Branch)|Bu Tian  Ji (Occupational and Environmental Epidemiology Branch)|Charles E. Land; PhD (Radiation Epidemiology Branch)|Claudine M Samanic (Occupational and Environmental Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51000
726,CP010185-06,"October 01, 2007 -  September 30, 2008",Bioterrorism Studies,Martha S Linet; PhD|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",Alice  Sigurdson; PhD|Andre  Bouville|Charles E. Land; PhD|Elaine  Ron; PhD|Maureen Cusack Hatch; MD|Nickolas  Luckyanov|Show all 9,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=50999
727,CP010187-04,"October 01, 2007 -  September 30, 2008",CGEMS,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51008
728,CP010188-04,"October 01, 2007 -  September 30, 2008",Risk prediction methods,"Barry Ira Graubard; PhD|IRP Faculty Profile  |Patricia  Hartge; ScD| |James V Lacey; MPH, PhD| | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Catherine G Schairer,NULL,Andrew  Freedman (Risk Factor Monitoring and Methods Branch)|Demetrius  Albanes; MD (Nutritional Epidemiology Branch)|Kathleen A Cronin (Statistical Research and Applications Branch),NULL,"1. Flegal KM, Graubard BI, Williamson DF, Gail MH (2008). Correcting bias, or biased corrections? Obesity (Silver Spring)  16, 229-31.   https://doi.org/10.1038/oby.2007.41|2. Flegal KM, Graubard BI, Williamson DF, Gail MH (2008). Simple examples should not be extrapolated to the US population. Int J Obes (Lond)  32, 875; author reply 876-7.   https://doi.org/10.1038/sj.ijo.0803788|3. Gail MH, Costantino JP, Pee D, Bondy M, Newman L, Selvan M, Anderson GL, Malone KE, Marchbanks PA, McCaskill-Stevens W, Norman SA, Simon MS, Spirtas R, Ursin G, Bernstein L (2007). Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst  99, 1782-92.   https://doi.org/10.1093/jnci/djm223",https://intramural.nih.gov/search/searchview.taf?ipid=51002
729,CP010190-03,"October 01, 2007 -  September 30, 2008",Genetic Epidemiology of Telomere Maintenance and Cancer Etiology,Mark H Greene; MD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",NULL,NULL,NULL,NULL,"1. Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP (2008). TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet  82, 501-9.   https://doi.org/10.1016/j.ajhg.2007.10.004|2. Savage SA, Greene MH (2007). The evidence for prostate cancer risk loci at 8q24 grows stronger. J Natl Cancer Inst  99, 1499-501.   https://doi.org/10.1093/jnci/djm186",https://intramural.nih.gov/search/searchview.taf?ipid=51011
730,CP010192-01,"October 01, 2007 -  September 30, 2008","Biorepository Processing, Storage, and Research","Shelia K Zahm; ScM, ScD",NULL,"Office of the Director, NCI",Karen E Berliner,NULL,Amy F Subar (Risk Factor Monitoring and Methods Branch)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)|Jorge R Toro (Genetic Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56608
731,CP010193-02,"October 01, 2007 -  September 30, 2008",Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer CohortCons,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Patricia  Hartge; ScD| | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI",NULL,NULL,Geoffrey Scott Tobias (Human Genetics Program)|Julie  Mendelsohn (Epidemiology and Biostatistics Program)|Kai  Yu (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51012
732,CP010194-02,"October 01, 2007 -  September 30, 2008",Diet and Cancer in India,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",Arthur  Schatzkin; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51013
733,CP010195-02,"October 01, 2007 -  September 30, 2008","Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study",Demetrius  Albanes; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,"Amanda  Cross (Nutritional Epidemiology Branch)|Arthur  Schatzkin; PhD (Nutritional Epidemiology Branch)|Barry Ira Graubard; PhD (Biostatistics Branch)|Christian Cormac Abnet; PhD, MPH (Nutritional Epidemiology Branch)|Jiyoung  Ahn (Nutritional Epidemiology Branch)|Kai  Yu (Biostatistics Branch)",NULL,"1. Albanes D, Taylor P, Solomon R, Weinstein S (2008) Flavonoid intake and risk of pancreatic cancer in male smokers  (Finland). Cancer Epidemiol Biomarkers Prev 553-562.|2. Bobe G, Weinstein SJ, Albanes D, Hirvonen T, Ashby J, Taylor PR, Virtamo J, Stolzenberg-Solomon RZ (2008). Flavonoid intake and risk of pancreatic cancer in male smokers (Finland). Cancer Epidemiol Biomarkers Prev  17, 553-62.   https://doi.org/10.1158/1055-9965.EPI-07-2523",https://intramural.nih.gov/search/searchview.taf?ipid=51014
734,CP010196-02,"October 01, 2007 -  September 30, 2008",Prospective Studies of Diet and Cancer in the AARP Cohort,Arthur  Schatzkin; PhD,NULL,"Nutritional Epidemiology Branch, NCI","Yikyung  Park|Rachael Zoe Solomon|Christian Cormac Abnet; PhD, MPH|Li  Jiao",NULL,"James V Lacey; MPH, PhD (Hormonal and Reproductive Epidemiology Branch)|Sara  Schonfeld (Radiation Epidemiology Branch)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)",NULL,"1. Abnet C, Fraumeni J (2008) A prospective study of BMI and risk of oesophageal and gastric  adenocarcinoma. Eur J Cancer 465-471.|2. Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni JF, Leitzmann M, Schatzkin A (2008). A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer  44, 465-71.   https://doi.org/10.1016/j.ejca.2007.12.009|3. Adams KF, Leitzmann MF, Albanes D, Kipnis V, Moore SC, Schatzkin A, Chow WH (2008). Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol  168, 268-77.   https://doi.org/10.1093/aje/kwn122|4. Ahn J, Schatzkin A, Lacey JV, Albanes D, Ballard-Barbash R, Adams KF, Kipnis V, Mouw T, Hollenbeck AR, Leitzmann MF (2007). Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med  167, 2091-102.   https://doi.org/10.1001/archinte.167.19.2091|5. Bao Y, Stolzenberg-Solomon R, Jiao L, Silverman DT, Subar AF, Park Y, Leitzmann MF, Hollenbeck A, Schatzkin A, Michaud DS (2008). Added sugar and sugar-sweetened foods and beverages and the risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr  88, 431-40.   https://doi.org/10.1093/ajcn/88.2.431|6. Brinton LA, Richesson D, Leitzmann MF, Gierach GL, Schatzkin A, Mouw T, Hollenbeck AR, Lacey JV (2008). Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Epidemiol Biomarkers Prev  17, 3150-60.   https://doi.org/10.1158/1055-9965.EPI-08-0435|7. Brinton LA, Richesson DA, Gierach GL, Lacey JV, Park Y, Hollenbeck AR, Schatzkin A (2008). Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst  100, 1477-81.   https://doi.org/10.1093/jnci/djn329|8. Cross AJ, Leitzmann MF, Gail MH, Hollenbeck AR, Schatzkin A, Sinha R (2007). A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med  4, e325.   https://doi.org/10.1371/journal.pmed.0040325|9. Flood A, Rastogi T, Wirfält E, Mitrou PN, Reedy J, Subar AF, Kipnis V, Mouw T, Hollenbeck AR, Leitzmann M, Schatzkin A (2008). Dietary patterns as identified by factor analysis and colorectal cancer among middle-aged Americans. Am J Clin Nutr  88, 176-84.   https://doi.org/10.1093/ajcn/88.1.176|10. Freedman ND, Abnet CC, Leitzmann MF, Hollenbeck AR, Schatzkin A (2007). Prospective investigation of the cigarette smoking-head and neck cancer association by sex. Cancer  110, 1593-601.   https://doi.org/10.1002/cncr.22957|11. Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A, Abnet CC (2008). Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol  9, 649-56.   https://doi.org/10.1016/S1470-2045(08)70154-2|12. Freedman ND, Park Y, Subar AF, Hollenbeck AR, Leitzmann MF, Schatzkin A, Abnet CC (2007). Fruit and vegetable intake and esophageal cancer in a large prospective cohort study. Int J Cancer  121, 2753-60.   https://doi.org/10.1002/ijc.22993|13. Freedman ND, Park Y, Subar AF, Hollenbeck AR, Leitzmann MF, Schatzkin A, Abnet CC (2008). Fruit and vegetable intake and head and neck cancer risk in a large United States prospective cohort study. Int J Cancer  122, 2330-6.   https://doi.org/10.1002/ijc.23319|14. Freedman ND, Schatzkin A, Leitzmann MF, Hollenbeck AR, Abnet CC (2007). Alcohol and head and neck cancer risk in a prospective study. Br J Cancer  96, 1469-74.   https://doi.org/10.1038/sj.bjc.6603713|15. Freedman ND, Subar AF, Hollenbeck AR, Leitzmann MF, Schatzkin A, Abnet CC (2008). Fruit and vegetable intake and gastric cancer risk in a large United States prospective cohort study. Cancer Causes Control  19, 459-67.   https://doi.org/10.1007/s10552-007-9107-4|16. Gierach GL, Lacey JV, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA (2008). Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res  10, R38.   https://doi.org/10.1186/bcr2089|17. Koster A, Leitzmann MF, Schatzkin A, Mouw T, Adams KF, van Eijk JT, Hollenbeck AR, Harris TB (2008). Waist circumference and mortality. Am J Epidemiol  167, 1465-75.   https://doi.org/10.1093/aje/kwn079|18. Leitzmann MF, Park Y, Blair A, Ballard-Barbash R, Mouw T, Hollenbeck AR, Schatzkin A (2007). Physical activity recommendations and decreased risk of mortality. Arch Intern Med  167, 2453-60.   https://doi.org/10.1001/archinte.167.22.2453|19. Mitrou PN, Kipnis V, Thiébaut AC, Reedy J, Subar AF, Wirfält E, Flood A, Mouw T, Hollenbeck AR, Leitzmann MF, Schatzkin A (2007). Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Intern Med  167, 2461-8.   https://doi.org/10.1001/archinte.167.22.2461|20. Moore SC, Chow WH, Schatzkin A, Adams KF, Park Y, Ballard-Barbash R, Hollenbeck A, Leitzmann MF (2008). Physical activity during adulthood and adolescence in relation to renal cell cancer. Am J Epidemiol  168, 149-57.   https://doi.org/10.1093/aje/kwn102|21. Moore SC, Peters TM, Ahn J, Park Y, Schatzkin A, Albanes D, Ballard-Barbash R, Hollenbeck A, Leitzmann MF (2008). Physical activity in relation to total, advanced, and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev  17, 2458-66.   https://doi.org/10.1158/1055-9965.EPI-08-0403|22. Mouw T, Koster A, Wright ME, Blank MM, Moore SC, Hollenbeck A, Schatzkin A (2008). Education and risk of cancer in a large cohort of men and women in the United States. PLoS One  3, e3639.   https://doi.org/10.1371/journal.pone.0003639|23. Park Y, Mitrou PN, Kipnis V, Hollenbeck A, Schatzkin A, Leitzmann MF (2007). Calcium, dairy foods, and risk of incident and fatal prostate cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol  166, 1270-9.   https://doi.org/10.1093/aje/kwm268|24. Reedy J, Mitrou PN, Krebs-Smith SM, Wirfält E, Flood A, Kipnis V, Leitzmann M, Mouw T, Hollenbeck A, Schatzkin A, Subar AF (2008). Index-based dietary patterns and risk of colorectal cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol  168, 38-48.   https://doi.org/10.1093/aje/kwn097|25. Stolzenberg-Solomon RZ, Adams K, Leitzmann M, Schairer C, Michaud DS, Hollenbeck A, Schatzkin A, Silverman DT (2008). Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am J Epidemiol  167, 586-97.   https://doi.org/10.1093/aje/kwm361|26. Stolzenberg-Solomon RZ, Cross AJ, Silverman DT, Schairer C, Thompson FE, Kipnis V, Subar AF, Hollenbeck A, Schatzkin A, Sinha R (2007). Meat and meat-mutagen intake and pancreatic cancer risk in the NIH-AARP cohort. Cancer Epidemiol Biomarkers Prev  16, 2664-75.   https://doi.org/10.1158/1055-9965.EPI-07-0378|27. Thiébaut AC, Kipnis V, Schatzkin A, Freedman LS (2008). The role of dietary measurement error in investigating the hypothesized link between dietary fat intake and breast cancer--a story with twists and turns. Cancer Invest  26, 68-73.   https://doi.org/10.1080/07357900701527918",https://intramural.nih.gov/search/searchview.taf?ipid=56816
735,CP010197-02,"October 01, 2007 -  September 30, 2008","Physical Activity, Energy Balance, and Cancer",Demetrius  Albanes; MD|IRP Faculty Profile  |Wong H Chow| | |Sholom  Wacholder; PhD|IRP Faculty Profile  |Arthur  Schatzkin; PhD,NULL,"Nutritional Epidemiology Branch, NCI",Steven  Moore|Rachael Zoe Solomon,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51015
736,CP010198-02,"October 01, 2007 -  September 30, 2008",Lower Gastrointestinal Cancer Studies,Arthur  Schatzkin; PhD,NULL,"Nutritional Epidemiology Branch, NCI",Amanda  Cross|Rashmi P Sinha; PhD,NULL,Elaine L Lanza (Laboratory of Cancer Prevention),NULL,"1. (2008) Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial. Cancer Causes Control (Epub) na:na.|2. Bobe G, Sansbury LB, Albert PS, Cross AJ, Kahle L, Ashby J, Slattery ML, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Daston C, Marshall JR, Schatzkin A, Lanza E (2008). Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev  17, 1344-53.   https://doi.org/10.1158/1055-9965.EPI-07-0747|3. Flood A, Mai V, Pfeiffer R, Kahle L, Remaley AT, Lanza E, Schatzkin A (2007). Elevated serum concentrations of insulin and glucose increase risk of recurrent colorectal adenomas. Gastroenterology  133, 1423-9.   https://doi.org/10.1053/j.gastro.2007.08.040|4. Flood A, Mai V, Pfeiffer R, Kahle L, Remaley AT, Rosen CJ, Lanza E, Schatzkin A (2008). The effects of a high-fruit and -vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3. Eur J Clin Nutr  62, 186-96.   https://doi.org/10.1038/sj.ejcn.1602726|5. Lim U, Flood A, Choi SW, Albanes D, Cross AJ, Schatzkin A, Sinha R, Katki HA, Cash B, Schoenfeld P, Stolzenberg-Solomon R (2008). Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women. Gastroenterology  134, 47-55.   https://doi.org/10.1053/j.gastro.2007.10.013|6. Murphy G, Sansbury L, Lanza E, Laiyemo A, Wang Z, Solomon R, Cross A, Albert P   (2008) Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention 							Trial.  Cancer Causes Control (Epub)  na pp.|7. Murphy G, Sansbury LB, Cross AJ, Stolzenberg-Solomon R, Laiyemo A, Albert PS, Wang Z, Schatzkin A, Lehman T, Kalidindi A, Modali R, Lanza E (2008). Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial. Cancer Causes Control  19, 751-8.   https://doi.org/10.1007/s10552-008-9137-6|8. Pfeiffer R, Lanza E, McShane L (2008) The effects of a high-fruit and -vegetable, high-fiber, low-fat  dietary intervention on serum concentrations of insulin, glucose, IGF-I  and IGFBP-3. Eur J Clin Nutr 186-196.|9. Schatzkin A, Lanza E, Pfeiffer R (2008) Insulin resistance and colorectal adenomas-Reply (Letter). Gastroenterology 1269-1270.|10. Schatzkin A, Lanza E, Wang Z, Murphy G (2008) Polynucleotide kinase 3' phosphatase variant, dietary variables and  risk of adenoma recurrence in the Polyp Prevention Trial. Eur J Cancer Prev 287-290.|11. Schatzkin A, Sinha R, Albanes D, Solomon R, Cross A (2008) Genomic methylation of leukocyte DNA in relation to colorectal  adenoma among asymptomatic women. CANCER RES 47-55.",https://intramural.nih.gov/search/searchview.taf?ipid=51016
737,CP010199-02,"October 01, 2007 -  September 30, 2008",Methods for Etiologic Studies of Diet and Cancer,Arthur  Schatzkin; PhD,NULL,"Nutritional Epidemiology Branch, NCI",Amanda  Cross|Rashmi P Sinha; PhD|Yikyung  Park|Rachael Zoe Solomon,NULL,Amy F Subar (Risk Factor Monitoring and Methods Branch)|Douglas N Midthune (Biometry Research Group)|Frances E Thompson (Risk Factor Monitoring and Methods Branch)|Richard P Troiano (Risk Factor Monitoring and Methods Branch)|Victor  Kipnis (Biometry Research Group),NULL,"1. Freedman LS, Kipnis V, Schatzkin A, Potischman N (2008). Methods of epidemiology: evaluating the fat-breast cancer hypothesis--comparing dietary instruments and other developments. Cancer J  14, 69-74.   https://doi.org/10.1097/PPO.0b013e31816a5e02|2. Schatzkin A, Dodd K, Subar A (2008) Using Biomarker Data to Adjust Estimates of the Distribution of Usual  Intakes for Misreporting: Application to Energy Intake in the US  Population. J Am Diet Assoc 455-464.|3. Schatzkin A, Freedman L (2008) The role of dietary measurement error in investigating the  hypothesized link between dietary fat intake and breast cancer--a story  with twists and turns. Cancer Invest 68-73.|4. Schatzkin A, Potischman N (2008) Methods of Epidemiology: Evaluating the Fat-Breast Cancer Hypothesis  - Comparing Dietary Instruments and Other Developments. Cancer J 69-74.|5. Yanetz R, Kipnis V, Carroll RJ, Dodd KW, Subar AF, Schatzkin A, Freedman LS (2008). Using biomarker data to adjust estimates of the distribution of usual intakes for misreporting: application to energy intake in the US population. J Am Diet Assoc  108, 455-64; discussion 464.   https://doi.org/10.1016/j.jada.2007.12.004",https://intramural.nih.gov/search/searchview.taf?ipid=51017
738,CP010200-01,"October 01, 2007 -  September 30, 2008",Genome-Wide Association Studies,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Nilanjan  Chatterjee| | |Joseph  Fraumeni; MD|IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,NULL,Mark  Purdue (Occupational and Environmental Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=56610
739,SC000165-17,"October 01, 2007 -  September 30, 2008",The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis,Michael  Birrer,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51030
740,SC000167-17,"October 01, 2007 -  September 30, 2008",Molecular Pathology of Pulmonary Carcinogenesis,Ilona  Linnoila; MD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,"Neil Edward Caporaso; MS, MD (National Cancer Institute)|Jin  Jen (National Cancer Institute)|Jeffrey E Green; MD (National Cancer Institute)|Phillip A Dennis; MD, PhD (National Cancer Institute)|Maria Teresa Pia Landi; MD, PhD (National Cancer Institute)",NULL,"1. Landi MT, Consonni D, Rotunno M, Bergen AW, Goldstein AM, Lubin JH, Goldin L, Alavanja M, Morgan G, Subar AF, Linnoila I, Previdi F, Corno M, Rubagotti M, Marinelli B, Albetti B, Colombi A, Tucker M, Wacholder S, Pesatori AC, Caporaso NE, Bertazzi PA (2008). Environment And Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health  8, 203.   https://doi.org/10.1186/1471-2458-8-203",https://intramural.nih.gov/search/searchview.taf?ipid=51031
741,SC000181-16,"October 01, 2007 -  September 30, 2008",The Molecular Genetics of Gynecologic Cancers,Michael  Birrer,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Laurent L Ozbun|Christopher S Newton; PhD|Vinod  Vathipadiekal,"Denise  Connelly (Ovarian SPORE, FOX Chase Cancer Center)|Samuel  Mok (Gynecologic Oncology, Harvard University)|Anil  Sood (Gynecologic Oncology, MDACC)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51032
742,SC000550-28,"October 01, 2007 -  September 30, 2008",Lymphoma Disease Discovery and Defintion,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Stefania  Pittaluga|Katherine Rainsford Calvo|Franziska Carola Eberle,NULL,"Jonathan Keith Killian (National Cancer Institute)|Paul S Meltzer; MD, PhD (National Cancer Institute)",NULL,"1. Calvo KR, Dabir B, Kovach A, Devor C, Bandle R, Bond A, Shih JH, Jaffe ES (2008). IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood  112, 3818-26.   https://doi.org/10.1182/blood-2008-02-138933",https://intramural.nih.gov/search/searchview.taf?ipid=51033
743,SC000853-55,"October 01, 2007 -  September 30, 2008",Surgical Pathology,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,"1. Filie AC, Asa SL, Geisinger KR, Logani S, Merino M, Nikiforov YE, Clark DP (2008). Utilization of ancillary studies in thyroid fine needle aspirates: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol  36, 438-41.   https://doi.org/10.1002/dc.20831|2. Mutter GL, Bergeron C, Deligdisch L, Ferenczy A, Glant M, Merino M, Williams AR, Blithe DL (2008) The spectrum of endometrial pathology induced by progesterone receptor modulators. Mod Pathol 21:591-8|3. Signoretti S, Bratslavsky G, Waldman FM, Reuter VE, Haaga J, Merino M, Thomas GV, Pins MR, Libermann T, Gillespie J, Tomaszewski JE, Compton CC, Hruszkewycz A, Linehan WM, Atkins MB (2008). Tissue-based research in kidney cancer: current challenges and future directions. Clin Cancer Res  14, 3699-705.   https://doi.org/10.1158/1078-0432.CCR-07-4733|4. Stegmann BJ, Sinaii N, Liu S, Segars J, Merino M, Nieman LK, Stratton P (2008). Using location, color, size, and depth to characterize and identify endometriosis lesions in a cohort of 133 women. Fertil Steril  89, 1632-6.   https://doi.org/10.1016/j.fertnstert.2007.05.042",https://intramural.nih.gov/search/searchview.taf?ipid=51034
744,SC000892-25,"October 01, 2007 -  September 30, 2008",Molecular Biology of the Metastatic Phenotype,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",NULL,"Jean-Yves  Daniel (Biologie de Differentiation et Development, Universite Victor Segalen)|Marie-Lise  Lacombe (Faculte de Medicine Saint Antoine, Iniversite Pierre et Marie Curie)|Kathy  Miller (Oncology, Indiana University)",William D Figg; PharmD (National Cancer Institute)|Seth M Steinberg; PhD (National Cancer Institute)|Maria  Merino; PhD (National Cancer Institute)|Nealapheur L Khan (National Cancer Institute)|Cari E Graff-Cherry (National Cancer Institute),Abdel G Elkahloun; PhD (NHGRI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51035
745,SC003657-34,"October 01, 2007 -  September 30, 2008",Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases,"Stephen I Katz; PhD, MD",NULL,"Dermatology Branch, NCI",Jay T Linton|Fumi  Miyagawa|Young-Hun  Cho|Emily Anne Nelson|Jan  Gutermuth,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51036
746,SC003669-19,"October 01, 2007 -  September 30, 2008",Regulation of Cutaneous Accessory Cell Activity in Health and Disease,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Michael C Lu|Christine A Dewitt; MD|Olga  Milgrom,NULL,"Stephen I Katz; PhD, MD (National Cancer Institute)",NULL,"1. Leitner W   (2008) Enhancement of DNA tumor vaccine efficacy by gene gun-mediated co-delivery of  threshold amounts of plasmid-encoded helper antigen.  Blood, in press.|2. Udey M   (2008) Characteristics and functions of murine cutaneous dendritic cells: a synopsis of  recent developments.  Mucosal Immunology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=51037
747,SC003670-16,"October 01, 2007 -  September 30, 2008",Keratinocyte Gene Therapy,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI",Carole L Yee|Atsushi  Terunuma|Jean-Philippe  Therrien,NULL,NULL,Jurgen B Schnermann; MD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51038
748,SC003800-38,"October 01, 2007 -  September 30, 2008",Surgical Consultants & Collaborative Research Involving Surgical Services at NIH,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Marybeth S Hughes|Itzhak  Avital,NULL,"Udai S Kammula (National Cancer Institute)|James Chung-Yin Yang; MD, PhD (National Cancer Institute)|Nicholas Phillip Restifo; MD (National Cancer Institute)|Richard Eldon Royal (National Cancer Institute)|Richard  Sherry; MD (National Cancer Institute)",NULL,"1. Abad JD, Wrzensinski C, Overwijk W, De Witte MA, Jorritsma A, Hsu C, Gattinoni L, Cohen CJ, Paulos CM, Palmer DC, Haanen JB, Schumacher TN, Rosenberg SA, Restifo NP, Morgan RA (2008). T-cell receptor gene therapy of established tumors in a murine melanoma model. J Immunother  31, 1-6.   https://doi.org/10.1097/CJI.0b013e31815c193f|2. Breunis WB, Tarazona-Santos E, Chen R, Kiley M, Rosenberg SA, Chanock SJ (2008). Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade. J Immunother  31, 586-90.   https://doi.org/10.1097/CJI.0b013e31817fd8f3|3. Heemskerk B, Liu K, Dudley ME, Johnson LA, Kaiser A, Downey S, Zheng Z, Shelton TE, Matsuda K, Robbins PF, Morgan RA, Rosenberg SA (2008). Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2. Hum Gene Ther  19, 496-510.   https://doi.org/10.1089/hum.2007.0171|4. Hinrichs CS, Spolski R, Paulos CM, Gattinoni L, Kerstann KW, Palmer DC, Klebanoff CA, Rosenberg SA, Leonard WJ, Restifo NP (2008). IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood  111, 5326-33.   https://doi.org/10.1182/blood-2007-09-113050|5. Klapper JA, Downey SG, Smith FO, Yang JC, Hughes MS, Kammula US, Sherry RM, Royal RE, Steinberg SM, Rosenberg S (2008). High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006. Cancer  113, 293-301.   https://doi.org/10.1002/cncr.23552|6. Palmer DC, Chan CC, Gattinoni L, Wrzesinski C, Paulos CM, Hinrichs CS, Powell DJ, Klebanoff CA, Finkelstein SE, Fariss RN, Yu Z, Nussenblatt RB, Rosenberg SA, Restifo NP (2008). Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity. Proc Natl Acad Sci U S A  105, 8061-6.   https://doi.org/10.1073/pnas.0710929105|7. Powell DJ, Attia P, Ghetie V, Schindler J, Vitetta ES, Rosenberg SA (2008). Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration. J Immunother  31, 189-98.   https://doi.org/10.1097/CJI.0b013e31815dc0e8|8. Robbins PF, Li YF, El-Gamil M, Zhao Y, Wargo JA, Zheng Z, Xu H, Morgan RA, Feldman SA, Johnson LA, Bennett AD, Dunn SM, Mahon TM, Jakobsen BK, Rosenberg SA (2008). Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions. J Immunol  180, 6116-31.   https://doi.org/10.4049/jimmunol.180.9.6116|9. Rosenberg SA (2008). Why perform sentinel-lymph-node biopsy in patients with melanoma? Nat Clin Pract Oncol  5, 1.   https://doi.org/10.1038/ncponc1022|10. Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME (2008). Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer  8, 299-308.   https://doi.org/10.1038/nrc2355|11. Wargo JA, Robbins PF, Li Y, Zhao Y, El-Gamil M, Caragacianu D, Zheng Z, Hong JA, Downey S, Schrump DS, Rosenberg SA, Morgan RA (2009). Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression. Cancer Immunol Immunother  58, 383-94.   https://doi.org/10.1007/s00262-008-0562-x|12. Yang S, Cohen CJ, Peng PD, Zhao Y, Cassard L, Yu Z, Zheng Z, Jones S, Restifo NP, Rosenberg SA, Morgan RA (2008). Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition. Gene Ther  15, 1411-23.   https://doi.org/10.1038/gt.2008.90",https://intramural.nih.gov/search/searchview.taf?ipid=51039
749,SC004002-39,"October 01, 2007 -  September 30, 2008",IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Liyanage P Perera; PhD|Yutaka  Tagaya; MD, PhD|Sigrid Priscilla Dubois|Carolyn  Goldman|Michael N Petrus|Kayhan  Garmestani; PhD|Show all 13",NULL,"Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)|Stephen I Katz; PhD, MD (Office of the Director)|John  Janik; MD (National Cancer Institute)|John Charles Morris; MD (National Cancer Institute)",Jorge A Carrasquillo; MD (CC) |Henry F McFarland; MD (NINDS) |Robert B. Nussenblatt; MD (NEI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51041
750,SC004020-31,"October 01, 2007 -  September 30, 2008","Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Masaki  Terabe|Charles D Pendleton|Amiran  Dzutsev; PhD|Qing  Zhu|Susan J Gagnon|Miranda  Oakley|Show all 12,"Vincenzo  Bronte|Donald  Burke (Ctr Immunization Research, Johns Hopkins Sch Publ Health)|David  Carbone (Medicine, Vanderbilt University)|Charles  Delisi|Debra  Donaldson; PhD (Immunology, Wyeth-Genetics Institute)|Guido  Forni (Clinical and Biological Sciences, University of Turin)|Show all 18","Allan  Hildesheim; PhD (National Cancer Institute)|William Marston Linehan; MD (National Cancer Institute)|Ligia  Pinto (Infection & Immunoepidemiology Branch)|Ira H Pastan; MD (National Cancer Institute)|Lee Jay Helman; MD (National Cancer Institute)|Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)","Warren  Strober; MD (NIAID) |Patricia  Earl; PhD (NIAID) |Brian R. Murphy; MD (NIAID) |Peter Leon Collins; PhD (NIAID) |Brian  Kelsall; MD (NIAID) |Gary J Nabel; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51043
751,SC006321-29,"October 01, 2007 -  September 30, 2008",Modulation of Therapeutic Response,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|William  Degraff|Anastasia L Sowers|Janet W Gamson|Rajani  Choudhuri|Askale Y Mathias,NULL,Murali  Krishna; PhD (National Cancer Institute)|Deborah E Citrin (National Cancer Institute),"Carter  Van Waes; MD, PhD (NIDCD) |Bruce J Baum; DMD, PhD (NIDCR)","1. Guo Z, Tsai MH, Shiao YH, Chen LH, Wei ML, Lv X, Gius D, Little JB, Mitchell JB, Chuang EY (2008). DNA (cytosine-5)-methyltransferase 1 as a mediator of mutant p53-determined p16(ink4A) down-regulation. J Biomed Sci  15, 163-8.   https://doi.org/10.1007/s11373-007-9222-y|2. Moens AL, Takimoto E, Tocchetti CG, Chakir K, Bedja D, Cormaci G, Ketner EA, Majmudar M, Gabrielson K, Halushka MK, Mitchell JB, Biswal S, Channon KM, Wolin MS, Alp NJ, Paolocci N, Champion HC, Kass DA (2008). Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation  117, 2626-36.   https://doi.org/10.1161/CIRCULATIONAHA.107.737031",https://intramural.nih.gov/search/searchview.taf?ipid=51045
752,SC006329-27,"October 01, 2007 -  September 30, 2008",Clinical Radiation Physics Service,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Guang  Li|Hu-Chen  Xie|Holly  Ning|Frank S Harrington|Barbara Chin Arora|Jason Yulin Cheng; PhD|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51022
753,SC006330-27,"October 01, 2007 -  September 30, 2008",Radiation Field Modeling and Computerized Treatment Planning,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Guang  Li|Hu-Chen  Xie|Holly  Ning|Frank S Harrington|Barbara Chin Arora|Jason Yulin Cheng; PhD|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51023
754,SC006353-26,"October 01, 2007 -  September 30, 2008",Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Diane E Milenic|Kwamena  Baidoo|Ambika  Bumb,"Barry  Allen (Experiemental Radiation Oncology, St. George Cancer Care Center)|Ruby  Meredith (UAB)|Andrew  Scott (Tumour Targeting Program, Ludwig Institute for Cancer Research)|Scott  Wilbur (Radiation Oncology, U. of Washington)","Peter L Choyke; MD (National Cancer Institute)|Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)|David R Gius; MD, PhD (National Cancer Institute)|James B Mitchell; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51046
755,SC006358-25,"October 01, 2007 -  September 30, 2008","Radiolysis, Photolysis, Sonolysis and Sonoprotection of Cells",Peter  Riesz; PhD,NULL,"Radiation Biology Branch, NCI",Shinji  Ito,"Takashi  Kondo (Department of Radiological Sciences, Toyama Medical and Pharmaceutical University)|Norio  Miyoshi (Pathology, Fukui Medical University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51047
756,SC006387-21,"October 01, 2007 -  September 30, 2008",Nitroxides as Protectors Against Oxidative Stress,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|William  Degraff|Anastasia L Sowers|Janet W Gamson|Rajani  Choudhuri|Eric Y Chuang|Show all 7,NULL,Murali  Krishna; PhD (National Cancer Institute)|Michael  Potter; MD (National Cancer Institute),NULL,"1. Ghosh MC, Tong WH, Zhang D, Ollivierre-Wilson H, Singh A, Krishna MC, Mitchell JB, Rouault TA (2008). Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice. Proc Natl Acad Sci U S A  105, 12028-33.   https://doi.org/10.1073/pnas.0805361105",https://intramural.nih.gov/search/searchview.taf?ipid=51048
757,SC006536-12,"October 01, 2007 -  September 30, 2008",Sample Processing and Analytical Methods Development for New Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Kathryn  Compton|Gareth  Peters|Lokesh  Jain|Matthew  Danish|Xiaohong  Chen|Diana  Roame|Show all 10,NULL,William Laurence Dahut; MD (National Cancer Institute)|Shivaani  Kummar; PhD (National Cancer Institute),NULL,"1. Chen X, Gardner ER, Figg WD (2008). Determination of the cyclic depsipeptide FK228 in human and mouse plasma by liquid chromatography with mass-spectrometric detection. J Chromatogr B Analyt Technol Biomed Life Sci  865, 153-8.   https://doi.org/10.1016/j.jchromb.2008.02.015|2. Chen X, Gardner ER, Price DK, Figg WD (2008). Development and validation of an LC-MS assay for finasteride and its application to prostate cancer prevention trial sample analysis. J Chromatogr Sci  46, 356-61.   https://doi.org/10.1093/chromsci/46.4.356|3. Gardner ER, Dahut W, Figg WD (2008). Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment. J Chromatogr B Analyt Technol Biomed Life Sci  862, 213-8.   https://doi.org/10.1016/j.jchromb.2007.12.013|4. Jain L, Gardner ER, Venitz J, Dahut W, Figg WD (2008). Development of a rapid and sensitive LC-MS/MS assay for the determination of sorafenib in human plasma. J Pharm Biomed Anal  46, 362-7.   https://doi.org/10.1016/j.jpba.2007.10.027",https://intramural.nih.gov/search/searchview.taf?ipid=51108
758,SC006537-15,"October 01, 2007 -  September 30, 2008",Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,William D Figg; PharmD|IRP Faculty Profile,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Tristan  Sissung|Kathryn  Compton|Lokesh  Jain|Matthew  Danish|Xiaohong  Chen|Jeanny B Aragon-Ching|Show all 9,"Alex  Sparreboom|Jurgen  Venitz (School of Pharmacy, Virginia Commonwealth University)","Phillip A Dennis; MD, PhD (National Cancer Institute)|Seth M Steinberg; PhD (National Cancer Institute)|Giovanni  Melillo (National Cancer Institute)|James A Zwiebel (National Cancer Institute)|Patricia  Steeg; PhD (National Cancer Institute)|Anthony  Murgo (National Cancer Institute)",NULL,"1. Figg W (2008) Polypharmacy in View of Advances in Cancer Treatment. The Oncology 1055-63.|2. Schrump DS, Fischette MR, Nguyen DM, Zhao M, Li X, Kunst TF, Hancox A, Hong JA, Chen GA, Kruchin E, Wright JJ, Rosing DR, Sparreboom A, Figg WD, Steinberg SM (2008). Clinical and molecular responses in lung cancer patients receiving Romidepsin. Clin Cancer Res  14, 188-98.   https://doi.org/10.1158/1078-0432.CCR-07-0135",https://intramural.nih.gov/search/searchview.taf?ipid=51109
759,SC006538-15,"October 01, 2007 -  September 30, 2008",Development of Angiogenesis Inhibitors,William D Figg; PharmD|IRP Faculty Profile,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Cindy Huong-Bich Chau|Kristina  Cook|Douglas K Price|Caitlin  Baum|Haihao  Sun|Stephen T Pisle|Show all 8,"Ken  Anderson (Medical Oncology/Hematologic Neoplasia, Dana-Farber Cancer Institute)|Judah  Folkman","Kevin  Gardner; MD, PhD (National Cancer Institute)|William Laurence Dahut; MD (National Cancer Institute)",NULL,"1. Figg W (2008) Angiogenesis Therapy, in DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. DePinho R, Weinberg R, eds, Lippincott Williams and Wilkins (Philadelphia), pp. 3,200.|2. Figg W (2008) Recent Advances in Angiogenesis Drug Development, in Angiogenesis: An Integrative Approach from Science to Medicine. Springer (Boston), pp. 421.|3. Figg W, Dahut W (2008) Development of Thalidomide and Its IMiD Derivatives, in Angiogenesis: An Integrative Approach from Science to Medicine. Springer (Boston), pp. 387.|4. Ge Y, Byun JS, De Luca P, Gueron G, Yabe IM, Sadiq-Ali SG, Figg WD, Quintero J, Haggerty CM, Li QQ, De Siervi A, Gardner K (2008). Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and flavopiridol. Mol Pharmacol  74, 872-83.   https://doi.org/10.1124/mol.107.040808|5. Li H, Raia V, Bertolini F, Price DK, Figg WD (2008). Circulating endothelial cells as a therapeutic marker for thalidomide in combined therapy with chemotherapy drugs in a human prostate cancer model. BJU Int  101, 884-8.   https://doi.org/10.1111/j.1464-410X.2007.07342.x",https://intramural.nih.gov/search/searchview.taf?ipid=51049
760,SC006581-25,"October 01, 2007 -  September 30, 2008",Molecular Pathogenesis of Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Yulia  Demchenko|Adriana  Zingone; MD|Edward S Ramsay,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,"1. Kuehl W, Kyle R, Grogan T, Harris N, Coupland R   (2008) Plasma cell neoplasms., in WHO Classification of Hematopoietic and Lymphoid Tumors, in press.|2. Bergsagel PL, Kuehl WM (2008). WSU-WM and BCWM.1 should not be assumed to represent Waldenström macroglobulinemia cell lines. Blood  112, 917.   https://doi.org/10.1182/blood-2008-05-154831|3. Kuehl WM (2008). Modeling multiple myeloma by AID-dependent conditional activation of MYC. Cancer Cell  13, 85-7.   https://doi.org/10.1016/j.ccr.2008.01.022",https://intramural.nih.gov/search/searchview.taf?ipid=51050
761,SC006660-24,"October 01, 2007 -  September 30, 2008",Defining the T-cell Response to Human Renal Cancer,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Qiong J Wang|Takashi  Inozume,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51024
762,SC006663-19,"October 01, 2007 -  September 30, 2008",Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer,David  Danforth,NULL,"Surgery Branch, NCI",NULL,NULL,Armando  Filie (National Cancer Institute)|Karl Thomas Ried; MD (National Cancer Institute)|Patricia  Steeg; PhD (National Cancer Institute)|Barbara V Vonderhaar; PhD (National Cancer Institute)|Mark H Greene; MD (National Cancer Institute)|Marybeth S Hughes (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51052
763,SC006732-20,"October 01, 2007 -  September 30, 2008",Multidrug resistance Mediated by P-glycoprotein,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Lyn  Mickley Huff,NULL,"Susan  Bates; MD (National Cancer Institute)|William D Figg; PharmD (National Cancer Institute)|Frank M Balis; MD, PhD (National Cancer Institute)",Robert  Innis; MD (NIMH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51053
764,SC006737-17,"October 01, 2007 -  September 30, 2008",Development of Novel Therapies for HIV Infection,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",David A Davis; MD|Victoria Y Wang|Kathleen M Wyvill|Karen O Aleman|Sarah  Daniels|Thomas S Uldrick,NULL,"Frank  Maldarelli (National Cancer Institute)|Hiroaki  Mitsuya (National Cancer Institute)|Yves  Pommier; PhD (National Cancer Institute)|Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)|Seth M Steinberg; PhD (National Cancer Institute)|George N Pavlakis; MD, PhD (National Cancer Institute)","Moinuddin  Hassan; PhD (NICHD) |Henry M. Fales; PhD (NHLBI) |Paul T Wingfield; PhD (NIAMS) |Rodney L Levine; MD, PhD (NHLBI)","1. Morrow M, Valentin A, Little R, Yarchoan R, Pavlakis GN (2008). A splenic marginal zone-like peripheral blood CD27+B220- B cell population is preferentially depleted in HIV type 1-infected individuals. AIDS Res Hum Retroviruses  24, 621-33.   https://doi.org/10.1089/aid.2007.0186",https://intramural.nih.gov/search/searchview.taf?ipid=51054
765,SC006738-16,"October 01, 2007 -  September 30, 2008",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Kenji  Maeda|Kiyoto  Tsuchiya|Debananda  Das; PhD|Hirotomo  Nakata|Yasuhiro  Hayashi|Shigeyoshi  Harada,NULL,Shintaro  Matsumi (National Cancer Institute),NULL,"1. Ghosh AK, Gemma S, Baldridge A, Wang YF, Kovalevsky AY, Koh Y, Weber IT, Mitsuya H (2008). Flexible cyclic ethers/polyethers as novel P2-ligands for HIV-1 protease inhibitors: design, synthesis, biological evaluation, and protein-ligand X-ray studies. J Med Chem  51, 6021-33.   https://doi.org/10.1021/jm8004543|2. Maeda K, Das D, Yin PD, Tsuchiya K, Ogata-Aoki H, Nakata H, Norman RB, Hackney LA, Takaoka Y, Mitsuya H (2008). Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition. J Mol Biol  381, 956-74.   https://doi.org/10.1016/j.jmb.2008.06.041|3. Mitsuya H, Maeda K, Das D, Ghosh AK (2008). Development of protease inhibitors and the fight with drug-resistant HIV-1 variants. Adv Pharmacol  56, 169-97.   https://doi.org/10.1016/S1054-3589(07)56006-0|4. Nakata H, Steinberg SM, Koh Y, Maeda K, Takaoka Y, Tamamura H, Fujii N, Mitsuya H (2008). Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugs. Antimicrob Agents Chemother  52, 2111-9.   https://doi.org/10.1128/AAC.01299-07",https://intramural.nih.gov/search/searchview.taf?ipid=51025
766,SC006741-15,"October 01, 2007 -  September 30, 2008",Lymphoma Studies,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (National Cancer Institute)|John  Janik; MD (National Cancer Institute)|Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)|Stefania  Pittaluga (National Cancer Institute)|Andrea  Abati; BS, MD (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Wilson WH, Dunleavy K, Pittaluga S, Hegde U, Grant N, Steinberg SM, Raffeld M, Gutierrez M, Chabner BA, Staudt L, Jaffe ES, Janik JE (2008). Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers. J Clin Oncol  26, 2717-24.   https://doi.org/10.1200/JCO.2007.13.1391",https://intramural.nih.gov/search/searchview.taf?ipid=51026
767,SC006743-15,"October 01, 2007 -  September 30, 2008",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Sunmin T Lee|Yeong Sang  Kim,NULL,"Daniel H Fowler (National Cancer Institute)|John Charles Morris; MD (National Cancer Institute)|William Marston Linehan; MD (National Cancer Institute)|J. Frederic Mushinski; MD (National Cancer Institute)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Leonard  Neckers; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51107
768,SC006830-38,"October 01, 2007 -  September 30, 2008",Treatment of Infections in Immunocompromised Children,Thomas J. Walsh; MD,NULL,"Pediatric Oncology Branch, NCI",Miki B Kasai|Jennifer D Rabb|Robert L Schaufele|Ruta  Petraitiene|Diana  Mickiene|Margaret  Cotton|Show all 10,NULL,"Stephen J Chanock; MD, PhD (National Cancer Institute)|John U Dennis (National Cancer Institute)|Alan S Wayne; MD (National Cancer Institute)","John D. Bacher; BS, DVM, MS (OD) |Patrick R. Murray; PhD (CC) |Anthony F Suffredini; MD (CC) |Yvonne D Shea (CC) |Richard  Childs; MD (NHLBI) |Karim Anton Calis; PharmD, MPH (CC)","1. Katragkou A, Kruhlak MJ, Simitsopoulou M, Chatzimoschou A, Taparkou A, Cotten CJ, Paliogianni F, Diza-Mataftsi E, Tsantali C, Walsh TJ, Roilides E (2010). Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents. J Infect Dis  201, 1941-9.   https://doi.org/10.1086/652783",https://intramural.nih.gov/search/searchview.taf?ipid=51055
769,SC006880-31,"October 01, 2007 -  September 30, 2008",Anticancer Drug Development for Childhood Cancers,"Frank M Balis; MD, PhD",NULL,"Pediatric Oncology Branch, NCI",Patricia O Whitcomb|Elizabeth  Fox; MD|Diane  Cole|Mary  Hawkins|Nalini M Jayaprakash|Alberta A Aikin|Show all 9,"Peter Charles Adamson; MD|Adekunle  Adesina|Rochelle  Bagatell (Pediatric Oncology, University of Arizona)|Eliel  Bayever (Oncology, Johnson & Johnson)|Susan  Blaney (Pediatric Oncology, Baylor)|Susan  Cohn (Pediatric Oncology, Children's Memorial Med Ctr)|Show all 22","Kenneth H Kraemer; MD (National Cancer Institute)|Yves  Pommier; PhD (National Cancer Institute)|Antonio  Fojo; MD, PhD (National Cancer Institute)|Susan  Bates; MD (National Cancer Institute)|Katherine Elizabeth Warren; MD (National Cancer Institute)|Maria  Tsokos; MD (National Cancer Institute)","Clara Chi Chen; MD (NIDDK) |Stephen John Marx; MD (NIDDK) |Constantine Argyrios Stratakis; MD, DSc (NICHD) |Maya Beth Lodish (NICHD)","1. Kim A, Fox E, Warren K, Blaney SM, Berg SL, Adamson PC, Libucha M, Byrley E, Balis FM, Widemann BC (2008). Characteristics and outcome of pediatric patients enrolled in phase I oncology trials. Oncologist  13, 679-89.   https://doi.org/10.1634/theoncologist.2008-0046",https://intramural.nih.gov/search/searchview.taf?ipid=51056
770,SC006891-20,"October 01, 2007 -  September 30, 2008",Solid Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Lauren M Long|Su-Young  Kim|Patrick  Grohar,NULL,"Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)|Crystal L. Mackall; MD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51057
771,SC006892-20,"October 01, 2007 -  September 30, 2008",Molecular Biology of Pediatric Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Xiaolin  Wan|Choh L Yeung|Su-Young  Kim|Patrick  Grohar,NULL,Nealapheur L Khan (National Cancer Institute)|Glenn  Merlino; PhD (National Cancer Institute),NULL,"1. Kim SY, Lee CH, Midura BV, Yeung C, Mendoza A, Hong SH, Ren L, Wong D, Korz W, Merzouk A, Salari H, Zhang H, Hwang ST, Khanna C, Helman LJ (2008). Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis  25, 201-11.   https://doi.org/10.1007/s10585-007-9133-3|2. Mackall CL, Rhee EH, Read EJ, Khuu HM, Leitman SF, Bernstein D, Tesso M, Long LM, Grindler D, Merino M, Kopp W, Tsokos M, Berzofsky JA, Helman LJ (2008). A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas. Clin Cancer Res  14, 4850-8.   https://doi.org/10.1158/1078-0432.CCR-07-4065",https://intramural.nih.gov/search/searchview.taf?ipid=51058
772,SC007202-24,"October 01, 2007 -  September 30, 2008",Biostatistics and Data Management Section,Seth M Steinberg; PhD|IRP Faculty Profile,"Frank M Balis; MD, PhD","Office of the Director, NCI",David J Venzon; PhD|David J Liewehr,NULL,"Wyndham H Wilson; MD, PhD (National Cancer Institute)|Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)|Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)|Richard Lawrence Piekarz (National Cancer Institute)|Susan  Bates; MD (National Cancer Institute)|Michael R Bishop; MD (National Cancer Institute)",Zenaide Maria Quezado; MD (CC),"1. Ahmad E, Steinberg SM, Goldin L, Hess CJ, Caporaso N, Kreitman RJ, Wiestner A, Wilson W, White T, Marti G, Stetler-Stevenson M (2008). Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia. Cytometry B Clin Cytom  74, 221-6.   https://doi.org/10.1002/cyto.b.20423|2. Azad NS, Annunziata CM, Steinberg SM, Minasian L, Premkumar A, Chow C, Kotz HL, Kohn EC (2008). Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy. Cancer  112, 1726-32.   https://doi.org/10.1002/cncr.23374|3. Azad NS, Posadas EM, Kwitkowski VE, Steinberg SM, Jain L, Annunziata CM, Minasian L, Sarosy G, Kotz HL, Premkumar A, Cao L, McNally D, Chow C, Chen HX, Wright JJ, Figg WD, Kohn EC (2008). Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity. J Clin Oncol  26, 3709-14.   https://doi.org/10.1200/JCO.2007.10.8332|4. Berna MJ, Annibale B, Marignani M, Luong TV, Corleto V, Pace A, Ito T, Liewehr D, Venzon DJ, Delle Fave G, Bordi C, Jensen RT (2008). A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab  93, 1582-91.   https://doi.org/10.1210/jc.2007-2279|5. Bishop MR, Dean RM, Steinberg SM, Odom J, Pavletic SZ, Chow C, Pittaluga S, Sportes C, Hardy NM, Gea-Banacloche J, Kolstad A, Gress RE, Fowler DH (2008). Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation. Ann Oncol  19, 1935-40.   https://doi.org/10.1093/annonc/mdn404|6. Cecchinato V, Tryniszewska E, Ma ZM, Vaccari M, Boasso A, Tsai WP, Petrovas C, Fuchs D, Heraud JM, Venzon D, Shearer GM, Koup RA, Lowy I, Miller CJ, Franchini G (2008). Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J Immunol  180, 5439-47.   https://doi.org/10.4049/jimmunol.180.8.5439|7. Dahut WL, Scripture C, Posadas E, Jain L, Gulley JL, Arlen PM, Wright JJ, Yu Y, Cao L, Steinberg SM, Aragon-Ching JB, Venitz J, Jones E, Chen CC, Figg WD (2008). A phase II clinical trial of sorafenib in androgen-independent prostate cancer. Clin Cancer Res  14, 209-14.   https://doi.org/10.1158/1078-0432.CCR-07-1355|8. Denduluri N, Yang SX, Berman AW, Nguyen D, Liewehr DJ, Steinberg SM, Swain SM (2008). Circulating biomarkers of bevacizumab activity in patients with breast cancer. Cancer Biol Ther  7, 15-20.   https://doi.org/10.4161/cbt.7.1.5337|9. Eng-Wong J, Orzano-Birgani J, Chow CK, Venzon D, Yao J, Galbo CE, Zujewski JA, Prindiville S   (2008) Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer.  Cancer Epidemiol Biomarkers Prev 17:1696-701.|10. Florese RH, Wiseman RW, Venzon D, Karl JA, Demberg T, Larsen K, Flanary L, Kalyanaraman VS, Pal R, Titti F, Patterson LJ, Heath MJ, O'Connor DH, Cafaro A, Ensoli B, Robert-Guroff M (2008). Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection. Vaccine  26, 3312-21.   https://doi.org/10.1016/j.vaccine.2008.03.100|11. Gardner ER, Ahlers CM, Shukla S, Sissung TM, Ockers SB, Price DK, Hamada A, Robey RW, Steinberg SM, Ambudkar SV, Dahut WL, Figg WD (2008). Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival. BJU Int  102, 1694-9.   https://doi.org/10.1111/j.1464-410X.2008.07913.x|12. Gregorc V, Hidalgo M, Spreafico A, Cusatis G, Ludovini V, Ingersoll RG, Marsh S, Steinberg SM, Viganò MG, Ghio D, Villa E, Sparreboom A, Baker SD (2008). Germline polymorphisms in EGFR and survival in patients with lung cancer receiving gefitinib. Clin Pharmacol Ther  83, 477-84.   https://doi.org/10.1038/sj.clpt.6100320|13. Gril B, Palmieri D, Bronder JL, Herring JM, Vega-Valle E, Feigenbaum L, Liewehr DJ, Steinberg SM, Merino MJ, Rubin SD, Steeg PS (2008). Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J Natl Cancer Inst  100, 1092-103.   https://doi.org/10.1093/jnci/djn216|14. Gulley JL, Aragon-Ching JB, Steinberg SM, Hussain MH, Sartor O, Higano CS, Petrylak DP, Chatta GS, Arlen PM, Figg WD, Dahut WL (2008). Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer. J Urol  180, 1432-7; discussion 1437.   https://doi.org/10.1016/j.juro.2008.06.017|15. Gulley JL, Arlen PM, Tsang KY, Yokokawa J, Palena C, Poole DJ, Remondo C, Cereda V, Jones JL, Pazdur MP, Higgins JP, Hodge JW, Steinberg SM, Kotz H, Dahut WL, Schlom J (2008). Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma. Clin Cancer Res  14, 3060-9.   https://doi.org/10.1158/1078-0432.CCR-08-0126|16. Hadley DW, Jenkins JF, Steinberg SM, Liewehr D, Moller S, Martin JC, Calzone KA, Soballe PW, Kirsch IR (2008). Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome. J Clin Oncol  26, 948-54.   https://doi.org/10.1200/JCO.2007.13.0575|17. Hamada A, Sissung T, Price DK, Danesi R, Chau CH, Sharifi N, Venzon D, Maeda K, Nagao K, Sparreboom A, Mitsuya H, Dahut WL, Figg WD (2008). Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer. Clin Cancer Res  14, 3312-8.   https://doi.org/10.1158/1078-0432.CCR-07-4118|18. Hoffman KE, Derdak J, Bernstein D, Reynolds JC, Avila NA, Gerber L, Steinberg SM, Chrousos G, Mackall CL, Mansky PJ (2008). Metabolic syndrome traits in long-term survivors of pediatric sarcoma. Pediatr Blood Cancer  50, 341-6.   https://doi.org/10.1002/pbc.21363|19. Klapper JA, Downey SG, Smith FO, Yang JC, Hughes MS, Kammula US, Sherry RM, Royal RE, Steinberg SM, Rosenberg S (2008). High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006. Cancer  113, 293-301.   https://doi.org/10.1002/cncr.23552|20. Lechleider RJ, Arlen PM, Tsang KY, Steinberg SM, Yokokawa J, Cereda V, Camphausen K, Schlom J, Dahut WL, Gulley JL (2008). Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant. Clin Cancer Res  14, 5284-91.   https://doi.org/10.1158/1078-0432.CCR-07-5162|21. Madan RA, Gulley JL, Schlom J, Steinberg SM, Liewehr DJ, Dahut WL, Arlen PM (2008). Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, nilutamide, and combination therapy. Clin Cancer Res  14, 4526-31.   https://doi.org/10.1158/1078-0432.CCR-07-5048|22. Miao N, Pingpank JF, Alexander HR, Steinberg SM, Beresneva T, Quezado ZM (2008). Percutaneous hepatic perfusion in patients with metastatic liver cancer: anesthetic, hemodynamic, and metabolic considerations. Ann Surg Oncol  15, 815-23.   https://doi.org/10.1245/s10434-007-9781-1|23. Murgo AJ, Kummar S, Rubinstein L, Gutierrez M, Collins J, Kinders R, Parchment RE, Ji J, Steinberg SM, Yang SX, Hollingshead M, Chen A, Helman L, Wiltrout R, Tomaszewski JE, Doroshow JH (2008). Designing phase 0 cancer clinical trials. Clin Cancer Res  14, 3675-82.   https://doi.org/10.1158/1078-0432.CCR-07-4560|24. Nakata H, Steinberg SM, Koh Y, Maeda K, Takaoka Y, Tamamura H, Fujii N, Mitsuya H (2008). Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugs. Antimicrob Agents Chemother  52, 2111-9.   https://doi.org/10.1128/AAC.01299-07|25. Norton JA, Venzon DJ, Berna MJ, Alexander HR, Fraker DL, Libutti SK, Marx SJ, Gibril F, Jensen RT (2008). Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. Ann Surg  247, 501-10.   https://doi.org/10.1097/SLA.0b013e31815efda5|26. Patterson LJ, Beal J, Demberg T, Florese RH, Malkevich N, Venzon D, Aldrich K, Richardson E, Kalyanaraman VS, Kalisz I, Lee EM, Montefiori DC, Robey FA, Robert-Guroff M (2008). Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques. Virology  374, 322-37.   https://doi.org/10.1016/j.virol.2007.12.037|27. Portera CC, Walshe JM, Rosing DR, Denduluri N, Berman AW, Vatas U, Velarde M, Chow CK, Steinberg SM, Nguyen D, Yang SX, Swain SM (2008). Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer. Clin Cancer Res  14, 2710-6.   https://doi.org/10.1158/1078-0432.CCR-07-4636|28. Powell AC, Stratakis CA, Patronas NJ, Steinberg SM, Batista D, Alexander HR, Pingpank JF, Keil M, Bartlett DL, Libutti SK (2008). Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasia. Surgery  143, 750-8.   https://doi.org/10.1016/j.surg.2008.03.022|29. Schrump DS, Fischette MR, Nguyen DM, Zhao M, Li X, Kunst TF, Hancox A, Hong JA, Chen GA, Kruchin E, Wright JJ, Rosing DR, Sparreboom A, Figg WD, Steinberg SM (2008). Clinical and molecular responses in lung cancer patients receiving Romidepsin. Clin Cancer Res  14, 188-98.   https://doi.org/10.1158/1078-0432.CCR-07-0135|30. Sharifi N, Hamada A, Sissung T, Danesi R, Venzon D, Baum C, Gulley JL, Price DK, Dahut WL, Figg WD (2008). A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer. BJU Int  102, 617-21.   https://doi.org/10.1111/j.1464-410X.2008.07629.x|31. Sissung TM, Baum CE, Deeken J, Price DK, Aragon-Ching J, Steinberg SM, Dahut W, Sparreboom A, Figg WD (2008). ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel. Clin Cancer Res  14, 4543-9.   https://doi.org/10.1158/1078-0432.CCR-07-4230|32. Sissung TM, Danesi R, Price DK, Steinberg SM, de Wit R, Zahid M, Gaikwad N, Cavalieri E, Dahut WL, Sackett DL, Figg WD, Sparreboom A (2008). Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel. Mol Cancer Ther  7, 19-26.   https://doi.org/10.1158/1535-7163.MCT-07-0557|33. Sportès C, Hakim FT, Memon SA, Zhang H, Chua KS, Brown MR, Fleisher TA, Krumlauf MC, Babb RR, Chow CK, Fry TJ, Engels J, Buffet R, Morre M, Amato RJ, Venzon DJ, Korngold R, Pecora A, Gress RE, Mackall CL (2008). Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med  205, 1701-14.   https://doi.org/10.1084/jem.20071681|34. Tan AR, Steinberg SM, Parr AL, Nguyen D, Yang SX (2008). Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment. Ann Oncol  19, 185-90.   https://doi.org/10.1093/annonc/mdm444|35. Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM (2008). BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet  45, 321-31.   https://doi.org/10.1136/jmg.2007.054304|36. Toubaji A, Achtar M, Provenzano M, Herrin VE, Behrens R, Hamilton M, Bernstein S, Venzon D, Gause B, Marincola F, Khleif SN (2008). Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers. Cancer Immunol Immunother  57, 1413-20.   https://doi.org/10.1007/s00262-008-0477-6|37. Vaccari M, Mattapallil J, Song K, Tsai WP, Hryniewicz A, Venzon D, Zanetti M, Reimann KA, Roederer M, Franchini G (2008). Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency. J Virol  82, 9629-38.   https://doi.org/10.1128/JVI.00893-08|38. Williams JA, Lumsden JM, Yu X, Feigenbaum L, Zhang J, Steinberg SM, Hodes RJ (2008). Regulation of thymic NKT cell development by the B7-CD28 costimulatory pathway. J Immunol  181, 907-17.   https://doi.org/10.4049/jimmunol.181.2.907|39. Wilson WH, Dunleavy K, Pittaluga S, Hegde U, Grant N, Steinberg SM, Raffeld M, Gutierrez M, Chabner BA, Staudt L, Jaffe ES, Janik JE (2008). Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers. J Clin Oncol  26, 2717-24.   https://doi.org/10.1200/JCO.2007.13.1391",https://intramural.nih.gov/search/searchview.taf?ipid=51018
773,SC007256-20,"October 01, 2007 -  September 30, 2008",Mechanisms of Oncogene Action in Tumorigenesis,Frederic  Kaye; MD,NULL,"Cancer Genetics Branch, NCI",Amy B Coxon|Yoon Soo  Park,NULL,"Maria  Zajac-Kaye; PhD (National Cancer Institute)|Paul S Meltzer; MD, PhD (National Cancer Institute)|Tatiana  Karpova (National Cancer Institute)|Leonard  Neckers; PhD (National Cancer Institute)",NULL,"1. Kaye F   (2008) Mucoepidermoid Cancer., in Encyclopedia of Cancer. Springer Verlag (Heidelberg), pp. 7000 pp.|2. Kaye F   (2008) Defining a candidate lung cancer gene.  Journal of the National Cancer Institute, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=51059
774,SC007263-16,"October 01, 2007 -  September 30, 2008",TRAIL-induced Cell Death in Breast Cancer Cells,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Janet  Pumphrey|Kathryn Jill Chavez,NULL,"Paul S Meltzer; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51060
775,SC007281-15,"October 01, 2007 -  September 30, 2008",Nitric Oxide as a Modifier of Oxidative Stress,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Lisa Ann Ridnour|Christopher H Switzer,NULL,Terry  Moody; PhD (Experimental Biochemistry Sect)|James B Mitchell; PhD (National Cancer Institute)|Murali  Krishna; PhD (National Cancer Institute)|Curtis  Harris; MD (National Cancer Institute)|Larry K Keefer; PhD (National Cancer Institute)|Grace  Yeh; PhD (National Cancer Institute),NULL,"1. Matsumoto S, Espey MG, Utsumi H, Devasahayam N, Matsumoto K, Matsumoto A, Hirata H, Wink DA, Kuppusamy P, Subramanian S, Mitchell JB, Krishna MC (2008). Dynamic monitoring of localized tumor oxygenation changes using RF pulsed electron paramagnetic resonance in conscious mice. Magn Reson Med  59, 619-25.   https://doi.org/10.1002/mrm.21500|2. Ridnour LA, Thomas DD, Switzer C, Flores-Santana W, Isenberg JS, Ambs S, Roberts DD, Wink DA (2008). Molecular mechanisms for discrete nitric oxide levels in cancer. Nitric Oxide  19, 73-6.   https://doi.org/10.1016/j.niox.2008.04.006|3. Wink DA, Paolocci N (2008). Mother was right: eat your vegetables and do not spit! When oral nitrate helps with high blood pressure. Hypertension  51, 617-9.   https://doi.org/10.1161/HYPERTENSIONAHA.107.106617",https://intramural.nih.gov/search/searchview.taf?ipid=51061
776,SC009144-24,"October 01, 2007 -  September 30, 2008",Mechanisms of transcription factor integration at the c-myc promoter,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Larry  Benjamin|Juhong  Liu|Zuqin  Nie; PhD|Matthew  Vogt|Na  Salony,NULL,Lino  Tessarollo (National Cancer Institute)|Gordon Lee Hager; PhD (National Cancer Institute),Keji  Zhao; PhD (NHLBI),"1. Kouzine F, Sanford S, Elisha-Feil Z, Levens D (2008). The functional response of upstream DNA to dynamic supercoiling in vivo. Nat Struct Mol Biol  15, 146-54.   https://doi.org/10.1038/nsmb.1372",https://intramural.nih.gov/search/searchview.taf?ipid=51062
777,SC009163-21,"October 01, 2007 -  September 30, 2008",Signal Transduction Therapy--Basic Science,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Victoria M Virador|Ebony R Hoskins|Giovanna  Casagrande|Andrea Katherine McCollum|Daniel  Kimm,NULL,"Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David Jay Goldstein (National Cancer Institute)|Michael  Birrer (National Cancer Institute)|David R Gius; MD, PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51063
778,SC009172-20,"October 01, 2007 -  September 30, 2008",Cellular Interactions with Thrombospondin,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Jeffrey S Isenberg|John M Sipes|Malgorzata  Ptaszynska|Elizabeth M Perruccio|Justin Brian Maxhimer; MD|Thomas W Miller; PhD,"Willaim  Frazier (Biochemistry and Molecular Biophysics, Washington University)|Cezary  Marcinkiewicz (Temple University)|Deane  Mosher (Medicine, University of Wisconsin)",David Anderson Wink (National Cancer Institute)|Maria  Tsokos; MD (National Cancer Institute),NULL,"1. Roberts D, Frazier W   (2008) In vivo applications of morpholino oligonucleotides., in Cell and Gene Therapy. Templeton N, ed.,  CRC Press, in press.|2. Calzada MJ, Kuznetsova SA, Sipes JM, Rodrigues RG, Cashel JA, Annis DS, Mosher DF, Roberts DD (2008). Calcium indirectly regulates immunochemical reactivity and functional activities of the N-domain of thrombospondin-1. Matrix Biol  27, 339-51.   https://doi.org/10.1016/j.matbio.2007.12.002|3. Isenberg JS, Frazier WA, Roberts DD (2008). Thrombospondin-1: a physiological regulator of nitric oxide signaling. Cell Mol Life Sci  65, 728-42.   https://doi.org/10.1007/s00018-007-7488-x|4. Isenberg JS, Hyodo F, Ridnour LA, Shannon CS, Wink DA, Krishna MC, Roberts DD (2008). Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow. Neoplasia  10, 886-96.   https://doi.org/10.1593/neo.08264|5. Isenberg JS, Pappan LK, Romeo MJ, Abu-Asab M, Tsokos M, Wink DA, Frazier WA, Roberts DD (2008). Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts. Ann Surg  247, 180-90.   https://doi.org/10.1097/SLA.0b013e31815685dc|6. Isenberg JS, Roberts DD, Frazier WA (2008). CD47: a new target in cardiovascular therapy. Arterioscler Thromb Vasc Biol  28, 615-21.   https://doi.org/10.1161/ATVBAHA.107.158154|7. Isenberg JS, Romeo MJ, Maxhimer JB, Smedley J, Frazier WA, Roberts DD (2008). Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease. Ann Surg  247, 860-8.   https://doi.org/10.1097/SLA.0b013e31816c4006|8. Isenberg JS, Romeo MJ, Yu C, Yu CK, Nghiem K, Monsale J, Rick ME, Wink DA, Frazier WA, Roberts DD (2008). Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood  111, 613-23.   https://doi.org/10.1182/blood-2007-06-098392|9. Isenberg JS, Yu C, Roberts DD (2008). Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells. Biochem Pharmacol  75, 875-82.   https://doi.org/10.1016/j.bcp.2007.10.025|10. Kuznetsova SA, Mahoney DJ, Martin-Manso G, Ali T, Nentwich HA, Sipes JM, Zeng B, Vogel T, Day AJ, Roberts DD (2008). TSG-6 binds via its CUB_C domain to the cell-binding domain of fibronectin and increases fibronectin matrix assembly. Matrix Biol  27, 201-10.   https://doi.org/10.1016/j.matbio.2007.10.003|11. Roberts D, Frazier W, Krishna M, Wink D   (2008) Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47  signaling.  Curr. Drug Targets, in press.|12. Roberts D, Maxhimer J, Hyodo F, Pendrak M, Ridnour L, DeGraff W, Tsokos M, Frazier W   (2008) Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury.  Am J. Pathol, in press.|13. Roberts D, Maxhimer J, Powers P, Tsokos M, Frazier W   (2008) Treatment of ischemia/reperfusion injury by limiting thrombospondin-1.  Surgery, in press.|14. Roberts DD (2008). Thrombospondins: from structure to therapeutics. Cell Mol Life Sci  65, 669-71.   https://doi.org/10.1007/s00018-007-7483-2|15. Roberts DD, Isenberg JD, Maxhimer JD (submitted in 2008) Radioprotectants Targeting Thrombospondin-1 And Cd47. Patents issued: 8,951,527 (US in 2015); 2009279676 (AU in 2015); 602009036069 (DE in 2016); 2340034 (EP in 2016); 2340034 (FR in 2016); 2340034 (GB in 2016); 2732102 (CA in 2018). Patent pending: PCT/US2009/052902 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=51020
779,SC009173-20,"October 01, 2007 -  September 30, 2008",Host Colonization and Vascular Dissemination of  Candida      albicans,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Michael L Pendrak|John M Sipes|Dhammika  Navarathna; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51021
780,SC009174-20,"October 01, 2007 -  September 30, 2008",Roles of Glycoconjugates and Redox Signaling in Tumor Biology,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Jeffrey S Isenberg|John M Sipes|Malgorzata  Ptaszynska|Thomas W Miller; PhD,"Anthony  Day (Biochemistry, University of Oxford)|Barry  Karger (Northeastern University)",David Anderson Wink (National Cancer Institute)|Maria  Tsokos; MD (National Cancer Institute),NULL,"1. Kuznetsova SA, Mahoney DJ, Martin-Manso G, Ali T, Nentwich HA, Sipes JM, Zeng B, Vogel T, Day AJ, Roberts DD (2008). TSG-6 binds via its CUB_C domain to the cell-binding domain of fibronectin and increases fibronectin matrix assembly. Matrix Biol  27, 201-10.   https://doi.org/10.1016/j.matbio.2007.10.003|2. Ptaszynska MM, Pendrak ML, Bandle RW, Stracke ML, Roberts DD (2008). Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells. Mol Cancer Res  6, 352-63.   https://doi.org/10.1158/1541-7786.MCR-07-0143|3. Ridnour LA, Thomas DD, Switzer C, Flores-Santana W, Isenberg JS, Ambs S, Roberts DD, Wink DA (2008). Molecular mechanisms for discrete nitric oxide levels in cancer. Nitric Oxide  19, 73-6.   https://doi.org/10.1016/j.niox.2008.04.006|4. Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, Donzelli S, Hussain P, Vecoli C, Paolocci N, Ambs S, Colton CA, Harris CC, Roberts DD, Wink DA (2008). The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med  45, 18-31.   https://doi.org/10.1016/j.freeradbiomed.2008.03.020",https://intramural.nih.gov/search/searchview.taf?ipid=51019
781,SC009179-20,"October 01, 2007 -  September 30, 2008",The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis,"William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Beiyang  Wei|Sandra  Jensen-Taubman|Liliana  Guedez; PhD|Dimitra  Bourmpoulia; PhD,"Junseo  Oh (Laboratory of Cellular Oncology, Korea University Graduate School Of Medicine)|Dong-Wan  Seo (Laboratory of Molecular Biochemistry, Kangwon National University)",Frank  Cuttitta; PhD (National Cancer Institute)|David  Salomon; PhD (National Cancer Institute),NULL,"1. Kim YS, Seo DW, Kong SK, Lee JH, Lee ES, Stetler-Stevenson M, Stetler-Stevenson WG (2008). TIMP1 induces CD44 expression and the activation and nuclear translocation of SHP1 during the late centrocyte/post-germinal center B cell differentiation. Cancer Lett  269, 37-45.   https://doi.org/10.1016/j.canlet.2008.04.020|2. Lee H, Lim C, Lee J, Kim N, Bang S, Lee H, Min B, Park G, Noda M, Stetler-Stevenson WG, Oh J (2008). TGF-beta signaling preserves RECK expression in activated pancreatic stellate cells. J Cell Biochem  104, 1065-74.   https://doi.org/10.1002/jcb.21692|3. Seo DW, Kim SH, Eom SH, Yoon HJ, Cho YR, Kim PH, Kim YK, Han JW, Diaz T, Wei BY, Stetler-Stevenson WG (2008). TIMP-2 disrupts FGF-2-induced downstream signaling pathways. Microvasc Res  76, 145-51.   https://doi.org/10.1016/j.mvr.2008.07.003|4. Stetler-Stevenson WG (2008). The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2. Cancer Metastasis Rev  27, 57-66.   https://doi.org/10.1007/s10555-007-9105-8|5. Stetler-Stevenson WG (2008). Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal  1, re6.   https://doi.org/10.1126/scisignal.127re6",https://intramural.nih.gov/search/searchview.taf?ipid=51065
782,SC009372-16,"October 01, 2007 -  September 30, 2008",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Catharine S Mccoy|Linda Shonk Weaver|Alexander  Ponomarev,NULL,"Robert J Kreitman; MD, PhD (National Cancer Institute)|Steven  Libutti; MD (National Cancer Institute)|Susan  Bates; MD (National Cancer Institute)|Ira H Pastan; MD (National Cancer Institute)|John  Janik; MD (National Cancer Institute)|John Charles Morris; MD (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI) |Steven M Holland; MD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51027
783,SC009374-17,"October 01, 2007 -  September 30, 2008",Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Victoria M Virador|Ebony R Hoskins|Geoffrey S Kim; MD|Giovanna  Casagrande|Daniel  Kimm,NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David Jay Goldstein (National Cancer Institute)|Gordon  Whiteley (National Cancer Institute)|William D Figg; PharmD (National Cancer Institute)|Barbara V Vonderhaar; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51066
784,SC009375-16,"October 01, 2007 -  September 30, 2008",Signal Transduction Therapy--Clinical,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Victoria M Virador|Ebony R Hoskins|Nilofer S Azad|Nicole Dupas Houston|Ryan  Henning|Daniel  Kimm,NULL,Yves  Pommier; PhD (National Cancer Institute)|Peter L Choyke; MD (National Cancer Institute)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David Jay Goldstein (National Cancer Institute)|Gordon  Whiteley (National Cancer Institute)|William Laurence Dahut; MD (National Cancer Institute),NULL,"1. Alessandro R, Fontana S, Giordano M, Corrado C, Colomba P, Flugy AM, Santoro A, Kohn EC, De Leo G (2008). Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia. J Cell Physiol  215, 111-21.   https://doi.org/10.1002/jcp.21290",https://intramural.nih.gov/search/searchview.taf?ipid=51067
785,SC009389-15,"October 01, 2007 -  September 30, 2008",A Mitogen-induced G Protein-coupled Receptor,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Yvona  Ward; PhD,NULL,Sheueyann  Cheng; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51068
786,SC009392-15,"October 01, 2007 -  September 30, 2008",Proteomic Analysis of Renal Tumors,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,"1. Signoretti S, Bratslavsky G, Waldman FM, Reuter VE, Haaga J, Merino M, Thomas GV, Pins MR, Libermann T, Gillespie J, Tomaszewski JE, Compton CC, Hruszkewycz A, Linehan WM, Atkins MB (2008). Tissue-based research in kidney cancer: current challenges and future directions. Clin Cancer Res  14, 3699-705.   https://doi.org/10.1158/1078-0432.CCR-07-4733",https://intramural.nih.gov/search/searchview.taf?ipid=51069
787,SC009394-15,"October 01, 2007 -  September 30, 2008",Diagnostic Electron Microscopy (EM),Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI",Mones  Abu-Asab,NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)",James H. Shelhamer; MD (CC),"1. Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, Tsokos M, Alt FW, Finkel T (2008). A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A  105, 3374-9.   https://doi.org/10.1073/pnas.0712145105|2. Lodish MB, Powell AC, Abu-Asab M, Cochran C, Lenz P, Libutti SK, Pingpank JF, Tsokos M, Gorden P (2008). Insulinoma and gastrinoma syndromes from a single intrapancreatic neuroendocrine tumor. J Clin Endocrinol Metab  93, 1123-8.   https://doi.org/10.1210/jc.2007-2449|3. Martin-Manso G, Galli S, Ridnour LA, Tsokos M, Wink DA, Roberts DD (2008). Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells. Cancer Res  68, 7090-9.   https://doi.org/10.1158/0008-5472.CAN-08-0643|4. Yang Y, Padilla-Nash HM, Vira MA, Abu-Asab MS, Val D, Worrell R, Tsokos M, Merino MJ, Pavlovich CP, Ried T, Linehan WM, Vocke CD (2008). The UOK 257 cell line: a novel model for studies of the human Birt-Hogg-Dubé gene pathway. Cancer Genet Cytogenet  180, 100-9.   https://doi.org/10.1016/j.cancergencyto.2007.10.010",https://intramural.nih.gov/search/searchview.taf?ipid=51070
788,SC009431-14,"October 01, 2007 -  September 30, 2008",Histologic and Molecular Characterization of Solid Pediatric Tumors,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI",Susana Beatriz Galli,NULL,Lee Jay Helman; MD (National Cancer Institute)|Crystal L. Mackall; MD (National Cancer Institute)|Elizabeth  Fox; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51071
789,SC010051-13,"October 01, 2007 -  September 30, 2008",Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Diane E Milenic|Kwamena  Baidoo|Ambika  Bumb,NULL,Peter L Choyke; MD (National Cancer Institute),NULL,"1. Chong HS, Ma X, Le T, Kwamena B, Milenic DE, Brady ED, Song HA, Brechbiel MW (2008). Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy. J Med Chem  51, 118-25.   https://doi.org/10.1021/jm070401q|2. Xu H, Baidoo KE, Wong KJ, Brechbiel MW (2008). A novel bifunctional maleimido CHX-A'' chelator for conjugation to thiol-containing biomolecules. Bioorg Med Chem Lett  18, 2679-83.   https://doi.org/10.1016/j.bmcl.2008.03.022",https://intramural.nih.gov/search/searchview.taf?ipid=51072
790,SC010058-13,"October 01, 2007 -  September 30, 2008",Regulation of Apoptosis in Ewings Sarcoma and Neuroblastoma,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI",Susana Beatriz Galli|Yan  Ren,NULL,Lee Jay Helman; MD (National Cancer Institute)|Crystal L. Mackall; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51073
791,SC010074-13,"October 01, 2007 -  September 30, 2008",Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI","Wanping  Xu|Hye-Sik  Kong|Shinji  Tsutsumi|Mehdi  Mollapour|Suiquan  Wang; PhD|Aki  Iwai; MD, PhD",NULL,James G McNally; PhD (National Cancer Institute)|Zhenggang  Liu; PhD (National Cancer Institute)|Jane Beth Trepel (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51074
792,SC010084-37,"October 01, 2007 -  September 30, 2008",Pediatric HIVAIDS Clinical Research,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Rohan  Hazra,NULL,Pamela  Wolters (National Cancer Institute),H. Clifford  Lane; MD (NIAID) |Eugene O Major; PhD (NINDS) |Joseph A Kovacs; MD (CC),"1. Purdy JB, Freeman AF, Martin SC, Ryder C, Elliott-DeSorbo DK, Zeichner S, Hazra R   (2008) Virologic response using directly observed therapy in adolescents with HIV: an adherence tool.  J Assoc Nurses AIDS Care 19:158-65.|2. Purdy JB, Gafni RI, Reynolds JC, Zeichner S, Hazra R   (2008) Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus.  J Pediatr 152:582-4.",https://intramural.nih.gov/search/searchview.taf?ipid=51076
793,SC010090-12,"October 01, 2007 -  September 30, 2008",Fluorescent Pteridine Nucleoside Analogs,"Frank M Balis; MD, PhD",NULL,"Pediatric Oncology Branch, NCI",Mary  Hawkins,"Lesley  Davenport (Biochemistry, Brooklyn College)|Basil  Hanss (Biochemistry, Mt. Sinai Univer)|Wei  Kong|Ishita  Mukerji (Biochemistry, Wesleyan Univer)|Alexander  Ross (Biochemsitry, Mt. Sinai Univer)|Robert  Stanley",Victor  Zhurkin; PhD (National Cancer Institute),"Jay Robert Knutson; PhD (NHLBI) |Gary Leonard Griffiths; BSc, PhD (NHLBI) |Peggy  Hsieh; PhD (NIDDK)","1. Hawkins ME (2007) Synthesis, purification and sample experiment for fluorescent pteridine-containing DNA: tools for studying DNA interactive systems. Nat Protoc 2:1013-21.|2. Turingan RS, Liu C, Hawkins ME, Martin CT (2007) Structural confirmation of a bent and open model for the initiation complex of T7 RNA polymerase. Biochemistry 46:1714-23.",https://intramural.nih.gov/search/searchview.taf?ipid=51077
794,SC010093-11,"October 01, 2007 -  September 30, 2008",Targeting the Epigenome for Lung Cancer Therapy,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Ana R Hancox|Julie A Hong|Tricia  Kunst|Yuwei  Zhang|Mary R Zhang,"Nasser  Altorki (Thoracic Surgery, Cornell University Medical Center)|Lloyd  Old (Cancer Immunology, Ludwig Cancer Institute)",Jane Beth Trepel (National Cancer Institute)|William D Figg; PharmD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51028
795,SC010098-06,"October 01, 2007 -  September 30, 2008",The Evaluation of Novel Therapeutics for Genitourinary Malignancies,William Laurence Dahut; MD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Lea  Latham|Marcia L Mulquin|Anna C Couvillon; NP|David D Draper,NULL,"Philip M Arlen; MD (National Cancer Institute)|William D Figg; PharmD (National Cancer Institute)|James L Gulley; MD, PhD (National Cancer Institute)|William Marston Linehan; MD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51110
796,SC010100-09,"October 01, 2007 -  September 30, 2008",The Glioma Molecular Diagnostic Initiative: Characterizing Brain Tumor Data,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Cheryl L Royce|Wei  Zhang|Jean-Claude  Zenklusen; PhD|Nancy B Garren|Jeongwu  Lee|Yuri  Kotliarov|Show all 26,NULL,Paul Stuart Albert (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51079
797,SC010277-11,"October 01, 2007 -  September 30, 2008",Chemokines in Skin Immune Cell Trafficking & Cancer Progression,"Sam  Hwang; MD, PhD",NULL,"Dermatology Branch, NCI",Lei  Fang|Vivian C Lee|Hiroshi  Mitsui|Xuesong  Wu,NULL,Chyi-Chia Richard Lee (National Cancer Institute)|Gordon  Whiteley (National Cancer Institute)|Nicholas Phillip Restifo; MD (National Cancer Institute)|Lee Jay Helman; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51080
798,SC010282-11,"October 01, 2007 -  September 30, 2008",Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Shannon I Skarshaug,NULL,"Wyndham H Wilson; MD, PhD (National Cancer Institute)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Michael R Bishop; MD (National Cancer Institute)|Daniel H Fowler (National Cancer Institute)|Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)|Neil Edward Caporaso; MS, MD (National Cancer Institute)","Gerald Ernest Marti (OD) |Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51082
799,SC010288-11,"October 01, 2007 -  September 30, 2008",Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",J  Foley|Jacopo  Mariotti|Shoba M Amarnath|Kaitlyn E Ryan|Miriam E Mossoba|Anu  Gangopadhyay|Show all 7,"Carl  June (Abramson Family Cancer Research Institute, University of Penn)|Robert  Korngold (Cancer Center, Hackensack University)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)","Ronald E Gress; MD (National Cancer Institute)|Michael R Bishop; MD (National Cancer Institute)|Steven  Pavletic; MD, MS (National Cancer Institute)|Frances  Hakim; PhD (National Cancer Institute)|Antonio  Fojo; MD, PhD (National Cancer Institute)",David F Stroncek; MD (CC) |Susan  Leitman; MD (CC) |Hanh M Khuu; MD (CC),"1. Mossoba ME, Walia JS, Rasaiah VI, Buxhoeveden N, Head R, Ying C, Foley JE, Bramson JL, Fowler DH, Medin JA (2008). Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2. Mol Ther  16, 607-17.   https://doi.org/10.1038/sj.mt.6300390|2. Pavletic SZ, Fowler DH (2008). ""Regulating"" rheumatoid arthritis via autotransplantation. Blood  111, 4838-9.   https://doi.org/10.1182/blood-2008-02-139048|3. Vasu S, Leitman SF, Tisdale JF, Hsieh MM, Childs RW, Barrett AJ, Fowler DH, Bishop MR, Kang EM, Malech HL, Dunbar CE, Khuu HM, Wesley R, Yau YY, Bolan CD (2008). Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood  112, 2092-100.   https://doi.org/10.1182/blood-2008-03-143677",https://intramural.nih.gov/search/searchview.taf?ipid=51083
800,SC010292-10,"October 01, 2007 -  September 30, 2008",Signal Transduction Pathways that Promote Survival of Lung Cancer Cells,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI",Chunyu  Zhang|Wei  Han|Shigeru  Kawabata,"Vali  Egilsson (Pathology, University of Iceland)|Pasi  Janne (Oncology, Dana-Farber Cancer Center)|William  Pao (Memorial Sloan Kettering Cancer Center)|William  Travis (Pathology, Memorial Sloan Kettering Cancer Center)","Ilona  Linnoila; MD (National Cancer Institute)|Stephen M Hewitt; MD, PhD (National Cancer Institute)|Curtis  Harris; MD (National Cancer Institute)|William D Figg; PharmD (National Cancer Institute)|Joanna H Shih (National Cancer Institute)|Frederic  Kaye; MD (National Cancer Institute)",NULL,"1. LoPiccolo J, Blumenthal GM, Bernstein WB, Dennis PA (2008). Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updat  11, 32-50.   https://doi.org/10.1016/j.drup.2007.11.003|2. Memmott RM, Gills JJ, Hollingshead M, Powers MC, Chen Z, Kemp B, Kozikowski A, Dennis PA (2008). Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells. Cancer Res  68, 580-8.   https://doi.org/10.1158/0008-5472.CAN-07-3091",https://intramural.nih.gov/search/searchview.taf?ipid=51085
801,SC010353-09,"October 01, 2007 -  September 30, 2008",Experimental Therapeutics of Pediatric Hematopoietic Malignancies,Alan S Wayne; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",Vicki  Richmond|Kelly D Richards,NULL,"Crystal L. Mackall; MD (National Cancer Institute)|Michael R Bishop; MD (National Cancer Institute)|Nealapheur L Khan (National Cancer Institute)|Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)|Diane Carol Arthur; MD (National Cancer Institute)|Ira H Pastan; MD (National Cancer Institute)","Austin John Barrett; MD (NHLBI) |Charles  Bolan; BS, MS, MD (CC) |Roger  Kurlander; MD (CC) |Katayoun  Rezvani; MD, PhD (NHLBI) |Hanh M Khuu; MD (CC) |David F Stroncek; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51086
802,SC010354-09,"October 01, 2007 -  September 30, 2008",Clinical Development of Novel Drugs for Children with Refractory Cancers,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Aerang  Kim,NULL,"Antonio  Fojo; MD, PhD (National Cancer Institute)","Jeffrey M Solomon; BS, MS, PhD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51087
803,SC010355-09,"October 01, 2007 -  September 30, 2008",Angiogenesis and Tumor Growth,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Ombretta  Salvucci|Matina  Economopoulou|Masashi  Narazaki,NULL,Peter L Choyke; MD (National Cancer Institute)|Stefania  Pittaluga (National Cancer Institute)|Robert  Yarchoan; MD (National Cancer Institute)|David A Davis; MD (National Cancer Institute),Dragan  Maric; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51088
804,SC010356-09,"October 01, 2007 -  September 30, 2008",A Role for KSHV in the Pathogenesis of Malignancies,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Paola  Gasperini|Peter J Mccormick|Ombretta  Salvucci|Shuhei  Sakakibara; PhD,NULL,"Robert  Yarchoan; MD (National Cancer Institute)|Stefania  Pittaluga (National Cancer Institute)|Seth M Steinberg; PhD (National Cancer Institute)|Richard  Little; MD, PhD (National Cancer Institute)|David A Davis; MD (National Cancer Institute)|Wyndham H Wilson; MD, PhD (National Cancer Institute)",Dragan  Maric; PhD (NINDS) |Joshua  Farber; MD (NIAID),"1. Gasperini P, Sakakibara S, Tosato G (2008). Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis. J Leukoc Biol  84, 994-1000.   https://doi.org/10.1189/jlb.1107777",https://intramural.nih.gov/search/searchview.taf?ipid=51089
805,SC010357-09,"October 01, 2007 -  September 30, 2008",Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"Zhi Ming  Zheng; MD, PhD|IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI",Vladimir  Majerciak|Rong  Jia|Xiaohong  Wang|Jeong Gu  Kang,NULL,Robert  Yarchoan; MD (National Cancer Institute)|Michael John Kruhlak; PhD (National Cancer Institute)|Barbara K Felber (National Cancer Institute)|Xinhua  Ji; PhD (National Cancer Institute),John Philip McCoy (NHLBI),"1. Zheng Z   (2008) Kaposi's sarcoma-associated herpesvirus ORF57 in viral RNA processing.  Front Biosci, in press.|2. Zheng Z   (2008) Regulation of bovine papillomavirus type 1 gene expression by RNA processing.  Front Biosci, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=51090
806,SC010365-09,"October 01, 2007 -  September 30, 2008",Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI",Nancy M Hardy,Sergio  Giralt (M.D. ANDERSON CANCER CENTER)|Carl  June (University of Pennsylvania)|Larry  Kwak (NCI)|Sattva  Neelapu (M.D. ANDERSON CANCER CENTER),Daniel H Fowler (National Cancer Institute)|Ronald E Gress; MD (National Cancer Institute)|Crystal L. Mackall; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51091
807,SC010366-08,"October 01, 2007 -  September 30, 2008",Identification of Genes for Predicting Prognosis in Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jun S Wei|Xinyu  Wen|Xiang  Guo,NULL,Carol J Thiele (National Cancer Institute)|Timothy D Veenstra (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51092
808,SC010368-08,"October 01, 2007 -  September 30, 2008",Targeting the Tumor Vasculature to Treat Cancer,Steven  Libutti; MD,NULL,"Surgery Branch, NCI",Dominique  Lorang; PhD|Anita T Tandle|Geoffrey D Seidel|Mei  He|Mijung  Kwon|Charles K Heller|Show all 11,NULL,"Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)|William G Stetler-Stevenson; MD, PhD (National Cancer Institute)|Michael R Emmert-Buck; MD, PhD (National Cancer Institute)",NULL,"1. Blansfield JA, Caragacianu D, Alexander HR, Tangrea MA, Morita SY, Lorang D, Schafer P, Muller G, Stirling D, Royal RE, Libutti SK (2008). Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy. Clin Cancer Res  14, 270-80.   https://doi.org/10.1158/1078-0432.CCR-07-1562|2. Chung JY, Braunschweig T, Williams R, Guerrero N, Hoffmann KM, Kwon M, Song YK, Libutti SK, Hewitt SM (2008). Factors in tissue handling and processing that impact RNA obtained from formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem  56, 1033-42.   https://doi.org/10.1369/jhc.2008.951863|3. Lodish MB, Powell AC, Abu-Asab M, Cochran C, Lenz P, Libutti SK, Pingpank JF, Tsokos M, Gorden P (2008). Insulinoma and gastrinoma syndromes from a single intrapancreatic neuroendocrine tumor. J Clin Endocrinol Metab  93, 1123-8.   https://doi.org/10.1210/jc.2007-2449|4. Prasad NB, Somervell H, Tufano RP, Dackiw AP, Marohn MR, Califano JA, Wang Y, Westra WH, Clark DP, Umbricht CB, Libutti SK, Zeiger MA (2008). Identification of genes differentially expressed in benign versus malignant thyroid tumors. Clin Cancer Res  14, 3327-37.   https://doi.org/10.1158/1078-0432.CCR-07-4495|5. Shen HC, He M, Powell A, Adem A, Lorang D, Heller C, Grover AC, Ylaya K, Hewitt SM, Marx SJ, Spiegel AM, Libutti SK (2009). Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1. Cancer Res  69, 1858-66.   https://doi.org/10.1158/0008-5472.CAN-08-3662|6. Shen HC, Rosen JE, Yang LM, Savage SA, Burns AL, Mateo CM, Agarwal SK, Chandrasekharappa SC, Spiegel AM, Collins FS, Marx SJ, Libutti SK (2008). Parathyroid tumor development involves deregulation of homeobox genes. Endocr Relat Cancer  15, 267-75.   https://doi.org/10.1677/ERC-07-0191",https://intramural.nih.gov/search/searchview.taf?ipid=51094
809,SC010370-08,"October 01, 2007 -  September 30, 2008",Comparative Genomics of Genes Located on Chromosomes X and Y,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",Warren  Johnson|Carlos Antonio Driscoll; PhD|Jill  Slattery|Agostinho  Antunes; PhD|Polina  Perelman|Joan  Pontius|Show all 10,NULL,Robert H Stephens (National Cancer Institute),NULL,"1. O'Brien S, Troyer J, Roelke M, Pecon-Slattery J, Packer C, Winterbach C, Winterbach H, Hemson G, Frank L, Stander P, Siefert L, Driciru M, Funston P, Alexander K, Prager K, Mills G, Wildt D, Bush M, Johnson W   (2008) The Evolutionary History of Lion: Integrating Host/Pathogen Molecular Genetics.  PLOS Genetics, in press.|2. O'Brien S, Troyer J, Roelke M, Pecon-Slattery J, Packer C, Winterbach C, Winterbach H, Hemson G, Frank L, Stander P, Siefert L, Driciru M, Funston P, Alexander K, Prager K, Mills G, Wildt D, Bush M, O'Brien S, Johnson W (2008) The Evolutionary History of Lion: Integrating HostPathogen Molecular Genetics. PLOS Genetics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=51095
810,SC010372-08,"October 01, 2007 -  September 30, 2008",Molecular Profiling of Patients Undergoing Radiotherapy,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Mary T Sproull|Dane  Avondoglio|Melissa  Kirk; BS|Uma  Shankavaram; PhD,NULL,NULL,NULL,"1. Simone NL, Ménard C, Soule BP, Albert PS, Guion P, Smith S, Godette D, Crouse NS, Sciuto LC, Cooley-Zgela T, Camphausen K, Coleman CN, Singh AK (2008). Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score. Int J Radiat Oncol Biol Phys  70, 90-5.   https://doi.org/10.1016/j.ijrobp.2007.05.057",https://intramural.nih.gov/search/searchview.taf?ipid=51097
811,SC010373-08,"October 01, 2007 -  September 30, 2008",The Synergy Between Radiotherapy and Molecularly Targeted Agents,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Mary T Sproull|Tamalee  Scott|Pamela  Tulleners|Hyuk-Chan  Kwon|Uma  Shankavaram; PhD,NULL,"Howard A Fine; MD, PhD (National Cancer Institute)|Patricia  Steeg; PhD (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51098
812,SC010375-08,"October 01, 2007 -  September 30, 2008",TAF7: A Check-point Regulator in Transcription Initiation,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Anne G M Gegonne Bosselut|Jocelyn D Weissman|Jie  Mu,NULL,John N Brady; PhD (National Cancer Institute)|Kent W Hunter; PhD (National Cancer Institute)|Kenneth  Buetow; PhD (National Cancer Institute)|Maxwell P Lee; PhD (National Cancer Institute)|Susan  Mackem; MD (National Cancer Institute)|Alfred  Singer; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51099
813,SC010376-08,"October 01, 2007 -  September 30, 2008",Molecular Mechanism of TNF Signaling and Apoptosis,Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Swati Suresh Choksi|You Sun  Kim|Michael J Morgan|Elena  Pobezinskaya|Li  Chen|Tao  Li,NULL,Michael  Birrer (National Cancer Institute),Chuxia  Deng; PhD (NIDDK) |J Silvio  Gutkind; PhD (NIDCR),"1. Morgan MJ, Kim YS, Liu ZG (2008). TNFalpha and reactive oxygen species in necrotic cell death. Cell Res  18, 343-9.   https://doi.org/10.1038/cr.2008.31",https://intramural.nih.gov/search/searchview.taf?ipid=51100
814,SC010378-08,"October 01, 2007 -  September 30, 2008",Activation of Proto-Oncogenes by Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Christopher  Slape|David L Caudell|Yang-Jo  Chung|Chul Won  Choi|Sarah H Beachy; PhD|Sheryl Maxine Gough|Show all 7,"Adolfo  Ferrando (Genetics, Columbia U.)|Theresa  Hahn (Medicine, Roswell Park Cancer Institute)|Trang  Hoang (Immunology, U. Montreal)|Christoph  Plass (Genetics, Ohio State Univ.)|Armelle  Regnault (Hematology, Hopital St. Louis)|Linda  Resar (Johns Hopkins)",Lino  Tessarollo (National Cancer Institute)|Linda  Wolff; PhD (National Cancer Institute),"Paul P. Liu; MD, PhD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51101
815,SC010379-08,"October 01, 2007 -  September 30, 2008",Mechanisms of Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Zhenhua  Zhang|Yue  Cheng|David L Caudell,NULL,Andre A Nussenzweig; PhD (National Cancer Institute),NULL,"1. Aplan P (2008) Chromosomal rearrangements leading to MLL gene fusions: clinical and biological aspects. Cancer Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=51102
816,SC010384-08,"October 01, 2007 -  September 30, 2008",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI","Thomas R Bauer|Laura M Tuschong|Rima  Adler; BA, MPhil|Michael J Hunter; PhD|Everette Jr Nelson","Carlos  Barbas; PhD (DepartmentMolec Biol, Scripps Research Inst)|Alan W Flake; MD (Department of Surgery, Children's Hospital of Philadelphia)|David  Russell (Hematology, University of Washington)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51103
817,SC010385-09,"October 01, 2007 -  September 30, 2008",Molecular Classification of Human and Mouse Hepatocellular Carcinoma,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",Timothy V Benjamin|Elizabeth A Conner|Marian E Durkin|Tanya N Hoang|Joe W Grisham|Yun Han Lee|Show all 7,NULL,Valentina  Factor (Cellular and Molecular Biology Section)|Douglas  Lowy; MD (National Cancer Institute)|Nicolae C Popescu; PhD (National Cancer Institute)|Frank Jess Gonzalez; PhD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51104
818,SC010386-07,"October 01, 2007 -  September 30, 2008",Crystallographic studies of chemokine receptors and their ligands,Jacek Tadeusz Lubkowski,NULL,"Macromolecular Crystallography Laboratory, NCI",Cyril  Barinka,NULL,Joost J Oppenheim; MD (National Cancer Institute)|Douglas  Lowy; MD (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=51105
819,SC010437-08,"October 01, 2007 -  September 30, 2008",Molecular Pathology of Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Rodrigo F Chuaqui|Gallya  Gannot|Michael  Tangrea|Sumana  Mukherjee|Jaime  Rodriguez,NULL,"Steven  Libutti; MD (National Cancer Institute)|Maria  Merino; PhD (National Cancer Institute)|William D Figg; PharmD (National Cancer Institute)|William Marston Linehan; MD (National Cancer Institute)|Philip  Taylor; MD, ScD (National Cancer Institute)",NULL,"1. Shou JZ, Hu N, Takikita M, Roth MJ, Johnson LL, Giffen C, Wang QH, Wang C, Wang Y, Su H, Kong LH, Emmert-Buck MR, Goldstein AM, Hewitt SM, Taylor PR (2008). Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell carcinomas and premalignant lesions in subjects from a high-risk population in China. Cancer Epidemiol Biomarkers Prev  17, 1424-35.   https://doi.org/10.1158/1055-9965.EPI-06-0666",https://intramural.nih.gov/search/searchview.taf?ipid=51106
